covariate_id,covariate_name,covariate_analysis_id
3,age group: 00-04,3
1003,age group: 05-09,3
1007,index month: 1,7
1901,Charlson index - Romano adaptation,901
1902,Diabetes Comorbidity Severity Index (DCSI),902
1903,CHADS2,903
1904,CHADS2VASc,904
2007,index month: 2,7
3003,age group: 15-19,3
3007,index month: 3,7
4003,age group: 20-24,3
4007,index month: 4,7
5007,index month: 5,7
6007,index month: 6,7
8007,index month: 8,7
9007,index month: 9,7
10003,age group: 50-54,3
10007,index month: 10,7
11003,age group: 55-59,3
11007,index month: 11,7
12003,age group: 60-64,3
12007,index month: 12,7
13003,age group: 65-69,3
14003,age group: 70-74,3
15003,age group: 75-79,3
16003,age group: 80-84,3
17003,age group: 85-89,3
19003,age group: 95-99,3
2016006,index year: 2016,6
2017006,index year: 2017,6
2018006,index year: 2018,6
2019006,index year: 2019,6
2020006,index year: 2020,6
8507001,gender = MALE,1
8532001,gender = FEMALE,1
29735210,condition_era group during day -365 through 0 days relative to index: Candidiasis of mouth,210
29735212,condition_era group during day -30 through 0 days relative to index: Candidiasis of mouth,212
72266210,condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of pleura,210
72266212,condition_era group during day -30 through 0 days relative to index: Secondary malignant neoplasm of pleura,212
76349210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of urinary system,210
76349212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of urinary system,212
78097210,condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of bone,210
78097212,condition_era group during day -30 through 0 days relative to index: Secondary malignant neoplasm of bone,212
79768210,condition_era group during day -365 through 0 days relative to index: Neoplasm of urinary system,210
79768212,condition_era group during day -30 through 0 days relative to index: Neoplasm of urinary system,212
80665210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of thorax,210
80665212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of thorax,212
135526210,condition_era group during day -365 through 0 days relative to index: Spinal cord disease,210
135526212,condition_era group during day -30 through 0 days relative to index: Spinal cord disease,212
192359210,condition_era group during day -365 through 0 days relative to index: Renal failure syndrome,210
192359212,condition_era group during day -30 through 0 days relative to index: Renal failure syndrome,212
192438210,condition_era group during day -365 through 0 days relative to index: Abdominal mass,210
192438212,condition_era group during day -30 through 0 days relative to index: Abdominal mass,212
192671210,condition_era group during day -365 through 0 days relative to index: Gastrointestinal hemorrhage,210
192671212,condition_era group during day -30 through 0 days relative to index: Gastrointestinal hemorrhage,212
192836210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of small intestine,210
192836212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of small intestine,212
194087210,condition_era group during day -365 through 0 days relative to index: Hepatitis due to infection,210
194087212,condition_era group during day -30 through 0 days relative to index: Hepatitis due to infection,212
194589210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of biliary tract,210
194589212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of biliary tract,212
194990210,condition_era group during day -365 through 0 days relative to index: Inflammatory disease of liver,210
194990212,condition_era group during day -30 through 0 days relative to index: Inflammatory disease of liver,212
195002210,condition_era group during day -365 through 0 days relative to index: Ulceration of intestine,210
195002212,condition_era group during day -30 through 0 days relative to index: Ulceration of intestine,212
195306210,condition_era group during day -365 through 0 days relative to index: Gastroduodenitis,210
195482210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of intestinal tract,210
195482212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of intestinal tract,212
196068210,condition_era group during day -365 through 0 days relative to index: Carcinoma in situ of male genital organ,210
196360210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of bladder,210
196360212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of bladder,212
196931210,condition_era group during day -365 through 0 days relative to index: Neoplasm of digestive tract,210
196931212,condition_era group during day -30 through 0 days relative to index: Neoplasm of digestive tract,212
197024210,condition_era group during day -365 through 0 days relative to index: Small intestinal hemorrhage,210
197024212,condition_era group during day -30 through 0 days relative to index: Small intestinal hemorrhage,212
197032210,condition_era group during day -365 through 0 days relative to index: Hyperplasia of prostate,210
197032212,condition_era group during day -30 through 0 days relative to index: Hyperplasia of prostate,212
197320210,condition_era group during day -365 through 0 days relative to index: Acute renal failure syndrome,210
197320212,condition_era group during day -30 through 0 days relative to index: Acute renal failure syndrome,212
197500210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of colon,210
197500212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of colon,212
197506210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of abdomen,210
197506212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of abdomen,212
197507210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of male genital organ,210
197507212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of male genital organ,212
197508210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of urinary bladder,210
197508212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of urinary bladder,212
197804210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of intra-abdominal organs,210
197804212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of intra-abdominal organs,212
198091210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of retroperitoneum,210
198091212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of retroperitoneum,212
198124210,condition_era group during day -365 through 0 days relative to index: Kidney disease,210
198124212,condition_era group during day -30 through 0 days relative to index: Kidney disease,212
198700210,condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of liver,210
198700212,condition_era group during day -30 through 0 days relative to index: Secondary malignant neoplasm of liver,212
198988210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of pelvis,210
198988212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of pelvis,212
199754210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of pancreas,210
199754212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of pancreas,212
200680210,condition_era group during day -365 through 0 days relative to index: Neoplasm of bladder,210
200680212,condition_era group during day -30 through 0 days relative to index: Neoplasm of bladder,212
200962210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of prostate,210
200962212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of prostate,212
200970210,condition_era group during day -365 through 0 days relative to index: Carcinoma in situ of prostate,210
201131210,condition_era group during day -365 through 0 days relative to index: Pelvic mass,210
201131212,condition_era group during day -30 through 0 days relative to index: Pelvic mass,212
201340210,condition_era group during day -365 through 0 days relative to index: Gastritis,210
201519210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of liver,210
201519212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of liver,212
201773210,condition_era group during day -365 through 0 days relative to index: Enteritis of small intestine,210
201820210,condition_era group during day -365 through 0 days relative to index: Diabetes mellitus,210
201820212,condition_era group during day -30 through 0 days relative to index: Diabetes mellitus,212
252280210,condition_era group during day -365 through 0 days relative to index: Neoplasm of respiratory tract,210
252280212,condition_era group during day -30 through 0 days relative to index: Neoplasm of respiratory tract,212
252662210,condition_era group during day -365 through 0 days relative to index: Tracheobronchial disorder,210
252662212,condition_era group during day -30 through 0 days relative to index: Tracheobronchial disorder,212
253506210,condition_era group during day -365 through 0 days relative to index: Pneumonitis,210
253506212,condition_era group during day -30 through 0 days relative to index: Pneumonitis,212
253717210,condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of respiratory tract,210
253717212,condition_era group during day -30 through 0 days relative to index: Secondary malignant neoplasm of respiratory tract,212
254061210,condition_era group during day -365 through 0 days relative to index: Pleural effusion,210
254061212,condition_era group during day -30 through 0 days relative to index: Pleural effusion,212
254591210,condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of lung,210
254591212,condition_era group during day -30 through 0 days relative to index: Secondary malignant neoplasm of lung,212
255573210,condition_era group during day -365 through 0 days relative to index: Chronic obstructive lung disease,210
255573212,condition_era group during day -30 through 0 days relative to index: Chronic obstructive lung disease,212
255848210,condition_era group during day -365 through 0 days relative to index: Pneumonia,210
255848212,condition_era group during day -30 through 0 days relative to index: Pneumonia,212
256451210,condition_era group during day -365 through 0 days relative to index: Bronchitis,210
256451212,condition_era group during day -30 through 0 days relative to index: Bronchitis,212
256722210,condition_era group during day -365 through 0 days relative to index: Bronchopneumonia,210
256722212,condition_era group during day -30 through 0 days relative to index: Bronchopneumonia,212
257004210,condition_era group during day -365 through 0 days relative to index: Acute exacerbation of chronic obstructive airways disease,210
257004212,condition_era group during day -30 through 0 days relative to index: Acute exacerbation of chronic obstructive airways disease,212
258369210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of lung,210
258369212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of lung,212
261236210,"condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of upper lobe, bronchus or lung",210
261236212,"condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of upper lobe, bronchus or lung",212
312437210,condition_era group during day -365 through 0 days relative to index: Dyspnea,210
312437212,condition_era group during day -30 through 0 days relative to index: Dyspnea,212
315643210,condition_era group during day -365 through 0 days relative to index: Tachyarrhythmia,210
315643212,condition_era group during day -30 through 0 days relative to index: Tachyarrhythmia,212
317002210,condition_era group during day -365 through 0 days relative to index: Low blood pressure,210
317009210,condition_era group during day -365 through 0 days relative to index: Asthma,210
317009212,condition_era group during day -30 through 0 days relative to index: Asthma,212
318096210,condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of lymph node,210
318096212,condition_era group during day -30 through 0 days relative to index: Secondary malignant neoplasm of lymph node,212
318459210,condition_era group during day -365 through 0 days relative to index: Respiratory insufficiency,210
318459212,condition_era group during day -30 through 0 days relative to index: Respiratory insufficiency,212
319049210,condition_era group during day -365 through 0 days relative to index: Acute respiratory failure,210
319049212,condition_era group during day -30 through 0 days relative to index: Acute respiratory failure,212
321588210,condition_era group during day -365 through 0 days relative to index: Heart disease,210
321588212,condition_era group during day -30 through 0 days relative to index: Heart disease,212
372604210,condition_era group during day -365 through 0 days relative to index: Movement disorder,210
373087210,condition_era group during day -365 through 0 days relative to index: Central nervous system complication,210
373087212,condition_era group during day -30 through 0 days relative to index: Central nervous system complication,212
373425210,condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of nervous system,210
373425212,condition_era group during day -30 through 0 days relative to index: Secondary malignant neoplasm of nervous system,212
373724210,condition_era group during day -365 through 0 days relative to index: Neoplasm of brain,210
373724212,condition_era group during day -30 through 0 days relative to index: Neoplasm of brain,212
373747210,condition_era group during day -365 through 0 days relative to index: Extrapyramidal disease,210
374009210,condition_era group during day -365 through 0 days relative to index: Organic mental disorder,210
374009212,condition_era group during day -30 through 0 days relative to index: Organic mental disorder,212
374888210,condition_era group during day -365 through 0 days relative to index: Dementia associated with another disease,210
374888212,condition_era group during day -30 through 0 days relative to index: Dementia associated with another disease,212
377091210,condition_era group during day -365 through 0 days relative to index: Seizure,210
377091212,condition_era group during day -30 through 0 days relative to index: Seizure,212
378253210,condition_era group during day -365 through 0 days relative to index: Headache,210
378253212,condition_era group during day -30 through 0 days relative to index: Headache,212
380378210,condition_era group during day -365 through 0 days relative to index: Epilepsy,210
380378212,condition_era group during day -30 through 0 days relative to index: Epilepsy,212
381270210,condition_era group during day -365 through 0 days relative to index: Parkinson's disease,210
381591210,condition_era group during day -365 through 0 days relative to index: Cerebrovascular disease,210
381591212,condition_era group during day -30 through 0 days relative to index: Cerebrovascular disease,212
432851210,condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplastic disease,210
432851212,condition_era group during day -30 through 0 days relative to index: Secondary malignant neoplastic disease,212
433423210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of pancreatic duct,210
433423212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of pancreatic duct,212
433435210,condition_era group during day -365 through 0 days relative to index: Carcinoma in situ,210
433516210,condition_era group during day -365 through 0 days relative to index: Duodenitis,210
433701210,condition_era group during day -365 through 0 days relative to index: Mycosis,210
433701212,condition_era group during day -30 through 0 days relative to index: Mycosis,212
433930802,observation during day -365 through 0 days relative to index: Motor vehicle on road in collision with another motor vehicle,802
433968210,condition_era group during day -365 through 0 days relative to index: Candidiasis,210
433968212,condition_era group during day -30 through 0 days relative to index: Candidiasis,212
434610210,condition_era group during day -365 through 0 days relative to index: Hyperkalemia,210
434610212,condition_era group during day -30 through 0 days relative to index: Hyperkalemia,212
435515210,condition_era group during day -365 through 0 days relative to index: Hypo-osmolality and or hyponatremia,210
435515212,condition_era group during day -30 through 0 days relative to index: Hypo-osmolality and or hyponatremia,212
435752210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of duodenum,210
435752212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of duodenum,212
435754210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of ascending colon,210
435754212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of ascending colon,212
435796210,condition_era group during day -365 through 0 days relative to index: Dehydration,210
435796212,condition_era group during day -30 through 0 days relative to index: Dehydration,212
437312210,condition_era group during day -365 through 0 days relative to index: Bleeding,210
437312212,condition_era group during day -30 through 0 days relative to index: Bleeding,212
437409210,condition_era group during day -365 through 0 days relative to index: Intracranial injury,210
437409212,condition_era group during day -30 through 0 days relative to index: Intracranial injury,212
437663210,condition_era group during day -365 through 0 days relative to index: Fever,210
437663212,condition_era group during day -30 through 0 days relative to index: Fever,212
437677210,condition_era group during day -365 through 0 days relative to index: Abnormal findings on diagnostic imaging of lung,210
437677212,condition_era group during day -30 through 0 days relative to index: Abnormal findings on diagnostic imaging of lung,212
438112210,condition_era group during day -365 through 0 days relative to index: Neoplastic disease,210
438112212,condition_era group during day -30 through 0 days relative to index: Neoplastic disease,212
439040210,condition_era group during day -365 through 0 days relative to index: Subdural hemorrhage,210
439040212,condition_era group during day -30 through 0 days relative to index: Subdural hemorrhage,212
439392210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm,210
439392212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm,212
439674210,condition_era group during day -365 through 0 days relative to index: Chronic viral hepatitis B without delta-agent,210
439674212,condition_era group during day -30 through 0 days relative to index: Chronic viral hepatitis B without delta-agent,212
439676210,condition_era group during day -365 through 0 days relative to index: Coronavirus infection,210
439676212,condition_era group during day -30 through 0 days relative to index: Coronavirus infection,212
439751210,condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of intrathoracic lymph nodes,210
439751212,condition_era group during day -30 through 0 days relative to index: Secondary malignant neoplasm of intrathoracic lymph nodes,212
439847210,condition_era group during day -365 through 0 days relative to index: Intracranial hemorrhage,210
439847212,condition_era group during day -30 through 0 days relative to index: Intracranial hemorrhage,212
440029210,condition_era group during day -365 through 0 days relative to index: Viral disease,210
440029212,condition_era group during day -30 through 0 days relative to index: Viral disease,212
440921210,condition_era group during day -365 through 0 days relative to index: Traumatic injury,210
440921212,condition_era group during day -30 through 0 days relative to index: Traumatic injury,212
441225210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of ampulla of Vater,210
441225212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of ampulla of Vater,212
441749802,observation during day -365 through 0 days relative to index: Fall on or from stairs or steps,802
441749804,observation during day -30 through 0 days relative to index: Fall on or from stairs or steps,804
441969210,condition_era group during day -365 through 0 days relative to index: Radiology result abnormal,210
441969212,condition_era group during day -30 through 0 days relative to index: Radiology result abnormal,212
443258210,condition_era group during day -365 through 0 days relative to index: Mass in head or neck,210
443258212,condition_era group during day -30 through 0 days relative to index: Mass in head or neck,212
443386210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of duodenum,210
443386212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of duodenum,212
443388210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of lung,210
443388212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of lung,212
443392210,condition_era group during day -365 through 0 days relative to index: Malignant neoplastic disease,210
443392212,condition_era group during day -30 through 0 days relative to index: Malignant neoplastic disease,212
443396210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of large intestine,210
443396212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of large intestine,212
443397210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of small intestine,210
443397212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of small intestine,212
443398210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of intestine,210
443398212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of intestine,212
443564210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of bone,210
443564212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of bone,212
443568210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of gastrointestinal tract,210
443568212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of gastrointestinal tract,212
443588210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of brain,210
443588212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of brain,212
443605210,condition_era group during day -365 through 0 days relative to index: Vascular dementia,210
443605212,condition_era group during day -30 through 0 days relative to index: Vascular dementia,212
443611210,condition_era group during day -365 through 0 days relative to index: Chronic kidney disease stage 5,210
443611212,condition_era group during day -30 through 0 days relative to index: Chronic kidney disease stage 5,212
443612210,condition_era group during day -365 through 0 days relative to index: Chronic kidney disease stage 4,210
443612212,condition_era group during day -30 through 0 days relative to index: Chronic kidney disease stage 4,212
444200210,condition_era group during day -365 through 0 days relative to index: Neoplasm of nervous system,210
444200212,condition_era group during day -30 through 0 days relative to index: Neoplasm of nervous system,212
444204210,condition_era group during day -365 through 0 days relative to index: Neoplasm of bone,210
444204212,condition_era group during day -30 through 0 days relative to index: Neoplasm of bone,212
706163702,measurement during day -365 through 0 days relative to index: SARS coronavirus 2 RNA [Presence] in Respiratory specimen by NAA with probe detection,702
706163704,measurement during day -30 through 0 days relative to index: SARS coronavirus 2 RNA [Presence] in Respiratory specimen by NAA with probe detection,704
708298410,drug_era group during day -365 through 0 days relative to index: Midazolam,410
708298412,drug_era group during day -30 through 0 days relative to index: Midazolam,412
710062410,drug_era group during day -365 through 0 days relative to index: Amitriptyline,410
711584410,drug_era group during day -365 through 0 days relative to index: Levetiracetam,410
711584412,drug_era group during day -30 through 0 days relative to index: Levetiracetam,412
711584413,drug_era group during day 0 through 0 days relative to index: Levetiracetam,413
713192410,drug_era group during day -365 through 0 days relative to index: fosphenytoin,410
715233410,drug_era group during day -365 through 0 days relative to index: Baclofen,410
715233412,drug_era group during day -30 through 0 days relative to index: Baclofen,412
715259410,drug_era group during day -365 through 0 days relative to index: duloxetine,410
715259412,drug_era group during day -30 through 0 days relative to index: duloxetine,412
715259413,drug_era group during day 0 through 0 days relative to index: duloxetine,413
715939410,drug_era group during day -365 through 0 days relative to index: Escitalopram,410
715939412,drug_era group during day -30 through 0 days relative to index: Escitalopram,412
715939413,drug_era group during day 0 through 0 days relative to index: Escitalopram,413
715997410,drug_era group during day -365 through 0 days relative to index: donepezil,410
715997412,drug_era group during day -30 through 0 days relative to index: donepezil,412
715997413,drug_era group during day 0 through 0 days relative to index: donepezil,413
718122410,drug_era group during day -365 through 0 days relative to index: oxcarbazepine,410
720810410,drug_era group during day -365 through 0 days relative to index: Pramipexole,410
720810412,drug_era group during day -30 through 0 days relative to index: Pramipexole,412
720810413,drug_era group during day 0 through 0 days relative to index: Pramipexole,413
723013410,drug_era group during day -365 through 0 days relative to index: Diazepam,410
723013412,drug_era group during day -30 through 0 days relative to index: Diazepam,412
723013413,drug_era group during day 0 through 0 days relative to index: Diazepam,413
732893410,drug_era group during day -365 through 0 days relative to index: Bupivacaine,410
734275410,drug_era group during day -365 through 0 days relative to index: Phenobarbital,410
734275412,drug_era group during day -30 through 0 days relative to index: Phenobarbital,412
734275413,drug_era group during day 0 through 0 days relative to index: Phenobarbital,413
734354410,drug_era group during day -365 through 0 days relative to index: pregabalin,410
734354412,drug_era group during day -30 through 0 days relative to index: pregabalin,412
734354413,drug_era group during day 0 through 0 days relative to index: pregabalin,413
735979410,drug_era group during day -365 through 0 days relative to index: Risperidone,410
742267410,drug_era group during day -365 through 0 days relative to index: topiramate,410
742267412,drug_era group during day -30 through 0 days relative to index: topiramate,412
742267413,drug_era group during day 0 through 0 days relative to index: topiramate,413
744740410,drug_era group during day -365 through 0 days relative to index: zolpidem,410
744740412,drug_era group during day -30 through 0 days relative to index: zolpidem,412
744740413,drug_era group during day 0 through 0 days relative to index: zolpidem,413
744798410,drug_era group during day -365 through 0 days relative to index: zonisamide,410
744798412,drug_era group during day -30 through 0 days relative to index: zonisamide,412
745466410,drug_era group during day -365 through 0 days relative to index: Valproate,410
745466412,drug_era group during day -30 through 0 days relative to index: Valproate,412
753626410,drug_era group during day -365 through 0 days relative to index: Propofol,410
753626412,drug_era group during day -30 through 0 days relative to index: Propofol,412
759740410,drug_era group during day -365 through 0 days relative to index: Pyridostigmine,410
762795502,procedure_occurrence during day -365 through 0 days relative to index: Percutaneous electrical nerve stimulation,502
762950502,procedure_occurrence during day -365 through 0 days relative to index: Three dimensional conformal radiotherapy,502
762950504,procedure_occurrence during day -30 through 0 days relative to index: Three dimensional conformal radiotherapy,504
764800210,condition_era group during day -365 through 0 days relative to index: Mass of pleura,210
764800212,condition_era group during day -30 through 0 days relative to index: Mass of pleura,212
766529410,drug_era group during day -365 through 0 days relative to index: Haloperidol,410
766529412,drug_era group during day -30 through 0 days relative to index: Haloperidol,412
766529413,drug_era group during day 0 through 0 days relative to index: Haloperidol,413
766814410,drug_era group during day -365 through 0 days relative to index: quetiapine,410
777221410,drug_era group during day -365 through 0 days relative to index: Hydroxyzine,410
777221412,drug_era group during day -30 through 0 days relative to index: Hydroxyzine,412
781039410,drug_era group during day -365 through 0 days relative to index: Alprazolam,410
781039412,drug_era group during day -30 through 0 days relative to index: Alprazolam,412
781039413,drug_era group during day 0 through 0 days relative to index: Alprazolam,413
785649410,drug_era group during day -365 through 0 days relative to index: Ketamine,410
787787410,drug_era group during day -365 through 0 days relative to index: hyaluronate,410
789578410,drug_era group during day -365 through 0 days relative to index: Levodopa,410
789578412,drug_era group during day -30 through 0 days relative to index: Levodopa,412
789578413,drug_era group during day 0 through 0 days relative to index: Levodopa,413
791967410,drug_era group during day -365 through 0 days relative to index: Lorazepam,410
791967412,drug_era group during day -30 through 0 days relative to index: Lorazepam,412
794852410,drug_era group during day -365 through 0 days relative to index: Chlorpromazine,410
794852412,drug_era group during day -30 through 0 days relative to index: Chlorpromazine,412
794852413,drug_era group during day 0 through 0 days relative to index: Chlorpromazine,413
797399410,drug_era group during day -365 through 0 days relative to index: gabapentin,410
797399412,drug_era group during day -30 through 0 days relative to index: gabapentin,412
797399413,drug_era group during day 0 through 0 days relative to index: gabapentin,413
798874410,drug_era group during day -365 through 0 days relative to index: Clonazepam,410
901318410,drug_era group during day -365 through 0 days relative to index: Sodium Ascorbate,410
901318412,drug_era group during day -30 through 0 days relative to index: Sodium Ascorbate,412
903963410,drug_era group during day -365 through 0 days relative to index: Triamcinolone,410
904453410,drug_era group during day -365 through 0 days relative to index: Esomeprazole,410
904453412,drug_era group during day -30 through 0 days relative to index: Esomeprazole,412
904453413,drug_era group during day 0 through 0 days relative to index: Esomeprazole,413
905233410,drug_era group during day -365 through 0 days relative to index: Mometasone,410
905233412,drug_era group during day -30 through 0 days relative to index: Mometasone,412
906780410,drug_era group during day -365 through 0 days relative to index: Metoclopramide,410
906780412,drug_era group during day -30 through 0 days relative to index: Metoclopramide,412
906780413,drug_era group during day 0 through 0 days relative to index: Metoclopramide,413
911354410,drug_era group during day -365 through 0 days relative to index: palonosetron,410
911354412,drug_era group during day -30 through 0 days relative to index: palonosetron,412
911486410,drug_era group during day -365 through 0 days relative to index: Glutamate,410
911486412,drug_era group during day -30 through 0 days relative to index: Glutamate,412
912362410,drug_era group during day -365 through 0 days relative to index: Ammonium Chloride,410
912362412,drug_era group during day -30 through 0 days relative to index: Ammonium Chloride,412
912362413,drug_era group during day 0 through 0 days relative to index: Ammonium Chloride,413
914335410,drug_era group during day -365 through 0 days relative to index: Atropine,410
914335412,drug_era group during day -30 through 0 days relative to index: Atropine,412
916005410,drug_era group during day -365 through 0 days relative to index: Solifenacin,410
916005412,drug_era group during day -30 through 0 days relative to index: Solifenacin,412
916005413,drug_era group during day 0 through 0 days relative to index: Solifenacin,413
917205410,drug_era group during day -365 through 0 days relative to index: Desonide,410
917205412,drug_era group during day -30 through 0 days relative to index: Desonide,412
923081410,drug_era group during day -365 through 0 days relative to index: Ofloxacin,410
923081412,drug_era group during day -30 through 0 days relative to index: Ofloxacin,412
924566410,drug_era group during day -365 through 0 days relative to index: tamsulosin,410
924566412,drug_era group during day -30 through 0 days relative to index: tamsulosin,412
924566413,drug_era group during day 0 through 0 days relative to index: tamsulosin,413
925952410,drug_era group during day -365 through 0 days relative to index: Oxytetracycline,410
926487410,drug_era group during day -365 through 0 days relative to index: Pancreatin,410
926487412,drug_era group during day -30 through 0 days relative to index: Pancreatin,412
928744410,drug_era group during day -365 through 0 days relative to index: Dimenhydrinate,410
929887410,drug_era group during day -365 through 0 days relative to index: lansoprazole,410
929887412,drug_era group during day -30 through 0 days relative to index: lansoprazole,412
929887413,drug_era group during day 0 through 0 days relative to index: lansoprazole,413
930021410,drug_era group during day -365 through 0 days relative to index: alfuzosin,410
937439410,drug_era group during day -365 through 0 days relative to index: Bethanechol,410
937439412,drug_era group during day -30 through 0 days relative to index: Bethanechol,412
937439413,drug_era group during day 0 through 0 days relative to index: Bethanechol,413
939134410,drug_era group during day -365 through 0 days relative to index: sertaconazole,410
939259410,drug_era group during day -365 through 0 days relative to index: Budesonide,410
939259412,drug_era group during day -30 through 0 days relative to index: Budesonide,412
939259413,drug_era group during day 0 through 0 days relative to index: Budesonide,413
939506410,drug_era group during day -365 through 0 days relative to index: Sodium Bicarbonate,410
939506412,drug_era group during day -30 through 0 days relative to index: Sodium Bicarbonate,412
939506413,drug_era group during day 0 through 0 days relative to index: Sodium Bicarbonate,413
940426410,drug_era group during day -365 through 0 days relative to index: calcium polycarbophil,410
940426412,drug_era group during day -30 through 0 days relative to index: calcium polycarbophil,412
940426413,drug_era group during day 0 through 0 days relative to index: calcium polycarbophil,413
942350410,drug_era group during day -365 through 0 days relative to index: torsemide,410
942350412,drug_era group during day -30 through 0 days relative to index: torsemide,412
942350413,drug_era group during day 0 through 0 days relative to index: torsemide,413
948078410,drug_era group during day -365 through 0 days relative to index: pantoprazole,410
948078412,drug_era group during day -30 through 0 days relative to index: pantoprazole,412
948078413,drug_era group during day 0 through 0 days relative to index: pantoprazole,413
948582410,drug_era group during day -365 through 0 days relative to index: Polymyxin B,410
950696410,drug_era group during day -365 through 0 days relative to index: Nizatidine,410
951511410,drug_era group during day -365 through 0 days relative to index: Mupirocin,410
951511412,drug_era group during day -30 through 0 days relative to index: Mupirocin,412
953076410,drug_era group during day -365 through 0 days relative to index: Famotidine,410
953076412,drug_era group during day -30 through 0 days relative to index: Famotidine,412
953076413,drug_era group during day 0 through 0 days relative to index: Famotidine,413
955632410,drug_era group during day -365 through 0 days relative to index: Fluorouracil,410
955632412,drug_era group during day -30 through 0 days relative to index: Fluorouracil,412
955632413,drug_era group during day 0 through 0 days relative to index: Fluorouracil,413
956653410,drug_era group during day -365 through 0 days relative to index: Fosfomycin,410
956653412,drug_era group during day -30 through 0 days relative to index: Fosfomycin,412
956874410,drug_era group during day -365 through 0 days relative to index: Furosemide,410
956874412,drug_era group during day -30 through 0 days relative to index: Furosemide,412
956874413,drug_era group during day 0 through 0 days relative to index: Furosemide,413
961047410,drug_era group during day -365 through 0 days relative to index: Ranitidine,410
961047412,drug_era group during day -30 through 0 days relative to index: Ranitidine,412
961047413,drug_era group during day 0 through 0 days relative to index: Ranitidine,413
961145410,drug_era group during day -365 through 0 days relative to index: Glycerin,410
961145412,drug_era group during day -30 through 0 days relative to index: Glycerin,412
967823410,drug_era group during day -365 through 0 days relative to index: Sodium Chloride,410
967823412,drug_era group during day -30 through 0 days relative to index: Sodium Chloride,412
967823413,drug_era group during day 0 through 0 days relative to index: Sodium Chloride,413
970250410,drug_era group during day -365 through 0 days relative to index: Spironolactone,410
974166410,drug_era group during day -365 through 0 days relative to index: Hydrochlorothiazide,410
974166412,drug_era group during day -30 through 0 days relative to index: Hydrochlorothiazide,412
974166413,drug_era group during day 0 through 0 days relative to index: Hydrochlorothiazide,413
975125410,drug_era group during day -365 through 0 days relative to index: Hydrocortisone,410
975125412,drug_era group during day -30 through 0 days relative to index: Hydrocortisone,412
975125413,drug_era group during day 0 through 0 days relative to index: Hydrocortisone,413
976545410,drug_era group during day -365 through 0 days relative to index: potassium citrate,410
976545412,drug_era group during day -30 through 0 days relative to index: potassium citrate,412
977968410,drug_era group during day -365 through 0 days relative to index: sodium citrate,410
977968412,drug_era group during day -30 through 0 days relative to index: sodium citrate,412
986517410,drug_era group during day -365 through 0 days relative to index: Cellulose,410
986517412,drug_era group during day -30 through 0 days relative to index: Cellulose,412
987153410,drug_era group during day -365 through 0 days relative to index: Lactobacillus acidophilus,410
987153412,drug_era group during day -30 through 0 days relative to index: Lactobacillus acidophilus,412
987245410,drug_era group during day -365 through 0 days relative to index: Lactulose,410
987245412,drug_era group during day -30 through 0 days relative to index: Lactulose,412
987245413,drug_era group during day 0 through 0 days relative to index: Lactulose,413
988095410,drug_era group during day -365 through 0 days relative to index: Ursodeoxycholate,410
988095412,drug_era group during day -30 through 0 days relative to index: Ursodeoxycholate,412
988294410,drug_era group during day -365 through 0 days relative to index: dexpanthenol,410
988294412,drug_era group during day -30 through 0 days relative to index: dexpanthenol,412
988294413,drug_era group during day 0 through 0 days relative to index: dexpanthenol,413
989878410,drug_era group during day -365 through 0 days relative to index: Lidocaine,410
989878412,drug_era group during day -30 through 0 days relative to index: Lidocaine,412
989878413,drug_era group during day 0 through 0 days relative to index: Lidocaine,413
990499410,"drug_era group during day -365 through 0 days relative to index: Sodium Phosphate, Monobasic",410
990499412,"drug_era group during day -30 through 0 days relative to index: Sodium Phosphate, Monobasic",412
991710410,"drug_era group during day -365 through 0 days relative to index: Sodium Phosphate, Dibasic",410
991710412,"drug_era group during day -30 through 0 days relative to index: Sodium Phosphate, Dibasic",412
991855410,drug_era group during day -365 through 0 days relative to index: Saccharomyces boulardii,410
991876410,drug_era group during day -365 through 0 days relative to index: Loperamide,410
991876412,drug_era group during day -30 through 0 days relative to index: Loperamide,412
993631410,drug_era group during day -365 through 0 days relative to index: Magnesium Oxide,410
993631412,drug_era group during day -30 through 0 days relative to index: Magnesium Oxide,412
993631413,drug_era group during day 0 through 0 days relative to index: Magnesium Oxide,413
996416410,drug_era group during day -365 through 0 days relative to index: Finasteride,410
996416412,drug_era group during day -30 through 0 days relative to index: Finasteride,412
996416413,drug_era group during day 0 through 0 days relative to index: Finasteride,413
997276410,drug_era group during day -365 through 0 days relative to index: Cimetidine,410
997276412,drug_era group during day -30 through 0 days relative to index: Cimetidine,412
997276413,drug_era group during day 0 through 0 days relative to index: Cimetidine,413
998415410,drug_era group during day -365 through 0 days relative to index: Clobetasol,410
1000772410,drug_era group during day -365 through 0 days relative to index: Granisetron,410
1000772412,drug_era group during day -30 through 0 days relative to index: Granisetron,412
1000772413,drug_era group during day 0 through 0 days relative to index: Granisetron,413
1036228410,drug_era group during day -365 through 0 days relative to index: Sucralfate,410
1036228412,drug_era group during day -30 through 0 days relative to index: Sucralfate,412
1036228413,drug_era group during day 0 through 0 days relative to index: Sucralfate,413
1102527410,drug_era group during day -365 through 0 days relative to index: Meperidine,410
1102527412,drug_era group during day -30 through 0 days relative to index: Meperidine,412
1102527413,drug_era group during day 0 through 0 days relative to index: Meperidine,413
1103314410,drug_era group during day -365 through 0 days relative to index: Tramadol,410
1103314412,drug_era group during day -30 through 0 days relative to index: Tramadol,412
1103314413,drug_era group during day 0 through 0 days relative to index: Tramadol,413
1105889410,drug_era group during day -365 through 0 days relative to index: Triprolidine,410
1105889412,drug_era group during day -30 through 0 days relative to index: Triprolidine,412
1106776410,drug_era group during day -365 through 0 days relative to index: tiotropium,410
1106776412,drug_era group during day -30 through 0 days relative to index: tiotropium,412
1110410410,drug_era group during day -365 through 0 days relative to index: Morphine,410
1110410412,drug_era group during day -30 through 0 days relative to index: Morphine,412
1112807410,drug_era group during day -365 through 0 days relative to index: Aspirin,410
1112807412,drug_era group during day -30 through 0 days relative to index: Aspirin,412
1112807413,drug_era group during day 0 through 0 days relative to index: Aspirin,413
1114220410,drug_era group during day -365 through 0 days relative to index: Naloxone,410
1114220412,drug_era group during day -30 through 0 days relative to index: Naloxone,412
1114220413,drug_era group during day 0 through 0 days relative to index: Naloxone,413
1124957410,drug_era group during day -365 through 0 days relative to index: Oxycodone,410
1124957412,drug_era group during day -30 through 0 days relative to index: Oxycodone,412
1124957413,drug_era group during day 0 through 0 days relative to index: Oxycodone,413
1125315410,drug_era group during day -365 through 0 days relative to index: Acetaminophen,410
1125315412,drug_era group during day -30 through 0 days relative to index: Acetaminophen,412
1125315413,drug_era group during day 0 through 0 days relative to index: Acetaminophen,413
1126658410,drug_era group during day -365 through 0 days relative to index: Hydromorphone,410
1126658412,drug_era group during day -30 through 0 days relative to index: Hydromorphone,412
1126658413,drug_era group during day 0 through 0 days relative to index: Hydromorphone,413
1133201410,drug_era group during day -365 through 0 days relative to index: Buprenorphine,410
1135766410,drug_era group during day -365 through 0 days relative to index: Phenylephrine,410
1135766412,drug_era group during day -30 through 0 days relative to index: Phenylephrine,412
1135766413,drug_era group during day 0 through 0 days relative to index: Phenylephrine,413
1136422410,drug_era group during day -365 through 0 days relative to index: levocetirizine,410
1136422412,drug_era group during day -30 through 0 days relative to index: levocetirizine,412
1136422413,drug_era group during day 0 through 0 days relative to index: levocetirizine,413
1136980410,drug_era group during day -365 through 0 days relative to index: Ketorolac,410
1136980412,drug_era group during day -30 through 0 days relative to index: Ketorolac,412
1136980413,drug_era group during day 0 through 0 days relative to index: Ketorolac,413
1137529410,drug_era group during day -365 through 0 days relative to index: salmeterol,410
1137529412,drug_era group during day -30 through 0 days relative to index: salmeterol,412
1137529413,drug_era group during day 0 through 0 days relative to index: salmeterol,413
1139042410,drug_era group during day -365 through 0 days relative to index: Acetylcysteine,410
1139042412,drug_era group during day -30 through 0 days relative to index: Acetylcysteine,412
1139042413,drug_era group during day 0 through 0 days relative to index: Acetylcysteine,413
1143374410,drug_era group during day -365 through 0 days relative to index: Ephedrine,410
1143374412,drug_era group during day -30 through 0 days relative to index: Ephedrine,412
1146810410,drug_era group during day -365 through 0 days relative to index: Piroxicam,410
1149380410,drug_era group during day -365 through 0 days relative to index: fluticasone,410
1149380412,drug_era group during day -30 through 0 days relative to index: fluticasone,412
1149380413,drug_era group during day 0 through 0 days relative to index: fluticasone,413
1153428410,drug_era group during day -365 through 0 days relative to index: fexofenadine,410
1153428412,drug_era group during day -30 through 0 days relative to index: fexofenadine,412
1153428413,drug_era group during day 0 through 0 days relative to index: fexofenadine,413
1154029410,drug_era group during day -365 through 0 days relative to index: Fentanyl,410
1154029412,drug_era group during day -30 through 0 days relative to index: Fentanyl,412
1154029413,drug_era group during day 0 through 0 days relative to index: Fentanyl,413
1154332410,drug_era group during day -365 through 0 days relative to index: Pseudoephedrine,410
1154332412,drug_era group during day -30 through 0 days relative to index: Pseudoephedrine,412
1154332413,drug_era group during day 0 through 0 days relative to index: Pseudoephedrine,413
1154343410,drug_era group during day -365 through 0 days relative to index: Albuterol,410
1154343412,drug_era group during day -30 through 0 days relative to index: Albuterol,412
1154343413,drug_era group during day 0 through 0 days relative to index: Albuterol,413
1163944410,drug_era group during day -365 through 0 days relative to index: Guaifenesin,410
1163944412,drug_era group during day -30 through 0 days relative to index: Guaifenesin,412
1163944413,drug_era group during day 0 through 0 days relative to index: Guaifenesin,413
1175203702,measurement during day -365 through 0 days relative to index: Rhinovirus RNA [Presence] in Lower respiratory specimen by NAA with probe detection,702
1175677702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Catheter tip by Gram stain,702
1175677704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Catheter tip by Gram stain,704
1175686702,measurement during day -365 through 0 days relative to index: Chlamydophila pneumoniae IgG Ab [Presence] in Serum by Immunoassay,702
1175686704,measurement during day -30 through 0 days relative to index: Chlamydophila pneumoniae IgG Ab [Presence] in Serum by Immunoassay,704
1175816702,measurement during day -365 through 0 days relative to index: Bacteria identified in Peritoneal fluid by Aerobe culture,702
1175952702,measurement during day -365 through 0 days relative to index: Bacteria identified in Bile fluid by Aerobe culture,702
1176187702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Bile fluid by Gram stain,702
1176187704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Bile fluid by Gram stain,704
1176221702,measurement during day -365 through 0 days relative to index: Bacteria identified in Catheter tip by Aerobe culture,702
1177480410,drug_era group during day -365 through 0 days relative to index: Ibuprofen,410
1177480412,drug_era group during day -30 through 0 days relative to index: Ibuprofen,412
1177480413,drug_era group during day 0 through 0 days relative to index: Ibuprofen,413
1189596410,drug_era group during day -365 through 0 days relative to index: dihydrocodeine,410
1189596412,drug_era group during day -30 through 0 days relative to index: dihydrocodeine,412
1189596413,drug_era group during day 0 through 0 days relative to index: dihydrocodeine,413
1192710410,drug_era group during day -365 through 0 days relative to index: Chlorpheniramine,410
1192710412,drug_era group during day -30 through 0 days relative to index: Chlorpheniramine,412
1192710413,drug_era group during day 0 through 0 days relative to index: Chlorpheniramine,413
1196677410,drug_era group during day -365 through 0 days relative to index: formoterol,410
1196677412,drug_era group during day -30 through 0 days relative to index: formoterol,412
1201620410,drug_era group during day -365 through 0 days relative to index: Codeine,410
1201620412,drug_era group during day -30 through 0 days relative to index: Codeine,412
1201620413,drug_era group during day 0 through 0 days relative to index: Codeine,413
1300751410,drug_era group during day -365 through 0 days relative to index: Polysaccharide iron complex,410
1300751412,drug_era group during day -30 through 0 days relative to index: Polysaccharide iron complex,412
1300751413,drug_era group during day 0 through 0 days relative to index: Polysaccharide iron complex,413
1300978410,drug_era group during day -365 through 0 days relative to index: Megestrol,410
1300978412,drug_era group during day -30 through 0 days relative to index: Megestrol,412
1300978413,drug_era group during day 0 through 0 days relative to index: Megestrol,413
1301152410,drug_era group during day -365 through 0 days relative to index: Melatonin,410
1304643410,drug_era group during day -365 through 0 days relative to index: darbepoetin alfa,410
1304643412,drug_era group during day -30 through 0 days relative to index: darbepoetin alfa,412
1304643413,drug_era group during day 0 through 0 days relative to index: darbepoetin alfa,413
1304919410,drug_era group during day -365 through 0 days relative to index: pemetrexed,410
1304919412,drug_era group during day -30 through 0 days relative to index: pemetrexed,412
1308842410,drug_era group during day -365 through 0 days relative to index: valsartan,410
1308842412,drug_era group during day -30 through 0 days relative to index: valsartan,412
1308842413,drug_era group during day 0 through 0 days relative to index: valsartan,413
1309204410,drug_era group during day -365 through 0 days relative to index: Adenosine,410
1309204412,drug_era group during day -30 through 0 days relative to index: Adenosine,412
1309204413,drug_era group during day 0 through 0 days relative to index: Adenosine,413
1314924410,drug_era group during day -365 through 0 days relative to index: gemcitabine,410
1314924412,drug_era group during day -30 through 0 days relative to index: gemcitabine,412
1314924413,drug_era group during day 0 through 0 days relative to index: gemcitabine,413
1318011410,drug_era group during day -365 through 0 days relative to index: oxaliplatin,410
1318137410,drug_era group during day -365 through 0 days relative to index: Nicardipine,410
1318137412,drug_era group during day -30 through 0 days relative to index: Nicardipine,412
1318853410,drug_era group during day -365 through 0 days relative to index: Nifedipine,410
1318853412,drug_era group during day -30 through 0 days relative to index: Nifedipine,412
1318853413,drug_era group during day 0 through 0 days relative to index: Nifedipine,413
1321341410,drug_era group during day -365 through 0 days relative to index: Norepinephrine,410
1321341412,drug_era group during day -30 through 0 days relative to index: Norepinephrine,412
1321341413,drug_era group during day 0 through 0 days relative to index: Norepinephrine,413
1322184410,drug_era group during day -365 through 0 days relative to index: clopidogrel,410
1322184412,drug_era group during day -30 through 0 days relative to index: clopidogrel,412
1322184413,drug_era group during day 0 through 0 days relative to index: clopidogrel,413
1328165410,drug_era group during day -365 through 0 days relative to index: Diltiazem,410
1328165412,drug_era group during day -30 through 0 days relative to index: Diltiazem,412
1332418410,drug_era group during day -365 through 0 days relative to index: Amlodipine,410
1332418412,drug_era group during day -30 through 0 days relative to index: Amlodipine,412
1332418413,drug_era group during day 0 through 0 days relative to index: Amlodipine,413
1337620410,drug_era group during day -365 through 0 days relative to index: capecitabine,410
1338005410,drug_era group during day -365 through 0 days relative to index: Bisoprolol,410
1338005412,drug_era group during day -30 through 0 days relative to index: Bisoprolol,412
1343039410,drug_era group during day -365 through 0 days relative to index: Triptorelin,410
1343346410,drug_era group during day -365 through 0 days relative to index: vinorelbine,410
1343346412,drug_era group during day -30 through 0 days relative to index: vinorelbine,412
1343346413,drug_era group during day 0 through 0 days relative to index: vinorelbine,413
1343916410,drug_era group during day -365 through 0 days relative to index: Epinephrine,410
1343916412,drug_era group during day -30 through 0 days relative to index: Epinephrine,412
1344143410,"drug_era group during day -365 through 0 days relative to index: Albumin Human, USP",410
1344143412,"drug_era group during day -30 through 0 days relative to index: Albumin Human, USP",412
1344143413,"drug_era group during day 0 through 0 days relative to index: Albumin Human, USP",413
1344381410,drug_era group during day -365 through 0 days relative to index: bicalutamide,410
1344381412,drug_era group during day -30 through 0 days relative to index: bicalutamide,412
1344381413,drug_era group during day 0 through 0 days relative to index: bicalutamide,413
1344905410,drug_era group during day -365 through 0 days relative to index: Carboplatin,410
1344905412,drug_era group during day -30 through 0 days relative to index: Carboplatin,412
1346823410,drug_era group during day -365 through 0 days relative to index: carvedilol,410
1346823412,drug_era group during day -30 through 0 days relative to index: carvedilol,412
1346823413,drug_era group during day 0 through 0 days relative to index: carvedilol,413
1350504410,drug_era group during day -365 through 0 days relative to index: Etoposide,410
1350504412,drug_era group during day -30 through 0 days relative to index: Etoposide,412
1351557410,drug_era group during day -365 through 0 days relative to index: candesartan,410
1351557412,drug_era group during day -30 through 0 days relative to index: candesartan,412
1351557413,drug_era group during day 0 through 0 days relative to index: candesartan,413
1353766410,drug_era group during day -365 through 0 days relative to index: Propranolol,410
1353766412,drug_era group during day -30 through 0 days relative to index: Propranolol,412
1353776410,drug_era group during day -365 through 0 days relative to index: Felodipine,410
1353776412,drug_era group during day -30 through 0 days relative to index: Felodipine,412
1353776413,drug_era group during day 0 through 0 days relative to index: Felodipine,413
1356018410,drug_era group during day -365 through 0 days relative to index: prucalopride,410
1356018412,drug_era group during day -30 through 0 days relative to index: prucalopride,412
1356018413,drug_era group during day 0 through 0 days relative to index: prucalopride,413
1359548410,drug_era group during day -365 through 0 days relative to index: lapatinib,410
1367268410,drug_era group during day -365 through 0 days relative to index: irinotecan,410
1367268412,drug_era group during day -30 through 0 days relative to index: irinotecan,412
1367268413,drug_era group during day 0 through 0 days relative to index: irinotecan,413
1367500410,drug_era group during day -365 through 0 days relative to index: Losartan,410
1367500412,drug_era group during day -30 through 0 days relative to index: Losartan,412
1367500413,drug_era group during day 0 through 0 days relative to index: Losartan,413
1367571410,drug_era group during day -365 through 0 days relative to index: heparin,410
1367571412,drug_era group during day -30 through 0 days relative to index: heparin,412
1367571413,drug_era group during day 0 through 0 days relative to index: heparin,413
1378382410,drug_era group during day -365 through 0 days relative to index: Paclitaxel,410
1386670410,drug_era group during day -365 through 0 days relative to index: Thioctate,410
1386670412,drug_era group during day -30 through 0 days relative to index: Thioctate,412
1386670413,drug_era group during day 0 through 0 days relative to index: Thioctate,413
1386957410,drug_era group during day -365 through 0 days relative to index: Labetalol,410
1386957412,drug_era group during day -30 through 0 days relative to index: Labetalol,412
1387104410,drug_era group during day -365 through 0 days relative to index: trastuzumab,410
1387104412,drug_era group during day -30 through 0 days relative to index: trastuzumab,412
1387104413,drug_era group during day 0 through 0 days relative to index: trastuzumab,413
1388796410,drug_era group during day -365 through 0 days relative to index: Leucovorin,410
1388796412,drug_era group during day -30 through 0 days relative to index: Leucovorin,412
1388796413,drug_era group during day 0 through 0 days relative to index: Leucovorin,413
1395773410,drug_era group during day -365 through 0 days relative to index: iron sucrose,410
1395773412,drug_era group during day -30 through 0 days relative to index: iron sucrose,412
1395773413,drug_era group during day 0 through 0 days relative to index: iron sucrose,413
1396012410,drug_era group during day -365 through 0 days relative to index: ferrous gluconate,410
1396012412,drug_era group during day -30 through 0 days relative to index: ferrous gluconate,412
1396131410,drug_era group during day -365 through 0 days relative to index: ferrous sulfate,410
1396131412,drug_era group during day -30 through 0 days relative to index: ferrous sulfate,412
1396131413,drug_era group during day 0 through 0 days relative to index: ferrous sulfate,413
1397599410,drug_era group during day -365 through 0 days relative to index: Cisplatin,410
1397599412,drug_era group during day -30 through 0 days relative to index: Cisplatin,412
1501700410,drug_era group during day -365 through 0 days relative to index: levothyroxine,410
1501700412,drug_era group during day -30 through 0 days relative to index: levothyroxine,412
1503297410,drug_era group during day -365 through 0 days relative to index: Metformin,410
1503297412,drug_era group during day -30 through 0 days relative to index: Metformin,412
1503297413,drug_era group during day 0 through 0 days relative to index: Metformin,413
1506270410,drug_era group during day -365 through 0 days relative to index: Methylprednisolone,410
1506270412,drug_era group during day -30 through 0 days relative to index: Methylprednisolone,412
1506270413,drug_era group during day 0 through 0 days relative to index: Methylprednisolone,413
1510813410,drug_era group during day -365 through 0 days relative to index: rosuvastatin,410
1513103410,drug_era group during day -365 through 0 days relative to index: Raloxifene,410
1513103412,drug_era group during day -30 through 0 days relative to index: Raloxifene,412
1518254410,drug_era group during day -365 through 0 days relative to index: Dexamethasone,410
1518254412,drug_era group during day -30 through 0 days relative to index: Dexamethasone,412
1518254413,drug_era group during day 0 through 0 days relative to index: Dexamethasone,413
1526475410,drug_era group during day -365 through 0 days relative to index: ezetimibe,410
1526475412,drug_era group during day -30 through 0 days relative to index: ezetimibe,412
1526475413,drug_era group during day 0 through 0 days relative to index: ezetimibe,413
1545958410,drug_era group during day -365 through 0 days relative to index: atorvastatin,410
1545958412,drug_era group during day -30 through 0 days relative to index: atorvastatin,412
1545958413,drug_era group during day 0 through 0 days relative to index: atorvastatin,413
1550023410,drug_era group during day -365 through 0 days relative to index: Insulin Lispro,410
1550023412,drug_era group during day -30 through 0 days relative to index: Insulin Lispro,412
1550023413,drug_era group during day 0 through 0 days relative to index: Insulin Lispro,413
1550557410,drug_era group during day -365 through 0 days relative to index: prednisolone,410
1550557412,drug_era group during day -30 through 0 days relative to index: prednisolone,412
1550557413,drug_era group during day 0 through 0 days relative to index: prednisolone,413
1553610410,drug_era group during day -365 through 0 days relative to index: Levocarnitine,410
1553610412,drug_era group during day -30 through 0 days relative to index: Levocarnitine,412
1553610413,drug_era group during day 0 through 0 days relative to index: Levocarnitine,413
1560524410,drug_era group during day -365 through 0 days relative to index: Glucose,410
1560524412,drug_era group during day -30 through 0 days relative to index: Glucose,412
1560524413,drug_era group during day 0 through 0 days relative to index: Glucose,413
1567198410,"drug_era group during day -365 through 0 days relative to index: Insulin, Aspart, Human",410
1567198412,"drug_era group during day -30 through 0 days relative to index: Insulin, Aspart, Human",412
1580747410,drug_era group during day -365 through 0 days relative to index: sitagliptin,410
1580747412,drug_era group during day -30 through 0 days relative to index: sitagliptin,412
1596977410,"drug_era group during day -365 through 0 days relative to index: Regular Insulin, Human",410
1596977412,"drug_era group during day -30 through 0 days relative to index: Regular Insulin, Human",412
1596977413,"drug_era group during day 0 through 0 days relative to index: Regular Insulin, Human",413
1597756410,drug_era group during day -365 through 0 days relative to index: glimepiride,410
1597756412,drug_era group during day -30 through 0 days relative to index: glimepiride,412
1597756413,drug_era group during day 0 through 0 days relative to index: glimepiride,413
1703687410,drug_era group during day -365 through 0 days relative to index: Acyclovir,410
1704183410,drug_era group during day -365 through 0 days relative to index: Lamivudine,410
1704183412,drug_era group during day -30 through 0 days relative to index: Lamivudine,412
1707164410,drug_era group during day -365 through 0 days relative to index: Metronidazole,410
1707164412,drug_era group during day -30 through 0 days relative to index: Metronidazole,412
1707164413,drug_era group during day 0 through 0 days relative to index: Metronidazole,413
1707687410,drug_era group during day -365 through 0 days relative to index: Vancomycin,410
1707687412,drug_era group during day -30 through 0 days relative to index: Vancomycin,412
1708880410,drug_era group during day -365 through 0 days relative to index: Minocycline,410
1708880412,drug_era group during day -30 through 0 days relative to index: Minocycline,412
1709170410,drug_era group during day -365 through 0 days relative to index: meropenem,410
1709170412,drug_era group during day -30 through 0 days relative to index: meropenem,412
1709170413,drug_era group during day 0 through 0 days relative to index: meropenem,413
1713332410,drug_era group during day -365 through 0 days relative to index: Amoxicillin,410
1713332412,drug_era group during day -30 through 0 days relative to index: Amoxicillin,412
1713930410,drug_era group during day -365 through 0 days relative to index: Nafcillin,410
1716721410,drug_era group during day -365 through 0 days relative to index: gemifloxacin,410
1716903410,drug_era group during day -365 through 0 days relative to index: moxifloxacin,410
1716903412,drug_era group during day -30 through 0 days relative to index: moxifloxacin,412
1716903413,drug_era group during day 0 through 0 days relative to index: moxifloxacin,413
1717327410,drug_era group during day -365 through 0 days relative to index: Ampicillin,410
1717327412,drug_era group during day -30 through 0 days relative to index: Ampicillin,412
1717327413,drug_era group during day 0 through 0 days relative to index: Ampicillin,413
1717963410,drug_era group during day -365 through 0 days relative to index: ertapenem,410
1717963412,drug_era group during day -30 through 0 days relative to index: ertapenem,412
1734104410,drug_era group during day -365 through 0 days relative to index: Azithromycin,410
1734104412,drug_era group during day -30 through 0 days relative to index: Azithromycin,412
1734104413,drug_era group during day 0 through 0 days relative to index: Azithromycin,413
1736887410,drug_era group during day -365 through 0 days relative to index: linezolid,410
1738170410,drug_era group during day -365 through 0 days relative to index: lopinavir,410
1738170412,drug_era group during day -30 through 0 days relative to index: lopinavir,412
1738170413,drug_era group during day 0 through 0 days relative to index: lopinavir,413
1741122410,drug_era group during day -365 through 0 days relative to index: tazobactam,410
1741122412,drug_era group during day -30 through 0 days relative to index: tazobactam,412
1741122413,drug_era group during day 0 through 0 days relative to index: tazobactam,413
1742253410,drug_era group during day -365 through 0 days relative to index: Levofloxacin,410
1742253412,drug_era group during day -30 through 0 days relative to index: Levofloxacin,412
1742253413,drug_era group during day 0 through 0 days relative to index: Levofloxacin,413
1742432410,drug_era group during day -365 through 0 days relative to index: tigecycline,410
1742432412,drug_era group during day -30 through 0 days relative to index: tigecycline,412
1746114410,drug_era group during day -365 through 0 days relative to index: Piperacillin,410
1746114412,drug_era group during day -30 through 0 days relative to index: Piperacillin,412
1746114413,drug_era group during day 0 through 0 days relative to index: Piperacillin,413
1748921410,drug_era group during day -365 through 0 days relative to index: Ritonavir,410
1748921412,drug_era group during day -30 through 0 days relative to index: Ritonavir,412
1748921413,drug_era group during day 0 through 0 days relative to index: Ritonavir,413
1748975410,drug_era group during day -365 through 0 days relative to index: cefepime,410
1749008410,drug_era group during day -365 through 0 days relative to index: cefpodoxime,410
1749008412,drug_era group during day -30 through 0 days relative to index: cefpodoxime,412
1749008413,drug_era group during day 0 through 0 days relative to index: cefpodoxime,413
1750087410,drug_era group during day -365 through 0 days relative to index: Povidone-Iodine,410
1750087412,drug_era group during day -30 through 0 days relative to index: Povidone-Iodine,412
1750500410,drug_era group during day -365 through 0 days relative to index: Clarithromycin,410
1750500412,drug_era group during day -30 through 0 days relative to index: Clarithromycin,412
1750500413,drug_era group during day 0 through 0 days relative to index: Clarithromycin,413
1754994410,drug_era group during day -365 through 0 days relative to index: Fluconazole,410
1754994412,drug_era group during day -30 through 0 days relative to index: Fluconazole,412
1754994413,drug_era group during day 0 through 0 days relative to index: Fluconazole,413
1759842410,drug_era group during day -365 through 0 days relative to index: Clavulanate,410
1759842412,drug_era group during day -30 through 0 days relative to index: Clavulanate,412
1763204410,drug_era group during day -365 through 0 days relative to index: Rifampin,410
1769535410,drug_era group during day -365 through 0 days relative to index: Cefadroxil,410
1771162410,drug_era group during day -365 through 0 days relative to index: Cefazolin,410
1771162412,drug_era group during day -30 through 0 days relative to index: Cefazolin,412
1774470410,drug_era group during day -365 through 0 days relative to index: Cefotaxime,410
1774470412,drug_era group during day -30 through 0 days relative to index: Cefotaxime,412
1774470413,drug_era group during day 0 through 0 days relative to index: Cefotaxime,413
1776684410,drug_era group during day -365 through 0 days relative to index: Ceftazidime,410
1777087410,drug_era group during day -365 through 0 days relative to index: Hydroxychloroquine,410
1777087412,drug_era group during day -30 through 0 days relative to index: Hydroxychloroquine,412
1777087413,drug_era group during day 0 through 0 days relative to index: Hydroxychloroquine,413
1777806410,drug_era group during day -365 through 0 days relative to index: Ceftriaxone,410
1777806412,drug_era group during day -30 through 0 days relative to index: Ceftriaxone,412
1777806413,drug_era group during day 0 through 0 days relative to index: Ceftriaxone,413
1790812410,drug_era group during day -365 through 0 days relative to index: Chlorhexidine,410
1790812412,drug_era group during day -30 through 0 days relative to index: Chlorhexidine,412
1790812413,drug_era group during day 0 through 0 days relative to index: Chlorhexidine,413
1790868410,drug_era group during day -365 through 0 days relative to index: Amikacin,410
1796458410,drug_era group during day -365 through 0 days relative to index: cefdinir,410
1797513410,drug_era group during day -365 through 0 days relative to index: Ciprofloxacin,410
1797513412,drug_era group during day -30 through 0 days relative to index: Ciprofloxacin,412
1797513413,drug_era group during day 0 through 0 days relative to index: Ciprofloxacin,413
1799139410,drug_era group during day -365 through 0 days relative to index: Oseltamivir,410
1799139412,drug_era group during day -30 through 0 days relative to index: Oseltamivir,412
1799139413,drug_era group during day 0 through 0 days relative to index: Oseltamivir,413
1836241410,drug_era group during day -365 through 0 days relative to index: Sulbactam,410
1836241412,drug_era group during day -30 through 0 days relative to index: Sulbactam,412
1836241413,drug_era group during day 0 through 0 days relative to index: Sulbactam,413
2006975502,"procedure_occurrence during day -365 through 0 days relative to index: Diagnostic interview, consultation, and evaluation",502
2006975504,"procedure_occurrence during day -30 through 0 days relative to index: Diagnostic interview, consultation, and evaluation",504
2007632502,procedure_occurrence during day -365 through 0 days relative to index: Application of other wound dressing,502
2007632504,procedure_occurrence during day -30 through 0 days relative to index: Application of other wound dressing,504
2007658502,procedure_occurrence during day -365 through 0 days relative to index: Other speech training and therapy,502
2007914502,procedure_occurrence during day -365 through 0 days relative to index: Insertion of other (naso-)gastric tube,502
2007914504,procedure_occurrence during day -30 through 0 days relative to index: Insertion of other (naso-)gastric tube,504
2108227502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2109603502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2109603504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
2109740502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2109747502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2211521502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2211521504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
2211755502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2211851502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2211851504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
2212946502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2213280502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2213560502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2213560504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
2314004502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2314004504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
2314008502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2314008504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
2314018502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2314047502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2314047504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
2314049502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2314049504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
2314112502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2314112504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
2314127502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2314136502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2314138502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2514438502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2514438504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
2614773602,"device_exposure during day -365 through 0 days relative to index: Indwelling catheter; foley type, three way for continuous irrigation, each",602
2614795602,"device_exposure during day -365 through 0 days relative to index: Ostomy skin barrier, liquid (spray, brush, etc.), per oz",602
2614875602,"device_exposure during day -365 through 0 days relative to index: Surgical stockings thigh length, each",602
2615154602,"device_exposure during day -365 through 0 days relative to index: Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing",602
2615155602,"device_exposure during day -365 through 0 days relative to index: Transparent film, sterile, more than 48 sq. in., each dressing",602
2615155604,"device_exposure during day -30 through 0 days relative to index: Transparent film, sterile, more than 48 sq. in., each dressing",604
2615200602,"device_exposure during day -365 through 0 days relative to index: Tubular dressing with or without elastic, any width, per linear yard",602
2615249602,"device_exposure during day -365 through 0 days relative to index: Aerosol mask, used with dme nebulizer",602
2615286602,"device_exposure during day -365 through 0 days relative to index: Tracheostomy/laryngectomy tube, non-cuffed, polyvinylchloride (pvc), silicone or equal, each",602
2615756602,"device_exposure during day -365 through 0 days relative to index: Catheter, drainage",602
2615756604,"device_exposure during day -30 through 0 days relative to index: Catheter, drainage",604
2615775602,device_exposure during day -365 through 0 days relative to index: Adhesion barrier,602
2787927502,"procedure_occurrence during day -365 through 0 days relative to index: Magnetic Resonance Imaging (MRI) of Liver using Other Contrast, Unenhanced and Enhanced",502
2787927504,"procedure_occurrence during day -30 through 0 days relative to index: Magnetic Resonance Imaging (MRI) of Liver using Other Contrast, Unenhanced and Enhanced",504
2789359502,"procedure_occurrence during day -365 through 0 days relative to index: Magnetic Resonance Imaging (MRI) of Brain using Other Contrast, Unenhanced and Enhanced",502
2793113502,procedure_occurrence during day -365 through 0 days relative to index: Ultrasonography of Neck,502
2793113504,procedure_occurrence during day -30 through 0 days relative to index: Ultrasonography of Neck,504
2793369502,procedure_occurrence during day -365 through 0 days relative to index: Positron Emission Tomographic (PET) Imaging of Brain using Fluorine 18 (F-18),502
3000067702,measurement during day -365 through 0 days relative to index: Parathyrin.intact [Mass/volume] in Serum or Plasma,702
3000067704,measurement during day -30 through 0 days relative to index: Parathyrin.intact [Mass/volume] in Serum or Plasma,704
3000093702,measurement during day -365 through 0 days relative to index: Morphology [Interpretation] in Blood Narrative,702
3000093704,measurement during day -30 through 0 days relative to index: Morphology [Interpretation] in Blood Narrative,704
3000127702,measurement during day -365 through 0 days relative to index: Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC),702
3000127704,measurement during day -30 through 0 days relative to index: Tetracycline [Susceptibility] by Minimum inhibitory concentration (MIC),704
3000236702,measurement during day -365 through 0 days relative to index: Nalidixate [Susceptibility] by Minimum inhibitory concentration (MIC),702
3000251702,measurement during day -365 through 0 days relative to index: Influenza virus B Ag [Presence] in Throat,702
3000337702,measurement during day -365 through 0 days relative to index: Cancer Ag 15-3 [Units/volume] in Pleural fluid,702
3000348702,measurement during day -365 through 0 days relative to index: Leukocyte esterase [Presence] in Urine by Test strip,702
3000348704,measurement during day -30 through 0 days relative to index: Leukocyte esterase [Presence] in Urine by Test strip,704
3000494702,measurement during day -365 through 0 days relative to index: Fungus identified in Unspecified specimen by Culture,702
3000494704,measurement during day -30 through 0 days relative to index: Fungus identified in Unspecified specimen by Culture,704
3000520702,measurement during day -365 through 0 days relative to index: cefOXitin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3000520704,measurement during day -30 through 0 days relative to index: cefOXitin [Susceptibility] by Minimum inhibitory concentration (MIC),704
3000593702,measurement during day -365 through 0 days relative to index: Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,702
3000593704,measurement during day -30 through 0 days relative to index: Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma,704
3000620702,measurement during day -365 through 0 days relative to index: Complement C3 [Mass/volume] in Serum or Plasma,702
3000769702,measurement during day -365 through 0 days relative to index: Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3000769704,measurement during day -30 through 0 days relative to index: Gentamicin [Susceptibility] by Minimum inhibitory concentration (MIC),704
3000796702,measurement during day -365 through 0 days relative to index: Bacteria identified in Pleural fluid by Aerobe culture,702
3000796704,measurement during day -30 through 0 days relative to index: Bacteria identified in Pleural fluid by Aerobe culture,704
3000809702,measurement during day -365 through 0 days relative to index: Color of Pleural fluid,702
3000809704,measurement during day -30 through 0 days relative to index: Color of Pleural fluid,704
3000835702,measurement during day -365 through 0 days relative to index: Fungus identified in Peritoneal fluid by Culture,702
3000835704,measurement during day -30 through 0 days relative to index: Fungus identified in Peritoneal fluid by Culture,704
3000850702,measurement during day -365 through 0 days relative to index: Epithelial cells [#/volume] in Urine,702
3000850704,measurement during day -30 through 0 days relative to index: Epithelial cells [#/volume] in Urine,704
3000984702,measurement during day -365 through 0 days relative to index: Phospholipid [Mass/volume] in Serum or Plasma,702
3001079702,measurement during day -365 through 0 days relative to index: Blood group antibody screen [Presence] in Serum or Plasma,702
3001079704,measurement during day -30 through 0 days relative to index: Blood group antibody screen [Presence] in Serum or Plasma,704
3001122702,measurement during day -365 through 0 days relative to index: Ferritin [Mass/volume] in Serum or Plasma,702
3001122704,measurement during day -30 through 0 days relative to index: Ferritin [Mass/volume] in Serum or Plasma,704
3001123702,measurement during day -365 through 0 days relative to index: Platelet mean volume [Entitic volume] in Blood,702
3001123704,measurement during day -30 through 0 days relative to index: Platelet mean volume [Entitic volume] in Blood,704
3001349702,measurement during day -365 through 0 days relative to index: Creatinine [Mass/volume] in 24 hour Urine,702
3001349704,measurement during day -30 through 0 days relative to index: Creatinine [Mass/volume] in 24 hour Urine,704
3001355702,measurement during day -365 through 0 days relative to index: Fungus identified in Sputum by Culture,702
3001355704,measurement during day -30 through 0 days relative to index: Fungus identified in Sputum by Culture,704
3001420702,measurement during day -365 through 0 days relative to index: Magnesium [Mass/volume] in Serum or Plasma,702
3001420704,measurement during day -30 through 0 days relative to index: Magnesium [Mass/volume] in Serum or Plasma,704
3001604702,measurement during day -365 through 0 days relative to index: Monocytes [#/volume] in Blood,702
3001604704,measurement during day -30 through 0 days relative to index: Monocytes [#/volume] in Blood,704
3001612702,measurement during day -365 through 0 days relative to index: Ticarcillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC),702
3001612704,measurement during day -30 through 0 days relative to index: Ticarcillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC),704
3001657702,measurement during day -365 through 0 days relative to index: Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood,702
3001657704,measurement during day -30 through 0 days relative to index: Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood,704
3001686702,measurement during day -365 through 0 days relative to index: Cold agglutinin [Titer] in Serum or Plasma,702
3001686704,measurement during day -30 through 0 days relative to index: Cold agglutinin [Titer] in Serum or Plasma,704
3001886702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Cerebral spinal fluid by Gram stain,702
3001886704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Cerebral spinal fluid by Gram stain,704
3002030702,measurement during day -365 through 0 days relative to index: Lymphocytes/100 leukocytes in Blood,702
3002030704,measurement during day -30 through 0 days relative to index: Lymphocytes/100 leukocytes in Blood,704
3002032702,measurement during day -365 through 0 days relative to index: Base excess in Venous blood by calculation,702
3002032704,measurement during day -30 through 0 days relative to index: Base excess in Venous blood by calculation,704
3002173702,measurement during day -365 through 0 days relative to index: Hemoglobin [Mass/volume] in Arterial blood,702
3002173704,measurement during day -30 through 0 days relative to index: Hemoglobin [Mass/volume] in Arterial blood,704
3002179702,measurement during day -365 through 0 days relative to index: Metamyelocytes/100 leukocytes in Blood,702
3002179704,measurement during day -30 through 0 days relative to index: Metamyelocytes/100 leukocytes in Blood,704
3002253702,measurement during day -365 through 0 days relative to index: Trichomonas vaginalis [Presence] in Urine sediment by Light microscopy,702
3002253704,measurement during day -30 through 0 days relative to index: Trichomonas vaginalis [Presence] in Urine sediment by Light microscopy,704
3002274702,measurement during day -365 through 0 days relative to index: Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3002274704,measurement during day -30 through 0 days relative to index: Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC),704
3002331702,measurement during day -365 through 0 days relative to index: Protein [Mass/volume] in Peritoneal fluid,702
3002331704,measurement during day -30 through 0 days relative to index: Protein [Mass/volume] in Peritoneal fluid,704
3002400702,measurement during day -365 through 0 days relative to index: Iron [Mass/volume] in Serum or Plasma,702
3002400704,measurement during day -30 through 0 days relative to index: Iron [Mass/volume] in Serum or Plasma,704
3002516702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Sputum by Gram stain,702
3002516704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Sputum by Gram stain,704
3002971702,measurement during day -365 through 0 days relative to index: Nuclear Ab [Titer] in Serum by Immunofluorescence,702
3002971704,measurement during day -30 through 0 days relative to index: Nuclear Ab [Titer] in Serum by Immunofluorescence,704
3002996702,measurement during day -365 through 0 days relative to index: Fungus identified in Cerebral spinal fluid by Culture,702
3002996704,measurement during day -30 through 0 days relative to index: Fungus identified in Cerebral spinal fluid by Culture,704
3003181702,measurement during day -365 through 0 days relative to index: Sodium [Moles/volume] in Urine,702
3003181704,measurement during day -30 through 0 days relative to index: Sodium [Moles/volume] in Urine,704
3003310702,measurement during day -365 through 0 days relative to index: Rh [Type] in Blood,702
3003310704,measurement during day -30 through 0 days relative to index: Rh [Type] in Blood,704
3003338702,measurement during day -365 through 0 days relative to index: MCHC [Mass/volume],702
3003338704,measurement during day -30 through 0 days relative to index: MCHC [Mass/volume],704
3003396702,measurement during day -365 through 0 days relative to index: Base excess in Arterial blood by calculation,702
3003396704,measurement during day -30 through 0 days relative to index: Base excess in Arterial blood by calculation,704
3003403702,measurement during day -365 through 0 days relative to index: Glucose [Mass/volume] in Pleural fluid,702
3003403704,measurement during day -30 through 0 days relative to index: Glucose [Mass/volume] in Pleural fluid,704
3003434702,measurement during day -365 through 0 days relative to index: Protein [Mass/volume] in Pleural fluid,702
3003434704,measurement during day -30 through 0 days relative to index: Protein [Mass/volume] in Pleural fluid,704
3003469702,measurement during day -365 through 0 days relative to index: Bilirubin crystals [#/area] in Urine sediment by Microscopy high power field,702
3003469704,measurement during day -30 through 0 days relative to index: Bilirubin crystals [#/area] in Urine sediment by Microscopy high power field,704
3003551702,measurement during day -365 through 0 days relative to index: Influenza virus A Ag [Presence] in Throat,702
3003694702,measurement during day -365 through 0 days relative to index: ABO and Rh group [Type] in Blood,702
3003694704,measurement during day -30 through 0 days relative to index: ABO and Rh group [Type] in Blood,704
3003745702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Urine by Gram stain,702
3003745704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Urine by Gram stain,704
3003785702,measurement during day -365 through 0 days relative to index: Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,702
3003785704,measurement during day -30 through 0 days relative to index: Carcinoembryonic Ag [Mass/volume] in Serum or Plasma,704
3004119702,measurement during day -365 through 0 days relative to index: Hemoglobin [Mass/volume] in Venous blood,702
3004119704,measurement during day -30 through 0 days relative to index: Hemoglobin [Mass/volume] in Venous blood,704
3004372702,measurement during day -365 through 0 days relative to index: Urate crystals amorphous [Presence] in Urine sediment by Light microscopy,702
3004372704,measurement during day -30 through 0 days relative to index: Urate crystals amorphous [Presence] in Urine sediment by Light microscopy,704
3004410702,measurement during day -365 through 0 days relative to index: Hemoglobin A1c/Hemoglobin.total in Blood,702
3004410704,measurement during day -30 through 0 days relative to index: Hemoglobin A1c/Hemoglobin.total in Blood,704
3004472702,measurement during day -365 through 0 days relative to index: Leukocytes [#/area] in Sputum by Microscopy high power field,702
3004472704,measurement during day -30 through 0 days relative to index: Leukocytes [#/area] in Sputum by Microscopy high power field,704
3004501702,measurement during day -365 through 0 days relative to index: Glucose [Mass/volume] in Serum or Plasma,702
3004501704,measurement during day -30 through 0 days relative to index: Glucose [Mass/volume] in Serum or Plasma,704
3004809702,measurement during day -365 through 0 days relative to index: Band form neutrophils/100 leukocytes in Blood,702
3004809704,measurement during day -30 through 0 days relative to index: Band form neutrophils/100 leukocytes in Blood,704
3004852702,measurement during day -365 through 0 days relative to index: Ammonium urate crystals [Presence] in Urine sediment by Light microscopy,702
3004852704,measurement during day -30 through 0 days relative to index: Ammonium urate crystals [Presence] in Urine sediment by Light microscopy,704
3004905702,measurement during day -365 through 0 days relative to index: Lipase [Enzymatic activity/volume] in Serum or Plasma,702
3004905704,measurement during day -30 through 0 days relative to index: Lipase [Enzymatic activity/volume] in Serum or Plasma,704
3005241702,measurement during day -365 through 0 days relative to index: Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC),702
3005241704,measurement during day -30 through 0 days relative to index: Linezolid [Susceptibility] by Minimum inhibitory concentration (MIC),704
3005384702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Pleural fluid by Gram stain,702
3005384704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Pleural fluid by Gram stain,704
3005473702,measurement during day -365 through 0 days relative to index: Phosphate crystals amorphous [Presence] in Urine sediment by Light microscopy,702
3005473704,measurement during day -30 through 0 days relative to index: Phosphate crystals amorphous [Presence] in Urine sediment by Light microscopy,704
3005535702,measurement during day -365 through 0 days relative to index: ceFAZolin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3005535704,measurement during day -30 through 0 days relative to index: ceFAZolin [Susceptibility] by Minimum inhibitory concentration (MIC),704
3005715702,measurement during day -365 through 0 days relative to index: Vancomycin [Mass/volume] in Serum or Plasma,702
3005715704,measurement during day -30 through 0 days relative to index: Vancomycin [Mass/volume] in Serum or Plasma,704
3005719702,measurement during day -365 through 0 days relative to index: IgG [Mass/volume] in Serum or Plasma,702
3005724702,measurement during day -365 through 0 days relative to index: B Ag [Presence] on Red Blood Cells,702
3005724704,measurement during day -30 through 0 days relative to index: B Ag [Presence] on Red Blood Cells,704
3005745702,measurement during day -365 through 0 days relative to index: Bacteria identified in Blood by Aerobe culture,702
3005745704,measurement during day -30 through 0 days relative to index: Bacteria identified in Blood by Aerobe culture,704
3005807702,measurement during day -365 through 0 days relative to index: Platelet function (closure time) collagen+EPINEPHrine induced [Time] in Blood,702
3006175702,measurement during day -365 through 0 days relative to index: Mucus [Presence] in Urine sediment by Light microscopy,702
3006175704,measurement during day -30 through 0 days relative to index: Mucus [Presence] in Urine sediment by Light microscopy,704
3006315702,measurement during day -365 through 0 days relative to index: Basophils [#/volume] in Blood,702
3006315704,measurement during day -30 through 0 days relative to index: Basophils [#/volume] in Blood,704
3006453702,measurement during day -365 through 0 days relative to index: Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,702
3006453704,measurement during day -30 through 0 days relative to index: Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay,704
3006490702,measurement during day -365 through 0 days relative to index: Calcium oxalate crystals [Presence] in Urine sediment by Light microscopy,702
3006490704,measurement during day -30 through 0 days relative to index: Calcium oxalate crystals [Presence] in Urine sediment by Light microscopy,704
3006504702,measurement during day -365 through 0 days relative to index: Eosinophils/100 leukocytes in Blood,702
3006504704,measurement during day -30 through 0 days relative to index: Eosinophils/100 leukocytes in Blood,704
3006661702,measurement during day -365 through 0 days relative to index: Calcium [Mass/volume] in Urine,702
3006661704,measurement during day -30 through 0 days relative to index: Calcium [Mass/volume] in Urine,704
3006673702,measurement during day -365 through 0 days relative to index: Bacteria identified in Blood by Anaerobe culture,702
3006673704,measurement during day -30 through 0 days relative to index: Bacteria identified in Blood by Anaerobe culture,704
3006923702,measurement during day -365 through 0 days relative to index: Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,702
3006923704,measurement during day -30 through 0 days relative to index: Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma,704
3007070702,measurement during day -365 through 0 days relative to index: Cholesterol in HDL [Mass/volume] in Serum or Plasma,702
3007070704,measurement during day -30 through 0 days relative to index: Cholesterol in HDL [Mass/volume] in Serum or Plasma,704
3007164702,measurement during day -365 through 0 days relative to index: IgA [Mass/volume] in Serum or Plasma,702
3007220702,measurement during day -365 through 0 days relative to index: Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,702
3007220704,measurement during day -30 through 0 days relative to index: Creatine kinase [Enzymatic activity/volume] in Serum or Plasma,704
3007224702,measurement during day -365 through 0 days relative to index: Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC),702
3007224704,measurement during day -30 through 0 days relative to index: Meropenem [Susceptibility] by Minimum inhibitory concentration (MIC),704
3007461702,measurement during day -365 through 0 days relative to index: Platelets [#/volume] in Blood,702
3007461704,measurement during day -30 through 0 days relative to index: Platelets [#/volume] in Blood,704
3007628702,measurement during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] standard in Venous blood,702
3007628704,measurement during day -30 through 0 days relative to index: Bicarbonate [Moles/volume] standard in Venous blood,704
3007654702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Wound by Gram stain,702
3007654704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Wound by Gram stain,704
3007662702,measurement during day -365 through 0 days relative to index: Aztreonam [Susceptibility] by Minimum inhibitory concentration (MIC),702
3007662704,measurement during day -30 through 0 days relative to index: Aztreonam [Susceptibility] by Minimum inhibitory concentration (MIC),704
3007808702,measurement during day -365 through 0 days relative to index: Renin [Enzymatic activity/volume] in Plasma,702
3007808704,measurement during day -30 through 0 days relative to index: Renin [Enzymatic activity/volume] in Plasma,704
3008037702,measurement during day -365 through 0 days relative to index: Lactate [Moles/volume] in Venous blood,702
3008037704,measurement during day -30 through 0 days relative to index: Lactate [Moles/volume] in Venous blood,704
3008152702,measurement during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] in Arterial blood,702
3008152704,measurement during day -30 through 0 days relative to index: Bicarbonate [Moles/volume] in Arterial blood,704
3008295702,measurement during day -365 through 0 days relative to index: Osmolality of Serum or Plasma,702
3008334702,measurement during day -365 through 0 days relative to index: Bacteria identified in Drain by Aerobe culture,702
3008582702,measurement during day -365 through 0 days relative to index: Bacteria identified in Aspirate by Aerobe culture,702
3008598702,measurement during day -365 through 0 days relative to index: Thyroxine (T4) free [Mass/volume] in Serum or Plasma,702
3008598704,measurement during day -30 through 0 days relative to index: Thyroxine (T4) free [Mass/volume] in Serum or Plasma,704
3008893702,measurement during day -365 through 0 days relative to index: Testosterone [Mass/volume] in Serum or Plasma,702
3008912702,measurement during day -365 through 0 days relative to index: Cefepime [Susceptibility] by Minimum inhibitory concentration (MIC),702
3008912704,measurement during day -30 through 0 days relative to index: Cefepime [Susceptibility] by Minimum inhibitory concentration (MIC),704
3009201702,measurement during day -365 through 0 days relative to index: Thyrotropin [Units/volume] in Serum or Plasma,702
3009201704,measurement during day -30 through 0 days relative to index: Thyrotropin [Units/volume] in Serum or Plasma,704
3009565702,measurement during day -365 through 0 days relative to index: Beta globulin/Protein.total in Urine by Electrophoresis,702
3009565704,measurement during day -30 through 0 days relative to index: Beta globulin/Protein.total in Urine by Electrophoresis,704
3009944702,measurement during day -365 through 0 days relative to index: Mycobacterium tuberculosis DNA [Presence] in Pleural fluid by NAA with probe detection,702
3009944704,measurement during day -30 through 0 days relative to index: Mycobacterium tuberculosis DNA [Presence] in Pleural fluid by NAA with probe detection,704
3009986702,measurement during day -365 through 0 days relative to index: Bacteria identified in Catheter tip by Culture,702
3009986704,measurement during day -30 through 0 days relative to index: Bacteria identified in Catheter tip by Culture,704
3010007702,measurement during day -365 through 0 days relative to index: Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3010007704,measurement during day -30 through 0 days relative to index: Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC),704
3010084702,measurement during day -365 through 0 days relative to index: C peptide [Mass/volume] in Serum or Plasma,702
3010084704,measurement during day -30 through 0 days relative to index: C peptide [Mass/volume] in Serum or Plasma,704
3010156702,measurement during day -365 through 0 days relative to index: C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,702
3010156704,measurement during day -30 through 0 days relative to index: C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method,704
3010157702,measurement during day -365 through 0 days relative to index: Gamma globulin/Protein.total in Urine by Electrophoresis,702
3010157704,measurement during day -30 through 0 days relative to index: Gamma globulin/Protein.total in Urine by Electrophoresis,704
3010189702,measurement during day -365 through 0 days relative to index: Epithelial cells [#/area] in Urine sediment by Microscopy high power field,702
3010189704,measurement during day -30 through 0 days relative to index: Epithelial cells [#/area] in Urine sediment by Microscopy high power field,704
3010224702,measurement during day -365 through 0 days relative to index: Large unstained cells/100 leukocytes in Blood,702
3010224704,measurement during day -30 through 0 days relative to index: Large unstained cells/100 leukocytes in Blood,704
3010340702,measurement during day -365 through 0 days relative to index: Triiodothyronine (T3) [Mass/volume] in Serum or Plasma,702
3010340704,measurement during day -30 through 0 days relative to index: Triiodothyronine (T3) [Mass/volume] in Serum or Plasma,704
3010521702,measurement during day -365 through 0 days relative to index: Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay,702
3010521704,measurement during day -30 through 0 days relative to index: Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay,704
3010745702,measurement during day -365 through 0 days relative to index: Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC),702
3010745704,measurement during day -30 through 0 days relative to index: Piperacillin+Tazobactam [Susceptibility] by Minimum inhibitory concentration (MIC),704
3010813702,measurement during day -365 through 0 days relative to index: Leukocytes [#/volume] in Blood,702
3010813704,measurement during day -30 through 0 days relative to index: Leukocytes [#/volume] in Blood,704
3010926702,measurement during day -365 through 0 days relative to index: Albumin/Protein.total in Urine by Electrophoresis,702
3010926704,measurement during day -30 through 0 days relative to index: Albumin/Protein.total in Urine by Electrophoresis,704
3011004702,measurement during day -365 through 0 days relative to index: Bilirubin.total [Mass/volume] in Peritoneal fluid,702
3011004704,measurement during day -30 through 0 days relative to index: Bilirubin.total [Mass/volume] in Peritoneal fluid,704
3011039702,measurement during day -365 through 0 days relative to index: Fusidate [Susceptibility] by Minimum inhibitory concentration (MIC),702
3011039704,measurement during day -30 through 0 days relative to index: Fusidate [Susceptibility] by Minimum inhibitory concentration (MIC),704
3011337702,measurement during day -365 through 0 days relative to index: Aldosterone [Mass/volume] in Serum or Plasma,702
3011337704,measurement during day -30 through 0 days relative to index: Aldosterone [Mass/volume] in Serum or Plasma,704
3011363702,measurement during day -365 through 0 days relative to index: Streptococcus pneumoniae Ag [Presence] in Urine,702
3011363704,measurement during day -30 through 0 days relative to index: Streptococcus pneumoniae Ag [Presence] in Urine,704
3011424702,measurement during day -365 through 0 days relative to index: Glucose [Mass/volume] in Blood by Automated test strip,702
3011424704,measurement during day -30 through 0 days relative to index: Glucose [Mass/volume] in Blood by Automated test strip,704
3011544702,measurement during day -365 through 0 days relative to index: Albumin [Mass/volume] in Pleural fluid,702
3011544704,measurement during day -30 through 0 days relative to index: Albumin [Mass/volume] in Pleural fluid,704
3011588702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Sputum by Acid fast stain,702
3011588704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Sputum by Acid fast stain,704
3011630702,measurement during day -365 through 0 days relative to index: Helicobacter pylori [Presence] in Stomach by urea breath test,702
3011648702,measurement during day -365 through 0 days relative to index: Oxygen content in Venous blood,702
3011648704,measurement during day -30 through 0 days relative to index: Oxygen content in Venous blood,704
3011705702,measurement during day -365 through 0 days relative to index: Protein [Mass/volume] in 24 hour Urine,702
3011705704,measurement during day -30 through 0 days relative to index: Protein [Mass/volume] in 24 hour Urine,704
3011797702,measurement during day -365 through 0 days relative to index: Bacteria identified in Abscess by Aerobe culture,702
3011907702,measurement during day -365 through 0 days relative to index: Ampicillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC),702
3011907704,measurement during day -30 through 0 days relative to index: Ampicillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC),704
3011958702,measurement during day -365 through 0 days relative to index: Ammonia [Moles/volume] in Plasma,702
3011958704,measurement during day -30 through 0 days relative to index: Ammonia [Moles/volume] in Plasma,704
3011960702,measurement during day -365 through 0 days relative to index: Natriuretic peptide B [Mass/volume] in Serum or Plasma,702
3011960704,measurement during day -30 through 0 days relative to index: Natriuretic peptide B [Mass/volume] in Serum or Plasma,704
3012096702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Unspecified specimen by KOH preparation,702
3012096704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Unspecified specimen by KOH preparation,704
3012471702,measurement during day -365 through 0 days relative to index: Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay,702
3012544702,measurement during day -365 through 0 days relative to index: pH of Venous blood,702
3012544704,measurement during day -30 through 0 days relative to index: pH of Venous blood,704
3012607702,measurement during day -365 through 0 days relative to index: Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3012607704,measurement during day -30 through 0 days relative to index: Teicoplanin [Susceptibility] by Minimum inhibitory concentration (MIC),704
3012625702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Cerebral spinal fluid by Acid fast stain,702
3012625704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Cerebral spinal fluid by Acid fast stain,704
3013055702,measurement during day -365 through 0 days relative to index: A Ab [Presence] in Serum or Plasma,702
3013055704,measurement during day -30 through 0 days relative to index: A Ab [Presence] in Serum or Plasma,704
3013115702,measurement during day -365 through 0 days relative to index: Eosinophils [#/volume] in Blood,702
3013115704,measurement during day -30 through 0 days relative to index: Eosinophils [#/volume] in Blood,704
3013146702,measurement during day -365 through 0 days relative to index: Bacteria identified in Wound by Aerobe culture,702
3013603702,measurement during day -365 through 0 days relative to index: Prostate specific Ag [Mass/volume] in Serum or Plasma,702
3013635702,measurement during day -365 through 0 days relative to index: Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC),702
3013635704,measurement during day -30 through 0 days relative to index: Trimethoprim+Sulfamethoxazole [Susceptibility] by Minimum inhibitory concentration (MIC),704
3013650702,measurement during day -365 through 0 days relative to index: Neutrophils [#/volume] in Blood by Automated count,702
3013650704,measurement during day -30 through 0 days relative to index: Neutrophils [#/volume] in Blood by Automated count,704
3013682702,measurement during day -365 through 0 days relative to index: Urea nitrogen [Mass/volume] in Serum or Plasma,702
3013682704,measurement during day -30 through 0 days relative to index: Urea nitrogen [Mass/volume] in Serum or Plasma,704
3013707702,measurement during day -365 through 0 days relative to index: Erythrocyte sedimentation rate by Westergren method,702
3013707704,measurement during day -30 through 0 days relative to index: Erythrocyte sedimentation rate by Westergren method,704
3013721702,measurement during day -365 through 0 days relative to index: Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,702
3013721704,measurement during day -30 through 0 days relative to index: Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma,704
3013735702,measurement during day -365 through 0 days relative to index: Carcinoembryonic Ag [Mass/volume] in Body fluid,702
3013735704,measurement during day -30 through 0 days relative to index: Carcinoembryonic Ag [Mass/volume] in Body fluid,704
3013801702,measurement during day -365 through 0 days relative to index: Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,702
3013801704,measurement during day -30 through 0 days relative to index: Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay,704
3013861702,measurement during day -365 through 0 days relative to index: Lipoprotein a [Mass/volume] in Serum or Plasma,702
3013861704,measurement during day -30 through 0 days relative to index: Lipoprotein a [Mass/volume] in Serum or Plasma,704
3013867702,measurement during day -365 through 0 days relative to index: Bacteria identified in Unspecified specimen by Aerobe culture,702
3014197702,measurement during day -365 through 0 days relative to index: Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3014197704,measurement during day -30 through 0 days relative to index: Oxacillin [Susceptibility] by Minimum inhibitory concentration (MIC),704
3014218702,measurement during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] standard in Arterial blood,702
3014218704,measurement during day -30 through 0 days relative to index: Bicarbonate [Moles/volume] standard in Arterial blood,704
3014352702,measurement during day -365 through 0 days relative to index: Rotavirus Ag [Presence] in Stool by Immunoassay,702
3014789702,measurement during day -365 through 0 days relative to index: Hippurate [Mass/volume] in Urine,702
3014789704,measurement during day -30 through 0 days relative to index: Hippurate [Mass/volume] in Urine,704
3015023702,measurement during day -365 through 0 days relative to index: Epithelial cells.renal [#/area] in Urine sediment by Microscopy high power field,702
3015023704,measurement during day -30 through 0 days relative to index: Epithelial cells.renal [#/area] in Urine sediment by Microscopy high power field,704
3015242702,measurement during day -365 through 0 days relative to index: Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,702
3015242704,measurement during day -30 through 0 days relative to index: Ferritin [Mass/volume] in Serum or Plasma by Immunoassay,704
3015274702,measurement during day -365 through 0 days relative to index: Minocycline [Susceptibility] by Minimum inhibitory concentration (MIC),702
3015274704,measurement during day -30 through 0 days relative to index: Minocycline [Susceptibility] by Minimum inhibitory concentration (MIC),704
3015406702,measurement during day -365 through 0 days relative to index: Norfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3015406704,measurement during day -30 through 0 days relative to index: Norfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC),704
3015481702,measurement during day -365 through 0 days relative to index: Prolactin [Mass/volume] in Serum or Plasma by Immunoassay,702
3015592702,measurement during day -365 through 0 days relative to index: Fungus identified in Body fluid by Culture,702
3015592704,measurement during day -30 through 0 days relative to index: Fungus identified in Body fluid by Culture,704
3015890702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Sputum by KOH preparation,702
3015890704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Sputum by KOH preparation,704
3015893702,measurement during day -365 through 0 days relative to index: Mycobacterium sp DNA [Presence] in Urine by NAA with probe detection,702
3016038702,measurement during day -365 through 0 days relative to index: Potassium [Moles/volume] in Urine,702
3016038704,measurement during day -30 through 0 days relative to index: Potassium [Moles/volume] in Urine,704
3016114702,measurement during day -365 through 0 days relative to index: Bacteria identified in Body fluid by Aerobe culture,702
3016201702,measurement during day -365 through 0 days relative to index: Valproate [Mass/volume] in Serum or Plasma,702
3016244702,measurement during day -365 through 0 days relative to index: Insulin [Units/volume] in Serum or Plasma,702
3016244704,measurement during day -30 through 0 days relative to index: Insulin [Units/volume] in Serum or Plasma,704
3016251702,measurement during day -365 through 0 days relative to index: Hemoglobin.gastrointestinal [Presence] in Stool,702
3016251704,measurement during day -30 through 0 days relative to index: Hemoglobin.gastrointestinal [Presence] in Stool,704
3016407702,measurement during day -365 through 0 days relative to index: Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay,702
3016426702,measurement during day -365 through 0 days relative to index: Methylmalonate [Moles/volume] in Serum or Plasma,702
3016502702,measurement during day -365 through 0 days relative to index: Oxygen saturation in Arterial blood,702
3016502704,measurement during day -30 through 0 days relative to index: Oxygen saturation in Arterial blood,704
3016608702,measurement during day -365 through 0 days relative to index: B Ab [Presence] in Serum or Plasma,702
3016608704,measurement during day -30 through 0 days relative to index: B Ab [Presence] in Serum or Plasma,704
3016723702,measurement during day -365 through 0 days relative to index: Creatinine [Mass/volume] in Serum or Plasma,702
3016723704,measurement during day -30 through 0 days relative to index: Creatinine [Mass/volume] in Serum or Plasma,704
3016724702,measurement during day -365 through 0 days relative to index: Homocysteine [Moles/volume] in Serum or Plasma,702
3016771702,measurement during day -365 through 0 days relative to index: Amylase [Enzymatic activity/volume] in Serum or Plasma,702
3016771704,measurement during day -30 through 0 days relative to index: Amylase [Enzymatic activity/volume] in Serum or Plasma,704
3016774702,measurement during day -365 through 0 days relative to index: Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3016774704,measurement during day -30 through 0 days relative to index: Ampicillin [Susceptibility] by Minimum inhibitory concentration (MIC),704
3016893702,measurement during day -365 through 0 days relative to index: Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3016893704,measurement during day -30 through 0 days relative to index: Erythromycin [Susceptibility] by Minimum inhibitory concentration (MIC),704
3016914702,measurement during day -365 through 0 days relative to index: Bacteria identified in Cerebral spinal fluid by Culture,702
3016914704,measurement during day -30 through 0 days relative to index: Bacteria identified in Cerebral spinal fluid by Culture,704
3016991702,measurement during day -365 through 0 days relative to index: Thyroxine (T4) [Mass/volume] in Serum or Plasma,702
3017028702,measurement during day -365 through 0 days relative to index: Hepatitis B virus DNA [Mass/volume] (viral load) in Serum by Probe with signal amplification,702
3017044702,measurement during day -365 through 0 days relative to index: Thyrotropin receptor Ab [Units/volume] in Serum,702
3017181702,measurement during day -365 through 0 days relative to index: Myelocytes/100 leukocytes in Blood,702
3017181704,measurement during day -30 through 0 days relative to index: Myelocytes/100 leukocytes in Blood,704
3017250702,measurement during day -365 through 0 days relative to index: Creatinine [Mass/volume] in Urine,702
3017250704,measurement during day -30 through 0 days relative to index: Creatinine [Mass/volume] in Urine,704
3017315702,measurement during day -365 through 0 days relative to index: Amylase [Enzymatic activity/volume] in Urine,702
3017315704,measurement during day -30 through 0 days relative to index: Amylase [Enzymatic activity/volume] in Urine,704
3017381702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Unspecified specimen by Rhodamine-auramine fluorochrome stain,702
3017381704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Unspecified specimen by Rhodamine-auramine fluorochrome stain,704
3017558702,measurement during day -365 through 0 days relative to index: Chlamydophila pneumoniae IgM Ab [Presence] in Serum,702
3017558704,measurement during day -30 through 0 days relative to index: Chlamydophila pneumoniae IgM Ab [Presence] in Serum,704
3017569702,measurement during day -365 through 0 days relative to index: Oxygen content in Arterial blood,702
3017569704,measurement during day -30 through 0 days relative to index: Oxygen content in Arterial blood,704
3017732702,measurement during day -365 through 0 days relative to index: Neutrophils [#/volume] in Blood,702
3017732704,measurement during day -30 through 0 days relative to index: Neutrophils [#/volume] in Blood,704
3017766702,measurement during day -365 through 0 days relative to index: Complement C4 [Mass/volume] in Serum or Plasma,702
3018088702,measurement during day -365 through 0 days relative to index: Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3018088704,measurement during day -30 through 0 days relative to index: Vancomycin [Susceptibility] by Minimum inhibitory concentration (MIC),704
3018199702,measurement during day -365 through 0 days relative to index: Band form neutrophils [#/volume] in Blood,702
3018199704,measurement during day -30 through 0 days relative to index: Band form neutrophils [#/volume] in Blood,704
3018677702,measurement during day -365 through 0 days relative to index: aPTT in Platelet poor plasma by Coagulation assay,702
3018677704,measurement during day -30 through 0 days relative to index: aPTT in Platelet poor plasma by Coagulation assay,704
3018718702,measurement during day -365 through 0 days relative to index: Plasma cells/100 leukocytes in Blood,702
3018718704,measurement during day -30 through 0 days relative to index: Plasma cells/100 leukocytes in Blood,704
3018954702,measurement during day -365 through 0 days relative to index: Choriogonadotropin (pregnancy test) [Presence] in Urine,702
3018954704,measurement during day -30 through 0 days relative to index: Choriogonadotropin (pregnancy test) [Presence] in Urine,704
3019029702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Pus by Gram stain,702
3019029704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Pus by Gram stain,704
3019069702,measurement during day -365 through 0 days relative to index: Monocytes/100 leukocytes in Blood,702
3019069704,measurement during day -30 through 0 days relative to index: Monocytes/100 leukocytes in Blood,704
3019169702,measurement during day -365 through 0 days relative to index: Leucine crystals [Presence] in Urine sediment by Light microscopy,702
3019169704,measurement during day -30 through 0 days relative to index: Leucine crystals [Presence] in Urine sediment by Light microscopy,704
3019198702,measurement during day -365 through 0 days relative to index: Lymphocytes [#/volume] in Blood,702
3019198704,measurement during day -30 through 0 days relative to index: Lymphocytes [#/volume] in Blood,704
3019284702,measurement during day -365 through 0 days relative to index: Hepatitis B virus surface Ag [Presence] in Serum,702
3019284704,measurement during day -30 through 0 days relative to index: Hepatitis B virus surface Ag [Presence] in Serum,704
3019800702,measurement during day -365 through 0 days relative to index: Troponin T.cardiac [Mass/volume] in Serum or Plasma,702
3019800704,measurement during day -30 through 0 days relative to index: Troponin T.cardiac [Mass/volume] in Serum or Plasma,704
3019897702,measurement during day -365 through 0 days relative to index: Erythrocyte distribution width [Ratio] by Automated count,702
3019897704,measurement during day -30 through 0 days relative to index: Erythrocyte distribution width [Ratio] by Automated count,704
3019977702,measurement during day -365 through 0 days relative to index: pH of Arterial blood,702
3019977704,measurement during day -30 through 0 days relative to index: pH of Arterial blood,704
3020149702,measurement during day -365 through 0 days relative to index: Calcidiol [Mass/volume] in Serum or Plasma,702
3020275702,measurement during day -365 through 0 days relative to index: Albumin/Globulin [Mass Ratio] in Urine,702
3020275704,measurement during day -30 through 0 days relative to index: Albumin/Globulin [Mass Ratio] in Urine,704
3020316702,measurement during day -365 through 0 days relative to index: Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,702
3020316704,measurement during day -30 through 0 days relative to index: Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay,704
3020318702,measurement during day -365 through 0 days relative to index: Prolymphocytes/100 leukocytes in Blood,702
3020318704,measurement during day -30 through 0 days relative to index: Prolymphocytes/100 leukocytes in Blood,704
3020389702,measurement during day -365 through 0 days relative to index: Ova and parasites identified in Stool by Concentration,702
3020630702,measurement during day -365 through 0 days relative to index: Protein [Mass/volume] in Serum or Plasma,702
3020630704,measurement during day -30 through 0 days relative to index: Protein [Mass/volume] in Serum or Plasma,704
3020891702,measurement during day -365 through 0 days relative to index: Body temperature,702
3021044702,measurement during day -365 through 0 days relative to index: Iron binding capacity [Mass/volume] in Serum or Plasma,702
3021044704,measurement during day -30 through 0 days relative to index: Iron binding capacity [Mass/volume] in Serum or Plasma,704
3021200702,measurement during day -365 through 0 days relative to index: Thyroglobulin Ab [Units/volume] in Serum by Radioimmunoassay (RIA),702
3021236702,measurement during day -365 through 0 days relative to index: Streptolysin O Ab [Units/volume] in Serum or Plasma,702
3021322702,measurement during day -365 through 0 days relative to index: Cryoglobulin [Presence] in Serum,702
3021322704,measurement during day -30 through 0 days relative to index: Cryoglobulin [Presence] in Serum,704
3021331702,measurement during day -365 through 0 days relative to index: Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3021331704,measurement during day -30 through 0 days relative to index: Clindamycin [Susceptibility] by Minimum inhibitory concentration (MIC),704
3021337702,measurement during day -365 through 0 days relative to index: Troponin I.cardiac [Mass/volume] in Serum or Plasma,702
3021337704,measurement during day -30 through 0 days relative to index: Troponin I.cardiac [Mass/volume] in Serum or Plasma,704
3021391702,measurement during day -365 through 0 days relative to index: Anion gap 3 in Serum or Plasma,702
3021391704,measurement during day -30 through 0 days relative to index: Anion gap 3 in Serum or Plasma,704
3021440702,measurement during day -365 through 0 days relative to index: Promyelocytes/100 leukocytes in Blood,702
3021440704,measurement during day -30 through 0 days relative to index: Promyelocytes/100 leukocytes in Blood,704
3021447702,measurement during day -365 through 0 days relative to index: Carbon dioxide [Partial pressure] in Venous blood,702
3021447704,measurement during day -30 through 0 days relative to index: Carbon dioxide [Partial pressure] in Venous blood,704
3021538702,measurement during day -365 through 0 days relative to index: Neutrophils [#/volume] in Pleural fluid,702
3021538704,measurement during day -30 through 0 days relative to index: Neutrophils [#/volume] in Pleural fluid,704
3021601702,measurement during day -365 through 0 days relative to index: Nitrite [Presence] in Urine by Test strip,702
3021601704,measurement during day -30 through 0 days relative to index: Nitrite [Presence] in Urine by Test strip,704
3021614702,measurement during day -365 through 0 days relative to index: Rheumatoid factor [Units/volume] in Serum or Plasma,702
3021737702,measurement during day -365 through 0 days relative to index: Glucose [Mass/volume] in Serum or Plasma --2 hours post meal,702
3021737704,measurement during day -30 through 0 days relative to index: Glucose [Mass/volume] in Serum or Plasma --2 hours post meal,704
3022090702,measurement during day -365 through 0 days relative to index: Fatty casts [Presence] in Urine sediment by Light microscopy,702
3022090704,measurement during day -30 through 0 days relative to index: Fatty casts [Presence] in Urine sediment by Light microscopy,704
3022096702,measurement during day -365 through 0 days relative to index: Basophils/100 leukocytes in Blood,702
3022096704,measurement during day -30 through 0 days relative to index: Basophils/100 leukocytes in Blood,704
3022164702,measurement during day -365 through 0 days relative to index: Urea nitrogen [Mass/volume] in Serum or Plasma --pre dialysis,702
3022164704,measurement during day -30 through 0 days relative to index: Urea nitrogen [Mass/volume] in Serum or Plasma --pre dialysis,704
3022192702,measurement during day -365 through 0 days relative to index: Triglyceride [Mass/volume] in Serum or Plasma,702
3022192704,measurement during day -30 through 0 days relative to index: Triglyceride [Mass/volume] in Serum or Plasma,704
3022217702,measurement during day -365 through 0 days relative to index: INR in Platelet poor plasma by Coagulation assay,702
3022217704,measurement during day -30 through 0 days relative to index: INR in Platelet poor plasma by Coagulation assay,704
3022243702,measurement during day -365 through 0 days relative to index: Creatinine [Mass/volume] in Serum or Plasma --pre dialysis,702
3022243704,measurement during day -30 through 0 days relative to index: Creatinine [Mass/volume] in Serum or Plasma --pre dialysis,704
3022250702,measurement during day -365 through 0 days relative to index: Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction,702
3022250704,measurement during day -30 through 0 days relative to index: Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction,704
3022270702,measurement during day -365 through 0 days relative to index: Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC),702
3022270704,measurement during day -30 through 0 days relative to index: Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC),704
3022327702,measurement during day -365 through 0 days relative to index: Calcium phosphate crystals [Presence] in Urine sediment by Light microscopy,702
3022327704,measurement during day -30 through 0 days relative to index: Calcium phosphate crystals [Presence] in Urine sediment by Light microscopy,704
3022548702,measurement during day -365 through 0 days relative to index: Glucose [Mass/volume] in Cerebral spinal fluid,702
3022548704,measurement during day -30 through 0 days relative to index: Glucose [Mass/volume] in Cerebral spinal fluid,704
3022756702,measurement during day -365 through 0 days relative to index: Ceruloplasmin [Mass/volume] in Serum or Plasma,702
3022767702,measurement during day -365 through 0 days relative to index: Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3022767704,measurement during day -30 through 0 days relative to index: Penicillin [Susceptibility] by Minimum inhibitory concentration (MIC),704
3022914702,measurement during day -365 through 0 days relative to index: Cancer Ag 19-9 [Units/volume] in Serum or Plasma,702
3023199702,measurement during day -365 through 0 days relative to index: Leukocytes [#/volume] in Pleural fluid,702
3023199704,measurement during day -30 through 0 days relative to index: Leukocytes [#/volume] in Pleural fluid,704
3023230702,measurement during day -365 through 0 days relative to index: Hematocrit [Volume Fraction] of Arterial blood,702
3023230704,measurement during day -30 through 0 days relative to index: Hematocrit [Volume Fraction] of Arterial blood,704
3023314702,measurement during day -365 through 0 days relative to index: Hematocrit [Volume Fraction] of Blood by Automated count,702
3023314704,measurement during day -30 through 0 days relative to index: Hematocrit [Volume Fraction] of Blood by Automated count,704
3023378702,measurement during day -365 through 0 days relative to index: Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,702
3023414702,measurement during day -365 through 0 days relative to index: Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC),702
3023414704,measurement during day -30 through 0 days relative to index: Amoxicillin+Clavulanate [Susceptibility] by Minimum inhibitory concentration (MIC),704
3023419702,measurement during day -365 through 0 days relative to index: Bacteria identified in Sputum by Culture,702
3023419704,measurement during day -30 through 0 days relative to index: Bacteria identified in Sputum by Culture,704
3023633702,measurement during day -365 through 0 days relative to index: Piperacillin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3023633704,measurement during day -30 through 0 days relative to index: Piperacillin [Susceptibility] by Minimum inhibitory concentration (MIC),704
3023993702,measurement during day -365 through 0 days relative to index: Large unstained cells [#/volume] in Blood,702
3023993704,measurement during day -30 through 0 days relative to index: Large unstained cells [#/volume] in Blood,704
3024093702,measurement during day -365 through 0 days relative to index: Fungi.yeastlike [#/area] in Urine sediment by Microscopy high power field,702
3024093704,measurement during day -30 through 0 days relative to index: Fungi.yeastlike [#/area] in Urine sediment by Microscopy high power field,704
3024128702,measurement during day -365 through 0 days relative to index: Bilirubin.total [Mass/volume] in Serum or Plasma,702
3024128704,measurement during day -30 through 0 days relative to index: Bilirubin.total [Mass/volume] in Serum or Plasma,704
3024171702,measurement during day -365 through 0 days relative to index: Respiratory rate,702
3024194702,measurement during day -365 through 0 days relative to index: Bacteria identified in Pleural fluid by Culture,702
3024194704,measurement during day -30 through 0 days relative to index: Bacteria identified in Pleural fluid by Culture,704
3024212702,measurement during day -365 through 0 days relative to index: Fungus identified in Bronchial specimen by Culture,702
3024212704,measurement during day -30 through 0 days relative to index: Fungus identified in Bronchial specimen by Culture,704
3024277702,measurement during day -365 through 0 days relative to index: Reverse ABO group [Type],702
3024277704,measurement during day -30 through 0 days relative to index: Reverse ABO group [Type],704
3024354702,measurement during day -365 through 0 days relative to index: Oxygen [Partial pressure] in Venous blood,702
3024354704,measurement during day -30 through 0 days relative to index: Oxygen [Partial pressure] in Venous blood,704
3024561702,measurement during day -365 through 0 days relative to index: Albumin [Mass/volume] in Serum or Plasma,702
3024561704,measurement during day -30 through 0 days relative to index: Albumin [Mass/volume] in Serum or Plasma,704
3024731702,measurement during day -365 through 0 days relative to index: MCV [Entitic volume],702
3024731704,measurement during day -30 through 0 days relative to index: MCV [Entitic volume],704
3024850702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Urine by Acid fast stain,702
3024850704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Urine by Acid fast stain,704
3024928702,measurement during day -365 through 0 days relative to index: Oxygen saturation in Venous blood,702
3024928704,measurement during day -30 through 0 days relative to index: Oxygen saturation in Venous blood,704
3025159702,measurement during day -365 through 0 days relative to index: Blasts/100 leukocytes in Blood,702
3025159704,measurement during day -30 through 0 days relative to index: Blasts/100 leukocytes in Blood,704
3025233702,measurement during day -365 through 0 days relative to index: Bacteria identified in Sputum by Aerobe culture,702
3025255702,measurement during day -365 through 0 days relative to index: Bacteria [#/area] in Urine sediment by Microscopy high power field,702
3025255704,measurement during day -30 through 0 days relative to index: Bacteria [#/area] in Urine sediment by Microscopy high power field,704
3025941702,measurement during day -365 through 0 days relative to index: Bacteria identified in Stool by Culture,702
3025941704,measurement during day -30 through 0 days relative to index: Bacteria identified in Stool by Culture,704
3026008702,measurement during day -365 through 0 days relative to index: Bacteria identified in Urine by Culture,702
3026008704,measurement during day -30 through 0 days relative to index: Bacteria identified in Urine by Culture,704
3026327702,measurement during day -365 through 0 days relative to index: Cholesterol crystals [Presence] in Urine sediment by Light microscopy,702
3026327704,measurement during day -30 through 0 days relative to index: Cholesterol crystals [Presence] in Urine sediment by Light microscopy,704
3026355702,measurement during day -365 through 0 days relative to index: Reagin Ab [Units/volume] in Serum by RPR,702
3026355704,measurement during day -30 through 0 days relative to index: Reagin Ab [Units/volume] in Serum by RPR,704
3026361702,measurement during day -365 through 0 days relative to index: Erythrocytes [#/volume] in Blood,702
3026361704,measurement during day -30 through 0 days relative to index: Erythrocytes [#/volume] in Blood,704
3026478702,measurement during day -365 through 0 days relative to index: Mycobacterium tuberculosis DNA [Presence] in Urine by NAA with probe detection,702
3026665702,measurement during day -365 through 0 days relative to index: Alpha 1 globulin/Protein.total in Urine by Electrophoresis,702
3026665704,measurement during day -30 through 0 days relative to index: Alpha 1 globulin/Protein.total in Urine by Electrophoresis,704
3026691702,measurement during day -365 through 0 days relative to index: Erythrocytes [Morphology] in Cerebral spinal fluid by Light microscopy,702
3026691704,measurement during day -30 through 0 days relative to index: Erythrocytes [Morphology] in Cerebral spinal fluid by Light microscopy,704
3026692702,measurement during day -365 through 0 days relative to index: Albumin [Mass/volume] in Peritoneal fluid,702
3026692704,measurement during day -30 through 0 days relative to index: Albumin [Mass/volume] in Peritoneal fluid,704
3026782702,measurement during day -365 through 0 days relative to index: Osmolality of Urine,702
3026910702,measurement during day -365 through 0 days relative to index: Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,702
3026910704,measurement during day -30 through 0 days relative to index: Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma,704
3027114702,measurement during day -365 through 0 days relative to index: Cholesterol [Mass/volume] in Serum or Plasma,702
3027114704,measurement during day -30 through 0 days relative to index: Cholesterol [Mass/volume] in Serum or Plasma,704
3027206702,measurement during day -365 through 0 days relative to index: Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA),702
3027273702,measurement during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] in Venous blood,702
3027273704,measurement during day -30 through 0 days relative to index: Bicarbonate [Moles/volume] in Venous blood,704
3027346702,measurement during day -365 through 0 days relative to index: Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,702
3027484702,measurement during day -365 through 0 days relative to index: Hemoglobin [Mass/volume] in Blood by calculation,702
3027484704,measurement during day -30 through 0 days relative to index: Hemoglobin [Mass/volume] in Blood by calculation,704
3027597702,measurement during day -365 through 0 days relative to index: Bilirubin.direct [Mass/volume] in Serum or Plasma,702
3027597704,measurement during day -30 through 0 days relative to index: Bilirubin.direct [Mass/volume] in Serum or Plasma,704
3027744702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain,702
3027744704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain,704
3027801702,measurement during day -365 through 0 days relative to index: Oxygen [Partial pressure] in Arterial blood,702
3027801704,measurement during day -30 through 0 days relative to index: Oxygen [Partial pressure] in Arterial blood,704
3027813702,measurement during day -365 through 0 days relative to index: Mycobacterium tuberculosis DNA [Presence] in Sputum by NAA with probe detection,702
3027945702,measurement during day -365 through 0 days relative to index: Reticulocytes/100 erythrocytes in Blood,702
3027945704,measurement during day -30 through 0 days relative to index: Reticulocytes/100 erythrocytes in Blood,704
3027946702,measurement during day -365 through 0 days relative to index: Carbon dioxide [Partial pressure] in Arterial blood,702
3027946704,measurement during day -30 through 0 days relative to index: Carbon dioxide [Partial pressure] in Arterial blood,704
3028026702,measurement during day -365 through 0 days relative to index: IgM [Mass/volume] in Serum or Plasma,702
3028308702,measurement during day -365 through 0 days relative to index: Erythrocytes [#/volume] in Pleural fluid,702
3028308704,measurement during day -30 through 0 days relative to index: Erythrocytes [#/volume] in Pleural fluid,704
3028437702,measurement during day -365 through 0 days relative to index: Cholesterol in LDL [Mass/volume] in Serum or Plasma,702
3028437704,measurement during day -30 through 0 days relative to index: Cholesterol in LDL [Mass/volume] in Serum or Plasma,704
3028558702,measurement during day -365 through 0 days relative to index: Alpha 2 globulin/Protein.total in Urine by Electrophoresis,702
3028558704,measurement during day -30 through 0 days relative to index: Alpha 2 globulin/Protein.total in Urine by Electrophoresis,704
3029103702,measurement during day -365 through 0 days relative to index: Nuclear Ab [Presence] in Serum by Immunofluorescence,702
3029162702,measurement during day -365 through 0 days relative to index: Epithelial cells.squamous [#/area] in Urine sediment by Automated count,702
3029162704,measurement during day -30 through 0 days relative to index: Epithelial cells.squamous [#/area] in Urine sediment by Automated count,704
3029187702,measurement during day -365 through 0 days relative to index: Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma,702
3029187704,measurement during day -30 through 0 days relative to index: Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma,704
3029305702,measurement during day -365 through 0 days relative to index: pH of Urine by Automated test strip,702
3029305704,measurement during day -30 through 0 days relative to index: pH of Urine by Automated test strip,704
3029707702,measurement during day -365 through 0 days relative to index: Crystals [#/volume] in Urine by Automated count,702
3029707704,measurement during day -30 through 0 days relative to index: Crystals [#/volume] in Urine by Automated count,704
3029925702,measurement during day -365 through 0 days relative to index: Color of Urine by Auto,702
3029925704,measurement during day -30 through 0 days relative to index: Color of Urine by Auto,704
3030260702,measurement during day -365 through 0 days relative to index: Glucose [Presence] in Urine by Automated test strip,702
3030260704,measurement during day -30 through 0 days relative to index: Glucose [Presence] in Urine by Automated test strip,704
3030366702,measurement during day -365 through 0 days relative to index: Cystatin C [Mass/volume] in Serum or Plasma,702
3030477702,measurement during day -365 through 0 days relative to index: Bilirubin.total [Presence] in Urine by Automated test strip,702
3030477704,measurement during day -30 through 0 days relative to index: Bilirubin.total [Presence] in Urine by Automated test strip,704
3030902702,measurement during day -365 through 0 days relative to index: Basophils [#/volume] in Pleural fluid,702
3030902704,measurement during day -30 through 0 days relative to index: Basophils [#/volume] in Pleural fluid,704
3031165702,measurement during day -365 through 0 days relative to index: Plasma cells [#/volume] in Body fluid,702
3031165704,measurement during day -30 through 0 days relative to index: Plasma cells [#/volume] in Body fluid,704
3031248702,measurement during day -365 through 0 days relative to index: Chloride [Moles/volume] in Arterial blood,702
3031248704,measurement during day -30 through 0 days relative to index: Chloride [Moles/volume] in Arterial blood,704
3031354702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Cerebral spinal fluid by Cyto stain,702
3031354704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Cerebral spinal fluid by Cyto stain,704
3031368702,measurement during day -365 through 0 days relative to index: Variant lymphocytes/100 leukocytes in Blood by Automated count,702
3031368704,measurement during day -30 through 0 days relative to index: Variant lymphocytes/100 leukocytes in Blood by Automated count,704
3031481702,measurement during day -365 through 0 days relative to index: Blasts [#/volume] in Pleural fluid,702
3031481704,measurement during day -30 through 0 days relative to index: Blasts [#/volume] in Pleural fluid,704
3031735702,measurement during day -365 through 0 days relative to index: Monocytes [#/volume] in Pleural fluid,702
3031735704,measurement during day -30 through 0 days relative to index: Monocytes [#/volume] in Pleural fluid,704
3032072702,measurement during day -365 through 0 days relative to index: Eosinophils [#/volume] in Pleural fluid,702
3032072704,measurement during day -30 through 0 days relative to index: Eosinophils [#/volume] in Pleural fluid,704
3032077702,measurement during day -365 through 0 days relative to index: Neutrophil cytoplasmic Ab [Presence] in Serum by Immunofluorescence,702
3032567702,measurement during day -365 through 0 days relative to index: Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,702
3033308702,measurement during day -365 through 0 days relative to index: Hyaline casts [Presence] in Urine sediment by Light microscopy,702
3033308704,measurement during day -30 through 0 days relative to index: Hyaline casts [Presence] in Urine sediment by Light microscopy,704
3033336702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Peritoneal fluid by Gram stain,702
3033336704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Peritoneal fluid by Gram stain,704
3033486702,measurement during day -365 through 0 days relative to index: Oval fat bodies (globules) [Presence] in Urine sediment by Light microscopy,702
3033486704,measurement during day -30 through 0 days relative to index: Oval fat bodies (globules) [Presence] in Urine sediment by Light microscopy,704
3033490702,measurement during day -365 through 0 days relative to index: Tobramycin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3033558702,measurement during day -365 through 0 days relative to index: Quinupristin+Dalfopristin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3033558704,measurement during day -30 through 0 days relative to index: Quinupristin+Dalfopristin [Susceptibility] by Minimum inhibitory concentration (MIC),704
3033658702,measurement during day -365 through 0 days relative to index: Prothrombin time (PT) actual/Normal,702
3033658704,measurement during day -30 through 0 days relative to index: Prothrombin time (PT) actual/Normal,704
3033705702,measurement during day -365 through 0 days relative to index: Calcium.ionized [Moles/volume] in Venous blood,702
3033705704,measurement during day -30 through 0 days relative to index: Calcium.ionized [Moles/volume] in Venous blood,704
3033745702,measurement during day -365 through 0 days relative to index: Troponin I.cardiac [Mass/volume] in Blood,702
3033745704,measurement during day -30 through 0 days relative to index: Troponin I.cardiac [Mass/volume] in Blood,704
3034104702,measurement during day -365 through 0 days relative to index: Urea nitrogen [Mass/volume] in Serum or Plasma --post dialysis,702
3034104704,measurement during day -30 through 0 days relative to index: Urea nitrogen [Mass/volume] in Serum or Plasma --post dialysis,704
3034426702,measurement during day -365 through 0 days relative to index: Prothrombin time (PT),702
3034426704,measurement during day -30 through 0 days relative to index: Prothrombin time (PT),704
3034442702,measurement during day -365 through 0 days relative to index: cefTRIAXone [Susceptibility] by Minimum inhibitory concentration (MIC),702
3034530702,measurement during day -365 through 0 days relative to index: Glucose [Mass/volume] in Blood --2 hours post meal,702
3034592702,measurement during day -365 through 0 days relative to index: Telithromycin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3034592704,measurement during day -30 through 0 days relative to index: Telithromycin [Susceptibility] by Minimum inhibitory concentration (MIC),704
3034708702,measurement during day -365 through 0 days relative to index: Nucleated erythrocytes/100 leukocytes [Ratio] in Blood,702
3034708704,measurement during day -30 through 0 days relative to index: Nucleated erythrocytes/100 leukocytes [Ratio] in Blood,704
3034776702,measurement during day -365 through 0 days relative to index: A Ag [Presence] on Red Blood Cells,702
3034776704,measurement during day -30 through 0 days relative to index: A Ag [Presence] on Red Blood Cells,704
3034976702,measurement during day -365 through 0 days relative to index: Hematocrit [Volume Fraction] of Venous blood,702
3034976704,measurement during day -30 through 0 days relative to index: Hematocrit [Volume Fraction] of Venous blood,704
3035133702,measurement during day -365 through 0 days relative to index: Fungus identified in Wound by Culture,702
3035133704,measurement during day -30 through 0 days relative to index: Fungus identified in Wound by Culture,704
3035285702,measurement during day -365 through 0 days relative to index: Chloride [Moles/volume] in Venous blood,702
3035285704,measurement during day -30 through 0 days relative to index: Chloride [Moles/volume] in Venous blood,704
3035551702,measurement during day -365 through 0 days relative to index: levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3035551704,measurement during day -30 through 0 days relative to index: levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC),704
3035583702,measurement during day -365 through 0 days relative to index: Leukocytes [#/area] in Urine sediment by Microscopy high power field,702
3035583704,measurement during day -30 through 0 days relative to index: Leukocytes [#/area] in Urine sediment by Microscopy high power field,704
3035643702,measurement during day -365 through 0 days relative to index: Imipenem [Susceptibility] by Minimum inhibitory concentration (MIC),702
3035643704,measurement during day -30 through 0 days relative to index: Imipenem [Susceptibility] by Minimum inhibitory concentration (MIC),704
3035768702,measurement during day -365 through 0 days relative to index: Promonocytes/100 leukocytes in Blood,702
3035768704,measurement during day -30 through 0 days relative to index: Promonocytes/100 leukocytes in Blood,704
3035814702,measurement during day -365 through 0 days relative to index: Ertapenem [Susceptibility] by Minimum inhibitory concentration (MIC),702
3035814704,measurement during day -30 through 0 days relative to index: Ertapenem [Susceptibility] by Minimum inhibitory concentration (MIC),704
3035851702,measurement during day -365 through 0 days relative to index: Transitional cells [#/area] in Urine sediment by Microscopy high power field,702
3035851704,measurement during day -30 through 0 days relative to index: Transitional cells [#/area] in Urine sediment by Microscopy high power field,704
3035941702,measurement during day -365 through 0 days relative to index: MCH [Entitic mass],702
3035941704,measurement during day -30 through 0 days relative to index: MCH [Entitic mass],704
3035995702,measurement during day -365 through 0 days relative to index: Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,702
3035995704,measurement during day -30 through 0 days relative to index: Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma,704
3036339702,measurement during day -365 through 0 days relative to index: rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3036339704,measurement during day -30 through 0 days relative to index: rifAMPin [Susceptibility] by Minimum inhibitory concentration (MIC),704
3036405702,measurement during day -365 through 0 days relative to index: Mupirocin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3036405704,measurement during day -30 through 0 days relative to index: Mupirocin [Susceptibility] by Minimum inhibitory concentration (MIC),704
3036428702,measurement during day -365 through 0 days relative to index: Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid,702
3036428704,measurement during day -30 through 0 days relative to index: Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid,704
3036535702,measurement during day -365 through 0 days relative to index: Thyroglobulin [Mass/volume] in Serum or Plasma,702
3036806702,measurement during day -365 through 0 days relative to index: Hepatitis B virus e Ab [Presence] in Serum or Plasma by Immunoassay,702
3036882702,measurement during day -365 through 0 days relative to index: Urate crystals [Presence] in Urine sediment by Light microscopy,702
3036882704,measurement during day -30 through 0 days relative to index: Urate crystals [Presence] in Urine sediment by Light microscopy,704
3036987702,measurement during day -365 through 0 days relative to index: Folate [Mass/volume] in Serum or Plasma,702
3036987704,measurement during day -30 through 0 days relative to index: Folate [Mass/volume] in Serum or Plasma,704
3037121702,measurement during day -365 through 0 days relative to index: Protein [Mass/volume] in Urine,702
3037121704,measurement during day -30 through 0 days relative to index: Protein [Mass/volume] in Urine,704
3037167702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Unspecified specimen by Gram stain,702
3037167704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Unspecified specimen by Gram stain,704
3037185702,measurement during day -365 through 0 days relative to index: Protein [Presence] in Urine,702
3037185704,measurement during day -30 through 0 days relative to index: Protein [Presence] in Urine,704
3037501702,measurement during day -365 through 0 days relative to index: Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3037501704,measurement during day -30 through 0 days relative to index: Nitrofurantoin [Susceptibility] by Minimum inhibitory concentration (MIC),704
3037549702,measurement during day -365 through 0 days relative to index: cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC),702
3037549704,measurement during day -30 through 0 days relative to index: cefTAZidime [Susceptibility] by Minimum inhibitory concentration (MIC),704
3037556702,measurement during day -365 through 0 days relative to index: Urate [Mass/volume] in Serum or Plasma,702
3037556704,measurement during day -30 through 0 days relative to index: Urate [Mass/volume] in Serum or Plasma,704
3037558702,measurement during day -365 through 0 days relative to index: Colistin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3037558704,measurement during day -30 through 0 days relative to index: Colistin [Susceptibility] by Minimum inhibitory concentration (MIC),704
3037663702,"measurement during day -365 through 0 days relative to index: Carbon dioxide, total [Moles/volume] in Arterial blood by calculation",702
3037663704,"measurement during day -30 through 0 days relative to index: Carbon dioxide, total [Moles/volume] in Arterial blood by calculation",704
3037908702,measurement during day -365 through 0 days relative to index: Alkaline phosphatase isoenzymes [Interpretation] in Serum or Plasma,702
3037908704,measurement during day -30 through 0 days relative to index: Alkaline phosphatase isoenzymes [Interpretation] in Serum or Plasma,704
3037971702,measurement during day -365 through 0 days relative to index: Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC),702
3037971704,measurement during day -30 through 0 days relative to index: Tigecycline [Susceptibility] by Minimum inhibitory concentration (MIC),704
3038106702,measurement during day -365 through 0 days relative to index: Epithelial casts [Presence] in Urine sediment by Light microscopy,702
3038106704,measurement during day -30 through 0 days relative to index: Epithelial casts [Presence] in Urine sediment by Light microscopy,704
3038315702,measurement during day -365 through 0 days relative to index: Erythrocytes.dysmorphic/100 erythrocytes in Urine sediment by Light microscopy,702
3038315704,measurement during day -30 through 0 days relative to index: Erythrocytes.dysmorphic/100 erythrocytes in Urine sediment by Light microscopy,704
3038328702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Sputum by Rhodamine-auramine fluorochrome stain,702
3038328704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Sputum by Rhodamine-auramine fluorochrome stain,704
3038553702,measurement during day -365 through 0 days relative to index: Body mass index (BMI) [Ratio],702
3038553704,measurement during day -30 through 0 days relative to index: Body mass index (BMI) [Ratio],704
3038636702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Cerebral spinal fluid by Rhodamine-auramine fluorochrome stain,702
3038636704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Cerebral spinal fluid by Rhodamine-auramine fluorochrome stain,704
3039000702,measurement during day -365 through 0 days relative to index: Anion gap in Blood,702
3039000704,measurement during day -30 through 0 days relative to index: Anion gap in Blood,704
3039057702,measurement during day -365 through 0 days relative to index: Leukocytes [#/area] in Stool by Microscopy high power field,702
3039057704,measurement during day -30 through 0 days relative to index: Leukocytes [#/area] in Stool by Microscopy high power field,704
3039312702,measurement during day -365 through 0 days relative to index: Plateletocrit [Volume Fraction] in Blood,702
3039312704,measurement during day -30 through 0 days relative to index: Plateletocrit [Volume Fraction] in Blood,704
3039413702,measurement during day -365 through 0 days relative to index: Cefuroxime [Susceptibility] by Minimum inhibitory concentration (MIC),702
3039417702,measurement during day -365 through 0 days relative to index: Platelet distribution width [Ratio] in Blood,702
3039417704,measurement during day -30 through 0 days relative to index: Platelet distribution width [Ratio] in Blood,704
3039448702,measurement during day -365 through 0 days relative to index: Bacteria identified in Bile fluid by Culture,702
3039448704,measurement during day -30 through 0 days relative to index: Bacteria identified in Bile fluid by Culture,704
3039919702,measurement during day -365 through 0 days relative to index: Specific gravity of Urine by Automated test strip,702
3039919704,measurement during day -30 through 0 days relative to index: Specific gravity of Urine by Automated test strip,704
3040147702,measurement during day -365 through 0 days relative to index: Neutrophil cytoplasmic Ab [Titer] in Serum by Immunofluorescence,702
3040147704,measurement during day -30 through 0 days relative to index: Neutrophil cytoplasmic Ab [Titer] in Serum by Immunofluorescence,704
3040317702,measurement during day -365 through 0 days relative to index: Sodium urate crystals [Presence] in Urine sediment by Light microscopy,702
3040317704,measurement during day -30 through 0 days relative to index: Sodium urate crystals [Presence] in Urine sediment by Light microscopy,704
3040827702,measurement during day -365 through 0 days relative to index: Bacteria identified in Anal by Culture,702
3040827704,measurement during day -30 through 0 days relative to index: Bacteria identified in Anal by Culture,704
3041096702,measurement during day -365 through 0 days relative to index: Erythrocytes [Presence] in Urine by Automated,702
3041096704,measurement during day -30 through 0 days relative to index: Erythrocytes [Presence] in Urine by Automated,704
3041097702,measurement during day -365 through 0 days relative to index: Spermatozoa [#/area] in Urine sediment by Automated count,702
3041097704,measurement during day -30 through 0 days relative to index: Spermatozoa [#/area] in Urine sediment by Automated count,704
3041354702,measurement during day -365 through 0 days relative to index: Potassium [Moles/volume] in Venous blood,702
3041354704,measurement during day -30 through 0 days relative to index: Potassium [Moles/volume] in Venous blood,704
3041383702,measurement during day -365 through 0 days relative to index: Bacteria identified in Gastric fluid by Culture,702
3041383704,measurement during day -30 through 0 days relative to index: Bacteria identified in Gastric fluid by Culture,704
3041412702,measurement during day -365 through 0 days relative to index: Epithelial cells.non-squamous [#/area] in Urine sediment by Automated count,702
3041412704,measurement during day -30 through 0 days relative to index: Epithelial cells.non-squamous [#/area] in Urine sediment by Automated count,704
3041473702,measurement during day -365 through 0 days relative to index: Sodium [Moles/volume] in Venous blood,702
3041473704,measurement during day -30 through 0 days relative to index: Sodium [Moles/volume] in Venous blood,704
3041748702,measurement during day -365 through 0 days relative to index: Fungus identified in Urine by Culture,702
3041748704,measurement during day -30 through 0 days relative to index: Fungus identified in Urine by Culture,704
3042857702,measurement during day -365 through 0 days relative to index: Mean peroxidase activity index [Presence] in Blood,702
3042857704,measurement during day -30 through 0 days relative to index: Mean peroxidase activity index [Presence] in Blood,704
3043263702,measurement during day -365 through 0 days relative to index: Urate crystals [#/area] in Urine sediment by Microscopy high power field,702
3043263704,measurement during day -30 through 0 days relative to index: Urate crystals [#/area] in Urine sediment by Microscopy high power field,704
3043409702,measurement during day -365 through 0 days relative to index: Potassium [Moles/volume] in Arterial blood,702
3043409704,measurement during day -30 through 0 days relative to index: Potassium [Moles/volume] in Arterial blood,704
3043695702,measurement during day -365 through 0 days relative to index: Oval fat bodies (globules) [#/area] in Urine sediment by Automated count,702
3043695704,measurement during day -30 through 0 days relative to index: Oval fat bodies (globules) [#/area] in Urine sediment by Automated count,704
3043706702,measurement during day -365 through 0 days relative to index: Sodium [Moles/volume] in Arterial blood,702
3043706704,measurement during day -30 through 0 days relative to index: Sodium [Moles/volume] in Arterial blood,704
3044141702,measurement during day -365 through 0 days relative to index: Influenza virus A Ag [Presence] in Nasopharynx,702
3044141704,measurement during day -30 through 0 days relative to index: Influenza virus A Ag [Presence] in Nasopharynx,704
3044331702,measurement during day -365 through 0 days relative to index: Calcium.ionized [Moles/volume] in Arterial blood,702
3044331704,measurement during day -30 through 0 days relative to index: Calcium.ionized [Moles/volume] in Arterial blood,704
3044408702,measurement during day -365 through 0 days relative to index: Influenza virus A+B Ag [Presence] in Nose,702
3044408704,measurement during day -30 through 0 days relative to index: Influenza virus A+B Ag [Presence] in Nose,704
3044620702,measurement during day -365 through 0 days relative to index: Acarboxyprothrombin [Mass/volume] in Serum or Plasma,702
3044862702,measurement during day -365 through 0 days relative to index: Parasites [#/area] in Urine sediment by Microscopy low power field,702
3044862704,measurement during day -30 through 0 days relative to index: Parasites [#/area] in Urine sediment by Microscopy low power field,704
3044936702,measurement during day -365 through 0 days relative to index: Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay,702
3044936704,measurement during day -30 through 0 days relative to index: Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay,704
3045068702,measurement during day -365 through 0 days relative to index: Mycoplasma pneumoniae IgG Ab [Presence] in Serum by Immunoassay,702
3045068704,measurement during day -30 through 0 days relative to index: Mycoplasma pneumoniae IgG Ab [Presence] in Serum by Immunoassay,704
3045414702,measurement during day -365 through 0 days relative to index: Leukocytes [Presence] in Urine,702
3045414704,measurement during day -30 through 0 days relative to index: Leukocytes [Presence] in Urine,704
3045424702,measurement during day -365 through 0 days relative to index: Erythrocytes [Presence] in Urine,702
3045424704,measurement during day -30 through 0 days relative to index: Erythrocytes [Presence] in Urine,704
3045646702,measurement during day -365 through 0 days relative to index: Triple phosphate crystals [#/area] in Urine sediment by Microscopy high power field,702
3045646704,measurement during day -30 through 0 days relative to index: Triple phosphate crystals [#/area] in Urine sediment by Microscopy high power field,704
3045831702,measurement during day -365 through 0 days relative to index: Influenza virus B Ag [Presence] in Nasopharynx,702
3045831704,measurement during day -30 through 0 days relative to index: Influenza virus B Ag [Presence] in Nasopharynx,704
3045874702,measurement during day -365 through 0 days relative to index: Casts [#/area] in Urine sediment by Automated count,702
3045874704,measurement during day -30 through 0 days relative to index: Casts [#/area] in Urine sediment by Automated count,704
3046861702,measurement during day -365 through 0 days relative to index: Legionella sp Ag [Presence] in Urine,702
3046861704,measurement during day -30 through 0 days relative to index: Legionella sp Ag [Presence] in Urine,704
3049111702,measurement during day -365 through 0 days relative to index: Enolase.neuron specific [Mass/volume] in Body fluid,702
3049111704,measurement during day -30 through 0 days relative to index: Enolase.neuron specific [Mass/volume] in Body fluid,704
3049133702,"measurement during day -365 through 0 days relative to index: Carbon dioxide, total [Moles/volume] in Venous blood by calculation",702
3049133704,"measurement during day -30 through 0 days relative to index: Carbon dioxide, total [Moles/volume] in Venous blood by calculation",704
3049473702,measurement during day -365 through 0 days relative to index: Enolase.neuron specific [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA),702
3049473704,measurement during day -30 through 0 days relative to index: Enolase.neuron specific [Mass/volume] in Serum or Plasma by Radioimmunoassay (RIA),704
3050627702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Urine by Rhodamine-auramine fluorochrome stain,702
3050627704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Urine by Rhodamine-auramine fluorochrome stain,704
3050896702,measurement during day -365 through 0 days relative to index: Arbekacin [Susceptibility] by Minimum inhibitory concentration (MIC),702
3050896704,measurement during day -30 through 0 days relative to index: Arbekacin [Susceptibility] by Minimum inhibitory concentration (MIC),704
3051269702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Bronchial specimen by Rhodamine-auramine fluorochrome stain,702
3051269704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Bronchial specimen by Rhodamine-auramine fluorochrome stain,704
3052648702,measurement during day -365 through 0 days relative to index: Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma by Immunoassay,702
3052648704,measurement during day -30 through 0 days relative to index: Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma by Immunoassay,704
4001171210,condition_era group during day -365 through 0 days relative to index: Liver cell carcinoma,210
4001171212,condition_era group during day -30 through 0 days relative to index: Liver cell carcinoma,212
4006969210,condition_era group during day -365 through 0 days relative to index: Acute respiratory disease,210
4006969212,condition_era group during day -30 through 0 days relative to index: Acute respiratory disease,212
4008576210,condition_era group during day -365 through 0 days relative to index: Diabetes mellitus without complication,210
4008576212,condition_era group during day -30 through 0 days relative to index: Diabetes mellitus without complication,212
4008955602,device_exposure during day -365 through 0 days relative to index: Surgical saw,602
4012809502,procedure_occurrence during day -365 through 0 days relative to index: Dementia test,502
4014781210,condition_era group during day -365 through 0 days relative to index: Closed traumatic subdural hemorrhage,210
4014781212,condition_era group during day -30 through 0 days relative to index: Closed traumatic subdural hemorrhage,212
4017107210,condition_era group during day -365 through 0 days relative to index: Traumatic subdural hemorrhage,210
4017107212,condition_era group during day -30 through 0 days relative to index: Traumatic subdural hemorrhage,212
4018852210,condition_era group during day -365 through 0 days relative to index: Acute genitourinary disorder,210
4018852212,condition_era group during day -30 through 0 days relative to index: Acute genitourinary disorder,212
4021989502,procedure_occurrence during day -365 through 0 days relative to index: Stereotactic radiosurgery,502
4023557602,device_exposure during day -365 through 0 days relative to index: Filter,602
4023557604,device_exposure during day -30 through 0 days relative to index: Filter,604
4024289502,procedure_occurrence during day -365 through 0 days relative to index: Radiography of ankle,502
4027663210,condition_era group during day -365 through 0 days relative to index: Peptic ulcer,210
4027663212,condition_era group during day -30 through 0 days relative to index: Peptic ulcer,212
4028062210,condition_era group during day -365 through 0 days relative to index: Infectious disease of abdomen,210
4028062212,condition_era group during day -30 through 0 days relative to index: Infectious disease of abdomen,212
4028242210,condition_era group during day -365 through 0 days relative to index: Chronic duodenal ulcer,210
4028242212,condition_era group during day -30 through 0 days relative to index: Chronic duodenal ulcer,212
4028253210,condition_era group during day -365 through 0 days relative to index: Neoplasm of digestive system,210
4028253212,condition_era group during day -30 through 0 days relative to index: Neoplasm of digestive system,212
4028876210,condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of lower respiratory tract,210
4028876212,condition_era group during day -30 through 0 days relative to index: Inflammatory disorder of lower respiratory tract,212
4029498210,condition_era group during day -365 through 0 days relative to index: Seizure disorder,210
4029498212,condition_era group during day -30 through 0 days relative to index: Seizure disorder,212
4029715502,procedure_occurrence during day -365 through 0 days relative to index: Radiation oncology AND/OR radiotherapy,502
4029715504,procedure_occurrence during day -30 through 0 days relative to index: Radiation oncology AND/OR radiotherapy,504
4030518210,condition_era group during day -365 through 0 days relative to index: Renal impairment,210
4030518212,condition_era group during day -30 through 0 days relative to index: Renal impairment,212
4032240502,procedure_occurrence during day -365 through 0 days relative to index: Respiratory tract rehabilitation procedure,502
4032240504,procedure_occurrence during day -30 through 0 days relative to index: Respiratory tract rehabilitation procedure,504
4035325502,procedure_occurrence during day -365 through 0 days relative to index: Infant development screening,502
4036803502,procedure_occurrence during day -365 through 0 days relative to index: General examination of patient,502
4037672502,procedure_occurrence during day -365 through 0 days relative to index: Ultrasonography,502
4037760502,"procedure_occurrence during day -365 through 0 days relative to index: Laboratory procedure, review by pathologist",502
4037760504,"procedure_occurrence during day -30 through 0 days relative to index: Laboratory procedure, review by pathologist",504
4040383502,procedure_occurrence during day -365 through 0 days relative to index: Functional training,502
4040580502,procedure_occurrence during day -365 through 0 days relative to index: Making of shielding block for radiotherapy,502
4040580504,procedure_occurrence during day -30 through 0 days relative to index: Making of shielding block for radiotherapy,504
4041664210,condition_era group during day -365 through 0 days relative to index: Difficulty breathing,210
4041664212,condition_era group during day -30 through 0 days relative to index: Difficulty breathing,212
4041681210,condition_era group during day -365 through 0 days relative to index: System disorder of the nervous system,210
4043371210,condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of digestive tract,210
4043738210,condition_era group during day -365 through 0 days relative to index: Hydrocephalus,210
4043738212,condition_era group during day -30 through 0 days relative to index: Hydrocephalus,212
4044013210,condition_era group during day -365 through 0 days relative to index: Hematologic neoplasm,210
4044013212,condition_era group during day -30 through 0 days relative to index: Hematologic neoplasm,212
4044942502,procedure_occurrence during day -365 through 0 days relative to index: Making of compensator for radiotherapy,502
4046903210,condition_era group during day -365 through 0 days relative to index: Post-traumatic hydrocephalus,210
4046903212,condition_era group during day -30 through 0 days relative to index: Post-traumatic hydrocephalus,212
4047288502,procedure_occurrence during day -365 through 0 days relative to index: Nasogastric feeding,502
4047288504,procedure_occurrence during day -30 through 0 days relative to index: Nasogastric feeding,504
4047747210,condition_era group during day -365 through 0 days relative to index: Subcortical vascular dementia,210
4047791210,condition_era group during day -365 through 0 days relative to index: Abnormal body temperature,210
4047791212,condition_era group during day -30 through 0 days relative to index: Abnormal body temperature,212
4048532602,device_exposure during day -365 through 0 days relative to index: Silk suture,602
4048532604,device_exposure during day -30 through 0 days relative to index: Silk suture,604
4051865502,procedure_occurrence during day -365 through 0 days relative to index: Denver developmental screening test,502
4054501210,condition_era group during day -365 through 0 days relative to index: Neoplasm of trunk,210
4054501212,condition_era group during day -30 through 0 days relative to index: Neoplasm of trunk,212
4054503210,condition_era group during day -365 through 0 days relative to index: Neoplasm of intra-abdominal organs,210
4054503212,condition_era group during day -30 through 0 days relative to index: Neoplasm of intra-abdominal organs,212
4054835210,condition_era group during day -365 through 0 days relative to index: Neoplasm of head,210
4054835212,condition_era group during day -30 through 0 days relative to index: Neoplasm of head,212
4054836210,condition_era group during day -365 through 0 days relative to index: Neoplasm of intrathoracic organs,210
4054836212,condition_era group during day -30 through 0 days relative to index: Neoplasm of intrathoracic organs,212
4054839210,condition_era group during day -365 through 0 days relative to index: Neoplasm of pelvis,210
4054839212,condition_era group during day -30 through 0 days relative to index: Neoplasm of pelvis,212
4055361210,condition_era group during day -365 through 0 days relative to index: Generalized epilepsy,210
4055361212,condition_era group during day -30 through 0 days relative to index: Generalized epilepsy,212
4055811502,procedure_occurrence during day -365 through 0 days relative to index: Urine examination,502
4057891502,procedure_occurrence during day -365 through 0 days relative to index: Plain X-ray of patella,502
4058335502,procedure_occurrence during day -365 through 0 days relative to index: CT of chest,502
4058335504,procedure_occurrence during day -30 through 0 days relative to index: CT of chest,504
4059953502,procedure_occurrence during day -365 through 0 days relative to index: Electrotherapy,502
4060084802,observation during day -365 through 0 days relative to index: H/O: radiation exposure,802
4060084804,observation during day -30 through 0 days relative to index: H/O: radiation exposure,804
4061009502,procedure_occurrence during day -365 through 0 days relative to index: CT of abdomen,502
4061009504,procedure_occurrence during day -30 through 0 days relative to index: CT of abdomen,504
4062346502,procedure_occurrence during day -365 through 0 days relative to index: Social counseling,502
4063381210,condition_era group during day -365 through 0 days relative to index: Chronic disease of respiratory system,210
4063381212,condition_era group during day -30 through 0 days relative to index: Chronic disease of respiratory system,212
4065263502,procedure_occurrence during day -365 through 0 days relative to index: Ambulatory blood pressure recording,502
4065263504,procedure_occurrence during day -30 through 0 days relative to index: Ambulatory blood pressure recording,504
4068261210,condition_era group during day -365 through 0 days relative to index: Bile duct proliferation,210
4068261212,condition_era group during day -30 through 0 days relative to index: Bile duct proliferation,212
4071011502,procedure_occurrence during day -365 through 0 days relative to index: Scaling of tooth,502
4074176602,device_exposure during day -365 through 0 days relative to index: Abdominal binder,602
4074176604,device_exposure during day -30 through 0 days relative to index: Abdominal binder,604
4074665502,procedure_occurrence during day -365 through 0 days relative to index: Controlled ventilation,502
4074665504,procedure_occurrence during day -30 through 0 days relative to index: Controlled ventilation,504
4075249210,condition_era group during day -365 through 0 days relative to index: Potassium disorder,210
4075249212,condition_era group during day -30 through 0 days relative to index: Potassium disorder,212
4075297502,procedure_occurrence during day -365 through 0 days relative to index: Block dissection of mediastinal lymph nodes,502
4075297504,procedure_occurrence during day -30 through 0 days relative to index: Block dissection of mediastinal lymph nodes,504
4075951502,procedure_occurrence during day -365 through 0 days relative to index: Intermittent urethral catheterization,502
4075951504,procedure_occurrence during day -30 through 0 days relative to index: Intermittent urethral catheterization,504
4076762502,procedure_occurrence during day -365 through 0 days relative to index: Insertion of indwelling urethral catheter,502
4076762504,procedure_occurrence during day -30 through 0 days relative to index: Insertion of indwelling urethral catheter,504
4076854502,procedure_occurrence during day -365 through 0 days relative to index: Progressive central nervous system disease rehabilitation,502
4079574502,"procedure_occurrence during day -365 through 0 days relative to index: CT guidance for treatment planning, teletherapy",502
4079574504,"procedure_occurrence during day -30 through 0 days relative to index: CT guidance for treatment planning, teletherapy",504
4080499502,procedure_occurrence during day -365 through 0 days relative to index: Dressing of wound,502
4080499504,procedure_occurrence during day -30 through 0 days relative to index: Dressing of wound,504
4082696502,procedure_occurrence during day -365 through 0 days relative to index: CT of lower limb,502
4082870502,procedure_occurrence during day -365 through 0 days relative to index: US scan of prostate,502
4085429502,procedure_occurrence during day -365 through 0 days relative to index: Cystoscopy,502
4085429504,procedure_occurrence during day -30 through 0 days relative to index: Cystoscopy,504
4086425502,procedure_occurrence during day -365 through 0 days relative to index: Patient controlled analgesia,502
4086425504,procedure_occurrence during day -30 through 0 days relative to index: Patient controlled analgesia,504
4087571502,procedure_occurrence during day -365 through 0 days relative to index: Injection of soft tissue,502
4087571504,procedure_occurrence during day -30 through 0 days relative to index: Injection of soft tissue,504
4088889502,procedure_occurrence during day -365 through 0 days relative to index: Individual psychotherapy,502
4091015210,condition_era group during day -365 through 0 days relative to index: Fluid volume disorder,210
4091015212,condition_era group during day -30 through 0 days relative to index: Fluid volume disorder,212
4092936210,condition_era group during day -365 through 0 days relative to index: Ischemic myocardial dysfunction,210
4094061210,condition_era group during day -365 through 0 days relative to index: Infection by Ascomycetes,210
4094061212,condition_era group during day -30 through 0 days relative to index: Infection by Ascomycetes,212
4094202210,condition_era group during day -365 through 0 days relative to index: Space-occupying lesion of nervous system,210
4094202212,condition_era group during day -30 through 0 days relative to index: Space-occupying lesion of nervous system,212
4094866210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of pancreatic duct,210
4094866212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of pancreatic duct,212
4094876210,"condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of lower lobe, bronchus or lung",210
4094876212,"condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of lower lobe, bronchus or lung",212
4095392502,procedure_occurrence during day -365 through 0 days relative to index: Deep fine needle aspiration biopsy under radiologic guidance,502
4095850210,condition_era group during day -365 through 0 days relative to index: Spinal injury,210
4095850212,condition_era group during day -30 through 0 days relative to index: Spinal injury,212
4097216602,device_exposure during day -365 through 0 days relative to index: Endotracheal tube,602
4097216604,device_exposure during day -30 through 0 days relative to index: Endotracheal tube,604
4098792502,procedure_occurrence during day -365 through 0 days relative to index: H-reflex studies,502
4098810502,procedure_occurrence during day -365 through 0 days relative to index: Prism cover test,502
4099014210,condition_era group during day -365 through 0 days relative to index: Duodenal ulcer with hemorrhage,210
4099014212,condition_era group during day -30 through 0 days relative to index: Duodenal ulcer with hemorrhage,212
4099521502,procedure_occurrence during day -365 through 0 days relative to index: Sensory nerve conduction study,502
4100065210,condition_era group during day -365 through 0 days relative to index: Disease due to Coronaviridae,210
4100065212,condition_era group during day -30 through 0 days relative to index: Disease due to Coronaviridae,212
4101227210,condition_era group during day -365 through 0 days relative to index: Liver mass,210
4101227212,condition_era group during day -30 through 0 days relative to index: Liver mass,212
4101468210,condition_era group during day -365 through 0 days relative to index: Gastroenteritis,210
4102082502,procedure_occurrence during day -365 through 0 days relative to index: Motor nerve conduction studies,502
4102114210,condition_era group during day -365 through 0 days relative to index: Mass of male genital structure,210
4102114212,condition_era group during day -30 through 0 days relative to index: Mass of male genital structure,212
4103523502,procedure_occurrence during day -365 through 0 days relative to index: Laryngoscopy,502
4103703210,condition_era group during day -365 through 0 days relative to index: Melena,210
4103703212,condition_era group during day -30 through 0 days relative to index: Melena,212
4104000210,condition_era group during day -365 through 0 days relative to index: Lesion of liver,210
4104000212,condition_era group during day -30 through 0 days relative to index: Lesion of liver,212
4104155210,condition_era group during day -365 through 0 days relative to index: Lesion of bladder,210
4104155212,condition_era group during day -30 through 0 days relative to index: Lesion of bladder,212
4105229602,device_exposure during day -365 through 0 days relative to index: Polypropylene suture,602
4106220502,procedure_occurrence during day -365 through 0 days relative to index: Radiography of shoulder,502
4108618502,procedure_occurrence during day -365 through 0 days relative to index: Examination of finger,502
4110584210,condition_era group during day -365 through 0 days relative to index: Tumor of exocrine pancreas,210
4110584212,condition_era group during day -30 through 0 days relative to index: Tumor of exocrine pancreas,212
4110961210,condition_era group during day -365 through 0 days relative to index: Generalized ischemic myocardial dysfunction,210
4111017210,condition_era group during day -365 through 0 days relative to index: Neoplasm of head and neck,210
4111017212,condition_era group during day -30 through 0 days relative to index: Neoplasm of head and neck,212
4111018210,condition_era group during day -365 through 0 days relative to index: Neoplasm of thorax,210
4111018212,condition_era group during day -30 through 0 days relative to index: Neoplasm of thorax,212
4111024210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of exocrine pancreas,210
4111024212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of exocrine pancreas,212
4111798210,condition_era group during day -365 through 0 days relative to index: Neoplasm of digestive organ,210
4111798212,condition_era group during day -30 through 0 days relative to index: Neoplasm of digestive organ,212
4112603210,"condition_era group during day -365 through 0 days relative to index: Tumor of esophagus, stomach and duodenum",210
4112603212,"condition_era group during day -30 through 0 days relative to index: Tumor of esophagus, stomach and duodenum",212
4112735210,condition_era group during day -365 through 0 days relative to index: Neoplasm of lower respiratory tract,210
4112735212,condition_era group during day -30 through 0 days relative to index: Neoplasm of lower respiratory tract,212
4112878210,condition_era group during day -365 through 0 days relative to index: Neoplasm of urinary tract proper,210
4112878212,condition_era group during day -30 through 0 days relative to index: Neoplasm of urinary tract proper,212
4113998210,condition_era group during day -365 through 0 days relative to index: Mass of urogenital structure,210
4113998212,condition_era group during day -30 through 0 days relative to index: Mass of urogenital structure,212
4114222210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of head and neck,210
4114222212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of head and neck,212
4114341210,condition_era group during day -365 through 0 days relative to index: Secondary lymphangitic carcinoma,210
4114341212,condition_era group during day -30 through 0 days relative to index: Secondary lymphangitic carcinoma,212
4115105210,condition_era group during day -365 through 0 days relative to index: Mass of respiratory structure,210
4115105212,condition_era group during day -30 through 0 days relative to index: Mass of respiratory structure,212
4115106210,condition_era group during day -365 through 0 days relative to index: Mass of digestive structure,210
4115106212,condition_era group during day -30 through 0 days relative to index: Mass of digestive structure,212
4115735210,condition_era group during day -365 through 0 days relative to index: Lesion of prostate,210
4115735212,condition_era group during day -30 through 0 days relative to index: Lesion of prostate,212
4116092210,condition_era group during day -365 through 0 days relative to index: Intracranial tumor,210
4116092212,condition_era group during day -30 through 0 days relative to index: Intracranial tumor,212
4116208210,condition_era group during day -365 through 0 days relative to index: Choroidal and/or chorioretinal disorder,210
4116208212,condition_era group during day -30 through 0 days relative to index: Choroidal and/or chorioretinal disorder,212
4116238210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of digestive organ,210
4116238212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of digestive organ,212
4116778210,condition_era group during day -365 through 0 days relative to index: Lesion of lung,210
4116778212,condition_era group during day -30 through 0 days relative to index: Lesion of lung,212
4116962210,condition_era group during day -365 through 0 days relative to index: Mass of lymphoreticular structure,210
4116962212,condition_era group during day -30 through 0 days relative to index: Mass of lymphoreticular structure,212
4116963210,condition_era group during day -365 through 0 days relative to index: Mass of urinary system structure,210
4116963212,condition_era group during day -30 through 0 days relative to index: Mass of urinary system structure,212
4116964210,condition_era group during day -365 through 0 days relative to index: Mass of musculoskeletal structure,210
4116964212,condition_era group during day -30 through 0 days relative to index: Mass of musculoskeletal structure,212
4118897502,procedure_occurrence during day -365 through 0 days relative to index: Inhalation general anesthesia,502
4118897504,procedure_occurrence during day -30 through 0 days relative to index: Inhalation general anesthesia,504
4120120502,procedure_occurrence during day -365 through 0 days relative to index: Hemodialysis,502
4120120504,procedure_occurrence during day -30 through 0 days relative to index: Hemodialysis,504
4121351602,device_exposure during day -365 through 0 days relative to index: Chest drain,602
4121351604,device_exposure during day -30 through 0 days relative to index: Chest drain,604
4121540602,device_exposure during day -365 through 0 days relative to index: Tracheostomy tube cuff,602
4121540604,device_exposure during day -30 through 0 days relative to index: Tracheostomy tube cuff,604
4121940502,procedure_occurrence during day -365 through 0 days relative to index: Root planing of tooth,502
4122234502,procedure_occurrence during day -365 through 0 days relative to index: Percutaneous endoscopic gastrostomy,502
4124141502,procedure_occurrence during day -365 through 0 days relative to index: Continuous suction drainage,502
4124141504,procedure_occurrence during day -30 through 0 days relative to index: Continuous suction drainage,504
4124706210,condition_era group during day -365 through 0 days relative to index: Myocardial dysfunction,210
4125342602,device_exposure during day -365 through 0 days relative to index: EEG electrode,602
4125342604,device_exposure during day -30 through 0 days relative to index: EEG electrode,604
4125906502,procedure_occurrence during day -365 through 0 days relative to index: Suture open wound,502
4126305210,condition_era group during day -365 through 0 days relative to index: Acute renal impairment,210
4126305212,condition_era group during day -30 through 0 days relative to index: Acute renal impairment,212
4126495502,procedure_occurrence during day -365 through 0 days relative to index: Activities of daily living assessment,502
4126495504,procedure_occurrence during day -30 through 0 days relative to index: Activities of daily living assessment,504
4128888210,condition_era group during day -365 through 0 days relative to index: Neoplasm of lung,210
4128888212,condition_era group during day -30 through 0 days relative to index: Neoplasm of lung,212
4129382210,condition_era group during day -365 through 0 days relative to index: Neoplasm of pleura,210
4129382212,condition_era group during day -30 through 0 days relative to index: Neoplasm of pleura,212
4129884210,condition_era group during day -365 through 0 days relative to index: Neoplasm of biliary tract,210
4129884212,condition_era group during day -30 through 0 days relative to index: Neoplasm of biliary tract,212
4129885210,condition_era group during day -365 through 0 days relative to index: Neoplasm of common bile duct,210
4129885212,condition_era group during day -30 through 0 days relative to index: Neoplasm of common bile duct,212
4129886210,condition_era group during day -365 through 0 days relative to index: Neoplasm of pancreas,210
4129886212,condition_era group during day -30 through 0 days relative to index: Neoplasm of pancreas,212
4129891210,condition_era group during day -365 through 0 days relative to index: Neoplasm of retroperitoneum,210
4129891212,condition_era group during day -30 through 0 days relative to index: Neoplasm of retroperitoneum,212
4129898210,condition_era group during day -365 through 0 days relative to index: Neoplasm of male genital organ,210
4129898212,condition_era group during day -30 through 0 days relative to index: Neoplasm of male genital organ,212
4129902210,condition_era group during day -365 through 0 days relative to index: Neoplasm of prostate,210
4129902212,condition_era group during day -30 through 0 days relative to index: Neoplasm of prostate,212
4130373210,condition_era group during day -365 through 0 days relative to index: Neoplasm of gastrointestinal tract,210
4130373212,condition_era group during day -30 through 0 days relative to index: Neoplasm of gastrointestinal tract,212
4130514210,condition_era group during day -365 through 0 days relative to index: Neoplasm of large intestine,210
4130514212,condition_era group during day -30 through 0 days relative to index: Neoplasm of large intestine,212
4130518210,condition_era group during day -365 through 0 days relative to index: Neoplasm of liver,210
4130518212,condition_era group during day -30 through 0 days relative to index: Neoplasm of liver,212
4130839210,condition_era group during day -365 through 0 days relative to index: Neoplasm of lymph node,210
4130839212,condition_era group during day -30 through 0 days relative to index: Neoplasm of lymph node,212
4130995210,condition_era group during day -365 through 0 days relative to index: Neoplasm of colon,210
4130995212,condition_era group during day -30 through 0 days relative to index: Neoplasm of colon,212
4130997210,condition_era group during day -365 through 0 days relative to index: Neoplasm of ascending colon,210
4130997212,condition_era group during day -30 through 0 days relative to index: Neoplasm of ascending colon,212
4130998210,condition_era group during day -365 through 0 days relative to index: Neoplasm of ampulla of Vater,210
4130998212,condition_era group during day -30 through 0 days relative to index: Neoplasm of ampulla of Vater,212
4131304210,condition_era group during day -365 through 0 days relative to index: Neoplasm of intrathoracic lymph nodes,210
4131304212,condition_era group during day -30 through 0 days relative to index: Neoplasm of intrathoracic lymph nodes,212
4131598210,condition_era group during day -365 through 0 days relative to index: Neoplasm of intestinal tract,210
4131598212,condition_era group during day -30 through 0 days relative to index: Neoplasm of intestinal tract,212
4131614210,condition_era group during day -365 through 0 days relative to index: Neoplasm of small intestine,210
4131614212,condition_era group during day -30 through 0 days relative to index: Neoplasm of small intestine,212
4131615210,condition_era group during day -365 through 0 days relative to index: Neoplasm of duodenum,210
4131615212,condition_era group during day -30 through 0 days relative to index: Neoplasm of duodenum,212
4131619210,condition_era group during day -365 through 0 days relative to index: Neoplasm of extrahepatic bile ducts,210
4131619212,condition_era group during day -30 through 0 days relative to index: Neoplasm of extrahepatic bile ducts,212
4131745210,condition_era group during day -365 through 0 days relative to index: Neoplasm of pancreatic duct,210
4131745212,condition_era group during day -30 through 0 days relative to index: Neoplasm of pancreatic duct,212
4131770210,condition_era group during day -365 through 0 days relative to index: Neoplasm of central nervous system,210
4131770212,condition_era group during day -30 through 0 days relative to index: Neoplasm of central nervous system,212
4132926210,condition_era group during day -365 through 0 days relative to index: Pain finding at anatomical site,210
4132926212,condition_era group during day -30 through 0 days relative to index: Pain finding at anatomical site,212
4133224210,condition_era group during day -365 through 0 days relative to index: Lobar pneumonia,210
4133224212,condition_era group during day -30 through 0 days relative to index: Lobar pneumonia,212
4133259602,device_exposure during day -365 through 0 days relative to index: Antihemorrhagic bandage,602
4133974210,condition_era group during day -365 through 0 days relative to index: Neoplasm of abdomen,210
4133974212,condition_era group during day -30 through 0 days relative to index: Neoplasm of abdomen,212
4134146210,condition_era group during day -365 through 0 days relative to index: Chronic peptic ulcer,210
4134146212,condition_era group during day -30 through 0 days relative to index: Chronic peptic ulcer,212
4134440210,condition_era group during day -365 through 0 days relative to index: Visual system disorder,210
4134440212,condition_era group during day -30 through 0 days relative to index: Visual system disorder,212
4134593210,condition_era group during day -365 through 0 days relative to index: Chronic digestive system disorder,210
4134593212,condition_era group during day -30 through 0 days relative to index: Chronic digestive system disorder,212
4134595210,condition_era group during day -365 through 0 days relative to index: Chronic disease of genitourinary system,210
4134595212,condition_era group during day -30 through 0 days relative to index: Chronic disease of genitourinary system,212
4134858602,device_exposure during day -365 through 0 days relative to index: Implantable venous access port,602
4134887210,condition_era group during day -365 through 0 days relative to index: Infectious disease of digestive tract,210
4134887212,condition_era group during day -30 through 0 days relative to index: Infectious disease of digestive tract,212
4135471502,procedure_occurrence during day -365 through 0 days relative to index: Radiography of kidney-ureter-bladder,502
4135471504,procedure_occurrence during day -30 through 0 days relative to index: Radiography of kidney-ureter-bladder,504
4137859502,procedure_occurrence during day -365 through 0 days relative to index: Transfusion of leucoreduced red blood cells,502
4137859504,procedure_occurrence during day -30 through 0 days relative to index: Transfusion of leucoreduced red blood cells,504
4138476502,procedure_occurrence during day -365 through 0 days relative to index: MRI of whole body,502
4138816502,procedure_occurrence during day -365 through 0 days relative to index: Cranioplasty,502
4139745502,procedure_occurrence during day -365 through 0 days relative to index: CT of abdomen with contrast,502
4139745504,procedure_occurrence during day -30 through 0 days relative to index: CT of abdomen with contrast,504
4140090210,condition_era group during day -365 through 0 days relative to index: Parkinsonism,210
4141649502,procedure_occurrence during day -365 through 0 days relative to index: Functional electrical skeletal muscle stimulation procedures,502
4142124210,condition_era group during day -365 through 0 days relative to index: Mass of duodenum,210
4142124212,condition_era group during day -30 through 0 days relative to index: Mass of duodenum,212
4143250210,condition_era group during day -365 through 0 days relative to index: Mass of colon,210
4143250212,condition_era group during day -30 through 0 days relative to index: Mass of colon,212
4143397210,condition_era group during day -365 through 0 days relative to index: Mass of pancreas,210
4143397212,condition_era group during day -30 through 0 days relative to index: Mass of pancreas,212
4145244502,procedure_occurrence during day -365 through 0 days relative to index: Diagnostic bronchoscopy,502
4145244504,procedure_occurrence during day -30 through 0 days relative to index: Diagnostic bronchoscopy,504
4145739502,procedure_occurrence during day -365 through 0 days relative to index: Computerized axial tomography of brain,502
4145739504,procedure_occurrence during day -30 through 0 days relative to index: Computerized axial tomography of brain,504
4145786502,procedure_occurrence during day -365 through 0 days relative to index: Endotracheal anesthesia,502
4145786504,procedure_occurrence during day -30 through 0 days relative to index: Endotracheal anesthesia,504
4147588502,procedure_occurrence during day -365 through 0 days relative to index: Excision of lesion of skin,502
4148273502,procedure_occurrence during day -365 through 0 days relative to index: Heat therapy,502
4149275602,device_exposure during day -365 through 0 days relative to index: Drainage bag,602
4149926602,device_exposure during day -365 through 0 days relative to index: Thoracoscope,602
4149926604,device_exposure during day -30 through 0 days relative to index: Thoracoscope,604
4149930502,procedure_occurrence during day -365 through 0 days relative to index: Pericardiocentesis,502
4149930504,procedure_occurrence during day -30 through 0 days relative to index: Pericardiocentesis,504
4151250210,"condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of upper lobe, bronchus or lung",210
4151250212,"condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of upper lobe, bronchus or lung",212
4153192502,procedure_occurrence during day -365 through 0 days relative to index: Evaluation of arterial blood gas studies,502
4154162210,condition_era group during day -365 through 0 days relative to index: Head and neck injury,210
4154162212,condition_era group during day -30 through 0 days relative to index: Head and neck injury,212
4154630210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of genitourinary organ,210
4154630212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of genitourinary organ,212
4155285210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of central nervous system,210
4155285212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of central nervous system,212
4157331210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of nervous system,210
4157331212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of nervous system,212
4157454210,"condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of lower lobe, bronchus or lung",210
4157454212,"condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of lower lobe, bronchus or lung",212
4159813602,device_exposure during day -365 through 0 days relative to index: Guide wire,602
4159813604,device_exposure during day -30 through 0 days relative to index: Guide wire,604
4160276210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of genital structure,210
4160276212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of genital structure,212
4160711502,procedure_occurrence during day -365 through 0 days relative to index: Nephrostomy using fluoroscopic guidance,502
4162282210,condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of the respiratory system,210
4162282212,condition_era group during day -30 through 0 days relative to index: Inflammatory disorder of the respiratory system,212
4162382502,procedure_occurrence during day -365 through 0 days relative to index: Post-anesthesia assessment,502
4162382504,procedure_occurrence during day -30 through 0 days relative to index: Post-anesthesia assessment,504
4163261210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of prostate,210
4163261212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of prostate,212
4163872502,procedure_occurrence during day -365 through 0 days relative to index: Plain chest X-ray,502
4163872504,procedure_occurrence during day -30 through 0 days relative to index: Plain chest X-ray,504
4166125210,"condition_era group during day -365 through 0 days relative to index: Localized swelling, mass and lump, neck",210
4166125212,"condition_era group during day -30 through 0 days relative to index: Localized swelling, mass and lump, neck",212
4166211502,procedure_occurrence during day -365 through 0 days relative to index: Diagnostic radiologic examination with fluoroscopy,502
4166211504,procedure_occurrence during day -30 through 0 days relative to index: Diagnostic radiologic examination with fluoroscopy,504
4166589210,condition_era group during day -365 through 0 days relative to index: Metastasis to digestive organs,210
4166589212,condition_era group during day -30 through 0 days relative to index: Metastasis to digestive organs,212
4166732802,observation during day -365 through 0 days relative to index: No history of procedure,802
4166732804,observation during day -30 through 0 days relative to index: No history of procedure,804
4167375602,device_exposure during day -365 through 0 days relative to index: Silicone tape,602
4167375604,device_exposure during day -30 through 0 days relative to index: Silicone tape,604
4168192802,observation during day -365 through 0 days relative to index: Procedure not done,802
4168192804,observation during day -30 through 0 days relative to index: Procedure not done,804
4169598210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of urinary system,210
4169598212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of urinary system,212
4170143210,condition_era group during day -365 through 0 days relative to index: Respiratory tract infection,210
4170143212,condition_era group during day -30 through 0 days relative to index: Respiratory tract infection,212
4171710502,procedure_occurrence during day -365 through 0 days relative to index: Diagnostic radiography of skull,502
4173938210,condition_era group during day -365 through 0 days relative to index: Mass lesion of brain,210
4173938212,condition_era group during day -30 through 0 days relative to index: Mass lesion of brain,212
4174044210,condition_era group during day -365 through 0 days relative to index: Chronic peptic ulcer with hemorrhage,210
4174044212,condition_era group during day -30 through 0 days relative to index: Chronic peptic ulcer with hemorrhage,212
4176880502,procedure_occurrence during day -365 through 0 days relative to index: Radiography of hand,502
4176880504,procedure_occurrence during day -30 through 0 days relative to index: Radiography of hand,504
4176944210,condition_era group during day -365 through 0 days relative to index: Infective disorder of head,210
4176944212,condition_era group during day -30 through 0 days relative to index: Infective disorder of head,212
4177067210,condition_era group during day -365 through 0 days relative to index: Mass of urinary bladder,210
4177067212,condition_era group during day -30 through 0 days relative to index: Mass of urinary bladder,212
4177105210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of extrahepatic bile duct,210
4177105212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of extrahepatic bile duct,212
4177236210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of pelvis,210
4177236212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of pelvis,212
4178818210,condition_era group during day -365 through 0 days relative to index: Inflammation of specific body systems,210
4178818212,condition_era group during day -30 through 0 days relative to index: Inflammation of specific body systems,212
4178904210,condition_era group during day -365 through 0 days relative to index: Body temperature above reference range,210
4178904212,condition_era group during day -30 through 0 days relative to index: Body temperature above reference range,212
4178966210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of ampulla of Vater,210
4178966212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of ampulla of Vater,212
4179206602,device_exposure during day -365 through 0 days relative to index: Central venous catheter,602
4179206604,device_exposure during day -30 through 0 days relative to index: Central venous catheter,604
4179720210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of gastrointestinal tract,210
4179720212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of gastrointestinal tract,212
4179815502,procedure_occurrence during day -365 through 0 days relative to index: Electromyography,502
4180170210,condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of the respiratory tract,210
4180170212,condition_era group during day -30 through 0 days relative to index: Inflammatory disorder of the respiratory tract,212
4180248502,procedure_occurrence during day -365 through 0 days relative to index: Rehabilitation therapy,502
4180313210,condition_era group during day -365 through 0 days relative to index: Neoplasm of musculoskeletal system,210
4180313212,condition_era group during day -30 through 0 days relative to index: Neoplasm of musculoskeletal system,212
4180790210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of colon,210
4180790212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of colon,212
4180793210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of pancreas,210
4180793212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of pancreas,212
4180794210,condition_era group during day -365 through 0 days relative to index: Malignant retroperitoneal tumor,210
4180794212,condition_era group during day -30 through 0 days relative to index: Malignant retroperitoneal tumor,212
4180795210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of pleura,210
4180795212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of pleura,212
4180915210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of urinary tract proper,210
4180915212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of urinary tract proper,212
4181063210,condition_era group during day -365 through 0 days relative to index: Inflammation of specific body organs,210
4181063212,condition_era group during day -30 through 0 days relative to index: Inflammation of specific body organs,212
4181345210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of biliary tract,210
4181345212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of biliary tract,212
4181487210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of male genital organ,210
4181487212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of male genital organ,212
4181778502,procedure_occurrence during day -365 through 0 days relative to index: Intravenous injection,502
4181778504,procedure_occurrence during day -30 through 0 days relative to index: Intravenous injection,504
4181917502,procedure_occurrence during day -365 through 0 days relative to index: Electroencephalogram,502
4182210210,condition_era group during day -365 through 0 days relative to index: Dementia,210
4182210212,condition_era group during day -30 through 0 days relative to index: Dementia,212
4182861502,procedure_occurrence during day -365 through 0 days relative to index: Measurement of central venous pressure,502
4184824602,device_exposure during day -365 through 0 days relative to index: Urinary collection bag,602
4184824604,device_exposure during day -30 through 0 days relative to index: Urinary collection bag,604
4187078502,procedure_occurrence during day -365 through 0 days relative to index: Electrocardiographic monitoring,502
4187078504,procedure_occurrence during day -30 through 0 days relative to index: Electrocardiographic monitoring,504
4187218210,condition_era group during day -365 through 0 days relative to index: Pneumonitis due to inhaled substance,210
4187218212,condition_era group during day -30 through 0 days relative to index: Pneumonitis due to inhaled substance,212
4189517502,procedure_occurrence during day -365 through 0 days relative to index: Ultrasonic guidance procedure,502
4189517504,procedure_occurrence during day -30 through 0 days relative to index: Ultrasonic guidance procedure,504
4190185210,condition_era group during day -365 through 0 days relative to index: Inflammatory disorder of digestive system,210
4190185212,condition_era group during day -30 through 0 days relative to index: Inflammatory disorder of digestive system,212
4190990502,procedure_occurrence during day -365 through 0 days relative to index: Neurological mental status determination,502
4193169210,condition_era group during day -365 through 0 days relative to index: Viral respiratory infection,210
4193169212,condition_era group during day -30 through 0 days relative to index: Viral respiratory infection,212
4193990210,condition_era group during day -365 through 0 days relative to index: Infection of digestive system,210
4193990212,condition_era group during day -30 through 0 days relative to index: Infection of digestive system,212
4195288502,procedure_occurrence during day -365 through 0 days relative to index: Fluoroscopy,502
4195288504,procedure_occurrence during day -30 through 0 days relative to index: Fluoroscopy,504
4196378502,procedure_occurrence during day -365 through 0 days relative to index: Flexible fiberoptic sigmoidoscopy,502
4198105502,procedure_occurrence during day -365 through 0 days relative to index: Nerve conduction study,502
4198381210,condition_era group during day -365 through 0 days relative to index: Ulcer of duodenum,210
4198381212,condition_era group during day -30 through 0 days relative to index: Ulcer of duodenum,212
4198451502,procedure_occurrence during day -365 through 0 days relative to index: Contrast radiography via drain,502
4198775502,procedure_occurrence during day -365 through 0 days relative to index: Ultrasonography of thyroid and parathyroid,502
4200516210,condition_era group during day -365 through 0 days relative to index: Lesion of brain,210
4200516212,condition_era group during day -30 through 0 days relative to index: Lesion of brain,212
4203096210,condition_era group during day -365 through 0 days relative to index: Lung mass,210
4203096212,condition_era group during day -30 through 0 days relative to index: Lung mass,212
4205144502,procedure_occurrence during day -365 through 0 days relative to index: Portable electroencephalogram,502
4205813210,condition_era group during day -365 through 0 days relative to index: Prostate mass,210
4205813212,condition_era group during day -30 through 0 days relative to index: Prostate mass,212
4206591210,condition_era group during day -365 through 0 days relative to index: Mass of trunk,210
4206591212,condition_era group during day -30 through 0 days relative to index: Mass of trunk,212
4206920502,procedure_occurrence during day -365 through 0 days relative to index: Nebulizer therapy,502
4206920504,procedure_occurrence during day -30 through 0 days relative to index: Nebulizer therapy,504
4210275502,procedure_occurrence during day -365 through 0 days relative to index: Dysphagia therapy regime,502
4212328210,condition_era group during day -365 through 0 days relative to index: Neoplasm affecting hematopoietic structure,210
4212328212,condition_era group during day -30 through 0 days relative to index: Neoplasm affecting hematopoietic structure,212
4214956802,observation during day -365 through 0 days relative to index: History of clinical finding in subject,802
4214956804,observation during day -30 through 0 days relative to index: History of clinical finding in subject,804
4218403502,"procedure_occurrence during day -365 through 0 days relative to index: Bone density study, dual photon absorptiometry",502
4219637602,device_exposure during day -365 through 0 days relative to index: Peripheral intravenous catheter,602
4219637604,device_exposure during day -30 through 0 days relative to index: Peripheral intravenous catheter,604
4222039602,device_exposure during day -365 through 0 days relative to index: Hydrocolloid dressing,602
4222039604,device_exposure during day -30 through 0 days relative to index: Hydrocolloid dressing,604
4222465602,device_exposure during day -365 through 0 days relative to index: Bile collection bag,602
4222465604,device_exposure during day -30 through 0 days relative to index: Bile collection bag,604
4224022602,device_exposure during day -365 through 0 days relative to index: Elastic adhesive bandage,602
4224204602,device_exposure during day -365 through 0 days relative to index: Polyurethane foam dressing,602
4224204604,device_exposure during day -30 through 0 days relative to index: Polyurethane foam dressing,604
4224205602,device_exposure during day -365 through 0 days relative to index: Polyurethane foam sterile film dressing,602
4224205604,device_exposure during day -30 through 0 days relative to index: Polyurethane foam sterile film dressing,604
4225119502,procedure_occurrence during day -365 through 0 days relative to index: Neurological examination,502
4229928602,device_exposure during day -365 through 0 days relative to index: Surgical adhesive tape,602
4229928604,device_exposure during day -30 through 0 days relative to index: Surgical adhesive tape,604
4229930602,device_exposure during day -365 through 0 days relative to index: Wound management dressing,602
4229930604,device_exposure during day -30 through 0 days relative to index: Wound management dressing,604
4230167502,procedure_occurrence during day -365 through 0 days relative to index: Artificial respiration,502
4231736502,procedure_occurrence during day -365 through 0 days relative to index: Partial lobectomy of lung,502
4231736504,procedure_occurrence during day -30 through 0 days relative to index: Partial lobectomy of lung,504
4232181210,condition_era group during day -365 through 0 days relative to index: Chronic duodenal ulcer with hemorrhage,210
4232181212,condition_era group during day -30 through 0 days relative to index: Chronic duodenal ulcer with hemorrhage,212
4233227502,procedure_occurrence during day -365 through 0 days relative to index: Orthopantogram,502
4233903210,condition_era group during day -365 through 0 days relative to index: Mass of thoracic structure,210
4233903212,condition_era group during day -30 through 0 days relative to index: Mass of thoracic structure,212
4234117602,device_exposure during day -365 through 0 days relative to index: Ventricular intracranial catheter,602
4234117604,device_exposure during day -30 through 0 days relative to index: Ventricular intracranial catheter,604
4234536502,procedure_occurrence during day -365 through 0 days relative to index: Transurethral prostatectomy,502
4235863210,condition_era group during day -365 through 0 days relative to index: Spinal cord injury,210
4235863212,condition_era group during day -30 through 0 days relative to index: Spinal cord injury,212
4236607602,device_exposure during day -365 through 0 days relative to index: Silicone gel sheet dressing,602
4236607604,device_exposure during day -30 through 0 days relative to index: Silicone gel sheet dressing,604
4237298502,procedure_occurrence during day -365 through 0 days relative to index: Pulmonary ventilation study,502
4237298504,procedure_occurrence during day -30 through 0 days relative to index: Pulmonary ventilation study,504
4239130502,procedure_occurrence during day -365 through 0 days relative to index: Oxygen therapy,502
4239130504,procedure_occurrence during day -30 through 0 days relative to index: Oxygen therapy,504
4239975210,condition_era group during day -365 through 0 days relative to index: Myocardial disease,210
4240305502,procedure_occurrence during day -365 through 0 days relative to index: Thoracentesis,502
4240305504,procedure_occurrence during day -30 through 0 days relative to index: Thoracentesis,504
4242411210,condition_era group during day -365 through 0 days relative to index: Acute nephropathy,210
4242411212,condition_era group during day -30 through 0 days relative to index: Acute nephropathy,212
4244369502,procedure_occurrence during day -365 through 0 days relative to index: Infusion chemotherapy for malignant neoplasm,502
4244369504,procedure_occurrence during day -30 through 0 days relative to index: Infusion chemotherapy for malignant neoplasm,504
4244986502,procedure_occurrence during day -365 through 0 days relative to index: CT of brain without contrast,502
4244986504,procedure_occurrence during day -30 through 0 days relative to index: CT of brain without contrast,504
4246034210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of common bile duct,210
4246034212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of common bile duct,212
4246125210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of large intestine,210
4246125212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of large intestine,212
4246127210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of liver,210
4246127212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of liver,212
4246451210,condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of brain,210
4246451212,condition_era group during day -30 through 0 days relative to index: Secondary malignant neoplasm of brain,212
4247120210,condition_era group during day -365 through 0 days relative to index: Gastrointestinal ulcer,210
4247120212,condition_era group during day -30 through 0 days relative to index: Gastrointestinal ulcer,212
4247331210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of intrathoracic organs,210
4247331212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of intrathoracic organs,212
4247719210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of ascending colon,210
4247719212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of ascending colon,212
4248028210,condition_era group during day -365 through 0 days relative to index: Supraventricular arrhythmia,210
4248028212,condition_era group during day -30 through 0 days relative to index: Supraventricular arrhythmia,212
4248061210,condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of intrathoracic organs,210
4248061212,condition_era group during day -30 through 0 days relative to index: Secondary malignant neoplasm of intrathoracic organs,212
4251589502,procedure_occurrence during day -365 through 0 days relative to index: Physical rehabilitation therapy management,502
4252419502,procedure_occurrence during day -365 through 0 days relative to index: Radiologic examination of knee,502
4252535210,condition_era group during day -365 through 0 days relative to index: Adenocarcinoma of liver,210
4252535212,condition_era group during day -30 through 0 days relative to index: Adenocarcinoma of liver,212
4254897502,procedure_occurrence during day -365 through 0 days relative to index: Occupational therapy management,502
4254899502,procedure_occurrence during day -365 through 0 days relative to index: Dietary regime management,502
4254899504,procedure_occurrence during day -30 through 0 days relative to index: Dietary regime management,504
4256228210,condition_era group during day -365 through 0 days relative to index: Respiratory failure,210
4256228212,condition_era group during day -30 through 0 days relative to index: Respiratory failure,212
4256761210,condition_era group during day -365 through 0 days relative to index: Imaging result abnormal,210
4256761212,condition_era group during day -30 through 0 days relative to index: Imaging result abnormal,212
4256924210,condition_era group during day -365 through 0 days relative to index: Acquired hydrocephalus,210
4256924212,condition_era group during day -30 through 0 days relative to index: Acquired hydrocephalus,212
4257833502,procedure_occurrence during day -365 through 0 days relative to index: Patient transfer management,502
4257954502,procedure_occurrence during day -365 through 0 days relative to index: Radiation therapy care education,502
4257954504,procedure_occurrence during day -30 through 0 days relative to index: Radiation therapy care education,504
4260263502,procedure_occurrence during day -365 through 0 days relative to index: Diffusion weighted magnetic resonance imaging,502
4261497502,procedure_occurrence during day -365 through 0 days relative to index: Ultrasonography of abdomen,502
4261999502,procedure_occurrence during day -365 through 0 days relative to index: Nutrition care management,502
4262010502,procedure_occurrence during day -365 through 0 days relative to index: Tracheostomy care management,502
4262010504,procedure_occurrence during day -30 through 0 days relative to index: Tracheostomy care management,504
4262269602,device_exposure during day -365 through 0 days relative to index: Sterile polypropylene monofilament suture,602
4262269604,device_exposure during day -30 through 0 days relative to index: Sterile polypropylene monofilament suture,604
4264477502,procedure_occurrence during day -365 through 0 days relative to index: Diagnostic radiography of abdomen,502
4264477504,procedure_occurrence during day -30 through 0 days relative to index: Diagnostic radiography of abdomen,504
4265034502,procedure_occurrence during day -365 through 0 days relative to index: Giving patient an enema,502
4265034504,procedure_occurrence during day -30 through 0 days relative to index: Giving patient an enema,504
4266367210,condition_era group during day -365 through 0 days relative to index: Influenza,210
4266367212,condition_era group during day -30 through 0 days relative to index: Influenza,212
4266866502,procedure_occurrence during day -365 through 0 days relative to index: Superficial fine needle aspiration biopsy,502
4266866504,procedure_occurrence during day -30 through 0 days relative to index: Superficial fine needle aspiration biopsy,504
4271310602,device_exposure during day -365 through 0 days relative to index: Tubular bandage,602
4271310604,device_exposure during day -30 through 0 days relative to index: Tubular bandage,604
4271696210,condition_era group during day -365 through 0 days relative to index: Peptic ulcer with hemorrhage,210
4271696212,condition_era group during day -30 through 0 days relative to index: Peptic ulcer with hemorrhage,212
4273629502,procedure_occurrence during day -365 through 0 days relative to index: Chemotherapy,502
4273629504,procedure_occurrence during day -30 through 0 days relative to index: Chemotherapy,504
4275423210,condition_era group during day -365 through 0 days relative to index: Supraventricular tachycardia,210
4275423212,condition_era group during day -30 through 0 days relative to index: Supraventricular tachycardia,212
4277745210,condition_era group during day -365 through 0 days relative to index: Disease due to Orthomyxoviridae,210
4277745212,condition_era group during day -30 through 0 days relative to index: Disease due to Orthomyxoviridae,212
4281232210,condition_era group during day -365 through 0 days relative to index: Type B viral hepatitis,210
4281232212,condition_era group during day -30 through 0 days relative to index: Type B viral hepatitis,212
4287375502,procedure_occurrence during day -365 through 0 days relative to index: Shunt of cerebral ventricle to extracranial site,502
4287375504,procedure_occurrence during day -30 through 0 days relative to index: Shunt of cerebral ventricle to extracranial site,504
4287399210,condition_era group during day -365 through 0 days relative to index: Retroperitoneal mass,210
4287399212,condition_era group during day -30 through 0 days relative to index: Retroperitoneal mass,212
4288386502,procedure_occurrence during day -365 through 0 days relative to index: Assessment of adverse drug reactions,502
4288734210,condition_era group during day -365 through 0 days relative to index: Bronchiolar disease,210
4288734212,condition_era group during day -30 through 0 days relative to index: Bronchiolar disease,212
4290232502,procedure_occurrence during day -365 through 0 days relative to index: Range of motion testing,502
4291005210,condition_era group during day -365 through 0 days relative to index: Viral hepatitis,210
4291005212,condition_era group during day -30 through 0 days relative to index: Viral hepatitis,212
4291649210,condition_era group during day -365 through 0 days relative to index: Upper gastrointestinal bleeding,210
4291649212,condition_era group during day -30 through 0 days relative to index: Upper gastrointestinal bleeding,212
4294382502,procedure_occurrence during day -365 through 0 days relative to index: Esophagogastroduodenoscopy,502
4295050502,procedure_occurrence during day -365 through 0 days relative to index: Injection administration management,502
4295073502,procedure_occurrence during day -365 through 0 days relative to index: Emergency treatment management,502
4295073504,procedure_occurrence during day -30 through 0 days relative to index: Emergency treatment management,504
4296519502,procedure_occurrence during day -365 through 0 days relative to index: Triage: emergency center,502
4296519504,procedure_occurrence during day -30 through 0 days relative to index: Triage: emergency center,504
4296529502,procedure_occurrence during day -365 through 0 days relative to index: Anesthesia management,502
4296529504,procedure_occurrence during day -30 through 0 days relative to index: Anesthesia management,504
4297038602,device_exposure during day -365 through 0 days relative to index: Soft silicone wound contact dressing with polyurethane foam film backing sterile 15cm x 15cm,602
4300595210,condition_era group during day -365 through 0 days relative to index: Neoplasm of endocrine system,210
4300595212,condition_era group during day -30 through 0 days relative to index: Neoplasm of endocrine system,212
4300866502,procedure_occurrence during day -365 through 0 days relative to index: Ultrasonography of urinary system,502
4301464502,procedure_occurrence during day -365 through 0 days relative to index: Chemotherapy care education,502
4301546502,procedure_occurrence during day -365 through 0 days relative to index: Blood specimen care management,502
4301546504,procedure_occurrence during day -30 through 0 days relative to index: Blood specimen care management,504
4302745502,procedure_occurrence during day -365 through 0 days relative to index: Irrigation of urinary bladder,502
4302745504,procedure_occurrence during day -30 through 0 days relative to index: Irrigation of urinary bladder,504
4303967502,procedure_occurrence during day -365 through 0 days relative to index: Fluoroscopic fistulography,502
4303967504,procedure_occurrence during day -30 through 0 days relative to index: Fluoroscopic fistulography,504
4304092502,procedure_occurrence during day -365 through 0 days relative to index: CT of abdomen and pelvis,502
4305077502,procedure_occurrence during day -365 through 0 days relative to index: Transurethral resection of bladder neoplasm,502
4305317502,procedure_occurrence during day -365 through 0 days relative to index: Computer assisted image analysis,502
4305317504,procedure_occurrence during day -30 through 0 days relative to index: Computer assisted image analysis,504
4305581502,procedure_occurrence during day -365 through 0 days relative to index: Application of dressing,502
4305581504,procedure_occurrence during day -30 through 0 days relative to index: Application of dressing,504
4306082210,condition_era group during day -365 through 0 days relative to index: Aspiration pneumonitis,210
4306082212,condition_era group during day -30 through 0 days relative to index: Aspiration pneumonitis,212
4309380502,procedure_occurrence during day -365 through 0 days relative to index: Radiography of nasal sinuses,502
4309380504,procedure_occurrence during day -30 through 0 days relative to index: Radiography of nasal sinuses,504
4311115210,condition_era group during day -365 through 0 days relative to index: Intracranial mass,210
4311115212,condition_era group during day -30 through 0 days relative to index: Intracranial mass,212
4311499210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of respiratory tract,210
4311499212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of respiratory tract,212
4312023210,condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of intra-abdominal organs,210
4312023212,condition_era group during day -30 through 0 days relative to index: Secondary malignant neoplasm of intra-abdominal organs,212
4312288210,condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of central nervous system,210
4312288212,condition_era group during day -30 through 0 days relative to index: Secondary malignant neoplasm of central nervous system,212
4312698210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of trunk,210
4312698212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of trunk,212
4313083210,condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of head,210
4313083212,condition_era group during day -30 through 0 days relative to index: Secondary malignant neoplasm of head,212
4314071210,condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of trunk,210
4314071212,condition_era group during day -30 through 0 days relative to index: Secondary malignant neoplasm of trunk,212
4318404210,condition_era group during day -365 through 0 days relative to index: Lung consolidation,210
4318404212,condition_era group during day -30 through 0 days relative to index: Lung consolidation,212
4318535210,condition_era group during day -365 through 0 days relative to index: Duodenal hemorrhage,210
4318535212,condition_era group during day -30 through 0 days relative to index: Duodenal hemorrhage,212
4323715502,procedure_occurrence during day -365 through 0 days relative to index: Transfusion of packed red blood cells,502
4323715504,procedure_occurrence during day -30 through 0 days relative to index: Transfusion of packed red blood cells,504
4324693502,procedure_occurrence during day -365 through 0 days relative to index: Mammography,502
4326757502,procedure_occurrence during day -365 through 0 days relative to index: Gait training procedure,502
4327032502,procedure_occurrence during day -365 through 0 days relative to index: CT of thorax with contrast,502
4327032504,procedure_occurrence during day -30 through 0 days relative to index: CT of thorax with contrast,504
4329041210,condition_era group during day -365 through 0 days relative to index: Pain,210
4329041212,condition_era group during day -30 through 0 days relative to index: Pain,212
4331031602,device_exposure during day -365 through 0 days relative to index: Endotracheal tube cuff,602
4331086602,device_exposure during day -365 through 0 days relative to index: Infusion pump,602
4331086604,device_exposure during day -30 through 0 days relative to index: Infusion pump,604
4331509210,condition_era group during day -365 through 0 days relative to index: Mass of head,210
4331509212,condition_era group during day -30 through 0 days relative to index: Mass of head,212
4332191502,procedure_occurrence during day -365 through 0 days relative to index: Whole body bone imaging,502
4332593502,procedure_occurrence during day -365 through 0 days relative to index: Spinal anesthesia,502
4332856502,procedure_occurrence during day -365 through 0 days relative to index: Local anesthetic dental infiltration,502
4334322210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of lower respiratory tract,210
4334322212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of lower respiratory tract,212
4335583502,procedure_occurrence during day -365 through 0 days relative to index: Tracheal intubation using rigid bronchoscope,502
4335583504,procedure_occurrence during day -30 through 0 days relative to index: Tracheal intubation using rigid bronchoscope,504
4335824502,procedure_occurrence during day -365 through 0 days relative to index: Exercise stress echocardiography,502
4335824504,procedure_occurrence during day -30 through 0 days relative to index: Exercise stress echocardiography,504
4335825502,procedure_occurrence during day -365 through 0 days relative to index: Transthoracic echocardiography,502
4335825504,procedure_occurrence during day -30 through 0 days relative to index: Transthoracic echocardiography,504
4338544210,condition_era group during day -365 through 0 days relative to index: Lower gastrointestinal hemorrhage,210
4338544212,condition_era group during day -30 through 0 days relative to index: Lower gastrointestinal hemorrhage,212
4341650210,condition_era group during day -365 through 0 days relative to index: Liver disorder due to infection,210
4341650212,condition_era group during day -30 through 0 days relative to index: Liver disorder due to infection,212
4342655210,condition_era group during day -365 through 0 days relative to index: Ulceration of small intestine,210
4342655212,condition_era group during day -30 through 0 days relative to index: Ulceration of small intestine,212
4342872210,condition_era group during day -365 through 0 days relative to index: Pancreatic duct disorder,210
4342872212,condition_era group during day -30 through 0 days relative to index: Pancreatic duct disorder,212
19000537410,drug_era group during day -365 through 0 days relative to index: Threonine,410
19000537412,drug_era group during day -30 through 0 days relative to index: Threonine,412
19003953410,drug_era group during day -365 through 0 days relative to index: Rocuronium,410
19003953412,drug_era group during day -30 through 0 days relative to index: Rocuronium,412
19004724410,drug_era group during day -365 through 0 days relative to index: Methionine,410
19004724412,drug_era group during day -30 through 0 days relative to index: Methionine,412
19005046410,drug_era group during day -365 through 0 days relative to index: pyridoxine,410
19005046412,drug_era group during day -30 through 0 days relative to index: pyridoxine,412
19005046413,drug_era group during day 0 through 0 days relative to index: pyridoxine,413
19005512410,drug_era group during day -365 through 0 days relative to index: Trimebutine,410
19005512412,drug_era group during day -30 through 0 days relative to index: Trimebutine,412
19005512413,drug_era group during day 0 through 0 days relative to index: Trimebutine,413
19006186410,drug_era group during day -365 through 0 days relative to index: Tryptophan,410
19006186412,drug_era group during day -30 through 0 days relative to index: Tryptophan,412
19006410410,drug_era group during day -365 through 0 days relative to index: Arginine,410
19006410412,drug_era group during day -30 through 0 days relative to index: Arginine,412
19006586410,drug_era group during day -365 through 0 days relative to index: rufinamide,410
19006586412,drug_era group during day -30 through 0 days relative to index: rufinamide,412
19006586413,drug_era group during day 0 through 0 days relative to index: rufinamide,413
19006692410,drug_era group during day -365 through 0 days relative to index: Tyrosine,410
19006692412,drug_era group during day -30 through 0 days relative to index: Tyrosine,412
19007572410,drug_era group during day -365 through 0 days relative to index: Valine,410
19007572412,drug_era group during day -30 through 0 days relative to index: Valine,412
19008009410,drug_era group during day -365 through 0 days relative to index: Cosyntropin,410
19008339410,drug_era group during day -365 through 0 days relative to index: Vitamin A,410
19008339412,drug_era group during day -30 through 0 days relative to index: Vitamin A,412
19008339413,drug_era group during day 0 through 0 days relative to index: Vitamin A,413
19008897410,drug_era group during day -365 through 0 days relative to index: manganese sulfate,410
19008897412,drug_era group during day -30 through 0 days relative to index: manganese sulfate,412
19009145410,drug_era group during day -365 through 0 days relative to index: mequitazine,410
19009145412,drug_era group during day -30 through 0 days relative to index: mequitazine,412
19009145413,drug_era group during day 0 through 0 days relative to index: mequitazine,413
19009705410,drug_era group during day -365 through 0 days relative to index: lenograstim,410
19009705412,drug_era group during day -30 through 0 days relative to index: lenograstim,412
19009705413,drug_era group during day 0 through 0 days relative to index: lenograstim,413
19010309410,drug_era group during day -365 through 0 days relative to index: Water,410
19010309412,drug_era group during day -30 through 0 days relative to index: Water,412
19010309413,drug_era group during day 0 through 0 days relative to index: Water,413
19011035410,drug_era group during day -365 through 0 days relative to index: Lactate,410
19011035412,drug_era group during day -30 through 0 days relative to index: Lactate,412
19011339410,drug_era group during day -365 through 0 days relative to index: mosapride,410
19011339412,drug_era group during day -30 through 0 days relative to index: mosapride,412
19011339413,drug_era group during day 0 through 0 days relative to index: mosapride,413
19011773410,drug_era group during day -365 through 0 days relative to index: Ascorbic Acid,410
19011773412,drug_era group during day -30 through 0 days relative to index: Ascorbic Acid,412
19011773413,drug_era group during day 0 through 0 days relative to index: Ascorbic Acid,413
19012686410,drug_era group during day -365 through 0 days relative to index: Aspartic Acid,410
19012686412,drug_era group during day -30 through 0 days relative to index: Aspartic Acid,412
19012925410,drug_era group during day -365 through 0 days relative to index: silodosin,410
19014977410,drug_era group during day -365 through 0 days relative to index: Nicorandil,410
19015768410,drug_era group during day -365 through 0 days relative to index: Methoxy polyethylene glycol-epoetin beta,410
19016463410,drug_era group during day -365 through 0 days relative to index: Benserazide,410
19016463412,drug_era group during day -30 through 0 days relative to index: Benserazide,412
19016463413,drug_era group during day 0 through 0 days relative to index: Benserazide,413
19016749410,drug_era group during day -365 through 0 days relative to index: remifentanil,410
19016749412,drug_era group during day -30 through 0 days relative to index: remifentanil,412
19017742410,drug_era group during day -365 through 0 days relative to index: febuxostat,410
19017742412,drug_era group during day -30 through 0 days relative to index: febuxostat,412
19017742413,drug_era group during day 0 through 0 days relative to index: febuxostat,413
19018403410,drug_era group during day -365 through 0 days relative to index: racecadotril,410
19018419410,drug_era group during day -365 through 0 days relative to index: Niacinamide,410
19018419412,drug_era group during day -30 through 0 days relative to index: Niacinamide,412
19018419413,drug_era group during day 0 through 0 days relative to index: Niacinamide,413
19018544410,drug_era group during day -365 through 0 days relative to index: Calcium,410
19018544412,drug_era group during day -30 through 0 days relative to index: Calcium,412
19018544413,drug_era group during day 0 through 0 days relative to index: Calcium,413
19019620410,drug_era group during day -365 through 0 days relative to index: Benzydamine,410
19019620412,drug_era group during day -30 through 0 days relative to index: Benzydamine,412
19019620413,drug_era group during day 0 through 0 days relative to index: Benzydamine,413
19024770410,drug_era group during day -365 through 0 days relative to index: Biotin,410
19024770412,drug_era group during day -30 through 0 days relative to index: Biotin,412
19024770413,drug_era group during day 0 through 0 days relative to index: Biotin,413
19025274410,drug_era group during day -365 through 0 days relative to index: Oxygen,410
19025274412,drug_era group during day -30 through 0 days relative to index: Oxygen,412
19025274413,drug_era group during day 0 through 0 days relative to index: Oxygen,413
19026459410,drug_era group during day -365 through 0 days relative to index: tapentadol,410
19026459412,drug_era group during day -30 through 0 days relative to index: tapentadol,412
19026459413,drug_era group during day 0 through 0 days relative to index: tapentadol,413
19026739410,drug_era group during day -365 through 0 days relative to index: Pantothenic Acid,410
19026739412,drug_era group during day -30 through 0 days relative to index: Pantothenic Acid,412
19026739413,drug_era group during day 0 through 0 days relative to index: Pantothenic Acid,413
19027362410,drug_era group during day -365 through 0 days relative to index: potassium phosphate,410
19027362412,drug_era group during day -30 through 0 days relative to index: potassium phosphate,412
19027958410,drug_era group during day -365 through 0 days relative to index: fesoterodine,410
19030059410,drug_era group during day -365 through 0 days relative to index: alginic acid,410
19030059412,drug_era group during day -30 through 0 days relative to index: alginic acid,412
19030059413,drug_era group during day 0 through 0 days relative to index: alginic acid,413
19034009410,drug_era group during day -365 through 0 days relative to index: ambroxol-theophylline-7-acetate,410
19034009412,drug_era group during day -30 through 0 days relative to index: ambroxol-theophylline-7-acetate,412
19034009413,drug_era group during day 0 through 0 days relative to index: ambroxol-theophylline-7-acetate,413
19035577410,drug_era group during day -365 through 0 days relative to index: Phenylalanine,410
19035577412,drug_era group during day -30 through 0 days relative to index: Phenylalanine,412
19035631410,drug_era group during day -365 through 0 days relative to index: Calcitriol,410
19035631412,drug_era group during day -30 through 0 days relative to index: Calcitriol,412
19035631413,drug_era group during day 0 through 0 days relative to index: Calcitriol,413
19035704410,drug_era group during day -365 through 0 days relative to index: Calcium Carbonate,410
19035704412,drug_era group during day -30 through 0 days relative to index: Calcium Carbonate,412
19035704413,drug_era group during day 0 through 0 days relative to index: Calcium Carbonate,413
19036781410,drug_era group during day -365 through 0 days relative to index: Calcium Chloride,410
19036781412,drug_era group during day -30 through 0 days relative to index: Calcium Chloride,412
19037038410,drug_era group during day -365 through 0 days relative to index: Calcium Gluconate,410
19037706410,drug_era group during day -365 through 0 days relative to index: bismuth oxide,410
19037706412,drug_era group during day -30 through 0 days relative to index: bismuth oxide,412
19037706413,drug_era group during day 0 through 0 days relative to index: bismuth oxide,413
19037833410,drug_era group during day -365 through 0 days relative to index: Domperidone,410
19038464410,drug_era group during day -365 through 0 days relative to index: soy protein isolate,410
19038464412,drug_era group during day -30 through 0 days relative to index: soy protein isolate,412
19040606410,drug_era group during day -365 through 0 days relative to index: Carbimazole,410
19041843410,drug_era group during day -365 through 0 days relative to index: Carbocysteine,410
19041843412,drug_era group during day -30 through 0 days relative to index: Carbocysteine,412
19041843413,drug_era group during day 0 through 0 days relative to index: Carbocysteine,413
19043191410,drug_era group during day -365 through 0 days relative to index: tulobuterol,410
19043191412,drug_era group during day -30 through 0 days relative to index: tulobuterol,412
19044522410,drug_era group during day -365 through 0 days relative to index: Zinc Sulfate,410
19044522412,drug_era group during day -30 through 0 days relative to index: Zinc Sulfate,412
19044727410,drug_era group during day -365 through 0 days relative to index: Vitamin K 1,410
19044727412,drug_era group during day -30 through 0 days relative to index: Vitamin K 1,412
19045045410,drug_era group during day -365 through 0 days relative to index: Ergocalciferol,410
19045045412,drug_era group during day -30 through 0 days relative to index: Ergocalciferol,412
19045045413,drug_era group during day 0 through 0 days relative to index: Ergocalciferol,413
19048026410,drug_era group during day -365 through 0 days relative to index: cobamamide,410
19048026412,drug_era group during day -30 through 0 days relative to index: cobamamide,412
19049105410,drug_era group during day -365 through 0 days relative to index: Potassium Chloride,410
19049105412,drug_era group during day -30 through 0 days relative to index: Potassium Chloride,412
19049105413,drug_era group during day 0 through 0 days relative to index: Potassium Chloride,413
19049877410,drug_era group during day -365 through 0 days relative to index: chromic chloride,410
19050832410,drug_era group during day -365 through 0 days relative to index: clobazam,410
19050832412,drug_era group during day -30 through 0 days relative to index: clobazam,412
19050832413,drug_era group during day 0 through 0 days relative to index: clobazam,413
19052489410,drug_era group during day -365 through 0 days relative to index: Alanine,410
19052489412,drug_era group during day -30 through 0 days relative to index: Alanine,412
19052736410,drug_era group during day -365 through 0 days relative to index: Proline,410
19052736412,drug_era group during day -30 through 0 days relative to index: Proline,412
19057346410,drug_era group during day -365 through 0 days relative to index: Copper Sulfate,410
19057346412,drug_era group during day -30 through 0 days relative to index: Copper Sulfate,412
19058092410,drug_era group during day -365 through 0 days relative to index: Gelatin,410
19058092412,drug_era group during day -30 through 0 days relative to index: Gelatin,412
19058572410,drug_era group during day -365 through 0 days relative to index: Calcium Citrate,410
19058572412,drug_era group during day -30 through 0 days relative to index: Calcium Citrate,412
19058896410,drug_era group during day -365 through 0 days relative to index: calcium lactate,410
19058933410,drug_era group during day -365 through 0 days relative to index: erdosteine,410
19058933412,drug_era group during day -30 through 0 days relative to index: erdosteine,412
19058933413,drug_era group during day 0 through 0 days relative to index: erdosteine,413
19059796410,drug_era group during day -365 through 0 days relative to index: Gliclazide,410
19059796412,drug_era group during day -30 through 0 days relative to index: Gliclazide,412
19059796413,drug_era group during day 0 through 0 days relative to index: Gliclazide,413
19060985410,drug_era group during day -365 through 0 days relative to index: Glutamine,410
19060985412,drug_era group during day -30 through 0 days relative to index: Glutamine,412
19062817410,drug_era group during day -365 through 0 days relative to index: Riboflavin,410
19062817412,drug_era group during day -30 through 0 days relative to index: Riboflavin,412
19062817413,drug_era group during day 0 through 0 days relative to index: Riboflavin,413
19066774410,drug_era group during day -365 through 0 days relative to index: Serine,410
19066774412,drug_era group during day -30 through 0 days relative to index: Serine,412
19066992410,drug_era group during day -365 through 0 days relative to index: Silymarin,410
19066992412,drug_era group during day -30 through 0 days relative to index: Silymarin,412
19069149410,drug_era group during day -365 through 0 days relative to index: Histidine,410
19069149412,drug_era group during day -30 through 0 days relative to index: Histidine,412
19070224410,drug_era group during day -365 through 0 days relative to index: Soybean Oil,410
19070224412,drug_era group during day -30 through 0 days relative to index: Soybean Oil,412
19070224413,drug_era group during day 0 through 0 days relative to index: Soybean Oil,413
19071236410,drug_era group during day -365 through 0 days relative to index: lactitol,410
19077117410,drug_era group during day -365 through 0 days relative to index: Hetastarch,410
19077884410,drug_era group during day -365 through 0 days relative to index: Sodium Acetate,410
19077884412,drug_era group during day -30 through 0 days relative to index: Sodium Acetate,412
19077884413,drug_era group during day 0 through 0 days relative to index: Sodium Acetate,413
19078092410,drug_era group during day -365 through 0 days relative to index: Sodium gluconate,410
19078092412,drug_era group during day -30 through 0 days relative to index: Sodium gluconate,412
19078092413,drug_era group during day 0 through 0 days relative to index: Sodium gluconate,413
19078399410,drug_era group during day -365 through 0 days relative to index: Teicoplanin,410
19078399412,drug_era group during day -30 through 0 days relative to index: Teicoplanin,412
19081224410,drug_era group during day -365 through 0 days relative to index: Iopamidol,410
19081224412,drug_era group during day -30 through 0 days relative to index: Iopamidol,412
19082306410,drug_era group during day -365 through 0 days relative to index: Isoleucine,410
19082306412,drug_era group during day -30 through 0 days relative to index: Isoleucine,412
19088167410,drug_era group during day -365 through 0 days relative to index: Ambroxol,410
19088167412,drug_era group during day -30 through 0 days relative to index: Ambroxol,412
19088167413,drug_era group during day 0 through 0 days relative to index: Ambroxol,413
19088571410,drug_era group during day -365 through 0 days relative to index: Leucine,410
19088571412,drug_era group during day -30 through 0 days relative to index: Leucine,412
19092167410,drug_era group during day -365 through 0 days relative to index: Sodium Acetate Trihydrate,410
19092377410,drug_era group during day -365 through 0 days relative to index: Lysine,410
19092377412,drug_era group during day -30 through 0 days relative to index: Lysine,412
19092849410,drug_era group during day -365 through 0 days relative to index: Magnesium Chloride,410
19092849412,drug_era group during day -30 through 0 days relative to index: Magnesium Chloride,412
19092849413,drug_era group during day 0 through 0 days relative to index: Magnesium Chloride,413
19095091410,drug_era group during day -365 through 0 days relative to index: potassium carbonate,410
19095091412,drug_era group during day -30 through 0 days relative to index: potassium carbonate,412
19095164410,drug_era group during day -365 through 0 days relative to index: Cholecalciferol,410
19095164412,drug_era group during day -30 through 0 days relative to index: Cholecalciferol,412
19095164413,drug_era group during day 0 through 0 days relative to index: Cholecalciferol,413
19098505410,drug_era group during day -365 through 0 days relative to index: Ginkgo Biloba Leaf Extract,410
19098505412,drug_era group during day -30 through 0 days relative to index: Ginkgo Biloba Leaf Extract,412
19110701410,drug_era group during day -365 through 0 days relative to index: Fish Oils,410
19110701412,drug_era group during day -30 through 0 days relative to index: Fish Oils,412
19110701413,drug_era group during day 0 through 0 days relative to index: Fish Oils,413
19111620410,drug_era group during day -365 through 0 days relative to index: Folic Acid,410
19111620412,drug_era group during day -30 through 0 days relative to index: Folic Acid,412
19111620413,drug_era group during day 0 through 0 days relative to index: Folic Acid,413
19112563410,drug_era group during day -365 through 0 days relative to index: Calcium polystyrene sulfonate product,410
19112563412,drug_era group during day -30 through 0 days relative to index: Calcium polystyrene sulfonate product,412
19112563413,drug_era group during day 0 through 0 days relative to index: Calcium polystyrene sulfonate product,413
19132965410,drug_era group during day -365 through 0 days relative to index: Plantago Seed,410
19132965412,drug_era group during day -30 through 0 days relative to index: Plantago Seed,412
19136247410,drug_era group during day -365 through 0 days relative to index: Sucrose,410
19136247412,drug_era group during day -30 through 0 days relative to index: Sucrose,412
19137056410,drug_era group during day -365 through 0 days relative to index: Theobromine,410
19137056412,drug_era group during day -30 through 0 days relative to index: Theobromine,412
19137056413,drug_era group during day 0 through 0 days relative to index: Theobromine,413
19137312410,drug_era group during day -365 through 0 days relative to index: Thiamine,410
19137312412,drug_era group during day -30 through 0 days relative to index: Thiamine,412
19137312413,drug_era group during day 0 through 0 days relative to index: Thiamine,413
21493467702,measurement during day -365 through 0 days relative to index: Salmonella enterica+bongori DNA [Presence] in Stool by NAA with non-probe detection,702
21493469702,measurement during day -365 through 0 days relative to index: Vibrio cholerae DNA [Presence] in Stool by NAA with non-probe detection,702
21493560702,measurement during day -365 through 0 days relative to index: Escherichia coli Stx1 and Stx2 toxin stx1+stx2 genes [Presence] in Stool by NAA with probe detection,702
21493566702,measurement during day -365 through 0 days relative to index: Clostridioides difficile toxin A+B tcdA+tcdB genes [Presence] in Stool by NAA with probe detection,702
21600001410,drug_era group during day -365 through 0 days relative to index: ALIMENTARY TRACT AND METABOLISM,410
21600001412,drug_era group during day -30 through 0 days relative to index: ALIMENTARY TRACT AND METABOLISM,412
21600001413,drug_era group during day 0 through 0 days relative to index: ALIMENTARY TRACT AND METABOLISM,413
21600002410,drug_era group during day -365 through 0 days relative to index: STOMATOLOGICAL PREPARATIONS,410
21600002412,drug_era group during day -30 through 0 days relative to index: STOMATOLOGICAL PREPARATIONS,412
21600002413,drug_era group during day 0 through 0 days relative to index: STOMATOLOGICAL PREPARATIONS,413
21600003410,drug_era group during day -365 through 0 days relative to index: STOMATOLOGICAL PREPARATIONS,410
21600003412,drug_era group during day -30 through 0 days relative to index: STOMATOLOGICAL PREPARATIONS,412
21600003413,drug_era group during day 0 through 0 days relative to index: STOMATOLOGICAL PREPARATIONS,413
21600011410,drug_era group during day -365 through 0 days relative to index: Antiinfectives and antiseptics for local oral treatment,410
21600011412,drug_era group during day -30 through 0 days relative to index: Antiinfectives and antiseptics for local oral treatment,412
21600011413,drug_era group during day 0 through 0 days relative to index: Antiinfectives and antiseptics for local oral treatment,413
21600033410,drug_era group during day -365 through 0 days relative to index: Corticosteroids for local oral treatment,410
21600033412,drug_era group during day -30 through 0 days relative to index: Corticosteroids for local oral treatment,412
21600033413,drug_era group during day 0 through 0 days relative to index: Corticosteroids for local oral treatment,413
21600038410,drug_era group during day -365 through 0 days relative to index: Other agents for local oral treatment,410
21600038412,drug_era group during day -30 through 0 days relative to index: Other agents for local oral treatment,412
21600038413,drug_era group during day 0 through 0 days relative to index: Other agents for local oral treatment,413
21600046410,drug_era group during day -365 through 0 days relative to index: DRUGS FOR ACID RELATED DISORDERS,410
21600046412,drug_era group during day -30 through 0 days relative to index: DRUGS FOR ACID RELATED DISORDERS,412
21600046413,drug_era group during day 0 through 0 days relative to index: DRUGS FOR ACID RELATED DISORDERS,413
21600047410,drug_era group during day -365 through 0 days relative to index: ANTACIDS,410
21600047412,drug_era group during day -30 through 0 days relative to index: ANTACIDS,412
21600047413,drug_era group during day 0 through 0 days relative to index: ANTACIDS,413
21600048410,drug_era group during day -365 through 0 days relative to index: Magnesium compounds,410
21600048412,drug_era group during day -30 through 0 days relative to index: Magnesium compounds,412
21600048413,drug_era group during day 0 through 0 days relative to index: Magnesium compounds,413
21600080410,drug_era group during day -365 through 0 days relative to index: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),410
21600080412,drug_era group during day -30 through 0 days relative to index: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),412
21600080413,drug_era group during day 0 through 0 days relative to index: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD),413
21600081410,drug_era group during day -365 through 0 days relative to index: H2-receptor antagonists,410
21600081412,drug_era group during day -30 through 0 days relative to index: H2-receptor antagonists,412
21600081413,drug_era group during day 0 through 0 days relative to index: H2-receptor antagonists,413
21600095410,drug_era group during day -365 through 0 days relative to index: Proton pump inhibitors,410
21600095412,drug_era group during day -30 through 0 days relative to index: Proton pump inhibitors,412
21600095413,drug_era group during day 0 through 0 days relative to index: Proton pump inhibitors,413
21600109410,drug_era group during day -365 through 0 days relative to index: Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),410
21600109412,drug_era group during day -30 through 0 days relative to index: Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),412
21600109413,drug_era group during day 0 through 0 days relative to index: Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD),413
21600127410,drug_era group during day -365 through 0 days relative to index: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,410
21600127412,drug_era group during day -30 through 0 days relative to index: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,412
21600127413,drug_era group during day 0 through 0 days relative to index: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,413
21600128410,drug_era group during day -365 through 0 days relative to index: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,410
21600128412,drug_era group during day -30 through 0 days relative to index: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,412
21600128413,drug_era group during day 0 through 0 days relative to index: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS,413
21600129410,"drug_era group during day -365 through 0 days relative to index: Synthetic anticholinergics, esters with tertiary amino group",410
21600129412,"drug_era group during day -30 through 0 days relative to index: Synthetic anticholinergics, esters with tertiary amino group",412
21600129413,"drug_era group during day 0 through 0 days relative to index: Synthetic anticholinergics, esters with tertiary amino group",413
21600139410,"drug_era group during day -365 through 0 days relative to index: Synthetic anticholinergics, quaternary ammonium compounds",410
21600190410,"drug_era group during day -365 through 0 days relative to index: BELLADONNA AND DERIVATIVES, PLAIN",410
21600190412,"drug_era group during day -30 through 0 days relative to index: BELLADONNA AND DERIVATIVES, PLAIN",412
21600191410,"drug_era group during day -365 through 0 days relative to index: Belladonna alkaloids, tertiary amines",410
21600191412,"drug_era group during day -30 through 0 days relative to index: Belladonna alkaloids, tertiary amines",412
21600279410,drug_era group during day -365 through 0 days relative to index: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,410
21600279412,drug_era group during day -30 through 0 days relative to index: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,412
21600279413,drug_era group during day 0 through 0 days relative to index: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES,413
21600280410,drug_era group during day -365 through 0 days relative to index: Adrenergic and dopaminergic agents,410
21600280412,drug_era group during day -30 through 0 days relative to index: Adrenergic and dopaminergic agents,412
21600280413,drug_era group during day 0 through 0 days relative to index: Adrenergic and dopaminergic agents,413
21600315410,drug_era group during day -365 through 0 days relative to index: VASODILATORS USED IN CARDIAC DISEASES,410
21600337410,drug_era group during day -365 through 0 days relative to index: Other vasodilators used in cardiac diseases,410
21600360410,drug_era group during day -365 through 0 days relative to index: OTHER CARDIAC PREPARATIONS,410
21600360412,drug_era group during day -30 through 0 days relative to index: OTHER CARDIAC PREPARATIONS,412
21600360413,drug_era group during day 0 through 0 days relative to index: OTHER CARDIAC PREPARATIONS,413
21600363410,drug_era group during day -365 through 0 days relative to index: Other cardiac preparations,410
21600363412,drug_era group during day -30 through 0 days relative to index: Other cardiac preparations,412
21600363413,drug_era group during day 0 through 0 days relative to index: Other cardiac preparations,413
21600482410,drug_era group during day -365 through 0 days relative to index: PROPULSIVES,410
21600482412,drug_era group during day -30 through 0 days relative to index: PROPULSIVES,412
21600482413,drug_era group during day 0 through 0 days relative to index: PROPULSIVES,413
21600483410,drug_era group during day -365 through 0 days relative to index: Propulsives,410
21600483412,drug_era group during day -30 through 0 days relative to index: Propulsives,412
21600483413,drug_era group during day 0 through 0 days relative to index: Propulsives,413
21600490410,drug_era group during day -365 through 0 days relative to index: ANTIEMETICS AND ANTINAUSEANTS,410
21600490412,drug_era group during day -30 through 0 days relative to index: ANTIEMETICS AND ANTINAUSEANTS,412
21600490413,drug_era group during day 0 through 0 days relative to index: ANTIEMETICS AND ANTINAUSEANTS,413
21600491410,drug_era group during day -365 through 0 days relative to index: ANTIEMETICS AND ANTINAUSEANTS,410
21600491412,drug_era group during day -30 through 0 days relative to index: ANTIEMETICS AND ANTINAUSEANTS,412
21600491413,drug_era group during day 0 through 0 days relative to index: ANTIEMETICS AND ANTINAUSEANTS,413
21600492410,drug_era group during day -365 through 0 days relative to index: Serotonin (5HT3) antagonists,410
21600492412,drug_era group during day -30 through 0 days relative to index: Serotonin (5HT3) antagonists,412
21600492413,drug_era group during day 0 through 0 days relative to index: Serotonin (5HT3) antagonists,413
21600509410,drug_era group during day -365 through 0 days relative to index: BILE AND LIVER THERAPY,410
21600509412,drug_era group during day -30 through 0 days relative to index: BILE AND LIVER THERAPY,412
21600510410,drug_era group during day -365 through 0 days relative to index: BILE THERAPY,410
21600510412,drug_era group during day -30 through 0 days relative to index: BILE THERAPY,412
21600511410,drug_era group during day -365 through 0 days relative to index: Bile acids and derivatives,410
21600511412,drug_era group during day -30 through 0 days relative to index: Bile acids and derivatives,412
21600521410,"drug_era group during day -365 through 0 days relative to index: LIVER THERAPY, LIPOTROPICS",410
21600521412,"drug_era group during day -30 through 0 days relative to index: LIVER THERAPY, LIPOTROPICS",412
21600522410,drug_era group during day -365 through 0 days relative to index: Liver therapy,410
21600522412,drug_era group during day -30 through 0 days relative to index: Liver therapy,412
21600531410,drug_era group during day -365 through 0 days relative to index: DRUGS FOR CONSTIPATION,410
21600531412,drug_era group during day -30 through 0 days relative to index: DRUGS FOR CONSTIPATION,412
21600531413,drug_era group during day 0 through 0 days relative to index: DRUGS FOR CONSTIPATION,413
21600532410,drug_era group during day -365 through 0 days relative to index: DRUGS FOR CONSTIPATION,410
21600532412,drug_era group during day -30 through 0 days relative to index: DRUGS FOR CONSTIPATION,412
21600532413,drug_era group during day 0 through 0 days relative to index: DRUGS FOR CONSTIPATION,413
21600554410,drug_era group during day -365 through 0 days relative to index: Bulk-forming laxatives,410
21600554412,drug_era group during day -30 through 0 days relative to index: Bulk-forming laxatives,412
21600554413,drug_era group during day 0 through 0 days relative to index: Bulk-forming laxatives,413
21600565410,drug_era group during day -365 through 0 days relative to index: Osmotically acting laxatives,410
21600565412,drug_era group during day -30 through 0 days relative to index: Osmotically acting laxatives,412
21600565413,drug_era group during day 0 through 0 days relative to index: Osmotically acting laxatives,413
21600583410,drug_era group during day -365 through 0 days relative to index: Enemas,410
21600583412,drug_era group during day -30 through 0 days relative to index: Enemas,412
21600596410,drug_era group during day -365 through 0 days relative to index: Other drugs for constipation,410
21600596412,drug_era group during day -30 through 0 days relative to index: Other drugs for constipation,412
21600600410,"drug_era group during day -365 through 0 days relative to index: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",410
21600600412,"drug_era group during day -30 through 0 days relative to index: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",412
21600600413,"drug_era group during day 0 through 0 days relative to index: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS",413
21600601410,drug_era group during day -365 through 0 days relative to index: INTESTINAL ANTIINFECTIVES,410
21600601412,drug_era group during day -30 through 0 days relative to index: INTESTINAL ANTIINFECTIVES,412
21600602410,drug_era group during day -365 through 0 days relative to index: Antibiotics,410
21600602412,drug_era group during day -30 through 0 days relative to index: Antibiotics,412
21600642410,drug_era group during day -365 through 0 days relative to index: ANTIPROPULSIVES,410
21600642412,drug_era group during day -30 through 0 days relative to index: ANTIPROPULSIVES,412
21600643410,drug_era group during day -365 through 0 days relative to index: Antipropulsives,410
21600643412,drug_era group during day -30 through 0 days relative to index: Antipropulsives,412
21600651410,drug_era group during day -365 through 0 days relative to index: INTESTINAL ANTIINFLAMMATORY AGENTS,410
21600651412,drug_era group during day -30 through 0 days relative to index: INTESTINAL ANTIINFLAMMATORY AGENTS,412
21600651413,drug_era group during day 0 through 0 days relative to index: INTESTINAL ANTIINFLAMMATORY AGENTS,413
21600652410,drug_era group during day -365 through 0 days relative to index: Corticosteroids acting locally,410
21600652412,drug_era group during day -30 through 0 days relative to index: Corticosteroids acting locally,412
21600652413,drug_era group during day 0 through 0 days relative to index: Corticosteroids acting locally,413
21600667410,drug_era group during day -365 through 0 days relative to index: ANTIDIARRHEAL MICROORGANISMS,410
21600668410,drug_era group during day -365 through 0 days relative to index: Antidiarrheal microorganisms,410
21600672410,drug_era group during day -365 through 0 days relative to index: OTHER ANTIDIARRHEALS,410
21600673410,drug_era group during day -365 through 0 days relative to index: Other antidiarrheals,410
21600697410,"drug_era group during day -365 through 0 days relative to index: DIGESTIVES, INCL. ENZYMES",410
21600697412,"drug_era group during day -30 through 0 days relative to index: DIGESTIVES, INCL. ENZYMES",412
21600698410,"drug_era group during day -365 through 0 days relative to index: DIGESTIVES, INCL. ENZYMES",410
21600698412,"drug_era group during day -30 through 0 days relative to index: DIGESTIVES, INCL. ENZYMES",412
21600704410,drug_era group during day -365 through 0 days relative to index: Acid preparations,410
21600704412,drug_era group during day -30 through 0 days relative to index: Acid preparations,412
21600712410,drug_era group during day -365 through 0 days relative to index: DRUGS USED IN DIABETES,410
21600712412,drug_era group during day -30 through 0 days relative to index: DRUGS USED IN DIABETES,412
21600712413,drug_era group during day 0 through 0 days relative to index: DRUGS USED IN DIABETES,413
21600713410,drug_era group during day -365 through 0 days relative to index: INSULINS AND ANALOGUES,410
21600713412,drug_era group during day -30 through 0 days relative to index: INSULINS AND ANALOGUES,412
21600713413,drug_era group during day 0 through 0 days relative to index: INSULINS AND ANALOGUES,413
21600714410,"drug_era group during day -365 through 0 days relative to index: Insulins and analogues for injection, fast-acting",410
21600714412,"drug_era group during day -30 through 0 days relative to index: Insulins and analogues for injection, fast-acting",412
21600714413,"drug_era group during day 0 through 0 days relative to index: Insulins and analogues for injection, fast-acting",413
21600722410,"drug_era group during day -365 through 0 days relative to index: Insulins and analogues for injection, intermediate-acting",410
21600722412,"drug_era group during day -30 through 0 days relative to index: Insulins and analogues for injection, intermediate-acting",412
21600722413,"drug_era group during day 0 through 0 days relative to index: Insulins and analogues for injection, intermediate-acting",413
21600728410,"drug_era group during day -365 through 0 days relative to index: Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",410
21600728412,"drug_era group during day -30 through 0 days relative to index: Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",412
21600728413,"drug_era group during day 0 through 0 days relative to index: Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",413
21600735410,"drug_era group during day -365 through 0 days relative to index: Insulins and analogues for injection, long-acting",410
21600735412,"drug_era group during day -30 through 0 days relative to index: Insulins and analogues for injection, long-acting",412
21600744410,"drug_era group during day -365 through 0 days relative to index: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",410
21600744412,"drug_era group during day -30 through 0 days relative to index: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",412
21600744413,"drug_era group during day 0 through 0 days relative to index: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",413
21600745410,drug_era group during day -365 through 0 days relative to index: Biguanides,410
21600745412,drug_era group during day -30 through 0 days relative to index: Biguanides,412
21600745413,drug_era group during day 0 through 0 days relative to index: Biguanides,413
21600749410,drug_era group during day -365 through 0 days relative to index: Sulfonylureas,410
21600749412,drug_era group during day -30 through 0 days relative to index: Sulfonylureas,412
21600749413,drug_era group during day 0 through 0 days relative to index: Sulfonylureas,413
21600783410,drug_era group during day -365 through 0 days relative to index: Dipeptidyl peptidase 4 (DPP-4) inhibitors,410
21600783412,drug_era group during day -30 through 0 days relative to index: Dipeptidyl peptidase 4 (DPP-4) inhibitors,412
21600783413,drug_era group during day 0 through 0 days relative to index: Dipeptidyl peptidase 4 (DPP-4) inhibitors,413
21600800410,drug_era group during day -365 through 0 days relative to index: VITAMINS,410
21600800412,drug_era group during day -30 through 0 days relative to index: VITAMINS,412
21600800413,drug_era group during day 0 through 0 days relative to index: VITAMINS,413
21600810410,"drug_era group during day -365 through 0 days relative to index: VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",410
21600810412,"drug_era group during day -30 through 0 days relative to index: VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",412
21600810413,"drug_era group during day 0 through 0 days relative to index: VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO",413
21600811410,"drug_era group during day -365 through 0 days relative to index: Vitamin A, plain",410
21600811412,"drug_era group during day -30 through 0 days relative to index: Vitamin A, plain",412
21600811413,"drug_era group during day 0 through 0 days relative to index: Vitamin A, plain",413
21600815410,drug_era group during day -365 through 0 days relative to index: Vitamin D and analogues,410
21600815412,drug_era group during day -30 through 0 days relative to index: Vitamin D and analogues,412
21600815413,drug_era group during day 0 through 0 days relative to index: Vitamin D and analogues,413
21600823410,"drug_era group during day -365 through 0 days relative to index: VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12",410
21600823412,"drug_era group during day -30 through 0 days relative to index: VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12",412
21600823413,"drug_era group during day 0 through 0 days relative to index: VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12",413
21600824410,"drug_era group during day -365 through 0 days relative to index: Vitamin B1, plain",410
21600824412,"drug_era group during day -30 through 0 days relative to index: Vitamin B1, plain",412
21600824413,"drug_era group during day 0 through 0 days relative to index: Vitamin B1, plain",413
21600835410,"drug_era group during day -365 through 0 days relative to index: ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS",410
21600835412,"drug_era group during day -30 through 0 days relative to index: ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS",412
21600835413,"drug_era group during day 0 through 0 days relative to index: ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS",413
21600836410,"drug_era group during day -365 through 0 days relative to index: Ascorbic acid (vitamin C), plain",410
21600836412,"drug_era group during day -30 through 0 days relative to index: Ascorbic acid (vitamin C), plain",412
21600836413,"drug_era group during day 0 through 0 days relative to index: Ascorbic acid (vitamin C), plain",413
21600840410,drug_era group during day -365 through 0 days relative to index: OTHER PLAIN VITAMIN PREPARATIONS,410
21600840412,drug_era group during day -30 through 0 days relative to index: OTHER PLAIN VITAMIN PREPARATIONS,412
21600840413,drug_era group during day 0 through 0 days relative to index: OTHER PLAIN VITAMIN PREPARATIONS,413
21600841410,drug_era group during day -365 through 0 days relative to index: Other plain vitamin preparations,410
21600841412,drug_era group during day -30 through 0 days relative to index: Other plain vitamin preparations,412
21600841413,drug_era group during day 0 through 0 days relative to index: Other plain vitamin preparations,413
21600857410,drug_era group during day -365 through 0 days relative to index: MINERAL SUPPLEMENTS,410
21600857412,drug_era group during day -30 through 0 days relative to index: MINERAL SUPPLEMENTS,412
21600857413,drug_era group during day 0 through 0 days relative to index: MINERAL SUPPLEMENTS,413
21600858410,drug_era group during day -365 through 0 days relative to index: CALCIUM,410
21600858412,drug_era group during day -30 through 0 days relative to index: CALCIUM,412
21600858413,drug_era group during day 0 through 0 days relative to index: CALCIUM,413
21600859410,drug_era group during day -365 through 0 days relative to index: Calcium,410
21600859412,drug_era group during day -30 through 0 days relative to index: Calcium,412
21600859413,drug_era group during day 0 through 0 days relative to index: Calcium,413
21600875410,drug_era group during day -365 through 0 days relative to index: POTASSIUM,410
21600875412,drug_era group during day -30 through 0 days relative to index: POTASSIUM,412
21600876410,drug_era group during day -365 through 0 days relative to index: Potassium,410
21600876412,drug_era group during day -30 through 0 days relative to index: Potassium,412
21600884410,drug_era group during day -365 through 0 days relative to index: OTHER MINERAL SUPPLEMENTS,410
21600884412,drug_era group during day -30 through 0 days relative to index: OTHER MINERAL SUPPLEMENTS,412
21600884413,drug_era group during day 0 through 0 days relative to index: OTHER MINERAL SUPPLEMENTS,413
21600885410,drug_era group during day -365 through 0 days relative to index: Sodium,410
21600885412,drug_era group during day -30 through 0 days relative to index: Sodium,412
21600885413,drug_era group during day 0 through 0 days relative to index: Sodium,413
21600888410,drug_era group during day -365 through 0 days relative to index: Zinc,410
21600888412,drug_era group during day -30 through 0 days relative to index: Zinc,412
21600892410,drug_era group during day -365 through 0 days relative to index: Magnesium,410
21600892412,drug_era group during day -30 through 0 days relative to index: Magnesium,412
21600892413,drug_era group during day 0 through 0 days relative to index: Magnesium,413
21600932410,drug_era group during day -365 through 0 days relative to index: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,410
21600932412,drug_era group during day -30 through 0 days relative to index: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,412
21600932413,drug_era group during day 0 through 0 days relative to index: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,413
21600933410,drug_era group during day -365 through 0 days relative to index: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,410
21600933412,drug_era group during day -30 through 0 days relative to index: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,412
21600933413,drug_era group during day 0 through 0 days relative to index: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS,413
21600934410,drug_era group during day -365 through 0 days relative to index: Amino acids and derivatives,410
21600934412,drug_era group during day -30 through 0 days relative to index: Amino acids and derivatives,412
21600934413,drug_era group during day 0 through 0 days relative to index: Amino acids and derivatives,413
21600951410,drug_era group during day -365 through 0 days relative to index: Various alimentary tract and metabolism products,410
21600951412,drug_era group during day -30 through 0 days relative to index: Various alimentary tract and metabolism products,412
21600951413,drug_era group during day 0 through 0 days relative to index: Various alimentary tract and metabolism products,413
21600959410,drug_era group during day -365 through 0 days relative to index: BLOOD AND BLOOD FORMING ORGANS,410
21600959412,drug_era group during day -30 through 0 days relative to index: BLOOD AND BLOOD FORMING ORGANS,412
21600959413,drug_era group during day 0 through 0 days relative to index: BLOOD AND BLOOD FORMING ORGANS,413
21600960410,drug_era group during day -365 through 0 days relative to index: ANTITHROMBOTIC AGENTS,410
21600960412,drug_era group during day -30 through 0 days relative to index: ANTITHROMBOTIC AGENTS,412
21600960413,drug_era group during day 0 through 0 days relative to index: ANTITHROMBOTIC AGENTS,413
21600961410,drug_era group during day -365 through 0 days relative to index: ANTITHROMBOTIC AGENTS,410
21600961412,drug_era group during day -30 through 0 days relative to index: ANTITHROMBOTIC AGENTS,412
21600961413,drug_era group during day 0 through 0 days relative to index: ANTITHROMBOTIC AGENTS,413
21600972410,drug_era group during day -365 through 0 days relative to index: Heparin group,410
21600972412,drug_era group during day -30 through 0 days relative to index: Heparin group,412
21600972413,drug_era group during day 0 through 0 days relative to index: Heparin group,413
21600985410,drug_era group during day -365 through 0 days relative to index: Platelet aggregation inhibitors excl. heparin,410
21600985412,drug_era group during day -30 through 0 days relative to index: Platelet aggregation inhibitors excl. heparin,412
21600985413,drug_era group during day 0 through 0 days relative to index: Platelet aggregation inhibitors excl. heparin,413
21601032410,drug_era group during day -365 through 0 days relative to index: ANTIHEMORRHAGICS,410
21601032412,drug_era group during day -30 through 0 days relative to index: ANTIHEMORRHAGICS,412
21601043410,drug_era group during day -365 through 0 days relative to index: VITAMIN K AND OTHER HEMOSTATICS,410
21601043412,drug_era group during day -30 through 0 days relative to index: VITAMIN K AND OTHER HEMOSTATICS,412
21601044410,drug_era group during day -365 through 0 days relative to index: Vitamin K,410
21601044412,drug_era group during day -30 through 0 days relative to index: Vitamin K,412
21601077410,drug_era group during day -365 through 0 days relative to index: ANTIANEMIC PREPARATIONS,410
21601077412,drug_era group during day -30 through 0 days relative to index: ANTIANEMIC PREPARATIONS,412
21601077413,drug_era group during day 0 through 0 days relative to index: ANTIANEMIC PREPARATIONS,413
21601078410,drug_era group during day -365 through 0 days relative to index: IRON PREPARATIONS,410
21601078412,drug_era group during day -30 through 0 days relative to index: IRON PREPARATIONS,412
21601078413,drug_era group during day 0 through 0 days relative to index: IRON PREPARATIONS,413
21601079410,"drug_era group during day -365 through 0 days relative to index: Iron bivalent, oral preparations",410
21601079412,"drug_era group during day -30 through 0 days relative to index: Iron bivalent, oral preparations",412
21601079413,"drug_era group during day 0 through 0 days relative to index: Iron bivalent, oral preparations",413
21601091410,"drug_era group during day -365 through 0 days relative to index: Iron trivalent, oral preparations",410
21601091412,"drug_era group during day -30 through 0 days relative to index: Iron trivalent, oral preparations",412
21601091413,"drug_era group during day 0 through 0 days relative to index: Iron trivalent, oral preparations",413
21601101410,"drug_era group during day -365 through 0 days relative to index: Iron, parenteral preparations",410
21601101412,"drug_era group during day -30 through 0 days relative to index: Iron, parenteral preparations",412
21601101413,"drug_era group during day 0 through 0 days relative to index: Iron, parenteral preparations",413
21601119410,drug_era group during day -365 through 0 days relative to index: VITAMIN B12 AND FOLIC ACID,410
21601119412,drug_era group during day -30 through 0 days relative to index: VITAMIN B12 AND FOLIC ACID,412
21601119413,drug_era group during day 0 through 0 days relative to index: VITAMIN B12 AND FOLIC ACID,413
21601120410,drug_era group during day -365 through 0 days relative to index: Vitamin B12 (cyanocobalamin and analogues),410
21601120412,drug_era group during day -30 through 0 days relative to index: Vitamin B12 (cyanocobalamin and analogues),412
21601128410,drug_era group during day -365 through 0 days relative to index: Folic acid and derivatives,410
21601128412,drug_era group during day -30 through 0 days relative to index: Folic acid and derivatives,412
21601128413,drug_era group during day 0 through 0 days relative to index: Folic acid and derivatives,413
21601131410,drug_era group during day -365 through 0 days relative to index: OTHER ANTIANEMIC PREPARATIONS,410
21601131412,drug_era group during day -30 through 0 days relative to index: OTHER ANTIANEMIC PREPARATIONS,412
21601131413,drug_era group during day 0 through 0 days relative to index: OTHER ANTIANEMIC PREPARATIONS,413
21601132410,drug_era group during day -365 through 0 days relative to index: Other antianemic preparations,410
21601132412,drug_era group during day -30 through 0 days relative to index: Other antianemic preparations,412
21601132413,drug_era group during day 0 through 0 days relative to index: Other antianemic preparations,413
21601136410,drug_era group during day -365 through 0 days relative to index: BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,410
21601136412,drug_era group during day -30 through 0 days relative to index: BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,412
21601136413,drug_era group during day 0 through 0 days relative to index: BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS,413
21601137410,drug_era group during day -365 through 0 days relative to index: BLOOD AND RELATED PRODUCTS,410
21601137412,drug_era group during day -30 through 0 days relative to index: BLOOD AND RELATED PRODUCTS,412
21601137413,drug_era group during day 0 through 0 days relative to index: BLOOD AND RELATED PRODUCTS,413
21601138410,drug_era group during day -365 through 0 days relative to index: Blood substitutes and plasma protein fractions,410
21601138412,drug_era group during day -30 through 0 days relative to index: Blood substitutes and plasma protein fractions,412
21601138413,drug_era group during day 0 through 0 days relative to index: Blood substitutes and plasma protein fractions,413
21601153410,drug_era group during day -365 through 0 days relative to index: I.V. SOLUTIONS,410
21601153412,drug_era group during day -30 through 0 days relative to index: I.V. SOLUTIONS,412
21601153413,drug_era group during day 0 through 0 days relative to index: I.V. SOLUTIONS,413
21601154410,drug_era group during day -365 through 0 days relative to index: Solutions for parenteral nutrition,410
21601154412,drug_era group during day -30 through 0 days relative to index: Solutions for parenteral nutrition,412
21601154413,drug_era group during day 0 through 0 days relative to index: Solutions for parenteral nutrition,413
21601160410,drug_era group during day -365 through 0 days relative to index: Solutions affecting the electrolyte balance,410
21601160412,drug_era group during day -30 through 0 days relative to index: Solutions affecting the electrolyte balance,412
21601160413,drug_era group during day 0 through 0 days relative to index: Solutions affecting the electrolyte balance,413
21601167410,drug_era group during day -365 through 0 days relative to index: IRRIGATING SOLUTIONS,410
21601167412,drug_era group during day -30 through 0 days relative to index: IRRIGATING SOLUTIONS,412
21601167413,drug_era group during day 0 through 0 days relative to index: IRRIGATING SOLUTIONS,413
21601179410,drug_era group during day -365 through 0 days relative to index: Salt solutions,410
21601179412,drug_era group during day -30 through 0 days relative to index: Salt solutions,412
21601179413,drug_era group during day 0 through 0 days relative to index: Salt solutions,413
21601194410,drug_era group during day -365 through 0 days relative to index: I.V. SOLUTION ADDITIVES,410
21601194412,drug_era group during day -30 through 0 days relative to index: I.V. SOLUTION ADDITIVES,412
21601194413,drug_era group during day 0 through 0 days relative to index: I.V. SOLUTION ADDITIVES,413
21601195410,drug_era group during day -365 through 0 days relative to index: Electrolyte solutions,410
21601195412,drug_era group during day -30 through 0 days relative to index: Electrolyte solutions,412
21601195413,drug_era group during day 0 through 0 days relative to index: Electrolyte solutions,413
21601215410,drug_era group during day -365 through 0 days relative to index: Amino acids,410
21601215412,drug_era group during day -30 through 0 days relative to index: Amino acids,412
21601237410,drug_era group during day -365 through 0 days relative to index: CARDIOVASCULAR SYSTEM,410
21601237412,drug_era group during day -30 through 0 days relative to index: CARDIOVASCULAR SYSTEM,412
21601237413,drug_era group during day 0 through 0 days relative to index: CARDIOVASCULAR SYSTEM,413
21601238410,drug_era group during day -365 through 0 days relative to index: CARDIAC THERAPY,410
21601238412,drug_era group during day -30 through 0 days relative to index: CARDIAC THERAPY,412
21601238413,drug_era group during day 0 through 0 days relative to index: CARDIAC THERAPY,413
21601386410,drug_era group during day -365 through 0 days relative to index: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,410
21601386412,drug_era group during day -30 through 0 days relative to index: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,412
21601386413,drug_era group during day 0 through 0 days relative to index: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS,413
21601387410,drug_era group during day -365 through 0 days relative to index: ANTINEOPLASTIC AGENTS,410
21601387412,drug_era group during day -30 through 0 days relative to index: ANTINEOPLASTIC AGENTS,412
21601387413,drug_era group during day 0 through 0 days relative to index: ANTINEOPLASTIC AGENTS,413
21601421410,drug_era group during day -365 through 0 days relative to index: ANTIMETABOLITES,410
21601421412,drug_era group during day -30 through 0 days relative to index: ANTIMETABOLITES,412
21601421413,drug_era group during day 0 through 0 days relative to index: ANTIMETABOLITES,413
21601422410,drug_era group during day -365 through 0 days relative to index: Folic acid analogues,410
21601422412,drug_era group during day -30 through 0 days relative to index: Folic acid analogues,412
21601434410,drug_era group during day -365 through 0 days relative to index: Pyrimidine analogues,410
21601434412,drug_era group during day -30 through 0 days relative to index: Pyrimidine analogues,412
21601434413,drug_era group during day 0 through 0 days relative to index: Pyrimidine analogues,413
21601445410,drug_era group during day -365 through 0 days relative to index: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,410
21601445412,drug_era group during day -30 through 0 days relative to index: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,412
21601445413,drug_era group during day 0 through 0 days relative to index: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS,413
21601446410,drug_era group during day -365 through 0 days relative to index: Vinca alkaloids and analogues,410
21601446412,drug_era group during day -30 through 0 days relative to index: Vinca alkaloids and analogues,412
21601446413,drug_era group during day 0 through 0 days relative to index: Vinca alkaloids and analogues,413
21601452410,drug_era group during day -365 through 0 days relative to index: Podophyllotoxin derivatives,410
21601452412,drug_era group during day -30 through 0 days relative to index: Podophyllotoxin derivatives,412
21601461410,drug_era group during day -365 through 0 days relative to index: DIURETICS,410
21601461412,drug_era group during day -30 through 0 days relative to index: DIURETICS,412
21601461413,drug_era group during day 0 through 0 days relative to index: DIURETICS,413
21601462410,"drug_era group during day -365 through 0 days relative to index: LOW-CEILING DIURETICS, THIAZIDES",410
21601462412,"drug_era group during day -30 through 0 days relative to index: LOW-CEILING DIURETICS, THIAZIDES",412
21601462413,"drug_era group during day 0 through 0 days relative to index: LOW-CEILING DIURETICS, THIAZIDES",413
21601463410,"drug_era group during day -365 through 0 days relative to index: Thiazides, plain",410
21601463412,"drug_era group during day -30 through 0 days relative to index: Thiazides, plain",412
21601463413,"drug_era group during day 0 through 0 days relative to index: Thiazides, plain",413
21601516410,drug_era group during day -365 through 0 days relative to index: HIGH-CEILING DIURETICS,410
21601516412,drug_era group during day -30 through 0 days relative to index: HIGH-CEILING DIURETICS,412
21601516413,drug_era group during day 0 through 0 days relative to index: HIGH-CEILING DIURETICS,413
21601517410,"drug_era group during day -365 through 0 days relative to index: Sulfonamides, plain",410
21601517412,"drug_era group during day -30 through 0 days relative to index: Sulfonamides, plain",412
21601517413,"drug_era group during day 0 through 0 days relative to index: Sulfonamides, plain",413
21601532410,drug_era group during day -365 through 0 days relative to index: POTASSIUM-SPARING AGENTS,410
21601533410,drug_era group during day -365 through 0 days relative to index: Aldosterone antagonists,410
21601664410,drug_era group during day -365 through 0 days relative to index: BETA BLOCKING AGENTS,410
21601664412,drug_era group during day -30 through 0 days relative to index: BETA BLOCKING AGENTS,412
21601664413,drug_era group during day 0 through 0 days relative to index: BETA BLOCKING AGENTS,413
21601665410,drug_era group during day -365 through 0 days relative to index: BETA BLOCKING AGENTS,410
21601665412,drug_era group during day -30 through 0 days relative to index: BETA BLOCKING AGENTS,412
21601665413,drug_era group during day 0 through 0 days relative to index: BETA BLOCKING AGENTS,413
21601666410,"drug_era group during day -365 through 0 days relative to index: Beta blocking agents, non-selective",410
21601666412,"drug_era group during day -30 through 0 days relative to index: Beta blocking agents, non-selective",412
21601682410,"drug_era group during day -365 through 0 days relative to index: Beta blocking agents, selective",410
21601682412,"drug_era group during day -30 through 0 days relative to index: Beta blocking agents, selective",412
21601698410,drug_era group during day -365 through 0 days relative to index: Alpha and beta blocking agents,410
21601698412,drug_era group during day -30 through 0 days relative to index: Alpha and beta blocking agents,412
21601698413,drug_era group during day 0 through 0 days relative to index: Alpha and beta blocking agents,413
21601744410,drug_era group during day -365 through 0 days relative to index: CALCIUM CHANNEL BLOCKERS,410
21601744412,drug_era group during day -30 through 0 days relative to index: CALCIUM CHANNEL BLOCKERS,412
21601744413,drug_era group during day 0 through 0 days relative to index: CALCIUM CHANNEL BLOCKERS,413
21601745410,drug_era group during day -365 through 0 days relative to index: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,410
21601745412,drug_era group during day -30 through 0 days relative to index: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,412
21601745413,drug_era group during day 0 through 0 days relative to index: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS,413
21601746410,drug_era group during day -365 through 0 days relative to index: Dihydropyridine derivatives,410
21601746412,drug_era group during day -30 through 0 days relative to index: Dihydropyridine derivatives,412
21601746413,drug_era group during day 0 through 0 days relative to index: Dihydropyridine derivatives,413
21601765410,drug_era group during day -365 through 0 days relative to index: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,410
21601765412,drug_era group during day -30 through 0 days relative to index: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS,412
21601770410,drug_era group during day -365 through 0 days relative to index: Benzothiazepine derivatives,410
21601770412,drug_era group during day -30 through 0 days relative to index: Benzothiazepine derivatives,412
21601782410,drug_era group during day -365 through 0 days relative to index: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,410
21601782412,drug_era group during day -30 through 0 days relative to index: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,412
21601782413,drug_era group during day 0 through 0 days relative to index: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM,413
21601822410,"drug_era group during day -365 through 0 days relative to index: ANGIOTENSIN II ANTAGONISTS, PLAIN",410
21601822412,"drug_era group during day -30 through 0 days relative to index: ANGIOTENSIN II ANTAGONISTS, PLAIN",412
21601822413,"drug_era group during day 0 through 0 days relative to index: ANGIOTENSIN II ANTAGONISTS, PLAIN",413
21601823410,"drug_era group during day -365 through 0 days relative to index: Angiotensin II antagonists, plain",410
21601823412,"drug_era group during day -30 through 0 days relative to index: Angiotensin II antagonists, plain",412
21601823413,"drug_era group during day 0 through 0 days relative to index: Angiotensin II antagonists, plain",413
21601853410,drug_era group during day -365 through 0 days relative to index: LIPID MODIFYING AGENTS,410
21601853412,drug_era group during day -30 through 0 days relative to index: LIPID MODIFYING AGENTS,412
21601853413,drug_era group during day 0 through 0 days relative to index: LIPID MODIFYING AGENTS,413
21601854410,"drug_era group during day -365 through 0 days relative to index: LIPID MODIFYING AGENTS, PLAIN",410
21601854412,"drug_era group during day -30 through 0 days relative to index: LIPID MODIFYING AGENTS, PLAIN",412
21601854413,"drug_era group during day 0 through 0 days relative to index: LIPID MODIFYING AGENTS, PLAIN",413
21601855410,drug_era group during day -365 through 0 days relative to index: HMG CoA reductase inhibitors,410
21601855412,drug_era group during day -30 through 0 days relative to index: HMG CoA reductase inhibitors,412
21601855413,drug_era group during day 0 through 0 days relative to index: HMG CoA reductase inhibitors,413
21601888410,drug_era group during day -365 through 0 days relative to index: Other lipid modifying agents,410
21601888412,drug_era group during day -30 through 0 days relative to index: Other lipid modifying agents,412
21601888413,drug_era group during day 0 through 0 days relative to index: Other lipid modifying agents,413
21601907410,drug_era group during day -365 through 0 days relative to index: DERMATOLOGICALS,410
21601907412,drug_era group during day -30 through 0 days relative to index: DERMATOLOGICALS,412
21601907413,drug_era group during day 0 through 0 days relative to index: DERMATOLOGICALS,413
21602002410,"drug_era group during day -365 through 0 days relative to index: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",410
21602002412,"drug_era group during day -30 through 0 days relative to index: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",412
21602002413,"drug_era group during day 0 through 0 days relative to index: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",413
21602003410,"drug_era group during day -365 through 0 days relative to index: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",410
21602003412,"drug_era group during day -30 through 0 days relative to index: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",412
21602003413,"drug_era group during day 0 through 0 days relative to index: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.",413
21602019410,drug_era group during day -365 through 0 days relative to index: Anesthetics for topical use,410
21602019412,drug_era group during day -30 through 0 days relative to index: Anesthetics for topical use,412
21602019413,drug_era group during day 0 through 0 days relative to index: Anesthetics for topical use,413
21602028410,drug_era group during day -365 through 0 days relative to index: ANTIPSORIATICS,410
21602028412,drug_era group during day -30 through 0 days relative to index: ANTIPSORIATICS,412
21602028413,drug_era group during day 0 through 0 days relative to index: ANTIPSORIATICS,413
21602029410,drug_era group during day -365 through 0 days relative to index: ANTIPSORIATICS FOR TOPICAL USE,410
21602029412,drug_era group during day -30 through 0 days relative to index: ANTIPSORIATICS FOR TOPICAL USE,412
21602029413,drug_era group during day 0 through 0 days relative to index: ANTIPSORIATICS FOR TOPICAL USE,413
21602037410,drug_era group during day -365 through 0 days relative to index: Other antipsoriatics for topical use,410
21602037412,drug_era group during day -30 through 0 days relative to index: Other antipsoriatics for topical use,412
21602037413,drug_era group during day 0 through 0 days relative to index: Other antipsoriatics for topical use,413
21602054410,drug_era group during day -365 through 0 days relative to index: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,410
21602054412,drug_era group during day -30 through 0 days relative to index: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,412
21602054413,drug_era group during day 0 through 0 days relative to index: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE,413
21602055410,drug_era group during day -365 through 0 days relative to index: ANTIBIOTICS FOR TOPICAL USE,410
21602055412,drug_era group during day -30 through 0 days relative to index: ANTIBIOTICS FOR TOPICAL USE,412
21602061410,drug_era group during day -365 through 0 days relative to index: Other antibiotics for topical use,410
21602061412,drug_era group during day -30 through 0 days relative to index: Other antibiotics for topical use,412
21602073410,drug_era group during day -365 through 0 days relative to index: CHEMOTHERAPEUTICS FOR TOPICAL USE,410
21602073412,drug_era group during day -30 through 0 days relative to index: CHEMOTHERAPEUTICS FOR TOPICAL USE,412
21602073413,drug_era group during day 0 through 0 days relative to index: CHEMOTHERAPEUTICS FOR TOPICAL USE,413
21602082410,drug_era group during day -365 through 0 days relative to index: Antivirals,410
21602095410,drug_era group during day -365 through 0 days relative to index: Other chemotherapeutics,410
21602095412,drug_era group during day -30 through 0 days relative to index: Other chemotherapeutics,412
21602095413,drug_era group during day 0 through 0 days relative to index: Other chemotherapeutics,413
21602098410,"drug_era group during day -365 through 0 days relative to index: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",410
21602098412,"drug_era group during day -30 through 0 days relative to index: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",412
21602098413,"drug_era group during day 0 through 0 days relative to index: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS",413
21602099410,"drug_era group during day -365 through 0 days relative to index: CORTICOSTEROIDS, PLAIN",410
21602099412,"drug_era group during day -30 through 0 days relative to index: CORTICOSTEROIDS, PLAIN",412
21602099413,"drug_era group during day 0 through 0 days relative to index: CORTICOSTEROIDS, PLAIN",413
21602100410,"drug_era group during day -365 through 0 days relative to index: Corticosteroids, weak (group I)",410
21602100412,"drug_era group during day -30 through 0 days relative to index: Corticosteroids, weak (group I)",412
21602100413,"drug_era group during day 0 through 0 days relative to index: Corticosteroids, weak (group I)",413
21602104410,"drug_era group during day -365 through 0 days relative to index: Corticosteroids, moderately potent (group II)",410
21602104412,"drug_era group during day -30 through 0 days relative to index: Corticosteroids, moderately potent (group II)",412
21602104413,"drug_era group during day 0 through 0 days relative to index: Corticosteroids, moderately potent (group II)",413
21602119410,"drug_era group during day -365 through 0 days relative to index: Corticosteroids, potent (group III)",410
21602119412,"drug_era group during day -30 through 0 days relative to index: Corticosteroids, potent (group III)",412
21602119413,"drug_era group during day 0 through 0 days relative to index: Corticosteroids, potent (group III)",413
21602140410,"drug_era group during day -365 through 0 days relative to index: Corticosteroids, very potent (group IV)",410
21602195410,drug_era group during day -365 through 0 days relative to index: ANTISEPTICS AND DISINFECTANTS,410
21602195412,drug_era group during day -30 through 0 days relative to index: ANTISEPTICS AND DISINFECTANTS,412
21602195413,drug_era group during day 0 through 0 days relative to index: ANTISEPTICS AND DISINFECTANTS,413
21602196410,drug_era group during day -365 through 0 days relative to index: ANTISEPTICS AND DISINFECTANTS,410
21602196412,drug_era group during day -30 through 0 days relative to index: ANTISEPTICS AND DISINFECTANTS,412
21602196413,drug_era group during day 0 through 0 days relative to index: ANTISEPTICS AND DISINFECTANTS,413
21602202410,drug_era group during day -365 through 0 days relative to index: Biguanides and amidines,410
21602202412,drug_era group during day -30 through 0 days relative to index: Biguanides and amidines,412
21602202413,drug_era group during day 0 through 0 days relative to index: Biguanides and amidines,413
21602219410,drug_era group during day -365 through 0 days relative to index: Iodine products,410
21602219412,drug_era group during day -30 through 0 days relative to index: Iodine products,412
21602261410,drug_era group during day -365 through 0 days relative to index: MEDICATED DRESSINGS,410
21602261412,drug_era group during day -30 through 0 days relative to index: MEDICATED DRESSINGS,412
21602262410,drug_era group during day -365 through 0 days relative to index: MEDICATED DRESSINGS,410
21602262412,drug_era group during day -30 through 0 days relative to index: MEDICATED DRESSINGS,412
21602263410,drug_era group during day -365 through 0 days relative to index: Medicated dressings with antiinfectives,410
21602263412,drug_era group during day -30 through 0 days relative to index: Medicated dressings with antiinfectives,412
21602323410,drug_era group during day -365 through 0 days relative to index: OTHER DERMATOLOGICAL PREPARATIONS,410
21602323412,drug_era group during day -30 through 0 days relative to index: OTHER DERMATOLOGICAL PREPARATIONS,412
21602324410,drug_era group during day -365 through 0 days relative to index: OTHER DERMATOLOGICAL PREPARATIONS,410
21602324412,drug_era group during day -30 through 0 days relative to index: OTHER DERMATOLOGICAL PREPARATIONS,412
21602326410,drug_era group during day -365 through 0 days relative to index: Medicated shampoos,410
21602326412,drug_era group during day -30 through 0 days relative to index: Medicated shampoos,412
21602359410,drug_era group during day -365 through 0 days relative to index: GENITO URINARY SYSTEM AND SEX HORMONES,410
21602359412,drug_era group during day -30 through 0 days relative to index: GENITO URINARY SYSTEM AND SEX HORMONES,412
21602359413,drug_era group during day 0 through 0 days relative to index: GENITO URINARY SYSTEM AND SEX HORMONES,413
21602360410,drug_era group during day -365 through 0 days relative to index: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,410
21602360412,drug_era group during day -30 through 0 days relative to index: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,412
21602361410,"drug_era group during day -365 through 0 days relative to index: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",410
21602361412,"drug_era group during day -30 through 0 days relative to index: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",412
21602384410,drug_era group during day -365 through 0 days relative to index: Organic acids,410
21602384412,drug_era group during day -30 through 0 days relative to index: Organic acids,412
21602410410,drug_era group during day -365 through 0 days relative to index: Other antiinfectives and antiseptics,410
21602410412,drug_era group during day -30 through 0 days relative to index: Other antiinfectives and antiseptics,412
21602471410,drug_era group during day -365 through 0 days relative to index: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,410
21602471412,drug_era group during day -30 through 0 days relative to index: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,412
21602618410,drug_era group during day -365 through 0 days relative to index: OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,410
21602618412,drug_era group during day -30 through 0 days relative to index: OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM,412
21602624410,drug_era group during day -365 through 0 days relative to index: Selective estrogen receptor modulators,410
21602624412,drug_era group during day -30 through 0 days relative to index: Selective estrogen receptor modulators,412
21602627410,drug_era group during day -365 through 0 days relative to index: UROLOGICALS,410
21602627412,drug_era group during day -30 through 0 days relative to index: UROLOGICALS,412
21602627413,drug_era group during day 0 through 0 days relative to index: UROLOGICALS,413
21602628410,drug_era group during day -365 through 0 days relative to index: UROLOGICALS,410
21602628412,drug_era group during day -30 through 0 days relative to index: UROLOGICALS,412
21602628413,drug_era group during day 0 through 0 days relative to index: UROLOGICALS,413
21602629410,drug_era group during day -365 through 0 days relative to index: Acidifiers,410
21602629412,drug_era group during day -30 through 0 days relative to index: Acidifiers,412
21602629413,drug_era group during day 0 through 0 days relative to index: Acidifiers,413
21602633410,drug_era group during day -365 through 0 days relative to index: Drugs for urinary frequency and incontinence,410
21602633412,drug_era group during day -30 through 0 days relative to index: Drugs for urinary frequency and incontinence,412
21602633413,drug_era group during day 0 through 0 days relative to index: Drugs for urinary frequency and incontinence,413
21602666410,drug_era group during day -365 through 0 days relative to index: DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,410
21602666412,drug_era group during day -30 through 0 days relative to index: DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,412
21602666413,drug_era group during day 0 through 0 days relative to index: DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY,413
21602667410,drug_era group during day -365 through 0 days relative to index: Alpha-adrenoreceptor antagonists,410
21602667412,drug_era group during day -30 through 0 days relative to index: Alpha-adrenoreceptor antagonists,412
21602667413,drug_era group during day 0 through 0 days relative to index: Alpha-adrenoreceptor antagonists,413
21602674410,drug_era group during day -365 through 0 days relative to index: Testosterone-5-alpha reductase inhibitors,410
21602674412,drug_era group during day -30 through 0 days relative to index: Testosterone-5-alpha reductase inhibitors,412
21602674413,drug_era group during day 0 through 0 days relative to index: Testosterone-5-alpha reductase inhibitors,413
21602681410,"drug_era group during day -365 through 0 days relative to index: SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",410
21602681412,"drug_era group during day -30 through 0 days relative to index: SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",412
21602681413,"drug_era group during day 0 through 0 days relative to index: SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",413
21602682410,drug_era group during day -365 through 0 days relative to index: PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES,410
21602683410,drug_era group during day -365 through 0 days relative to index: ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES,410
21602684410,drug_era group during day -365 through 0 days relative to index: ACTH,410
21602722410,drug_era group during day -365 through 0 days relative to index: CORTICOSTEROIDS FOR SYSTEMIC USE,410
21602722412,drug_era group during day -30 through 0 days relative to index: CORTICOSTEROIDS FOR SYSTEMIC USE,412
21602722413,drug_era group during day 0 through 0 days relative to index: CORTICOSTEROIDS FOR SYSTEMIC USE,413
21602723410,"drug_era group during day -365 through 0 days relative to index: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",410
21602723412,"drug_era group during day -30 through 0 days relative to index: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",412
21602723413,"drug_era group during day 0 through 0 days relative to index: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",413
21602728410,drug_era group during day -365 through 0 days relative to index: Glucocorticoids,410
21602728412,drug_era group during day -30 through 0 days relative to index: Glucocorticoids,412
21602728413,drug_era group during day 0 through 0 days relative to index: Glucocorticoids,413
21602751410,drug_era group during day -365 through 0 days relative to index: THYROID THERAPY,410
21602751412,drug_era group during day -30 through 0 days relative to index: THYROID THERAPY,412
21602752410,drug_era group during day -365 through 0 days relative to index: THYROID PREPARATIONS,410
21602752412,drug_era group during day -30 through 0 days relative to index: THYROID PREPARATIONS,412
21602753410,drug_era group during day -365 through 0 days relative to index: Thyroid hormones,410
21602753412,drug_era group during day -30 through 0 days relative to index: Thyroid hormones,412
21602759410,drug_era group during day -365 through 0 days relative to index: ANTITHYROID PREPARATIONS,410
21602764410,drug_era group during day -365 through 0 days relative to index: Sulfur-containing imidazole derivatives,410
21602795410,drug_era group during day -365 through 0 days relative to index: ANTIINFECTIVES FOR SYSTEMIC USE,410
21602795412,drug_era group during day -30 through 0 days relative to index: ANTIINFECTIVES FOR SYSTEMIC USE,412
21602795413,drug_era group during day 0 through 0 days relative to index: ANTIINFECTIVES FOR SYSTEMIC USE,413
21602796410,drug_era group during day -365 through 0 days relative to index: ANTIBACTERIALS FOR SYSTEMIC USE,410
21602796412,drug_era group during day -30 through 0 days relative to index: ANTIBACTERIALS FOR SYSTEMIC USE,412
21602796413,drug_era group during day 0 through 0 days relative to index: ANTIBACTERIALS FOR SYSTEMIC USE,413
21602797410,drug_era group during day -365 through 0 days relative to index: TETRACYCLINES,410
21602797412,drug_era group during day -30 through 0 days relative to index: TETRACYCLINES,412
21602798410,drug_era group during day -365 through 0 days relative to index: Tetracyclines,410
21602798412,drug_era group during day -30 through 0 days relative to index: Tetracyclines,412
21602818410,"drug_era group during day -365 through 0 days relative to index: BETA-LACTAM ANTIBACTERIALS, PENICILLINS",410
21602818412,"drug_era group during day -30 through 0 days relative to index: BETA-LACTAM ANTIBACTERIALS, PENICILLINS",412
21602818413,"drug_era group during day 0 through 0 days relative to index: BETA-LACTAM ANTIBACTERIALS, PENICILLINS",413
21602819410,drug_era group during day -365 through 0 days relative to index: Penicillins with extended spectrum,410
21602819412,drug_era group during day -30 through 0 days relative to index: Penicillins with extended spectrum,412
21602819413,drug_era group during day 0 through 0 days relative to index: Penicillins with extended spectrum,413
21602852410,drug_era group during day -365 through 0 days relative to index: Beta-lactamase resistant penicillins,410
21602858410,drug_era group during day -365 through 0 days relative to index: Beta-lactamase inhibitors,410
21602858412,drug_era group during day -30 through 0 days relative to index: Beta-lactamase inhibitors,412
21602858413,drug_era group during day 0 through 0 days relative to index: Beta-lactamase inhibitors,413
21602868410,drug_era group during day -365 through 0 days relative to index: OTHER BETA-LACTAM ANTIBACTERIALS,410
21602868412,drug_era group during day -30 through 0 days relative to index: OTHER BETA-LACTAM ANTIBACTERIALS,412
21602868413,drug_era group during day 0 through 0 days relative to index: OTHER BETA-LACTAM ANTIBACTERIALS,413
21602869410,drug_era group during day -365 through 0 days relative to index: First-generation cephalosporins,410
21602869412,drug_era group during day -30 through 0 days relative to index: First-generation cephalosporins,412
21602894410,drug_era group during day -365 through 0 days relative to index: Third-generation cephalosporins,410
21602894412,drug_era group during day -30 through 0 days relative to index: Third-generation cephalosporins,412
21602894413,drug_era group during day 0 through 0 days relative to index: Third-generation cephalosporins,413
21602914410,drug_era group during day -365 through 0 days relative to index: Fourth-generation cephalosporins,410
21602920410,drug_era group during day -365 through 0 days relative to index: Carbapenems,410
21602920412,drug_era group during day -30 through 0 days relative to index: Carbapenems,412
21602920413,drug_era group during day 0 through 0 days relative to index: Carbapenems,413
21602968410,"drug_era group during day -365 through 0 days relative to index: MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",410
21602968412,"drug_era group during day -30 through 0 days relative to index: MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",412
21602968413,"drug_era group during day 0 through 0 days relative to index: MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",413
21602969410,drug_era group during day -365 through 0 days relative to index: Macrolides,410
21602969412,drug_era group during day -30 through 0 days relative to index: Macrolides,412
21602969413,drug_era group during day 0 through 0 days relative to index: Macrolides,413
21602990410,drug_era group during day -365 through 0 days relative to index: AMINOGLYCOSIDE ANTIBACTERIALS,410
21602994410,drug_era group during day -365 through 0 days relative to index: Other aminoglycosides,410
21603006410,drug_era group during day -365 through 0 days relative to index: QUINOLONE ANTIBACTERIALS,410
21603006412,drug_era group during day -30 through 0 days relative to index: QUINOLONE ANTIBACTERIALS,412
21603006413,drug_era group during day 0 through 0 days relative to index: QUINOLONE ANTIBACTERIALS,413
21603007410,drug_era group during day -365 through 0 days relative to index: Fluoroquinolones,410
21603007412,drug_era group during day -30 through 0 days relative to index: Fluoroquinolones,412
21603007413,drug_era group during day 0 through 0 days relative to index: Fluoroquinolones,413
21603041410,drug_era group during day -365 through 0 days relative to index: OTHER ANTIBACTERIALS,410
21603041412,drug_era group during day -30 through 0 days relative to index: OTHER ANTIBACTERIALS,412
21603042410,drug_era group during day -365 through 0 days relative to index: Glycopeptide antibacterials,410
21603042412,drug_era group during day -30 through 0 days relative to index: Glycopeptide antibacterials,412
21603060410,drug_era group during day -365 through 0 days relative to index: Other antibacterials,410
21603060412,drug_era group during day -30 through 0 days relative to index: Other antibacterials,412
21603071410,drug_era group during day -365 through 0 days relative to index: ANTIMYCOTICS FOR SYSTEMIC USE,410
21603071412,drug_era group during day -30 through 0 days relative to index: ANTIMYCOTICS FOR SYSTEMIC USE,412
21603071413,drug_era group during day 0 through 0 days relative to index: ANTIMYCOTICS FOR SYSTEMIC USE,413
21603072410,drug_era group during day -365 through 0 days relative to index: ANTIMYCOTICS FOR SYSTEMIC USE,410
21603072412,drug_era group during day -30 through 0 days relative to index: ANTIMYCOTICS FOR SYSTEMIC USE,412
21603072413,drug_era group during day 0 through 0 days relative to index: ANTIMYCOTICS FOR SYSTEMIC USE,413
21603079410,drug_era group during day -365 through 0 days relative to index: Triazole derivatives,410
21603079412,drug_era group during day -30 through 0 days relative to index: Triazole derivatives,412
21603079413,drug_era group during day 0 through 0 days relative to index: Triazole derivatives,413
21603089410,drug_era group during day -365 through 0 days relative to index: ANTIMYCOBACTERIALS,410
21603090410,drug_era group during day -365 through 0 days relative to index: DRUGS FOR TREATMENT OF TUBERCULOSIS,410
21603095410,drug_era group during day -365 through 0 days relative to index: Antibiotics,410
21603126410,drug_era group during day -365 through 0 days relative to index: ANTIVIRALS FOR SYSTEMIC USE,410
21603126412,drug_era group during day -30 through 0 days relative to index: ANTIVIRALS FOR SYSTEMIC USE,412
21603126413,drug_era group during day 0 through 0 days relative to index: ANTIVIRALS FOR SYSTEMIC USE,413
21603127410,drug_era group during day -365 through 0 days relative to index: DIRECT ACTING ANTIVIRALS,410
21603127412,drug_era group during day -30 through 0 days relative to index: DIRECT ACTING ANTIVIRALS,412
21603127413,drug_era group during day 0 through 0 days relative to index: DIRECT ACTING ANTIVIRALS,413
21603130410,drug_era group during day -365 through 0 days relative to index: Nucleosides and nucleotides excl. reverse transcriptase inhibitors,410
21603148410,drug_era group during day -365 through 0 days relative to index: Protease inhibitors,410
21603148412,drug_era group during day -30 through 0 days relative to index: Protease inhibitors,412
21603148413,drug_era group during day 0 through 0 days relative to index: Protease inhibitors,413
21603159410,drug_era group during day -365 through 0 days relative to index: Nucleoside and nucleotide reverse transcriptase inhibitors,410
21603159412,drug_era group during day -30 through 0 days relative to index: Nucleoside and nucleotide reverse transcriptase inhibitors,412
21603177410,drug_era group during day -365 through 0 days relative to index: Neuraminidase inhibitors,410
21603177412,drug_era group during day -30 through 0 days relative to index: Neuraminidase inhibitors,412
21603177413,drug_era group during day 0 through 0 days relative to index: Neuraminidase inhibitors,413
21603196410,drug_era group during day -365 through 0 days relative to index: Other nasal preparations,410
21603196412,drug_era group during day -30 through 0 days relative to index: Other nasal preparations,412
21603207410,drug_era group during day -365 through 0 days relative to index: NASAL DECONGESTANTS FOR SYSTEMIC USE,410
21603207412,drug_era group during day -30 through 0 days relative to index: NASAL DECONGESTANTS FOR SYSTEMIC USE,412
21603207413,drug_era group during day 0 through 0 days relative to index: NASAL DECONGESTANTS FOR SYSTEMIC USE,413
21603208410,drug_era group during day -365 through 0 days relative to index: Sympathomimetics,410
21603208412,drug_era group during day -30 through 0 days relative to index: Sympathomimetics,412
21603208413,drug_era group during day 0 through 0 days relative to index: Sympathomimetics,413
21603215410,drug_era group during day -365 through 0 days relative to index: THROAT PREPARATIONS,410
21603215412,drug_era group during day -30 through 0 days relative to index: THROAT PREPARATIONS,412
21603215413,drug_era group during day 0 through 0 days relative to index: THROAT PREPARATIONS,413
21603216410,drug_era group during day -365 through 0 days relative to index: THROAT PREPARATIONS,410
21603216412,drug_era group during day -30 through 0 days relative to index: THROAT PREPARATIONS,412
21603216413,drug_era group during day 0 through 0 days relative to index: THROAT PREPARATIONS,413
21603217410,drug_era group during day -365 through 0 days relative to index: Antiseptics,410
21603217412,drug_era group during day -30 through 0 days relative to index: Antiseptics,412
21603217413,drug_era group during day 0 through 0 days relative to index: Antiseptics,413
21603241410,"drug_era group during day -365 through 0 days relative to index: Anesthetics, local",410
21603241412,"drug_era group during day -30 through 0 days relative to index: Anesthetics, local",412
21603241413,"drug_era group during day 0 through 0 days relative to index: Anesthetics, local",413
21603248410,drug_era group during day -365 through 0 days relative to index: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,410
21603248412,drug_era group during day -30 through 0 days relative to index: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,412
21603248413,drug_era group during day 0 through 0 days relative to index: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,413
21603249410,"drug_era group during day -365 through 0 days relative to index: ADRENERGICS, INHALANTS",410
21603249412,"drug_era group during day -30 through 0 days relative to index: ADRENERGICS, INHALANTS",412
21603249413,"drug_era group during day 0 through 0 days relative to index: ADRENERGICS, INHALANTS",413
21603255410,drug_era group during day -365 through 0 days relative to index: Selective beta-2-adrenoreceptor agonists,410
21603255412,drug_era group during day -30 through 0 days relative to index: Selective beta-2-adrenoreceptor agonists,412
21603255413,drug_era group during day 0 through 0 days relative to index: Selective beta-2-adrenoreceptor agonists,413
21603282410,"drug_era group during day -365 through 0 days relative to index: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",410
21603282412,"drug_era group during day -30 through 0 days relative to index: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",412
21603282413,"drug_era group during day 0 through 0 days relative to index: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",413
21603283410,drug_era group during day -365 through 0 days relative to index: Glucocorticoids,410
21603283412,drug_era group during day -30 through 0 days relative to index: Glucocorticoids,412
21603283413,drug_era group during day 0 through 0 days relative to index: Glucocorticoids,413
21603292410,drug_era group during day -365 through 0 days relative to index: Anticholinergics,410
21603292412,drug_era group during day -30 through 0 days relative to index: Anticholinergics,412
21603302410,drug_era group during day -365 through 0 days relative to index: ADRENERGICS FOR SYSTEMIC USE,410
21603302412,drug_era group during day -30 through 0 days relative to index: ADRENERGICS FOR SYSTEMIC USE,412
21603302413,drug_era group during day 0 through 0 days relative to index: ADRENERGICS FOR SYSTEMIC USE,413
21603303410,drug_era group during day -365 through 0 days relative to index: Alpha- and beta-adrenoreceptor agonists,410
21603303412,drug_era group during day -30 through 0 days relative to index: Alpha- and beta-adrenoreceptor agonists,412
21603311410,drug_era group during day -365 through 0 days relative to index: Selective beta-2-adrenoreceptor agonists,410
21603311412,drug_era group during day -30 through 0 days relative to index: Selective beta-2-adrenoreceptor agonists,412
21603311413,drug_era group during day 0 through 0 days relative to index: Selective beta-2-adrenoreceptor agonists,413
21603365410,drug_era group during day -365 through 0 days relative to index: COUGH AND COLD PREPARATIONS,410
21603365412,drug_era group during day -30 through 0 days relative to index: COUGH AND COLD PREPARATIONS,412
21603365413,drug_era group during day 0 through 0 days relative to index: COUGH AND COLD PREPARATIONS,413
21603366410,"drug_era group during day -365 through 0 days relative to index: EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",410
21603366412,"drug_era group during day -30 through 0 days relative to index: EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",412
21603366413,"drug_era group during day 0 through 0 days relative to index: EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS",413
21603367410,drug_era group during day -365 through 0 days relative to index: Expectorants,410
21603367412,drug_era group during day -30 through 0 days relative to index: Expectorants,412
21603367413,drug_era group during day 0 through 0 days relative to index: Expectorants,413
21603379410,drug_era group during day -365 through 0 days relative to index: Mucolytics,410
21603379412,drug_era group during day -30 through 0 days relative to index: Mucolytics,412
21603379413,drug_era group during day 0 through 0 days relative to index: Mucolytics,413
21603395410,"drug_era group during day -365 through 0 days relative to index: COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",410
21603395412,"drug_era group during day -30 through 0 days relative to index: COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",412
21603395413,"drug_era group during day 0 through 0 days relative to index: COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS",413
21603396410,drug_era group during day -365 through 0 days relative to index: Opium alkaloids and derivatives,410
21603396412,drug_era group during day -30 through 0 days relative to index: Opium alkaloids and derivatives,412
21603396413,drug_era group during day 0 through 0 days relative to index: Opium alkaloids and derivatives,413
21603444410,drug_era group during day -365 through 0 days relative to index: ANTIHISTAMINES FOR SYSTEMIC USE,410
21603444412,drug_era group during day -30 through 0 days relative to index: ANTIHISTAMINES FOR SYSTEMIC USE,412
21603444413,drug_era group during day 0 through 0 days relative to index: ANTIHISTAMINES FOR SYSTEMIC USE,413
21603445410,drug_era group during day -365 through 0 days relative to index: ANTIHISTAMINES FOR SYSTEMIC USE,410
21603445412,drug_era group during day -30 through 0 days relative to index: ANTIHISTAMINES FOR SYSTEMIC USE,412
21603445413,drug_era group during day 0 through 0 days relative to index: ANTIHISTAMINES FOR SYSTEMIC USE,413
21603458410,drug_era group during day -365 through 0 days relative to index: Substituted alkylamines,410
21603458412,drug_era group during day -30 through 0 days relative to index: Substituted alkylamines,412
21603458413,drug_era group during day 0 through 0 days relative to index: Substituted alkylamines,413
21603479410,drug_era group during day -365 through 0 days relative to index: Phenothiazine derivatives,410
21603479412,drug_era group during day -30 through 0 days relative to index: Phenothiazine derivatives,412
21603479413,drug_era group during day 0 through 0 days relative to index: Phenothiazine derivatives,413
21603491410,drug_era group during day -365 through 0 days relative to index: Piperazine derivatives,410
21603491412,drug_era group during day -30 through 0 days relative to index: Piperazine derivatives,412
21603491413,drug_era group during day 0 through 0 days relative to index: Piperazine derivatives,413
21603503410,drug_era group during day -365 through 0 days relative to index: Other antihistamines for systemic use,410
21603503412,drug_era group during day -30 through 0 days relative to index: Other antihistamines for systemic use,412
21603503413,drug_era group during day 0 through 0 days relative to index: Other antihistamines for systemic use,413
21603550410,drug_era group during day -365 through 0 days relative to index: SENSORY ORGANS,410
21603550412,drug_era group during day -30 through 0 days relative to index: SENSORY ORGANS,412
21603550413,drug_era group during day 0 through 0 days relative to index: SENSORY ORGANS,413
21603551410,drug_era group during day -365 through 0 days relative to index: OPHTHALMOLOGICALS,410
21603551412,drug_era group during day -30 through 0 days relative to index: OPHTHALMOLOGICALS,412
21603551413,drug_era group during day 0 through 0 days relative to index: OPHTHALMOLOGICALS,413
21603552410,drug_era group during day -365 through 0 days relative to index: ANTIINFECTIVES,410
21603552412,drug_era group during day -30 through 0 days relative to index: ANTIINFECTIVES,412
21603552413,drug_era group during day 0 through 0 days relative to index: ANTIINFECTIVES,413
21603585410,drug_era group during day -365 through 0 days relative to index: Antivirals,410
21603594410,drug_era group during day -365 through 0 days relative to index: Other antiinfectives,410
21603594412,drug_era group during day -30 through 0 days relative to index: Other antiinfectives,412
21603594413,drug_era group during day 0 through 0 days relative to index: Other antiinfectives,413
21603616410,drug_era group during day -365 through 0 days relative to index: ANTIINFLAMMATORY AGENTS,410
21603616412,drug_era group during day -30 through 0 days relative to index: ANTIINFLAMMATORY AGENTS,412
21603616413,drug_era group during day 0 through 0 days relative to index: ANTIINFLAMMATORY AGENTS,413
21603617410,"drug_era group during day -365 through 0 days relative to index: Corticosteroids, plain",410
21603617412,"drug_era group during day -30 through 0 days relative to index: Corticosteroids, plain",412
21603617413,"drug_era group during day 0 through 0 days relative to index: Corticosteroids, plain",413
21603638410,"drug_era group during day -365 through 0 days relative to index: Antiinflammatory agents, non-steroids",410
21603638412,"drug_era group during day -30 through 0 days relative to index: Antiinflammatory agents, non-steroids",412
21603638413,"drug_era group during day 0 through 0 days relative to index: Antiinflammatory agents, non-steroids",413
21603671410,drug_era group during day -365 through 0 days relative to index: ANTIGLAUCOMA PREPARATIONS AND MIOTICS,410
21603671412,drug_era group during day -30 through 0 days relative to index: ANTIGLAUCOMA PREPARATIONS AND MIOTICS,412
21603672410,drug_era group during day -365 through 0 days relative to index: Sympathomimetics in glaucoma therapy,410
21603672412,drug_era group during day -30 through 0 days relative to index: Sympathomimetics in glaucoma therapy,412
21603722410,drug_era group during day -365 through 0 days relative to index: Taxanes,410
21603746410,drug_era group during day -365 through 0 days relative to index: OTHER ANTINEOPLASTIC AGENTS,410
21603746412,drug_era group during day -30 through 0 days relative to index: OTHER ANTINEOPLASTIC AGENTS,412
21603746413,drug_era group during day 0 through 0 days relative to index: OTHER ANTINEOPLASTIC AGENTS,413
21603747410,drug_era group during day -365 through 0 days relative to index: Platinum compounds,410
21603747412,drug_era group during day -30 through 0 days relative to index: Platinum compounds,412
21603754410,drug_era group during day -365 through 0 days relative to index: Monoclonal antibodies,410
21603754412,drug_era group during day -30 through 0 days relative to index: Monoclonal antibodies,412
21603754413,drug_era group during day 0 through 0 days relative to index: Monoclonal antibodies,413
21603771410,drug_era group during day -365 through 0 days relative to index: Protein kinase inhibitors,410
21603783410,drug_era group during day -365 through 0 days relative to index: Other antineoplastic agents,410
21603783412,drug_era group during day -30 through 0 days relative to index: Other antineoplastic agents,412
21603783413,drug_era group during day 0 through 0 days relative to index: Other antineoplastic agents,413
21603812410,drug_era group during day -365 through 0 days relative to index: ENDOCRINE THERAPY,410
21603812412,drug_era group during day -30 through 0 days relative to index: ENDOCRINE THERAPY,412
21603812413,drug_era group during day 0 through 0 days relative to index: ENDOCRINE THERAPY,413
21603813410,drug_era group during day -365 through 0 days relative to index: HORMONES AND RELATED AGENTS,410
21603813412,drug_era group during day -30 through 0 days relative to index: HORMONES AND RELATED AGENTS,412
21603813413,drug_era group during day 0 through 0 days relative to index: HORMONES AND RELATED AGENTS,413
21603819410,drug_era group during day -365 through 0 days relative to index: Progestogens,410
21603819412,drug_era group during day -30 through 0 days relative to index: Progestogens,412
21603819413,drug_era group during day 0 through 0 days relative to index: Progestogens,413
21603823410,drug_era group during day -365 through 0 days relative to index: Gonadotropin releasing hormone analogues,410
21603829410,drug_era group during day -365 through 0 days relative to index: HORMONE ANTAGONISTS AND RELATED AGENTS,410
21603829412,drug_era group during day -30 through 0 days relative to index: HORMONE ANTAGONISTS AND RELATED AGENTS,412
21603829413,drug_era group during day 0 through 0 days relative to index: HORMONE ANTAGONISTS AND RELATED AGENTS,413
21603834410,drug_era group during day -365 through 0 days relative to index: Anti-androgens,410
21603834412,drug_era group during day -30 through 0 days relative to index: Anti-androgens,412
21603834413,drug_era group during day 0 through 0 days relative to index: Anti-androgens,413
21603848410,drug_era group during day -365 through 0 days relative to index: IMMUNOSTIMULANTS,410
21603848412,drug_era group during day -30 through 0 days relative to index: IMMUNOSTIMULANTS,412
21603848413,drug_era group during day 0 through 0 days relative to index: IMMUNOSTIMULANTS,413
21603849410,drug_era group during day -365 through 0 days relative to index: IMMUNOSTIMULANTS,410
21603849412,drug_era group during day -30 through 0 days relative to index: IMMUNOSTIMULANTS,412
21603849413,drug_era group during day 0 through 0 days relative to index: IMMUNOSTIMULANTS,413
21603850410,drug_era group during day -365 through 0 days relative to index: Colony stimulating factors,410
21603850412,drug_era group during day -30 through 0 days relative to index: Colony stimulating factors,412
21603850413,drug_era group during day 0 through 0 days relative to index: Colony stimulating factors,413
21603931410,drug_era group during day -365 through 0 days relative to index: MUSCULO-SKELETAL SYSTEM,410
21603931412,drug_era group during day -30 through 0 days relative to index: MUSCULO-SKELETAL SYSTEM,412
21603931413,drug_era group during day 0 through 0 days relative to index: MUSCULO-SKELETAL SYSTEM,413
21603932410,drug_era group during day -365 through 0 days relative to index: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,410
21603932412,drug_era group during day -30 through 0 days relative to index: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,412
21603932413,drug_era group during day 0 through 0 days relative to index: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS,413
21603933410,"drug_era group during day -365 through 0 days relative to index: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",410
21603933412,"drug_era group during day -30 through 0 days relative to index: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",412
21603933413,"drug_era group during day 0 through 0 days relative to index: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",413
21603940410,drug_era group during day -365 through 0 days relative to index: Acetic acid derivatives and related substances,410
21603940412,drug_era group during day -30 through 0 days relative to index: Acetic acid derivatives and related substances,412
21603940413,drug_era group during day 0 through 0 days relative to index: Acetic acid derivatives and related substances,413
21603960410,drug_era group during day -365 through 0 days relative to index: Oxicams,410
21603966410,drug_era group during day -365 through 0 days relative to index: Propionic acid derivatives,410
21603966412,drug_era group during day -30 through 0 days relative to index: Propionic acid derivatives,412
21603966413,drug_era group during day 0 through 0 days relative to index: Propionic acid derivatives,413
21604034410,drug_era group during day -365 through 0 days relative to index: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,410
21604034412,drug_era group during day -30 through 0 days relative to index: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,412
21604034413,drug_era group during day 0 through 0 days relative to index: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,413
21604035410,drug_era group during day -365 through 0 days relative to index: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,410
21604035412,drug_era group during day -30 through 0 days relative to index: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,412
21604035413,drug_era group during day 0 through 0 days relative to index: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN,413
21604036410,"drug_era group during day -365 through 0 days relative to index: Antiinflammatory preparations, non-steroids for topical use",410
21604036412,"drug_era group during day -30 through 0 days relative to index: Antiinflammatory preparations, non-steroids for topical use",412
21604036413,"drug_era group during day 0 through 0 days relative to index: Antiinflammatory preparations, non-steroids for topical use",413
21604069410,drug_era group during day -365 through 0 days relative to index: MUSCLE RELAXANTS,410
21604069412,drug_era group during day -30 through 0 days relative to index: MUSCLE RELAXANTS,412
21604070410,"drug_era group during day -365 through 0 days relative to index: MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",410
21604070412,"drug_era group during day -30 through 0 days relative to index: MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",412
21604077410,drug_era group during day -365 through 0 days relative to index: Other quaternary ammonium compounds,410
21604077412,drug_era group during day -30 through 0 days relative to index: Other quaternary ammonium compounds,412
21604091410,"drug_era group during day -365 through 0 days relative to index: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",410
21604091412,"drug_era group during day -30 through 0 days relative to index: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",412
21604114410,drug_era group during day -365 through 0 days relative to index: Other centrally acting agents,410
21604114412,drug_era group during day -30 through 0 days relative to index: Other centrally acting agents,412
21604128410,drug_era group during day -365 through 0 days relative to index: ANTIGOUT PREPARATIONS,410
21604128412,drug_era group during day -30 through 0 days relative to index: ANTIGOUT PREPARATIONS,412
21604128413,drug_era group during day 0 through 0 days relative to index: ANTIGOUT PREPARATIONS,413
21604129410,drug_era group during day -365 through 0 days relative to index: ANTIGOUT PREPARATIONS,410
21604129412,drug_era group during day -30 through 0 days relative to index: ANTIGOUT PREPARATIONS,412
21604129413,drug_era group during day 0 through 0 days relative to index: ANTIGOUT PREPARATIONS,413
21604130410,drug_era group during day -365 through 0 days relative to index: Preparations inhibiting uric acid production,410
21604130412,drug_era group during day -30 through 0 days relative to index: Preparations inhibiting uric acid production,412
21604130413,drug_era group during day 0 through 0 days relative to index: Preparations inhibiting uric acid production,413
21604146410,drug_era group during day -365 through 0 days relative to index: DRUGS FOR TREATMENT OF BONE DISEASES,410
21604147410,drug_era group during day -365 through 0 days relative to index: DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION,410
21604165410,drug_era group during day -365 through 0 days relative to index: Other drugs affecting bone structure and mineralization,410
21604170410,drug_era group during day -365 through 0 days relative to index: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,410
21604171410,drug_era group during day -365 through 0 days relative to index: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM,410
21604178410,drug_era group during day -365 through 0 days relative to index: Other drugs for disorders of the musculo-skeletal system,410
21604180410,drug_era group during day -365 through 0 days relative to index: NERVOUS SYSTEM,410
21604180412,drug_era group during day -30 through 0 days relative to index: NERVOUS SYSTEM,412
21604180413,drug_era group during day 0 through 0 days relative to index: NERVOUS SYSTEM,413
21604181410,drug_era group during day -365 through 0 days relative to index: ANESTHETICS,410
21604181412,drug_era group during day -30 through 0 days relative to index: ANESTHETICS,412
21604181413,drug_era group during day 0 through 0 days relative to index: ANESTHETICS,413
21604182410,"drug_era group during day -365 through 0 days relative to index: ANESTHETICS, GENERAL",410
21604182412,"drug_era group during day -30 through 0 days relative to index: ANESTHETICS, GENERAL",412
21604182413,"drug_era group during day 0 through 0 days relative to index: ANESTHETICS, GENERAL",413
21604200410,drug_era group during day -365 through 0 days relative to index: Opioid anesthetics,410
21604200412,drug_era group during day -30 through 0 days relative to index: Opioid anesthetics,412
21604200413,drug_era group during day 0 through 0 days relative to index: Opioid anesthetics,413
21604208410,drug_era group during day -365 through 0 days relative to index: Other general anesthetics,410
21604208412,drug_era group during day -30 through 0 days relative to index: Other general anesthetics,412
21604220410,"drug_era group during day -365 through 0 days relative to index: ANESTHETICS, LOCAL",410
21604220412,"drug_era group during day -30 through 0 days relative to index: ANESTHETICS, LOCAL",412
21604220413,"drug_era group during day 0 through 0 days relative to index: ANESTHETICS, LOCAL",413
21604228410,drug_era group during day -365 through 0 days relative to index: Amides,410
21604228412,drug_era group during day -30 through 0 days relative to index: Amides,412
21604228413,drug_era group during day 0 through 0 days relative to index: Amides,413
21604253410,drug_era group during day -365 through 0 days relative to index: ANALGESICS,410
21604253412,drug_era group during day -30 through 0 days relative to index: ANALGESICS,412
21604253413,drug_era group during day 0 through 0 days relative to index: ANALGESICS,413
21604254410,drug_era group during day -365 through 0 days relative to index: OPIOIDS,410
21604254412,drug_era group during day -30 through 0 days relative to index: OPIOIDS,412
21604254413,drug_era group during day 0 through 0 days relative to index: OPIOIDS,413
21604255410,drug_era group during day -365 through 0 days relative to index: Natural opium alkaloids,410
21604255412,drug_era group during day -30 through 0 days relative to index: Natural opium alkaloids,412
21604255413,drug_era group during day 0 through 0 days relative to index: Natural opium alkaloids,413
21604269410,drug_era group during day -365 through 0 days relative to index: Phenylpiperidine derivatives,410
21604269412,drug_era group during day -30 through 0 days relative to index: Phenylpiperidine derivatives,412
21604269413,drug_era group during day 0 through 0 days relative to index: Phenylpiperidine derivatives,413
21604286410,drug_era group during day -365 through 0 days relative to index: Oripavine derivatives,410
21604296410,drug_era group during day -365 through 0 days relative to index: Other opioids,410
21604296412,drug_era group during day -30 through 0 days relative to index: Other opioids,412
21604296413,drug_era group during day 0 through 0 days relative to index: Other opioids,413
21604303410,drug_era group during day -365 through 0 days relative to index: OTHER ANALGESICS AND ANTIPYRETICS,410
21604303412,drug_era group during day -30 through 0 days relative to index: OTHER ANALGESICS AND ANTIPYRETICS,412
21604303413,drug_era group during day 0 through 0 days relative to index: OTHER ANALGESICS AND ANTIPYRETICS,413
21604304410,drug_era group during day -365 through 0 days relative to index: Salicylic acid and derivatives,410
21604304412,drug_era group during day -30 through 0 days relative to index: Salicylic acid and derivatives,412
21604304413,drug_era group during day 0 through 0 days relative to index: Salicylic acid and derivatives,413
21604343410,drug_era group during day -365 through 0 days relative to index: Anilides,410
21604343412,drug_era group during day -30 through 0 days relative to index: Anilides,412
21604343413,drug_era group during day 0 through 0 days relative to index: Anilides,413
21604389410,drug_era group during day -365 through 0 days relative to index: ANTIEPILEPTICS,410
21604389412,drug_era group during day -30 through 0 days relative to index: ANTIEPILEPTICS,412
21604389413,drug_era group during day 0 through 0 days relative to index: ANTIEPILEPTICS,413
21604390410,drug_era group during day -365 through 0 days relative to index: ANTIEPILEPTICS,410
21604390412,drug_era group during day -30 through 0 days relative to index: ANTIEPILEPTICS,412
21604390413,drug_era group during day 0 through 0 days relative to index: ANTIEPILEPTICS,413
21604391410,drug_era group during day -365 through 0 days relative to index: Barbiturates and derivatives,410
21604391412,drug_era group during day -30 through 0 days relative to index: Barbiturates and derivatives,412
21604391413,drug_era group during day 0 through 0 days relative to index: Barbiturates and derivatives,413
21604397410,drug_era group during day -365 through 0 days relative to index: Hydantoin derivatives,410
21604414410,drug_era group during day -365 through 0 days relative to index: Benzodiazepine derivatives,410
21604416410,drug_era group during day -365 through 0 days relative to index: Carboxamide derivatives,410
21604416412,drug_era group during day -30 through 0 days relative to index: Carboxamide derivatives,412
21604416413,drug_era group during day 0 through 0 days relative to index: Carboxamide derivatives,413
21604421410,drug_era group during day -365 through 0 days relative to index: Fatty acid derivatives,410
21604421412,drug_era group during day -30 through 0 days relative to index: Fatty acid derivatives,412
21604428410,drug_era group during day -365 through 0 days relative to index: Other antiepileptics,410
21604428412,drug_era group during day -30 through 0 days relative to index: Other antiepileptics,412
21604428413,drug_era group during day 0 through 0 days relative to index: Other antiepileptics,413
21604443410,drug_era group during day -365 through 0 days relative to index: ANTI-PARKINSON DRUGS,410
21604443412,drug_era group during day -30 through 0 days relative to index: ANTI-PARKINSON DRUGS,412
21604443413,drug_era group during day 0 through 0 days relative to index: ANTI-PARKINSON DRUGS,413
21604462410,drug_era group during day -365 through 0 days relative to index: DOPAMINERGIC AGENTS,410
21604462412,drug_era group during day -30 through 0 days relative to index: DOPAMINERGIC AGENTS,412
21604462413,drug_era group during day 0 through 0 days relative to index: DOPAMINERGIC AGENTS,413
21604463410,drug_era group during day -365 through 0 days relative to index: Dopa and dopa derivatives,410
21604463412,drug_era group during day -30 through 0 days relative to index: Dopa and dopa derivatives,412
21604463413,drug_era group during day 0 through 0 days relative to index: Dopa and dopa derivatives,413
21604472410,drug_era group during day -365 through 0 days relative to index: Dopamine agonists,410
21604472412,drug_era group during day -30 through 0 days relative to index: Dopamine agonists,412
21604472413,drug_era group during day 0 through 0 days relative to index: Dopamine agonists,413
21604489410,drug_era group during day -365 through 0 days relative to index: PSYCHOLEPTICS,410
21604489412,drug_era group during day -30 through 0 days relative to index: PSYCHOLEPTICS,412
21604489413,drug_era group during day 0 through 0 days relative to index: PSYCHOLEPTICS,413
21604490410,drug_era group during day -365 through 0 days relative to index: ANTIPSYCHOTICS,410
21604490412,drug_era group during day -30 through 0 days relative to index: ANTIPSYCHOTICS,412
21604490413,drug_era group during day 0 through 0 days relative to index: ANTIPSYCHOTICS,413
21604491410,drug_era group during day -365 through 0 days relative to index: Phenothiazines with aliphatic side-chain,410
21604491412,drug_era group during day -30 through 0 days relative to index: Phenothiazines with aliphatic side-chain,412
21604491413,drug_era group during day 0 through 0 days relative to index: Phenothiazines with aliphatic side-chain,413
21604515410,drug_era group during day -365 through 0 days relative to index: Butyrophenone derivatives,410
21604515412,drug_era group during day -30 through 0 days relative to index: Butyrophenone derivatives,412
21604515413,drug_era group during day 0 through 0 days relative to index: Butyrophenone derivatives,413
21604540410,"drug_era group during day -365 through 0 days relative to index: Diazepines, oxazepines, thiazepines and oxepines",410
21604557410,drug_era group during day -365 through 0 days relative to index: Other antipsychotics,410
21604564410,drug_era group during day -365 through 0 days relative to index: ANXIOLYTICS,410
21604564412,drug_era group during day -30 through 0 days relative to index: ANXIOLYTICS,412
21604564413,drug_era group during day 0 through 0 days relative to index: ANXIOLYTICS,413
21604565410,drug_era group during day -365 through 0 days relative to index: Benzodiazepine derivatives,410
21604565412,drug_era group during day -30 through 0 days relative to index: Benzodiazepine derivatives,412
21604565413,drug_era group during day 0 through 0 days relative to index: Benzodiazepine derivatives,413
21604589410,drug_era group during day -365 through 0 days relative to index: Diphenylmethane derivatives,410
21604589412,drug_era group during day -30 through 0 days relative to index: Diphenylmethane derivatives,412
21604606410,drug_era group during day -365 through 0 days relative to index: HYPNOTICS AND SEDATIVES,410
21604606412,drug_era group during day -30 through 0 days relative to index: HYPNOTICS AND SEDATIVES,412
21604606413,drug_era group during day 0 through 0 days relative to index: HYPNOTICS AND SEDATIVES,413
21604635410,drug_era group during day -365 through 0 days relative to index: Benzodiazepine derivatives,410
21604635412,drug_era group during day -30 through 0 days relative to index: Benzodiazepine derivatives,412
21604653410,drug_era group during day -365 through 0 days relative to index: Benzodiazepine related drugs,410
21604653412,drug_era group during day -30 through 0 days relative to index: Benzodiazepine related drugs,412
21604653413,drug_era group during day 0 through 0 days relative to index: Benzodiazepine related drugs,413
21604658410,drug_era group during day -365 through 0 days relative to index: Melatonin receptor agonists,410
21604685410,drug_era group during day -365 through 0 days relative to index: PSYCHOANALEPTICS,410
21604685412,drug_era group during day -30 through 0 days relative to index: PSYCHOANALEPTICS,412
21604685413,drug_era group during day 0 through 0 days relative to index: PSYCHOANALEPTICS,413
21604686410,drug_era group during day -365 through 0 days relative to index: ANTIDEPRESSANTS,410
21604686412,drug_era group during day -30 through 0 days relative to index: ANTIDEPRESSANTS,412
21604686413,drug_era group during day 0 through 0 days relative to index: ANTIDEPRESSANTS,413
21604687410,drug_era group during day -365 through 0 days relative to index: Non-selective monoamine reuptake inhibitors,410
21604709410,drug_era group during day -365 through 0 days relative to index: Selective serotonin reuptake inhibitors,410
21604709412,drug_era group during day -30 through 0 days relative to index: Selective serotonin reuptake inhibitors,412
21604709413,drug_era group during day 0 through 0 days relative to index: Selective serotonin reuptake inhibitors,413
21604729410,drug_era group during day -365 through 0 days relative to index: Other antidepressants,410
21604729412,drug_era group during day -30 through 0 days relative to index: Other antidepressants,412
21604729413,drug_era group during day 0 through 0 days relative to index: Other antidepressants,413
21604792410,drug_era group during day -365 through 0 days relative to index: ANTI-DEMENTIA DRUGS,410
21604792412,drug_era group during day -30 through 0 days relative to index: ANTI-DEMENTIA DRUGS,412
21604792413,drug_era group during day 0 through 0 days relative to index: ANTI-DEMENTIA DRUGS,413
21604793410,drug_era group during day -365 through 0 days relative to index: Anticholinesterases,410
21604793412,drug_era group during day -30 through 0 days relative to index: Anticholinesterases,412
21604793413,drug_era group during day 0 through 0 days relative to index: Anticholinesterases,413
21604801410,drug_era group during day -365 through 0 days relative to index: OTHER NERVOUS SYSTEM DRUGS,410
21604801412,drug_era group during day -30 through 0 days relative to index: OTHER NERVOUS SYSTEM DRUGS,412
21604801413,drug_era group during day 0 through 0 days relative to index: OTHER NERVOUS SYSTEM DRUGS,413
21604802410,drug_era group during day -365 through 0 days relative to index: PARASYMPATHOMIMETICS,410
21604802412,drug_era group during day -30 through 0 days relative to index: PARASYMPATHOMIMETICS,412
21604802413,drug_era group during day 0 through 0 days relative to index: PARASYMPATHOMIMETICS,413
21604803410,drug_era group during day -365 through 0 days relative to index: Anticholinesterases,410
21604809410,drug_era group during day -365 through 0 days relative to index: Choline esters,410
21604809412,drug_era group during day -30 through 0 days relative to index: Choline esters,412
21604809413,drug_era group during day 0 through 0 days relative to index: Choline esters,413
21604816410,drug_era group during day -365 through 0 days relative to index: DRUGS USED IN ADDICTIVE DISORDERS,410
21604825410,drug_era group during day -365 through 0 days relative to index: Drugs used in opioid dependence,410
21604847410,"drug_era group during day -365 through 0 days relative to index: ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",410
21604847412,"drug_era group during day -30 through 0 days relative to index: ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",412
21604847413,"drug_era group during day 0 through 0 days relative to index: ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS",413
21604848410,drug_era group during day -365 through 0 days relative to index: ANTIPROTOZOALS,410
21604848412,drug_era group during day -30 through 0 days relative to index: ANTIPROTOZOALS,412
21604848413,drug_era group during day 0 through 0 days relative to index: ANTIPROTOZOALS,413
21604849410,drug_era group during day -365 through 0 days relative to index: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,410
21604849412,drug_era group during day -30 through 0 days relative to index: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,412
21604849413,drug_era group during day 0 through 0 days relative to index: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES,413
21604856410,drug_era group during day -365 through 0 days relative to index: Nitroimidazole derivatives,410
21604856412,drug_era group during day -30 through 0 days relative to index: Nitroimidazole derivatives,412
21604856413,drug_era group during day 0 through 0 days relative to index: Nitroimidazole derivatives,413
21604886410,drug_era group during day -365 through 0 days relative to index: ANTIMALARIALS,410
21604886412,drug_era group during day -30 through 0 days relative to index: ANTIMALARIALS,412
21604886413,drug_era group during day 0 through 0 days relative to index: ANTIMALARIALS,413
21604887410,drug_era group during day -365 through 0 days relative to index: Aminoquinolines,410
21604887412,drug_era group during day -30 through 0 days relative to index: Aminoquinolines,412
21604887413,drug_era group during day 0 through 0 days relative to index: Aminoquinolines,413
21605007410,drug_era group during day -365 through 0 days relative to index: RESPIRATORY SYSTEM,410
21605007412,drug_era group during day -30 through 0 days relative to index: RESPIRATORY SYSTEM,412
21605007413,drug_era group during day 0 through 0 days relative to index: RESPIRATORY SYSTEM,413
21605008410,drug_era group during day -365 through 0 days relative to index: NASAL PREPARATIONS,410
21605008412,drug_era group during day -30 through 0 days relative to index: NASAL PREPARATIONS,412
21605008413,drug_era group during day 0 through 0 days relative to index: NASAL PREPARATIONS,413
21605009410,drug_era group during day -365 through 0 days relative to index: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,410
21605009412,drug_era group during day -30 through 0 days relative to index: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,412
21605009413,drug_era group during day 0 through 0 days relative to index: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE,413
21605010410,"drug_era group during day -365 through 0 days relative to index: Sympathomimetics, plain",410
21605010412,"drug_era group during day -30 through 0 days relative to index: Sympathomimetics, plain",412
21605010413,"drug_era group during day 0 through 0 days relative to index: Sympathomimetics, plain",413
21605042410,drug_era group during day -365 through 0 days relative to index: Corticosteroids,410
21605042412,drug_era group during day -30 through 0 days relative to index: Corticosteroids,412
21605042413,drug_era group during day 0 through 0 days relative to index: Corticosteroids,413
21605058410,drug_era group during day -365 through 0 days relative to index: MYDRIATICS AND CYCLOPLEGICS,410
21605058412,drug_era group during day -30 through 0 days relative to index: MYDRIATICS AND CYCLOPLEGICS,412
21605058413,drug_era group during day 0 through 0 days relative to index: MYDRIATICS AND CYCLOPLEGICS,413
21605059410,drug_era group during day -365 through 0 days relative to index: Anticholinergics,410
21605059412,drug_era group during day -30 through 0 days relative to index: Anticholinergics,412
21605067410,drug_era group during day -365 through 0 days relative to index: Sympathomimetics excl. antiglaucoma preparations,410
21605067412,drug_era group during day -30 through 0 days relative to index: Sympathomimetics excl. antiglaucoma preparations,412
21605067413,drug_era group during day 0 through 0 days relative to index: Sympathomimetics excl. antiglaucoma preparations,413
21605125410,drug_era group during day -365 through 0 days relative to index: OTHER OPHTHALMOLOGICALS,410
21605125412,drug_era group during day -30 through 0 days relative to index: OTHER OPHTHALMOLOGICALS,412
21605125413,drug_era group during day 0 through 0 days relative to index: OTHER OPHTHALMOLOGICALS,413
21605126410,drug_era group during day -365 through 0 days relative to index: Other ophthalmologicals,410
21605126412,drug_era group during day -30 through 0 days relative to index: Other ophthalmologicals,412
21605126413,drug_era group during day 0 through 0 days relative to index: Other ophthalmologicals,413
21605187410,drug_era group during day -365 through 0 days relative to index: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS,410
21605187412,drug_era group during day -30 through 0 days relative to index: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS,412
21605187413,drug_era group during day 0 through 0 days relative to index: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS,413
21605199410,drug_era group during day -365 through 0 days relative to index: CORTICOSTEROIDS,410
21605199412,drug_era group during day -30 through 0 days relative to index: CORTICOSTEROIDS,412
21605199413,drug_era group during day 0 through 0 days relative to index: CORTICOSTEROIDS,413
21605200410,drug_era group during day -365 through 0 days relative to index: Corticosteroids,410
21605200412,drug_era group during day -30 through 0 days relative to index: Corticosteroids,412
21605200413,drug_era group during day 0 through 0 days relative to index: Corticosteroids,413
21605212410,drug_era group during day -365 through 0 days relative to index: VARIOUS,410
21605212412,drug_era group during day -30 through 0 days relative to index: VARIOUS,412
21605212413,drug_era group during day 0 through 0 days relative to index: VARIOUS,413
21605227410,drug_era group during day -365 through 0 days relative to index: ALL OTHER THERAPEUTIC PRODUCTS,410
21605227412,drug_era group during day -30 through 0 days relative to index: ALL OTHER THERAPEUTIC PRODUCTS,412
21605227413,drug_era group during day 0 through 0 days relative to index: ALL OTHER THERAPEUTIC PRODUCTS,413
21605228410,drug_era group during day -365 through 0 days relative to index: ALL OTHER THERAPEUTIC PRODUCTS,410
21605228412,drug_era group during day -30 through 0 days relative to index: ALL OTHER THERAPEUTIC PRODUCTS,412
21605228413,drug_era group during day 0 through 0 days relative to index: ALL OTHER THERAPEUTIC PRODUCTS,413
21605229410,drug_era group during day -365 through 0 days relative to index: Antidotes,410
21605229412,drug_era group during day -30 through 0 days relative to index: Antidotes,412
21605229413,drug_era group during day 0 through 0 days relative to index: Antidotes,413
21605268410,drug_era group during day -365 through 0 days relative to index: Detoxifying agents for antineoplastic treatment,410
21605268412,drug_era group during day -30 through 0 days relative to index: Detoxifying agents for antineoplastic treatment,412
21605268413,drug_era group during day 0 through 0 days relative to index: Detoxifying agents for antineoplastic treatment,413
21605285410,drug_era group during day -365 through 0 days relative to index: Medical gases,410
21605285412,drug_era group during day -30 through 0 days relative to index: Medical gases,412
21605285413,drug_era group during day 0 through 0 days relative to index: Medical gases,413
21605342410,drug_era group during day -365 through 0 days relative to index: GENERAL NUTRIENTS,410
21605342412,drug_era group during day -30 through 0 days relative to index: GENERAL NUTRIENTS,412
21605342413,drug_era group during day 0 through 0 days relative to index: GENERAL NUTRIENTS,413
21605348410,drug_era group during day -365 through 0 days relative to index: OTHER NUTRIENTS,410
21605348412,drug_era group during day -30 through 0 days relative to index: OTHER NUTRIENTS,412
21605348413,drug_era group during day 0 through 0 days relative to index: OTHER NUTRIENTS,413
21605351410,drug_era group during day -365 through 0 days relative to index: Carbohydrates,410
21605351412,drug_era group during day -30 through 0 days relative to index: Carbohydrates,412
21605351413,drug_era group during day 0 through 0 days relative to index: Carbohydrates,413
21605372410,drug_era group during day -365 through 0 days relative to index: CONTRAST MEDIA,410
21605372412,drug_era group during day -30 through 0 days relative to index: CONTRAST MEDIA,412
21605373410,"drug_era group during day -365 through 0 days relative to index: X-RAY CONTRAST MEDIA, IODINATED",410
21605373412,"drug_era group during day -30 through 0 days relative to index: X-RAY CONTRAST MEDIA, IODINATED",412
21605385410,"drug_era group during day -365 through 0 days relative to index: Watersoluble, nephrotropic, low osmolar X-ray contrast media",410
21605385412,"drug_era group during day -30 through 0 days relative to index: Watersoluble, nephrotropic, low osmolar X-ray contrast media",412
30003482710,measurement within normal range during day -365 through 0 days relative to index: Leukocyte esterase [Presence] in Urine by Test strip,710
30003483710,measurement above normal range during day -365 through 0 days relative to index: Leukocyte esterase [Presence] in Urine by Test strip,710
30009842710,measurement within normal range during day -365 through 0 days relative to index: Phospholipid [Mass/volume] in Serum or Plasma,710
30011231710,measurement below normal range during day -365 through 0 days relative to index: Platelet mean volume [Entitic volume] in Blood,710
30011232710,measurement within normal range during day -365 through 0 days relative to index: Platelet mean volume [Entitic volume] in Blood,710
30011233710,measurement above normal range during day -365 through 0 days relative to index: Platelet mean volume [Entitic volume] in Blood,710
30016041710,measurement below normal range during day -365 through 0 days relative to index: Monocytes [#/volume] in Blood,710
30016042710,measurement within normal range during day -365 through 0 days relative to index: Monocytes [#/volume] in Blood,710
30016043710,measurement above normal range during day -365 through 0 days relative to index: Monocytes [#/volume] in Blood,710
30020301710,measurement below normal range during day -365 through 0 days relative to index: Lymphocytes/100 leukocytes in Blood,710
30020302710,measurement within normal range during day -365 through 0 days relative to index: Lymphocytes/100 leukocytes in Blood,710
30020303710,measurement above normal range during day -365 through 0 days relative to index: Lymphocytes/100 leukocytes in Blood,710
30021731710,measurement below normal range during day -365 through 0 days relative to index: Hemoglobin [Mass/volume] in Arterial blood,710
30021732710,measurement within normal range during day -365 through 0 days relative to index: Hemoglobin [Mass/volume] in Arterial blood,710
30021733710,measurement above normal range during day -365 through 0 days relative to index: Hemoglobin [Mass/volume] in Arterial blood,710
30033381710,measurement below normal range during day -365 through 0 days relative to index: MCHC [Mass/volume],710
30033382710,measurement within normal range during day -365 through 0 days relative to index: MCHC [Mass/volume],710
30033383710,measurement above normal range during day -365 through 0 days relative to index: MCHC [Mass/volume],710
30041191710,measurement below normal range during day -365 through 0 days relative to index: Hemoglobin [Mass/volume] in Venous blood,710
30041192710,measurement within normal range during day -365 through 0 days relative to index: Hemoglobin [Mass/volume] in Venous blood,710
30063152710,measurement within normal range during day -365 through 0 days relative to index: Basophils [#/volume] in Blood,710
30063153710,measurement above normal range during day -365 through 0 days relative to index: Basophils [#/volume] in Blood,710
30065041710,measurement below normal range during day -365 through 0 days relative to index: Eosinophils/100 leukocytes in Blood,710
30065042710,measurement within normal range during day -365 through 0 days relative to index: Eosinophils/100 leukocytes in Blood,710
30065043710,measurement above normal range during day -365 through 0 days relative to index: Eosinophils/100 leukocytes in Blood,710
30074611710,measurement below normal range during day -365 through 0 days relative to index: Platelets [#/volume] in Blood,710
30074612710,measurement within normal range during day -365 through 0 days relative to index: Platelets [#/volume] in Blood,710
30074613710,measurement above normal range during day -365 through 0 days relative to index: Platelets [#/volume] in Blood,710
30076281710,measurement below normal range during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] standard in Venous blood,710
30076282710,measurement within normal range during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] standard in Venous blood,710
30076283710,measurement above normal range during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] standard in Venous blood,710
30081521710,measurement below normal range during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] in Arterial blood,710
30081522710,measurement within normal range during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] in Arterial blood,710
30081523710,measurement above normal range during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] in Arterial blood,710
30101892710,measurement within normal range during day -365 through 0 days relative to index: Epithelial cells [#/area] in Urine sediment by Microscopy high power field,710
30101893710,measurement above normal range during day -365 through 0 days relative to index: Epithelial cells [#/area] in Urine sediment by Microscopy high power field,710
30102242710,measurement within normal range during day -365 through 0 days relative to index: Large unstained cells/100 leukocytes in Blood,710
30102243710,measurement above normal range during day -365 through 0 days relative to index: Large unstained cells/100 leukocytes in Blood,710
30108131710,measurement below normal range during day -365 through 0 days relative to index: Leukocytes [#/volume] in Blood,710
30108132710,measurement within normal range during day -365 through 0 days relative to index: Leukocytes [#/volume] in Blood,710
30108133710,measurement above normal range during day -365 through 0 days relative to index: Leukocytes [#/volume] in Blood,710
30125442710,measurement within normal range during day -365 through 0 days relative to index: pH of Venous blood,710
30125443710,measurement above normal range during day -365 through 0 days relative to index: pH of Venous blood,710
30131151710,measurement below normal range during day -365 through 0 days relative to index: Eosinophils [#/volume] in Blood,710
30131152710,measurement within normal range during day -365 through 0 days relative to index: Eosinophils [#/volume] in Blood,710
30131153710,measurement above normal range during day -365 through 0 days relative to index: Eosinophils [#/volume] in Blood,710
30136501710,measurement below normal range during day -365 through 0 days relative to index: Neutrophils [#/volume] in Blood by Automated count,710
30136502710,measurement within normal range during day -365 through 0 days relative to index: Neutrophils [#/volume] in Blood by Automated count,710
30136503710,measurement above normal range during day -365 through 0 days relative to index: Neutrophils [#/volume] in Blood by Automated count,710
30142181710,measurement below normal range during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] standard in Arterial blood,710
30142182710,measurement within normal range during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] standard in Arterial blood,710
30142183710,measurement above normal range during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] standard in Arterial blood,710
30165021710,measurement below normal range during day -365 through 0 days relative to index: Oxygen saturation in Arterial blood,710
30165022710,measurement within normal range during day -365 through 0 days relative to index: Oxygen saturation in Arterial blood,710
30165023710,measurement above normal range during day -365 through 0 days relative to index: Oxygen saturation in Arterial blood,710
30175691710,measurement below normal range during day -365 through 0 days relative to index: Oxygen content in Arterial blood,710
30175692710,measurement within normal range during day -365 through 0 days relative to index: Oxygen content in Arterial blood,710
30175693710,measurement above normal range during day -365 through 0 days relative to index: Oxygen content in Arterial blood,710
30177321710,measurement below normal range during day -365 through 0 days relative to index: Neutrophils [#/volume] in Blood,710
30177322710,measurement within normal range during day -365 through 0 days relative to index: Neutrophils [#/volume] in Blood,710
30177323710,measurement above normal range during day -365 through 0 days relative to index: Neutrophils [#/volume] in Blood,710
30190691710,measurement below normal range during day -365 through 0 days relative to index: Monocytes/100 leukocytes in Blood,710
30190692710,measurement within normal range during day -365 through 0 days relative to index: Monocytes/100 leukocytes in Blood,710
30190693710,measurement above normal range during day -365 through 0 days relative to index: Monocytes/100 leukocytes in Blood,710
30191981710,measurement below normal range during day -365 through 0 days relative to index: Lymphocytes [#/volume] in Blood,710
30191982710,measurement within normal range during day -365 through 0 days relative to index: Lymphocytes [#/volume] in Blood,710
30191983710,measurement above normal range during day -365 through 0 days relative to index: Lymphocytes [#/volume] in Blood,710
30198971710,measurement below normal range during day -365 through 0 days relative to index: Erythrocyte distribution width [Ratio] by Automated count,710
30198972710,measurement within normal range during day -365 through 0 days relative to index: Erythrocyte distribution width [Ratio] by Automated count,710
30198973710,measurement above normal range during day -365 through 0 days relative to index: Erythrocyte distribution width [Ratio] by Automated count,710
30199771710,measurement below normal range during day -365 through 0 days relative to index: pH of Arterial blood,710
30199772710,measurement within normal range during day -365 through 0 days relative to index: pH of Arterial blood,710
30199773710,measurement above normal range during day -365 through 0 days relative to index: pH of Arterial blood,710
30213911710,measurement below normal range during day -365 through 0 days relative to index: Anion gap 3 in Serum or Plasma,710
30213912710,measurement within normal range during day -365 through 0 days relative to index: Anion gap 3 in Serum or Plasma,710
30214471710,measurement below normal range during day -365 through 0 days relative to index: Carbon dioxide [Partial pressure] in Venous blood,710
30214472710,measurement within normal range during day -365 through 0 days relative to index: Carbon dioxide [Partial pressure] in Venous blood,710
30214473710,measurement above normal range during day -365 through 0 days relative to index: Carbon dioxide [Partial pressure] in Venous blood,710
30220962710,measurement within normal range during day -365 through 0 days relative to index: Basophils/100 leukocytes in Blood,710
30220963710,measurement above normal range during day -365 through 0 days relative to index: Basophils/100 leukocytes in Blood,710
30222171710,measurement below normal range during day -365 through 0 days relative to index: INR in Platelet poor plasma by Coagulation assay,710
30222172710,measurement within normal range during day -365 through 0 days relative to index: INR in Platelet poor plasma by Coagulation assay,710
30222173710,measurement above normal range during day -365 through 0 days relative to index: INR in Platelet poor plasma by Coagulation assay,710
30232301710,measurement below normal range during day -365 through 0 days relative to index: Hematocrit [Volume Fraction] of Arterial blood,710
30232302710,measurement within normal range during day -365 through 0 days relative to index: Hematocrit [Volume Fraction] of Arterial blood,710
30232303710,measurement above normal range during day -365 through 0 days relative to index: Hematocrit [Volume Fraction] of Arterial blood,710
30233141710,measurement below normal range during day -365 through 0 days relative to index: Hematocrit [Volume Fraction] of Blood by Automated count,710
30233142710,measurement within normal range during day -365 through 0 days relative to index: Hematocrit [Volume Fraction] of Blood by Automated count,710
30233143710,measurement above normal range during day -365 through 0 days relative to index: Hematocrit [Volume Fraction] of Blood by Automated count,710
30239932710,measurement within normal range during day -365 through 0 days relative to index: Large unstained cells [#/volume] in Blood,710
30239933710,measurement above normal range during day -365 through 0 days relative to index: Large unstained cells [#/volume] in Blood,710
30243541710,measurement below normal range during day -365 through 0 days relative to index: Oxygen [Partial pressure] in Venous blood,710
30243542710,measurement within normal range during day -365 through 0 days relative to index: Oxygen [Partial pressure] in Venous blood,710
30243543710,measurement above normal range during day -365 through 0 days relative to index: Oxygen [Partial pressure] in Venous blood,710
30247311710,measurement below normal range during day -365 through 0 days relative to index: MCV [Entitic volume],710
30247312710,measurement within normal range during day -365 through 0 days relative to index: MCV [Entitic volume],710
30247313710,measurement above normal range during day -365 through 0 days relative to index: MCV [Entitic volume],710
30249281710,measurement below normal range during day -365 through 0 days relative to index: Oxygen saturation in Venous blood,710
30249282710,measurement within normal range during day -365 through 0 days relative to index: Oxygen saturation in Venous blood,710
30249283710,measurement above normal range during day -365 through 0 days relative to index: Oxygen saturation in Venous blood,710
30252552710,measurement within normal range during day -365 through 0 days relative to index: Bacteria [#/area] in Urine sediment by Microscopy high power field,710
30252553710,measurement above normal range during day -365 through 0 days relative to index: Bacteria [#/area] in Urine sediment by Microscopy high power field,710
30263611710,measurement below normal range during day -365 through 0 days relative to index: Erythrocytes [#/volume] in Blood,710
30263612710,measurement within normal range during day -365 through 0 days relative to index: Erythrocytes [#/volume] in Blood,710
30272731710,measurement below normal range during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] in Venous blood,710
30272732710,measurement within normal range during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] in Venous blood,710
30272733710,measurement above normal range during day -365 through 0 days relative to index: Bicarbonate [Moles/volume] in Venous blood,710
30273462710,measurement within normal range during day -365 through 0 days relative to index: Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,710
30273463710,measurement above normal range during day -365 through 0 days relative to index: Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,710
30274841710,measurement below normal range during day -365 through 0 days relative to index: Hemoglobin [Mass/volume] in Blood by calculation,710
30274842710,measurement within normal range during day -365 through 0 days relative to index: Hemoglobin [Mass/volume] in Blood by calculation,710
30274843710,measurement above normal range during day -365 through 0 days relative to index: Hemoglobin [Mass/volume] in Blood by calculation,710
30278011710,measurement below normal range during day -365 through 0 days relative to index: Oxygen [Partial pressure] in Arterial blood,710
30278012710,measurement within normal range during day -365 through 0 days relative to index: Oxygen [Partial pressure] in Arterial blood,710
30278013710,measurement above normal range during day -365 through 0 days relative to index: Oxygen [Partial pressure] in Arterial blood,710
30279461710,measurement below normal range during day -365 through 0 days relative to index: Carbon dioxide [Partial pressure] in Arterial blood,710
30279462710,measurement within normal range during day -365 through 0 days relative to index: Carbon dioxide [Partial pressure] in Arterial blood,710
30279463710,measurement above normal range during day -365 through 0 days relative to index: Carbon dioxide [Partial pressure] in Arterial blood,710
30293052710,measurement within normal range during day -365 through 0 days relative to index: pH of Urine by Automated test strip,710
30293053710,measurement above normal range during day -365 through 0 days relative to index: pH of Urine by Automated test strip,710
30312481710,measurement below normal range during day -365 through 0 days relative to index: Chloride [Moles/volume] in Arterial blood,710
30312482710,measurement within normal range during day -365 through 0 days relative to index: Chloride [Moles/volume] in Arterial blood,710
30312483710,measurement above normal range during day -365 through 0 days relative to index: Chloride [Moles/volume] in Arterial blood,710
30325672710,measurement within normal range during day -365 through 0 days relative to index: Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,710
30325673710,measurement above normal range during day -365 through 0 days relative to index: Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,710
30336581710,measurement below normal range during day -365 through 0 days relative to index: Prothrombin time (PT) actual/Normal,710
30336582710,measurement within normal range during day -365 through 0 days relative to index: Prothrombin time (PT) actual/Normal,710
30336583710,measurement above normal range during day -365 through 0 days relative to index: Prothrombin time (PT) actual/Normal,710
30344261710,measurement below normal range during day -365 through 0 days relative to index: Prothrombin time (PT),710
30344262710,measurement within normal range during day -365 through 0 days relative to index: Prothrombin time (PT),710
30344263710,measurement above normal range during day -365 through 0 days relative to index: Prothrombin time (PT),710
30349761710,measurement below normal range during day -365 through 0 days relative to index: Hematocrit [Volume Fraction] of Venous blood,710
30349762710,measurement within normal range during day -365 through 0 days relative to index: Hematocrit [Volume Fraction] of Venous blood,710
30352852710,measurement within normal range during day -365 through 0 days relative to index: Chloride [Moles/volume] in Venous blood,710
30352853710,measurement above normal range during day -365 through 0 days relative to index: Chloride [Moles/volume] in Venous blood,710
30359411710,measurement below normal range during day -365 through 0 days relative to index: MCH [Entitic mass],710
30359412710,measurement within normal range during day -365 through 0 days relative to index: MCH [Entitic mass],710
30359413710,measurement above normal range during day -365 through 0 days relative to index: MCH [Entitic mass],710
30376631710,"measurement below normal range during day -365 through 0 days relative to index: Carbon dioxide, total [Moles/volume] in Arterial blood by calculation",710
30376632710,"measurement within normal range during day -365 through 0 days relative to index: Carbon dioxide, total [Moles/volume] in Arterial blood by calculation",710
30376633710,"measurement above normal range during day -365 through 0 days relative to index: Carbon dioxide, total [Moles/volume] in Arterial blood by calculation",710
30393121710,measurement below normal range during day -365 through 0 days relative to index: Plateletocrit [Volume Fraction] in Blood,710
30393122710,measurement within normal range during day -365 through 0 days relative to index: Plateletocrit [Volume Fraction] in Blood,710
30393123710,measurement above normal range during day -365 through 0 days relative to index: Plateletocrit [Volume Fraction] in Blood,710
30394171710,measurement below normal range during day -365 through 0 days relative to index: Platelet distribution width [Ratio] in Blood,710
30394172710,measurement within normal range during day -365 through 0 days relative to index: Platelet distribution width [Ratio] in Blood,710
30394173710,measurement above normal range during day -365 through 0 days relative to index: Platelet distribution width [Ratio] in Blood,710
30399192710,measurement within normal range during day -365 through 0 days relative to index: Specific gravity of Urine by Automated test strip,710
30410962710,measurement within normal range during day -365 through 0 days relative to index: Erythrocytes [Presence] in Urine by Automated,710
30410963710,measurement above normal range during day -365 through 0 days relative to index: Erythrocytes [Presence] in Urine by Automated,710
30413541710,measurement below normal range during day -365 through 0 days relative to index: Potassium [Moles/volume] in Venous blood,710
30413542710,measurement within normal range during day -365 through 0 days relative to index: Potassium [Moles/volume] in Venous blood,710
30413543710,measurement above normal range during day -365 through 0 days relative to index: Potassium [Moles/volume] in Venous blood,710
30414731710,measurement below normal range during day -365 through 0 days relative to index: Sodium [Moles/volume] in Venous blood,710
30414732710,measurement within normal range during day -365 through 0 days relative to index: Sodium [Moles/volume] in Venous blood,710
30434091710,measurement below normal range during day -365 through 0 days relative to index: Potassium [Moles/volume] in Arterial blood,710
30434092710,measurement within normal range during day -365 through 0 days relative to index: Potassium [Moles/volume] in Arterial blood,710
30434093710,measurement above normal range during day -365 through 0 days relative to index: Potassium [Moles/volume] in Arterial blood,710
30437061710,measurement below normal range during day -365 through 0 days relative to index: Sodium [Moles/volume] in Arterial blood,710
30437062710,measurement within normal range during day -365 through 0 days relative to index: Sodium [Moles/volume] in Arterial blood,710
30437063710,measurement above normal range during day -365 through 0 days relative to index: Sodium [Moles/volume] in Arterial blood,710
30491331710,"measurement below normal range during day -365 through 0 days relative to index: Carbon dioxide, total [Moles/volume] in Venous blood by calculation",710
30491332710,"measurement within normal range during day -365 through 0 days relative to index: Carbon dioxide, total [Moles/volume] in Venous blood by calculation",710
30491333710,"measurement above normal range during day -365 through 0 days relative to index: Carbon dioxide, total [Moles/volume] in Venous blood by calculation",710
35602717410,drug_era group during day -365 through 0 days relative to index: insulin degludec,410
35602717412,drug_era group during day -30 through 0 days relative to index: insulin degludec,412
35604767410,drug_era group during day -365 through 0 days relative to index: methylephedrine,410
35604767412,drug_era group during day -30 through 0 days relative to index: methylephedrine,412
35604767413,drug_era group during day 0 through 0 days relative to index: methylephedrine,413
36303293702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Wound by Acid fast stain,702
36303293704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Wound by Acid fast stain,704
36303377702,measurement during day -365 through 0 days relative to index: Mixed cellular casts [#/area] in Urine sediment,702
36303377704,measurement during day -30 through 0 days relative to index: Mixed cellular casts [#/area] in Urine sediment,704
36303545702,measurement during day -365 through 0 days relative to index: Bacteria identified in Cerebral spinal fluid by Anaerobe culture,702
36303545704,measurement during day -30 through 0 days relative to index: Bacteria identified in Cerebral spinal fluid by Anaerobe culture,704
36303760702,measurement during day -365 through 0 days relative to index: Microscopic observation [Presence] in Pleural fluid by Acid fast stain,702
36303760704,measurement during day -30 through 0 days relative to index: Microscopic observation [Presence] in Pleural fluid by Acid fast stain,704
36303793702,measurement during day -365 through 0 days relative to index: Bacteria identified in Pleural fluid by Anaerobe culture,702
36303793704,measurement during day -30 through 0 days relative to index: Bacteria identified in Pleural fluid by Anaerobe culture,704
36304237702,measurement during day -365 through 0 days relative to index: Mycoplasma pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with probe detection,702
36304237704,measurement during day -30 through 0 days relative to index: Mycoplasma pneumoniae DNA [Presence] in Lower respiratory specimen by NAA with probe detection,704
36304372702,measurement during day -365 through 0 days relative to index: Mycobacterium tuberculosis complex rpoB gene rifAMPin resistance mutation [Presence] by Molecular method,702
36304464702,measurement during day -365 through 0 days relative to index: Human coronavirus OC43 RNA [Presence] in Upper respiratory specimen by NAA with probe detection,702
36304464704,measurement during day -30 through 0 days relative to index: Human coronavirus OC43 RNA [Presence] in Upper respiratory specimen by NAA with probe detection,704
36304467702,measurement during day -365 through 0 days relative to index: Waxy casts [#/area] in Urine sediment,702
36304467704,measurement during day -30 through 0 days relative to index: Waxy casts [#/area] in Urine sediment,704
36304548702,measurement during day -365 through 0 days relative to index: Human coronavirus NL63 RNA [Presence] in Upper respiratory specimen by NAA with probe detection,702
36304548704,measurement during day -30 through 0 days relative to index: Human coronavirus NL63 RNA [Presence] in Upper respiratory specimen by NAA with probe detection,704
36304601702,measurement during day -365 through 0 days relative to index: Human coronavirus 229E RNA [Presence] in Upper respiratory specimen by NAA with probe detection,702
36304601704,measurement during day -30 through 0 days relative to index: Human coronavirus 229E RNA [Presence] in Upper respiratory specimen by NAA with probe detection,704
36304684702,measurement during day -365 through 0 days relative to index: WBC casts [#/area] in Urine sediment,702
36304684704,measurement during day -30 through 0 days relative to index: WBC casts [#/area] in Urine sediment,704
36304849702,measurement during day -365 through 0 days relative to index: RBC casts [#/area] in Urine sediment,702
36304849704,measurement during day -30 through 0 days relative to index: RBC casts [#/area] in Urine sediment,704
36304961702,measurement during day -365 through 0 days relative to index: Human coronavirus OC43 RNA [Presence] in Lower respiratory specimen by NAA with probe detection,702
36305217702,measurement during day -365 through 0 days relative to index: Fungus identified in Pleural fluid by Culture,702
36305217704,measurement during day -30 through 0 days relative to index: Fungus identified in Pleural fluid by Culture,704
36305419702,measurement during day -365 through 0 days relative to index: Bacteria identified in Cerebral spinal fluid by Aerobe culture,702
36305419704,measurement during day -30 through 0 days relative to index: Bacteria identified in Cerebral spinal fluid by Aerobe culture,704
36305541702,measurement during day -365 through 0 days relative to index: Fungus identified in Mouth by Culture,702
36305541704,measurement during day -30 through 0 days relative to index: Fungus identified in Mouth by Culture,704
36305654702,measurement during day -365 through 0 days relative to index: Tyrosine crystals [#/area] in Urine sediment,702
36305654704,measurement during day -30 through 0 days relative to index: Tyrosine crystals [#/area] in Urine sediment,704
36305655702,measurement during day -365 through 0 days relative to index: Human bocavirus DNA [Presence] in Upper respiratory specimen by NAA with probe detection,702
36305676702,measurement during day -365 through 0 days relative to index: Human coronavirus HKU1 RNA [Presence] in Upper respiratory specimen by NAA with probe detection,702
36305689702,measurement during day -365 through 0 days relative to index: Fungus identified in Peritoneal dialysis fluid by Culture,702
36305689704,measurement during day -30 through 0 days relative to index: Fungus identified in Peritoneal dialysis fluid by Culture,704
36305963702,measurement during day -365 through 0 days relative to index: Granular casts [#/area] in Urine sediment,702
36305963704,measurement during day -30 through 0 days relative to index: Granular casts [#/area] in Urine sediment,704
36683531210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of colon and/or rectum,210
36683531212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of colon and/or rectum,212
36684472210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of abdomen,210
36684472212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of abdomen,212
36685860502,procedure_occurrence during day -365 through 0 days relative to index: Management of infusion pump,502
36685860504,procedure_occurrence during day -30 through 0 days relative to index: Management of infusion pump,504
36713200502,procedure_occurrence during day -365 through 0 days relative to index: CT of chest without contrast,502
36713200504,procedure_occurrence during day -30 through 0 days relative to index: CT of chest without contrast,504
36714388210,condition_era group during day -365 through 0 days relative to index: Influenza caused by seasonal influenza virus,210
36714388212,condition_era group during day -30 through 0 days relative to index: Influenza caused by seasonal influenza virus,212
36716620210,condition_era group during day -365 through 0 days relative to index: Malignant epithelial neoplasm,210
36716620212,condition_era group during day -30 through 0 days relative to index: Malignant epithelial neoplasm,212
36878639410,drug_era group during day -365 through 0 days relative to index: ivy leaf extract,410
36878639412,drug_era group during day -30 through 0 days relative to index: ivy leaf extract,412
36878639413,drug_era group during day 0 through 0 days relative to index: ivy leaf extract,413
36878696410,drug_era group during day -365 through 0 days relative to index: L-Ornithine-L-Aspartate,410
36878696412,drug_era group during day -30 through 0 days relative to index: L-Ornithine-L-Aspartate,412
36878696413,drug_era group during day 0 through 0 days relative to index: L-Ornithine-L-Aspartate,413
36878752410,drug_era group during day -365 through 0 days relative to index: smectite,410
36878752412,drug_era group during day -30 through 0 days relative to index: smectite,412
36878752413,drug_era group during day 0 through 0 days relative to index: smectite,413
36879181410,drug_era group during day -365 through 0 days relative to index: streptococcus faecalis,410
37016775210,condition_era group during day -365 through 0 days relative to index: Traumatic and/or non-traumatic injury of back,210
37016775212,condition_era group during day -30 through 0 days relative to index: Traumatic and/or non-traumatic injury of back,212
37019510702,measurement during day -365 through 0 days relative to index: Respiratory syncytial virus A RNA [Presence] in Upper respiratory specimen by NAA with probe detection,702
37019752702,measurement during day -365 through 0 days relative to index: Respiratory syncytial virus B RNA [Presence] in Upper respiratory specimen by NAA with probe detection,702
37019976702,measurement during day -365 through 0 days relative to index: Parainfluenza virus 3 RNA [Presence] in Upper respiratory specimen by NAA with probe detection,702
37019984702,measurement during day -365 through 0 days relative to index: Parainfluenza virus 4 RNA [Presence] in Upper respiratory specimen by NAA with probe detection,702
37020057702,measurement during day -365 through 0 days relative to index: Human metapneumovirus RNA [Presence] in Upper respiratory specimen by NAA with probe detection,702
37020093702,measurement during day -365 through 0 days relative to index: Adenovirus DNA [Presence] in Upper respiratory specimen by NAA with probe detection,702
37020818702,measurement during day -365 through 0 days relative to index: Yersinia enterocolitica DNA [Presence] in Stool by NAA with probe detection,702
37020881702,measurement during day -365 through 0 days relative to index: Parainfluenza virus 1 RNA [Presence] in Upper respiratory specimen by NAA with probe detection,702
37021346702,measurement during day -365 through 0 days relative to index: Parainfluenza virus 2 RNA [Presence] in Upper respiratory specimen by NAA with probe detection,702
37109313502,procedure_occurrence during day -365 through 0 days relative to index: CT of abdomen without contrast,502
37109313504,procedure_occurrence during day -30 through 0 days relative to index: CT of abdomen without contrast,504
37109569502,procedure_occurrence during day -365 through 0 days relative to index: Training in extending range of activity of daily living,502
37110208210,condition_era group during day -365 through 0 days relative to index: Lesion of genitalia,210
37110208212,condition_era group during day -30 through 0 days relative to index: Lesion of genitalia,212
37111256502,procedure_occurrence during day -365 through 0 days relative to index: PET CT FDG (fluorodeoxyglucose) imaging of base of brain to mid-thigh,502
37310281702,measurement during day -365 through 0 days relative to index: 2019 novel coronavirus not detected,702
37310281704,measurement during day -30 through 0 days relative to index: 2019 novel coronavirus not detected,704
37310458210,condition_era group during day -365 through 0 days relative to index: Metastatic malignant neoplasm of viscera,210
37310458212,condition_era group during day -30 through 0 days relative to index: Metastatic malignant neoplasm of viscera,212
37311061210,condition_era group during day -365 through 0 days relative to index: Disease caused by severe acute respiratory syndrome coronavirus 2,210
37311061212,condition_era group during day -30 through 0 days relative to index: Disease caused by severe acute respiratory syndrome coronavirus 2,212
37399728502,procedure_occurrence during day -365 through 0 days relative to index: Assessment using CDR,502
40165678410,drug_era group during day -365 through 0 days relative to index: Palm Oil,410
40165678412,drug_era group during day -30 through 0 days relative to index: Palm Oil,412
40166571410,drug_era group during day -365 through 0 days relative to index: bepotastine,410
40167569410,drug_era group during day -365 through 0 days relative to index: peramivir,410
40167569412,drug_era group during day -30 through 0 days relative to index: peramivir,412
40167569413,drug_era group during day 0 through 0 days relative to index: peramivir,413
40222444410,drug_era group during day -365 through 0 days relative to index: denosumab,410
40235485410,drug_era group during day -365 through 0 days relative to index: azilsartan,410
40239216410,drug_era group during day -365 through 0 days relative to index: Linagliptin,410
40239216412,drug_era group during day -30 through 0 days relative to index: Linagliptin,412
40239216413,drug_era group during day 0 through 0 days relative to index: Linagliptin,413
40479411802,observation during day -365 through 0 days relative to index: Suspected clinical finding,802
40479411804,observation during day -30 through 0 days relative to index: Suspected clinical finding,804
40480052602,"device_exposure during day -365 through 0 days relative to index: Tape for stabilization of intravenous catheter, device",602
40480052604,"device_exposure during day -30 through 0 days relative to index: Tape for stabilization of intravenous catheter, device",604
40480519502,procedure_occurrence during day -365 through 0 days relative to index: Intensity modulated radiation therapy,502
40480519504,procedure_occurrence during day -30 through 0 days relative to index: Intensity modulated radiation therapy,504
40480560502,procedure_occurrence during day -365 through 0 days relative to index: Single photon emission computed tomography with computed tomography cardiac stress ventriculography,502
40481420502,procedure_occurrence during day -365 through 0 days relative to index: Single photon emission computed tomography with computed tomography ventriculography at cardiac rest,502
40481910210,condition_era group during day -365 through 0 days relative to index: Neoplasm of lymphoid system structure,210
40481910212,condition_era group during day -30 through 0 days relative to index: Neoplasm of lymphoid system structure,212
40481925802,observation during day -365 through 0 days relative to index: No history of clinical finding in subject,802
40481925804,observation during day -30 through 0 days relative to index: No history of clinical finding in subject,804
40482732502,procedure_occurrence during day -365 through 0 days relative to index: Insertion of tunneled venous catheter,502
40482784210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of skeletal system,210
40482784212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of skeletal system,212
40484156210,condition_era group during day -365 through 0 days relative to index: Malignant adenomatous neoplasm,210
40484156212,condition_era group during day -30 through 0 days relative to index: Malignant adenomatous neoplasm,212
40485387210,condition_era group during day -365 through 0 days relative to index: Neoplasm of skeletal system,210
40485387212,condition_era group during day -30 through 0 days relative to index: Neoplasm of skeletal system,212
40486896210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of extrahepatic bile duct,210
40486896212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of extrahepatic bile duct,212
40488919210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of urinary organ,210
40488919212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of urinary organ,212
40488964210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of connective tissue,210
40488964212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of connective tissue,212
40489931602,device_exposure during day -365 through 0 days relative to index: Catheter stabilization device,602
40489931604,device_exposure during day -30 through 0 days relative to index: Catheter stabilization device,604
40491001210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of digestive system,210
40491001212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of digestive system,212
40491439210,condition_era group during day -365 through 0 days relative to index: Tumor of respiratory system,210
40491439212,condition_era group during day -30 through 0 days relative to index: Tumor of respiratory system,212
40492037210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of intraabdominal organ,210
40492037212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of intraabdominal organ,212
40492724502,procedure_occurrence during day -365 through 0 days relative to index: Assessment using psychotic symptom rating scale,502
40493428210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of respiratory system,210
40493428212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of respiratory system,212
40758562702,measurement during day -365 through 0 days relative to index: Immature cells/100 leukocytes in Blood,702
40758562704,measurement during day -30 through 0 days relative to index: Immature cells/100 leukocytes in Blood,704
40758731702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Pleural fluid by Cyto stain,702
40758731704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Pleural fluid by Cyto stain,704
40760844702,measurement during day -365 through 0 days relative to index: Ketones [Presence] in Urine by Automated test strip,702
40760844704,measurement during day -30 through 0 days relative to index: Ketones [Presence] in Urine by Automated test strip,704
40762485702,measurement during day -365 through 0 days relative to index: Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay,702
40762485704,measurement during day -30 through 0 days relative to index: Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay,704
40763082702,measurement during day -365 through 0 days relative to index: Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction,702
40763082704,measurement during day -30 through 0 days relative to index: Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction,704
40763084702,measurement during day -365 through 0 days relative to index: Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid by Lactate to pyruvate reaction,702
40763084704,measurement during day -30 through 0 days relative to index: Lactate dehydrogenase [Enzymatic activity/volume] in Cerebral spinal fluid by Lactate to pyruvate reaction,704
40765040702,measurement during day -365 through 0 days relative to index: 25-Hydroxyvitamin D2+25-Hydroxyvitamin D3 [Mass/volume] in Serum or Plasma,702
40765224702,measurement during day -365 through 0 days relative to index: Urobilinogen [Presence] in Urine by Automated test strip,702
40765224704,measurement during day -30 through 0 days relative to index: Urobilinogen [Presence] in Urine by Automated test strip,704
40770971702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Body fluid by KOH preparation,702
40770971704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Body fluid by KOH preparation,704
40770997702,measurement during day -365 through 0 days relative to index: Macrophages [#/volume] in Pleural fluid by Manual count,702
40770997704,measurement during day -30 through 0 days relative to index: Macrophages [#/volume] in Pleural fluid by Manual count,704
40771492702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Urine by KOH preparation,702
40771492704,measurement during day -30 through 0 days relative to index: Microscopic observation [Identifier] in Urine by KOH preparation,704
40771528702,measurement during day -365 through 0 days relative to index: Mononuclear cells atypical/100 leukocytes in Blood by Manual count,702
40771528704,measurement during day -30 through 0 days relative to index: Mononuclear cells atypical/100 leukocytes in Blood by Manual count,704
42529190702,measurement during day -365 through 0 days relative to index: Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma by Immunoassay,702
42529195702,measurement during day -365 through 0 days relative to index: Beta-2-Microglobulin [Mass/volume] in Serum or Plasma by Immunoassay,702
42529195704,measurement during day -30 through 0 days relative to index: Beta-2-Microglobulin [Mass/volume] in Serum or Plasma by Immunoassay,704
42529199702,measurement during day -365 through 0 days relative to index: Cancer Ag 125 [Units/volume] in Serum or Plasma by Immunoassay,702
42529201702,measurement during day -365 through 0 days relative to index: Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay,702
42529201704,measurement during day -30 through 0 days relative to index: Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay,704
42529202702,measurement during day -365 through 0 days relative to index: Carcinoembryonic Ag [Mass/volume] in Serum or Plasma by Immunoassay,702
42529202704,measurement during day -30 through 0 days relative to index: Carcinoembryonic Ag [Mass/volume] in Serum or Plasma by Immunoassay,704
42529205702,measurement during day -365 through 0 days relative to index: Cortisol [Mass/volume] in Serum or Plasma by Immunoassay,702
42529209702,measurement during day -365 through 0 days relative to index: Creatine kinase.MB [Mass/volume] in Serum or Plasma by Immunoassay,702
42529209704,measurement during day -30 through 0 days relative to index: Creatine kinase.MB [Mass/volume] in Serum or Plasma by Immunoassay,704
42529213702,measurement during day -365 through 0 days relative to index: Estradiol (E2) [Mass/volume] in Serum or Plasma by Immunoassay,702
42529229702,measurement during day -365 through 0 days relative to index: Prostate specific Ag [Mass/volume] in Serum or Plasma by Immunoassay,702
42529229704,measurement during day -30 through 0 days relative to index: Prostate specific Ag [Mass/volume] in Serum or Plasma by Immunoassay,704
42537748210,condition_era group during day -365 through 0 days relative to index: Acquired absence of organ,210
42537748212,condition_era group during day -30 through 0 days relative to index: Acquired absence of organ,212
42537893210,condition_era group during day -365 through 0 days relative to index: Traumatic injury of vertebral region of back,210
42537893212,condition_era group during day -30 through 0 days relative to index: Traumatic injury of vertebral region of back,212
42538857210,condition_era group during day -365 through 0 days relative to index: Subcortical dementia,210
42596177210,condition_era group during day -365 through 0 days relative to index: Mass of intestine,210
42596177212,condition_era group during day -30 through 0 days relative to index: Mass of intestine,212
42596178210,condition_era group during day -365 through 0 days relative to index: Large intestinal mass,210
42596178212,condition_era group during day -30 through 0 days relative to index: Large intestinal mass,212
42596182210,condition_era group during day -365 through 0 days relative to index: Small intestinal mass,210
42596182212,condition_era group during day -30 through 0 days relative to index: Small intestinal mass,212
42629079410,drug_era group during day -365 through 0 days relative to index: atezolizumab,410
42629079412,drug_era group during day -30 through 0 days relative to index: atezolizumab,412
42709318410,drug_era group during day -365 through 0 days relative to index: Tocopherol,410
42709318412,drug_era group during day -30 through 0 days relative to index: Tocopherol,412
42709318413,drug_era group during day 0 through 0 days relative to index: Tocopherol,413
42709921210,condition_era group during day -365 through 0 days relative to index: Hemorrhage into subdural space of neuraxis,210
42709921212,condition_era group during day -30 through 0 days relative to index: Hemorrhage into subdural space of neuraxis,212
42709988502,procedure_occurrence during day -365 through 0 days relative to index: Insertion of nontunneled central venous catheter,502
42742392502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
42742498502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
42742498504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
42869452702,measurement during day -365 through 0 days relative to index: Immature granulocytes/100 leukocytes in Blood by Automated count,702
42869452704,measurement during day -30 through 0 days relative to index: Immature granulocytes/100 leukocytes in Blood by Automated count,704
42870368702,measurement during day -365 through 0 days relative to index: Campylobacter sp DNA.diarrheagenic [Presence] in Stool by NAA with probe detection,702
42873007210,condition_era group during day -365 through 0 days relative to index: Closed injury of head,210
42873007212,condition_era group during day -30 through 0 days relative to index: Closed injury of head,212
42873123210,condition_era group during day -365 through 0 days relative to index: Hemorrhage of intracranial meningeal space,210
42873123212,condition_era group during day -30 through 0 days relative to index: Hemorrhage of intracranial meningeal space,212
42873124210,condition_era group during day -365 through 0 days relative to index: Hemorrhage into meningeal space of neuraxis,210
42873124212,condition_era group during day -30 through 0 days relative to index: Hemorrhage into meningeal space of neuraxis,212
42873157210,condition_era group during day -365 through 0 days relative to index: Intracranial hemorrhage following injury,210
42873157212,condition_era group during day -30 through 0 days relative to index: Intracranial hemorrhage following injury,212
42873636410,drug_era group during day -365 through 0 days relative to index: mirabegron,410
42873636412,drug_era group during day -30 through 0 days relative to index: mirabegron,412
42898363410,drug_era group during day -365 through 0 days relative to index: Artemisia argyi leaf extract,410
42898363412,drug_era group during day -30 through 0 days relative to index: Artemisia argyi leaf extract,412
42898675410,drug_era group during day -365 through 0 days relative to index: Bacillus subtilis,410
42899398410,drug_era group during day -365 through 0 days relative to index: Medium chain triglycerides,410
42899398412,drug_era group during day -30 through 0 days relative to index: Medium chain triglycerides,412
42899398413,drug_era group during day 0 through 0 days relative to index: Medium chain triglycerides,413
42899536410,drug_era group during day -365 through 0 days relative to index: Oil of garlic,410
42899557410,drug_era group during day -365 through 0 days relative to index: PERILLA FRUTESCENS SEED OIL,410
42899557412,drug_era group during day -30 through 0 days relative to index: PERILLA FRUTESCENS SEED OIL,412
42900448410,drug_era group during day -365 through 0 days relative to index: olive oil,410
42900448412,drug_era group during day -30 through 0 days relative to index: olive oil,412
42900448413,drug_era group during day 0 through 0 days relative to index: olive oil,413
42903876410,drug_era group during day -365 through 0 days relative to index: tricaprylin,410
42903876412,drug_era group during day -30 through 0 days relative to index: tricaprylin,412
43008791602,device_exposure during day -365 through 0 days relative to index: AMIRAL Injectable Solution,602
43008791604,device_exposure during day -30 through 0 days relative to index: AMIRAL Injectable Solution,604
43008796602,device_exposure during day -365 through 0 days relative to index: B-BAG Powder for Hemodialysis Solution,602
43008796604,device_exposure during day -30 through 0 days relative to index: B-BAG Powder for Hemodialysis Solution,604
43008870602,device_exposure during day -365 through 0 days relative to index: FRESOL G Hemodialysis Solution,602
43008870604,device_exposure during day -30 through 0 days relative to index: FRESOL G Hemodialysis Solution,604
43008880602,device_exposure during day -365 through 0 days relative to index: HARMONILAN Oral Suspension,602
43008880604,device_exposure during day -30 through 0 days relative to index: HARMONILAN Oral Suspension,604
43008881602,device_exposure during day -365 through 0 days relative to index: HARMONILAN Oral Suspension,602
43008881604,device_exposure during day -30 through 0 days relative to index: HARMONILAN Oral Suspension,604
43008894602,device_exposure during day -365 through 0 days relative to index: HEMO B DEX Hemodialysis Solution,602
43008894604,device_exposure during day -30 through 0 days relative to index: HEMO B DEX Hemodialysis Solution,604
43008937602,device_exposure during day -365 through 0 days relative to index: NEPHROSTERIL Injectable Solution,602
43008937604,device_exposure during day -30 through 0 days relative to index: NEPHROSTERIL Injectable Solution,604
43008954602,device_exposure during day -365 through 0 days relative to index: PRIMEN Injectable Solution,602
43008957602,device_exposure during day -365 through 0 days relative to index: PROAMIN Injectable Solution,602
43008989410,drug_era group during day -365 through 0 days relative to index: almagate,410
43008992410,drug_era group during day -365 through 0 days relative to index: biphenyl dimethyl dicarboxylate,410
43008995410,drug_era group during day -365 through 0 days relative to index: corydalis tuberÂ·pharbitis seed(5:1) 50% ethanol ext.,410
43008995412,drug_era group during day -30 through 0 days relative to index: corydalis tuberÂ·pharbitis seed(5:1) 50% ethanol ext.,412
43008995413,drug_era group during day 0 through 0 days relative to index: corydalis tuberÂ·pharbitis seed(5:1) 50% ethanol ext.,413
43009001410,drug_era group during day -365 through 0 days relative to index: fimasartan potassium,410
43009001412,drug_era group during day -30 through 0 days relative to index: fimasartan potassium,412
43009002410,drug_era group during day -365 through 0 days relative to index: irsogladine maleate,410
43009003410,drug_era group during day -365 through 0 days relative to index: lafutidine,410
43009008410,drug_era group during day -365 through 0 days relative to index: rebamipide,410
43009008412,drug_era group during day -30 through 0 days relative to index: rebamipide,412
43009009410,drug_era group during day -365 through 0 days relative to index: sultamicillin,410
43009009412,drug_era group during day -30 through 0 days relative to index: sultamicillin,412
43009009413,drug_era group during day 0 through 0 days relative to index: sultamicillin,413
43009017410,drug_era group during day -365 through 0 days relative to index: cilnidipine,410
43009019410,drug_era group during day -365 through 0 days relative to index: doxofylline,410
43009019412,drug_era group during day -30 through 0 days relative to index: doxofylline,412
43009019413,drug_era group during day 0 through 0 days relative to index: doxofylline,413
43009035410,drug_era group during day -365 through 0 days relative to index: arotinolol hydrochloride,410
43009035412,drug_era group during day -30 through 0 days relative to index: arotinolol hydrochloride,412
43009035413,drug_era group during day 0 through 0 days relative to index: arotinolol hydrochloride,413
43009053410,drug_era group during day -365 through 0 days relative to index: itopride hydrochloride,410
43009068410,drug_era group during day -365 through 0 days relative to index: sulglycotide,410
43009068412,drug_era group during day -30 through 0 days relative to index: sulglycotide,412
43009068413,drug_era group during day 0 through 0 days relative to index: sulglycotide,413
43009070410,drug_era group during day -365 through 0 days relative to index: teneligliptin,410
43009082410,drug_era group during day -365 through 0 days relative to index: cefbuperazone sodium,410
43009086410,drug_era group during day -365 through 0 days relative to index: erythropoietin,410
43009086412,drug_era group during day -30 through 0 days relative to index: erythropoietin,412
43009086413,drug_era group during day 0 through 0 days relative to index: erythropoietin,413
43009087410,drug_era group during day -365 through 0 days relative to index: flomoxef sodium,410
43009087412,drug_era group during day -30 through 0 days relative to index: flomoxef sodium,412
43009089410,drug_era group during day -365 through 0 days relative to index: gemigliptin,410
43009089412,drug_era group during day -30 through 0 days relative to index: gemigliptin,412
43009089413,drug_era group during day 0 through 0 days relative to index: gemigliptin,413
43009090410,drug_era group during day -365 through 0 days relative to index: hemocoagulase,410
43009096410,drug_era group during day -365 through 0 days relative to index: nafamostat mesilate,410
43009096412,drug_era group during day -30 through 0 days relative to index: nafamostat mesilate,412
43009096413,drug_era group during day 0 through 0 days relative to index: nafamostat mesilate,413
43009099410,drug_era group during day -365 through 0 days relative to index: ramosetron hydrochloride,410
43009099412,drug_era group during day -30 through 0 days relative to index: ramosetron hydrochloride,412
43012210410,drug_era group during day -365 through 0 days relative to index: geranylgeranylacetone,410
43012210412,drug_era group during day -30 through 0 days relative to index: geranylgeranylacetone,412
43012210413,drug_era group during day 0 through 0 days relative to index: geranylgeranylacetone,413
43012279410,drug_era group during day -365 through 0 days relative to index: maltodextrin,410
43012279412,drug_era group during day -30 through 0 days relative to index: maltodextrin,412
43525922410,drug_era group during day -365 through 0 days relative to index: Coptis chinensis root extract,410
43525922412,drug_era group during day -30 through 0 days relative to index: Coptis chinensis root extract,412
43525922413,drug_era group during day 0 through 0 days relative to index: Coptis chinensis root extract,413
43531003210,condition_era group during day -365 through 0 days relative to index: Essential tremor,210
43532539410,drug_era group during day -365 through 0 days relative to index: vilanterol,410
43532539412,drug_era group during day -30 through 0 days relative to index: vilanterol,412
43532539413,drug_era group during day 0 through 0 days relative to index: vilanterol,413
43533595702,measurement during day -365 through 0 days relative to index: Magnesium Ionized [Moles/volume] in Blood by Ion-selective membrane electrode (ISE),702
43533595704,measurement during day -30 through 0 days relative to index: Magnesium Ionized [Moles/volume] in Blood by Ion-selective membrane electrode (ISE),704
43534760410,drug_era group during day -365 through 0 days relative to index: Direct factor Xa inhibitors,410
44506785410,drug_era group during day -365 through 0 days relative to index: Caseins,410
44506785412,drug_era group during day -30 through 0 days relative to index: Caseins,412
44513978502,procedure_occurrence during day -365 through 0 days relative to index: Image controlled percutaneous drainage of abdominal abscess NEC,502
44513978504,procedure_occurrence during day -30 through 0 days relative to index: Image controlled percutaneous drainage of abdominal abscess NEC,504
44784217210,condition_era group during day -365 through 0 days relative to index: Cardiac arrhythmia,210
44784217212,condition_era group during day -30 through 0 days relative to index: Cardiac arrhythmia,212
44784283802,observation during day -365 through 0 days relative to index: Requires influenza virus vaccination,802
44785907410,drug_era group during day -365 through 0 days relative to index: umeclidinium,410
44788941502,procedure_occurrence during day -365 through 0 days relative to index: Language expression assessment,502
44789813502,procedure_occurrence during day -365 through 0 days relative to index: Percutaneous transhepatic biliary drainage single,502
44789813504,procedure_occurrence during day -30 through 0 days relative to index: Percutaneous transhepatic biliary drainage single,504
44802448502,procedure_occurrence during day -365 through 0 days relative to index: Prompting to change position,502
44802448504,procedure_occurrence during day -30 through 0 days relative to index: Prompting to change position,504
44806352502,procedure_occurrence during day -365 through 0 days relative to index: Continuous intravenous infusion of therapeutic substance,502
44806352504,procedure_occurrence during day -30 through 0 days relative to index: Continuous intravenous infusion of therapeutic substance,504
44806769502,procedure_occurrence during day -365 through 0 days relative to index: Rigid ureteroscopy,502
44806773210,condition_era group during day -365 through 0 days relative to index: Secondary malignant neoplasm of liver and intrahepatic bile duct,210
44806773212,condition_era group during day -30 through 0 days relative to index: Secondary malignant neoplasm of liver and intrahepatic bile duct,212
44816450502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
44816450504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
44816657702,measurement during day -365 through 0 days relative to index: Yeast [Presence] in Unspecified specimen by Gram stain,702
44816657704,measurement during day -30 through 0 days relative to index: Yeast [Presence] in Unspecified specimen by Gram stain,704
44817130702,measurement during day -365 through 0 days relative to index: Procalcitonin [Mass/volume] in Serum or Plasma by Immunoassay,702
44817130704,measurement during day -30 through 0 days relative to index: Procalcitonin [Mass/volume] in Serum or Plasma by Immunoassay,704
45757926602,device_exposure during day -365 through 0 days relative to index: Peripheral vascular guidewire,602
45758185602,device_exposure during day -365 through 0 days relative to index: Patient-controlled analgesia infusion pump,602
45758185604,device_exposure during day -30 through 0 days relative to index: Patient-controlled analgesia infusion pump,604
45758561602,device_exposure during day -365 through 0 days relative to index: Polyglycolic acid suture,602
45758561604,device_exposure during day -30 through 0 days relative to index: Polyglycolic acid suture,604
45758825602,device_exposure during day -365 through 0 days relative to index: Microflow infusion system,602
45758825604,device_exposure during day -30 through 0 days relative to index: Microflow infusion system,604
45758903602,"device_exposure during day -365 through 0 days relative to index: Nylon suture, monofilament",602
45758903604,"device_exposure during day -30 through 0 days relative to index: Nylon suture, monofilament",604
45758977602,device_exposure during day -365 through 0 days relative to index: Polyglactin suture,602
45758977604,device_exposure during day -30 through 0 days relative to index: Polyglactin suture,604
45759086602,device_exposure during day -365 through 0 days relative to index: Polyglyconate suture,602
45759471602,device_exposure during day -365 through 0 days relative to index: Oxygen sensor,602
45759471604,device_exposure during day -30 through 0 days relative to index: Oxygen sensor,604
45759886602,device_exposure during day -365 through 0 days relative to index: Skin stapler,602
45759886604,device_exposure during day -30 through 0 days relative to index: Skin stapler,604
45759984602,device_exposure during day -365 through 0 days relative to index: Subcutaneous injection/infusion port needle,602
45759984604,device_exposure during day -30 through 0 days relative to index: Subcutaneous injection/infusion port needle,604
45760191602,"device_exposure during day -365 through 0 days relative to index: Syringe filter, clinical",602
45760191604,"device_exposure during day -30 through 0 days relative to index: Syringe filter, clinical",604
45760363602,device_exposure during day -365 through 0 days relative to index: Suction system bottle,602
45760363604,device_exposure during day -30 through 0 days relative to index: Suction system bottle,604
45760407602,"device_exposure during day -365 through 0 days relative to index: Backflow valve, in-line, single-use",602
45761254602,device_exposure during day -365 through 0 days relative to index: Bronchial balloon catheter,602
45761254604,device_exposure during day -30 through 0 days relative to index: Bronchial balloon catheter,604
45761573602,device_exposure during day -365 through 0 days relative to index: Catheter introducer,602
45761717602,"device_exposure during day -365 through 0 days relative to index: Cerebrospinal fluid drainage kit, ventricular",602
45762626602,device_exposure during day -365 through 0 days relative to index: Intermittent venous compression system,602
45762899602,device_exposure during day -365 through 0 days relative to index: Intravenous line filter,602
45763425602,device_exposure during day -365 through 0 days relative to index: Gastrostomy tube,602
45763613210,condition_era group during day -365 through 0 days relative to index: Colonic lesion,210
45763613212,condition_era group during day -30 through 0 days relative to index: Colonic lesion,212
45763923502,procedure_occurrence during day -365 through 0 days relative to index: Assessment of psychotic and behavioral symptoms of dementia,502
45764348602,"device_exposure during day -365 through 0 days relative to index: Craniofacial fixation plate, non-bioabsorbable",602
45765044602,"device_exposure during day -365 through 0 days relative to index: Endoscopic manual linear cutting stapler, single-use",602
45765044604,"device_exposure during day -30 through 0 days relative to index: Endoscopic manual linear cutting stapler, single-use",604
45765046602,"device_exposure during day -365 through 0 days relative to index: Open-surgery manual linear stapler, single-use",602
45765046604,"device_exposure during day -30 through 0 days relative to index: Open-surgery manual linear stapler, single-use",604
45765283602,device_exposure during day -365 through 0 days relative to index: Medical image management system,602
45765283604,device_exposure during day -30 through 0 days relative to index: Medical image management system,604
45767778602,device_exposure during day -365 through 0 days relative to index: Gastrointestinal ostomy tube,602
45767867602,device_exposure during day -365 through 0 days relative to index: Enteral feeding kit,602
45768017602,device_exposure during day -365 through 0 days relative to index: Ligation clip,602
45768017604,device_exposure during day -30 through 0 days relative to index: Ligation clip,604
45768037602,device_exposure during day -365 through 0 days relative to index: Endotherapy biopsy forceps,602
45768037604,device_exposure during day -30 through 0 days relative to index: Endotherapy biopsy forceps,604
45768200602,device_exposure during day -365 through 0 days relative to index: Ventilator breathing circuit,602
45771974602,device_exposure during day -365 through 0 days relative to index: First aid gauze/bandage,602
45772120210,condition_era group during day -365 through 0 days relative to index: Gastroduodenal disorder,210
45772660602,device_exposure during day -365 through 0 days relative to index: Nebulizing system tubing set,602
45772660604,device_exposure during day -30 through 0 days relative to index: Nebulizing system tubing set,604
45773261602,"device_exposure during day -365 through 0 days relative to index: Craniofacial bone screw, non-bioabsorbable",602
45775116410,drug_era group during day -365 through 0 days relative to index: olodaterol,410
45775116412,drug_era group during day -30 through 0 days relative to index: olodaterol,412
45775571410,drug_era group during day -365 through 0 days relative to index: glycopyrronium,410
45892847410,drug_era group during day -365 through 0 days relative to index: edoxaban,410
46235753702,measurement during day -365 through 0 days relative to index: Enterovirus RNA [Presence] in Nasopharynx by NAA with probe detection,702
46257455502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
46271022210,condition_era group during day -365 through 0 days relative to index: Chronic kidney disease,210
46271022212,condition_era group during day -30 through 0 days relative to index: Chronic kidney disease,212
46273183210,condition_era group during day -365 through 0 days relative to index: Intestinal hemorrhage,210
46273183212,condition_era group during day -30 through 0 days relative to index: Intestinal hemorrhage,212
46275993410,drug_era group during day -365 through 0 days relative to index: influenza A virus (H1N1) antigen,410
46275996410,drug_era group during day -365 through 0 days relative to index: influenza A virus (H3N2) antigen,410
46275999410,drug_era group during day -365 through 0 days relative to index: influenza B virus antigen,410
3015481704,measurement during day -30 through 0 days relative to index: Prolactin [Mass/volume] in Serum or Plasma by Immunoassay,704
6003,age group: 30-34,3
7007,index month: 7,7
8003,age group: 40-44,3
9003,age group: 45-49,3
2011006,index year: 2011,6
2013006,index year: 2013,6
2015006,index year: 2015,6
74582210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of rectum,210
74582212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of rectum,212
79864210,condition_era group during day -365 through 0 days relative to index: Hematuria syndrome,210
79864212,condition_era group during day -30 through 0 days relative to index: Hematuria syndrome,212
136580210,condition_era group during day -365 through 0 days relative to index: Dehiscence of surgical wound,210
136580212,condition_era group during day -30 through 0 days relative to index: Dehiscence of surgical wound,212
192956210,condition_era group during day -365 through 0 days relative to index: Cholecystitis,210
192956212,condition_era group during day -30 through 0 days relative to index: Cholecystitis,212
193422210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of body of stomach,210
193422212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of body of stomach,212
193518210,condition_era group during day -365 through 0 days relative to index: Intestinal obstruction,210
193518212,condition_era group during day -30 through 0 days relative to index: Intestinal obstruction,212
195856210,condition_era group during day -365 through 0 days relative to index: Cholangitis,210
195856212,condition_era group during day -30 through 0 days relative to index: Cholangitis,212
196044210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of stomach,210
196044212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of stomach,212
196068212,condition_era group during day -30 through 0 days relative to index: Carcinoma in situ of male genital organ,212
196152210,condition_era group during day -365 through 0 days relative to index: Peritonitis,210
196152212,condition_era group during day -30 through 0 days relative to index: Peritonitis,212
200219210,condition_era group during day -365 through 0 days relative to index: Abdominal pain,210
200219212,condition_era group during day -30 through 0 days relative to index: Abdominal pain,212
200765210,condition_era group during day -365 through 0 days relative to index: Chronic cholecystitis,210
200765212,condition_era group during day -30 through 0 days relative to index: Chronic cholecystitis,212
200970212,condition_era group during day -30 through 0 days relative to index: Carcinoma in situ of prostate,212
318800210,condition_era group during day -365 through 0 days relative to index: Gastroesophageal reflux disease,210
318800212,condition_era group during day -30 through 0 days relative to index: Gastroesophageal reflux disease,212
321042210,condition_era group during day -365 through 0 days relative to index: Cardiac arrest,210
321042212,condition_era group during day -30 through 0 days relative to index: Cardiac arrest,212
374631210,condition_era group during day -365 through 0 days relative to index: Motor neuron disease,210
374631212,condition_era group during day -30 through 0 days relative to index: Motor neuron disease,212
376713210,condition_era group during day -365 through 0 days relative to index: Cerebral hemorrhage,210
376713212,condition_era group during day -30 through 0 days relative to index: Cerebral hemorrhage,212
377845210,condition_era group during day -365 through 0 days relative to index: Anoxic encephalopathy,210
377845212,condition_era group during day -30 through 0 days relative to index: Anoxic encephalopathy,212
432837210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of cecum,210
432837212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of cecum,212
432867210,condition_era group during day -365 through 0 days relative to index: Hyperlipidemia,210
432867212,condition_era group during day -30 through 0 days relative to index: Hyperlipidemia,212
433435212,condition_era group during day -30 through 0 days relative to index: Carcinoma in situ,212
434547210,condition_era group during day -365 through 0 days relative to index: Complication of surgical procedure,210
434547212,condition_era group during day -30 through 0 days relative to index: Complication of surgical procedure,212
436635210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of sigmoid colon,210
436635212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of sigmoid colon,212
437643802,observation during day -365 through 0 days relative to index: Abnormal gait,802
438699210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of rectosigmoid junction,210
438699212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of rectosigmoid junction,212
440448210,condition_era group during day -365 through 0 days relative to index: Appendicitis,210
440448212,condition_era group during day -30 through 0 days relative to index: Appendicitis,212
442019210,condition_era group during day -365 through 0 days relative to index: Complication of procedure,210
442019212,condition_era group during day -30 through 0 days relative to index: Complication of procedure,212
443381210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of sigmoid colon,210
443381212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of sigmoid colon,212
443387210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of stomach,210
443387212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of stomach,212
443390210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of rectum,210
443390212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of rectum,212
443391210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of cecum,210
443391212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of cecum,212
443752210,condition_era group during day -365 through 0 days relative to index: Ventricular hemorrhage,210
443752212,condition_era group during day -30 through 0 days relative to index: Ventricular hemorrhage,212
444208210,condition_era group during day -365 through 0 days relative to index: Chronic inflammatory disorder,210
444208212,condition_era group during day -30 through 0 days relative to index: Chronic inflammatory disorder,212
708298413,drug_era group during day 0 through 0 days relative to index: Midazolam,413
710062412,drug_era group during day -30 through 0 days relative to index: Amitriptyline,412
710062413,drug_era group during day 0 through 0 days relative to index: Amitriptyline,413
732893412,drug_era group during day -30 through 0 days relative to index: Bupivacaine,412
732893413,drug_era group during day 0 through 0 days relative to index: Bupivacaine,413
735951410,drug_era group during day -365 through 0 days relative to index: Riluzole,410
735951412,drug_era group during day -30 through 0 days relative to index: Riluzole,412
735951413,drug_era group during day 0 through 0 days relative to index: Riluzole,413
753626413,drug_era group during day 0 through 0 days relative to index: Propofol,413
764858210,condition_era group during day -365 through 0 days relative to index: Cecal mass,210
764858212,condition_era group during day -30 through 0 days relative to index: Cecal mass,212
765126210,condition_era group during day -365 through 0 days relative to index: Mass of vocal cord,210
765126212,condition_era group during day -30 through 0 days relative to index: Mass of vocal cord,212
766814412,drug_era group during day -30 through 0 days relative to index: quetiapine,412
798874412,drug_era group during day -30 through 0 days relative to index: Clonazepam,412
798874413,drug_era group during day 0 through 0 days relative to index: Clonazepam,413
901318413,drug_era group during day 0 through 0 days relative to index: Sodium Ascorbate,413
911354413,drug_era group during day 0 through 0 days relative to index: palonosetron,413
911486413,drug_era group during day 0 through 0 days relative to index: Glutamate,413
914335413,drug_era group during day 0 through 0 days relative to index: Atropine,413
915981410,drug_era group during day -365 through 0 days relative to index: Neomycin,410
919839410,drug_era group during day -365 through 0 days relative to index: Arnica extract,410
923645410,drug_era group during day -365 through 0 days relative to index: Omeprazole,410
923645412,drug_era group during day -30 through 0 days relative to index: Omeprazole,412
923645413,drug_era group during day 0 through 0 days relative to index: Omeprazole,413
924939410,drug_era group during day -365 through 0 days relative to index: Bisacodyl,410
924939412,drug_era group during day -30 through 0 days relative to index: Bisacodyl,412
939976410,drug_era group during day -365 through 0 days relative to index: sodium sulfate,410
939976412,drug_era group during day -30 through 0 days relative to index: sodium sulfate,412
939976413,drug_era group during day 0 through 0 days relative to index: sodium sulfate,413
959196410,drug_era group during day -365 through 0 days relative to index: Witch Hazel,410
961145413,drug_era group during day 0 through 0 days relative to index: Glycerin,413
970250412,drug_era group during day -30 through 0 days relative to index: Spironolactone,412
986417410,drug_era group during day -365 through 0 days relative to index: POLYETHYLENE GLYCOL 3350,410
986417412,drug_era group during day -30 through 0 days relative to index: POLYETHYLENE GLYCOL 3350,412
986417413,drug_era group during day 0 through 0 days relative to index: POLYETHYLENE GLYCOL 3350,413
988095413,drug_era group during day 0 through 0 days relative to index: Ursodeoxycholate,413
989482410,drug_era group during day -365 through 0 days relative to index: Dutasteride,410
989482412,drug_era group during day -30 through 0 days relative to index: Dutasteride,412
989482413,drug_era group during day 0 through 0 days relative to index: Dutasteride,413
990499413,"drug_era group during day 0 through 0 days relative to index: Sodium Phosphate, Monobasic",413
991710413,"drug_era group during day 0 through 0 days relative to index: Sodium Phosphate, Dibasic",413
991876413,drug_era group during day 0 through 0 days relative to index: Loperamide,413
1000560410,drug_era group during day -365 through 0 days relative to index: Ondansetron,410
1103006410,drug_era group during day -365 through 0 days relative to index: desloratadine,410
1103006412,drug_era group during day -30 through 0 days relative to index: desloratadine,412
1114122410,drug_era group during day -365 through 0 days relative to index: Nalbuphine,410
1116109410,drug_era group during day -365 through 0 days relative to index: Belladonna Alkaloids,410
1143374413,drug_era group during day 0 through 0 days relative to index: Ephedrine,413
1154161410,drug_era group during day -365 through 0 days relative to index: montelukast,410
1195334410,drug_era group during day -365 through 0 days relative to index: Choline,410
1195334412,drug_era group during day -30 through 0 days relative to index: Choline,412
1195334413,drug_era group during day 0 through 0 days relative to index: Choline,413
1301025410,drug_era group during day -365 through 0 days relative to index: Enoxaparin,410
1301025412,drug_era group during day -30 through 0 days relative to index: Enoxaparin,412
1301025413,drug_era group during day 0 through 0 days relative to index: Enoxaparin,413
1304850410,drug_era group during day -365 through 0 days relative to index: Filgrastim,410
1304850412,drug_era group during day -30 through 0 days relative to index: Filgrastim,412
1308290410,drug_era group during day -365 through 0 days relative to index: Vincristine,410
1309944410,drug_era group during day -365 through 0 days relative to index: Amiodarone,410
1309944412,drug_era group during day -30 through 0 days relative to index: Amiodarone,412
1309944413,drug_era group during day 0 through 0 days relative to index: Amiodarone,413
1315942410,drug_era group during day -365 through 0 days relative to index: docetaxel,410
1318137413,drug_era group during day 0 through 0 days relative to index: Nicardipine,413
1319133410,drug_era group during day -365 through 0 days relative to index: Nimodipine,410
1329241410,drug_era group during day -365 through 0 days relative to index: Bleomycin,410
1337860410,drug_era group during day -365 through 0 days relative to index: Dopamine,410
1337860412,drug_era group during day -30 through 0 days relative to index: Dopamine,412
1337860413,drug_era group during day 0 through 0 days relative to index: Dopamine,413
1343916413,drug_era group during day 0 through 0 days relative to index: Epinephrine,413
1363053410,drug_era group during day -365 through 0 days relative to index: Doxazosin,410
1378382412,drug_era group during day -30 through 0 days relative to index: Paclitaxel,412
1398677410,drug_era group during day -365 through 0 days relative to index: Echinacea angustifolia root extract,410
1398816410,drug_era group during day -365 through 0 days relative to index: Echinacea purpurea root extract,410
1707687413,drug_era group during day 0 through 0 days relative to index: Vancomycin,413
1710281410,drug_era group during day -365 through 0 days relative to index: tenofovir disoproxil,410
1710281412,drug_era group during day -30 through 0 days relative to index: tenofovir disoproxil,412
1710281413,drug_era group during day 0 through 0 days relative to index: tenofovir disoproxil,413
1711246410,drug_era group during day -365 through 0 days relative to index: entecavir,410
1711246412,drug_era group during day -30 through 0 days relative to index: entecavir,412
1711246413,drug_era group during day 0 through 0 days relative to index: entecavir,413
1756831410,drug_era group during day -365 through 0 days relative to index: darunavir,410
1756831412,drug_era group during day -30 through 0 days relative to index: darunavir,412
1756831413,drug_era group during day 0 through 0 days relative to index: darunavir,413
1777254410,drug_era group during day -365 through 0 days relative to index: Ceftizoxime,410
1777254412,drug_era group during day -30 through 0 days relative to index: Ceftizoxime,412
1777254413,drug_era group during day 0 through 0 days relative to index: Ceftizoxime,413
2000841502,procedure_occurrence during day -365 through 0 days relative to index: Endoscopic robotic assisted procedure,502
2008358502,procedure_occurrence during day -365 through 0 days relative to index: Other electric countershock of heart,502
2008358504,procedure_occurrence during day -30 through 0 days relative to index: Other electric countershock of heart,504
2109141502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2109141504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
2109234502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2109800502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2211755504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
2211794502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2213280504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
2213295502,procedure_occurrence during day -365 through 0 days relative to index: Unknown concept,502
2314018504,procedure_occurrence during day -30 through 0 days relative to index: Unknown concept,504
2614773604,"device_exposure during day -30 through 0 days relative to index: Indwelling catheter; foley type, three way for continuous irrigation, each",604
2614875604,"device_exposure during day -30 through 0 days relative to index: Surgical stockings thigh length, each",604
2749934502,"procedure_occurrence during day -365 through 0 days relative to index: Hepatobiliary System and Pancreas, Drainage",502
2749934504,"procedure_occurrence during day -30 through 0 days relative to index: Hepatobiliary System and Pancreas, Drainage",504
2787543502,"procedure_occurrence during day -365 through 0 days relative to index: Monitoring of Venous Saturation, Central, Open Approach",502
2789359504,"procedure_occurrence during day -30 through 0 days relative to index: Magnetic Resonance Imaging (MRI) of Brain using Other Contrast, Unenhanced and Enhanced",504
2789361502,procedure_occurrence during day -365 through 0 days relative to index: Magnetic Resonance Imaging (MRI) of Brain,502
2789361504,procedure_occurrence during day -30 through 0 days relative to index: Magnetic Resonance Imaging (MRI) of Brain,504
2789554502,"procedure_occurrence during day -365 through 0 days relative to index: Magnetic Resonance Imaging (MRI) of Spinal Cord using Other Contrast, Unenhanced and Enhanced",502
2789554504,"procedure_occurrence during day -30 through 0 days relative to index: Magnetic Resonance Imaging (MRI) of Spinal Cord using Other Contrast, Unenhanced and Enhanced",504
2791494502,"procedure_occurrence during day -365 through 0 days relative to index: Magnetic Resonance Imaging (MRI) of Pelvis using Other Contrast, Unenhanced and Enhanced",502
2791494504,"procedure_occurrence during day -30 through 0 days relative to index: Magnetic Resonance Imaging (MRI) of Pelvis using Other Contrast, Unenhanced and Enhanced",504
3000515702,measurement during day -365 through 0 days relative to index: Antithrombin actual/normal in Platelet poor plasma by Chromogenic method,702
3000620704,measurement during day -30 through 0 days relative to index: Complement C3 [Mass/volume] in Serum or Plasma,704
3001145702,measurement during day -365 through 0 days relative to index: Cytomegalovirus IgM Ab [Presence] in Serum or Plasma by Immunoassay,702
3004789702,measurement during day -365 through 0 days relative to index: Transferrin [Mass/volume] in Serum or Plasma,702
3004789704,measurement during day -30 through 0 days relative to index: Transferrin [Mass/volume] in Serum or Plasma,704
3005411702,measurement during day -365 through 0 days relative to index: Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma,702
3005411704,measurement during day -30 through 0 days relative to index: Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma,704
3005719704,measurement during day -30 through 0 days relative to index: IgG [Mass/volume] in Serum or Plasma,704
3006157702,measurement during day -365 through 0 days relative to index: Reagin Ab [Titer] in Cerebral spinal fluid by VDRL,702
3006157704,measurement during day -30 through 0 days relative to index: Reagin Ab [Titer] in Cerebral spinal fluid by VDRL,704
3006636702,measurement during day -365 through 0 days relative to index: Metanephrines [Mass/time] in 24 hour Urine,702
3007164704,measurement during day -30 through 0 days relative to index: IgA [Mass/volume] in Serum or Plasma,704
3008295704,measurement during day -30 through 0 days relative to index: Osmolality of Serum or Plasma,704
3009306702,measurement during day -365 through 0 days relative to index: Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,702
3009306704,measurement during day -30 through 0 days relative to index: Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma,704
3009698702,measurement during day -365 through 0 days relative to index: Epstein Barr virus capsid IgM Ab [Titer] in Serum,702
3011630704,measurement during day -30 through 0 days relative to index: Helicobacter pylori [Presence] in Stomach by urea breath test,704
3012220702,measurement during day -365 through 0 days relative to index: Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay,702
3012471704,measurement during day -30 through 0 days relative to index: Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay,704
3013742702,measurement during day -365 through 0 days relative to index: Prealbumin [Mass/volume] in Serum or Plasma,702
3014952702,measurement during day -365 through 0 days relative to index: Taenia solium larva IgG Ab [Presence] in Serum,702
3014952704,measurement during day -30 through 0 days relative to index: Taenia solium larva IgG Ab [Presence] in Serum,704
3016407704,measurement during day -30 through 0 days relative to index: Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay,704
3016426704,measurement during day -30 through 0 days relative to index: Methylmalonate [Moles/volume] in Serum or Plasma,704
3016991704,measurement during day -30 through 0 days relative to index: Thyroxine (T4) [Mass/volume] in Serum or Plasma,704
3017028704,measurement during day -30 through 0 days relative to index: Hepatitis B virus DNA [Mass/volume] (viral load) in Serum by Probe with signal amplification,704
3017766704,measurement during day -30 through 0 days relative to index: Complement C4 [Mass/volume] in Serum or Plasma,704
3020389704,measurement during day -30 through 0 days relative to index: Ova and parasites identified in Stool by Concentration,704
3020891704,measurement during day -30 through 0 days relative to index: Body temperature,704
3021236704,measurement during day -30 through 0 days relative to index: Streptolysin O Ab [Units/volume] in Serum or Plasma,704
3021614704,measurement during day -30 through 0 days relative to index: Rheumatoid factor [Units/volume] in Serum or Plasma,704
3021641702,measurement during day -365 through 0 days relative to index: Microscopic observation [Identifier] in Cerebral spinal fluid by India ink prep,702
3022914704,measurement during day -30 through 0 days relative to index: Cancer Ag 19-9 [Units/volume] in Serum or Plasma,704
3023378704,measurement during day -30 through 0 days relative to index: Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay,704
3023871702,measurement during day -365 through 0 days relative to index: Helicobacter pylori IgG Ab [Presence] in Serum or Plasma by Immunoassay,702
3023871704,measurement during day -30 through 0 days relative to index: Helicobacter pylori IgG Ab [Presence] in Serum or Plasma by Immunoassay,704
3025591702,measurement during day -365 through 0 days relative to index: Vanillylmandelate [Mass/time] in 24 hour Urine,702
3026782704,measurement during day -30 through 0 days relative to index: Osmolality of Urine,704
3027346704,measurement during day -30 through 0 days relative to index: Hepatitis B virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection,704
3028026704,measurement during day -30 through 0 days relative to index: IgM [Mass/volume] in Serum or Plasma,704
3029103704,measurement during day -30 through 0 days relative to index: Nuclear Ab [Presence] in Serum by Immunofluorescence,704
3032077704,measurement during day -30 through 0 days relative to index: Neutrophil cytoplasmic Ab [Presence] in Serum by Immunofluorescence,704
3032567704,measurement during day -30 through 0 days relative to index: Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection,704
3034212702,measurement during day -365 through 0 days relative to index: Protein Fractions [Interpretation] in Urine by Immunofixation,702
3036806704,measurement during day -30 through 0 days relative to index: Hepatitis B virus e Ab [Presence] in Serum or Plasma by Immunoassay,704
3037551702,measurement during day -365 through 0 days relative to index: Cancer Ag 125 [Units/volume] in Serum or Plasma,702
3037551704,measurement during day -30 through 0 days relative to index: Cancer Ag 125 [Units/volume] in Serum or Plasma,704
3038222702,measurement during day -365 through 0 days relative to index: Protein Fractions [Interpretation] in Serum or Plasma by Immunofixation,702
3041145702,measurement during day -365 through 0 days relative to index: Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay,702
3044620704,measurement during day -30 through 0 days relative to index: Acarboxyprothrombin [Mass/volume] in Serum or Plasma,704
3046517702,measurement during day -365 through 0 days relative to index: Herpes simplex virus 1+2 Ab [Presence] in Cerebral spinal fluid,702
4001664210,condition_era group during day -365 through 0 days relative to index: Intrahepatic bile duct carcinoma,210
4001664212,condition_era group during day -30 through 0 days relative to index: Intrahepatic bile duct carcinoma,212
4013354502,procedure_occurrence during day -365 through 0 days relative to index: Insertion of endotracheal tube,502
4013354504,procedure_occurrence during day -30 through 0 days relative to index: Insertion of endotracheal tube,504
4021434502,procedure_occurrence during day -365 through 0 days relative to index: Cystoscopic removal of ureteric stent,502
4028913502,procedure_occurrence during day -365 through 0 days relative to index: Ultrasound procedure on female genital system AND/OR pregnancy related structure,502
4028913504,procedure_occurrence during day -30 through 0 days relative to index: Ultrasound procedure on female genital system AND/OR pregnancy related structure,504
4042056210,condition_era group during day -365 through 0 days relative to index: Lipids abnormal,210
4042056212,condition_era group during day -30 through 0 days relative to index: Lipids abnormal,212
4043371212,condition_era group during day -30 through 0 days relative to index: Inflammatory disorder of digestive tract,212
4044905502,procedure_occurrence during day -365 through 0 days relative to index: Percutaneous urinary vesicostomy,502
4051221210,condition_era group during day -365 through 0 days relative to index: Increased lipid,210
4051221212,condition_era group during day -30 through 0 days relative to index: Increased lipid,212
4060499502,procedure_occurrence during day -365 through 0 days relative to index: CT of neck,502
4061010502,procedure_occurrence during day -365 through 0 days relative to index: Computerized diagnostic radiology,502
4061010504,procedure_occurrence during day -30 through 0 days relative to index: Computerized diagnostic radiology,504
4067461502,procedure_occurrence during day -365 through 0 days relative to index: Resection of segment of liver,502
4069129502,procedure_occurrence during day -365 through 0 days relative to index: Wedge resection of liver,502
4076780502,procedure_occurrence during day -365 through 0 days relative to index: Intraosseous injection,502
4076780504,procedure_occurrence during day -30 through 0 days relative to index: Intraosseous injection,504
4080549502,procedure_occurrence during day -365 through 0 days relative to index: Lumbar puncture,502
4082555602,device_exposure during day -365 through 0 days relative to index: Antithromboembolic stockings,602
4082555604,device_exposure during day -30 through 0 days relative to index: Antithromboembolic stockings,604
4082840502,procedure_occurrence during day -365 through 0 days relative to index: MRI of cervical spine,502
4082846502,procedure_occurrence during day -365 through 0 days relative to index: MRI of cerebral vessels,502
4082846504,procedure_occurrence during day -30 through 0 days relative to index: MRI of cerebral vessels,504
4085090602,device_exposure during day -365 through 0 days relative to index: Absorbable ligature,602
4086417502,procedure_occurrence during day -365 through 0 days relative to index: Maintenance of general anesthesia,502
4087647210,condition_era group during day -365 through 0 days relative to index: Rectal mass,210
4087647212,condition_era group during day -30 through 0 days relative to index: Rectal mass,212
4087970602,device_exposure during day -365 through 0 days relative to index: Ostomy belt,602
4087970604,device_exposure during day -30 through 0 days relative to index: Ostomy belt,604
4089462210,condition_era group during day -365 through 0 days relative to index: Ventricular premature complex,210
4089462212,condition_era group during day -30 through 0 days relative to index: Ventricular premature complex,212
4091901210,condition_era group during day -365 through 0 days relative to index: Aberrant premature complexes,210
4091901212,condition_era group during day -30 through 0 days relative to index: Aberrant premature complexes,212
4092980502,procedure_occurrence during day -365 through 0 days relative to index: Laryngeal stroboscopy,502
4092980504,procedure_occurrence during day -30 through 0 days relative to index: Laryngeal stroboscopy,504
4094865210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of intrahepatic gall duct,210
4094865212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of intrahepatic gall duct,212
4095320210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of body of stomach,210
4095320212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of body of stomach,212
4095392504,procedure_occurrence during day -30 through 0 days relative to index: Deep fine needle aspiration biopsy under radiologic guidance,504
4096616210,condition_era group during day -365 through 0 days relative to index: Diffuse brain injury,210
4096616212,condition_era group during day -30 through 0 days relative to index: Diffuse brain injury,212
4098784502,procedure_occurrence during day -365 through 0 days relative to index: Repetitive nerve stimulation,502
4100606210,condition_era group during day -365 through 0 days relative to index: Mass of neck,210
4100606212,condition_era group during day -30 through 0 days relative to index: Mass of neck,212
4103523504,procedure_occurrence during day -30 through 0 days relative to index: Laryngoscopy,504
4103992210,condition_era group during day -365 through 0 days relative to index: Mass of stomach,210
4103992212,condition_era group during day -30 through 0 days relative to index: Mass of stomach,212
4103995210,condition_era group during day -365 through 0 days relative to index: Lesion of rectum,210
4103995212,condition_era group during day -30 through 0 days relative to index: Lesion of rectum,212
4110185210,"condition_era group during day -365 through 0 days relative to index: Intracerebral hemorrhage, intraventricular",210
4110185212,"condition_era group during day -30 through 0 days relative to index: Intracerebral hemorrhage, intraventricular",212
4112475502,procedure_occurrence during day -365 through 0 days relative to index: Taking swab for specific organism,502
4113547210,condition_era group during day -365 through 0 days relative to index: Lesion of stomach,210
4113547212,condition_era group during day -30 through 0 days relative to index: Lesion of stomach,212
4115254210,condition_era group during day -365 through 0 days relative to index: Lesion of larynx,210
4115254212,condition_era group during day -30 through 0 days relative to index: Lesion of larynx,212
4116811210,condition_era group during day -365 through 0 days relative to index: Pain of truncal structure,210
4116811212,condition_era group during day -30 through 0 days relative to index: Pain of truncal structure,212
4117276210,condition_era group during day -365 through 0 days relative to index: Lesion of vocal cord,210
4117276212,condition_era group during day -30 through 0 days relative to index: Lesion of vocal cord,212
4117709602,device_exposure during day -365 through 0 days relative to index: Suprapubic catheter,602
4120252602,device_exposure during day -365 through 0 days relative to index: Ureteric stent,602
4129389210,condition_era group during day -365 through 0 days relative to index: Gastrointestinal obstruction,210
4129389212,condition_era group during day -30 through 0 days relative to index: Gastrointestinal obstruction,212
4129642602,device_exposure during day -365 through 0 days relative to index: Closed-circuit suction catheter,602
4129642604,device_exposure during day -30 through 0 days relative to index: Closed-circuit suction catheter,604
4129880210,condition_era group during day -365 through 0 days relative to index: Neoplasm of sigmoid colon,210
4129880212,condition_era group during day -30 through 0 days relative to index: Neoplasm of sigmoid colon,212
4130036210,condition_era group during day -365 through 0 days relative to index: Brain damage due to hypoxia,210
4130036212,condition_era group during day -30 through 0 days relative to index: Brain damage due to hypoxia,212
4130511210,condition_era group during day -365 through 0 days relative to index: Neoplasm of body of stomach,210
4130511212,condition_era group during day -30 through 0 days relative to index: Neoplasm of body of stomach,212
4130519210,condition_era group during day -365 through 0 days relative to index: Neoplasm of intrahepatic bile ducts,210
4130519212,condition_era group during day -30 through 0 days relative to index: Neoplasm of intrahepatic bile ducts,212
4130996210,condition_era group during day -365 through 0 days relative to index: Neoplasm of cecum,210
4130996212,condition_era group during day -30 through 0 days relative to index: Neoplasm of cecum,212
4131611210,condition_era group during day -365 through 0 days relative to index: Neoplasm of stomach,210
4131611212,condition_era group during day -30 through 0 days relative to index: Neoplasm of stomach,212
4131616210,condition_era group during day -365 through 0 days relative to index: Neoplasm of rectum,210
4131616212,condition_era group during day -30 through 0 days relative to index: Neoplasm of rectum,212
4131617210,condition_era group during day -365 through 0 days relative to index: Neoplasm of rectosigmoid junction,210
4131617212,condition_era group during day -30 through 0 days relative to index: Neoplasm of rectosigmoid junction,212
4133611210,condition_era group during day -365 through 0 days relative to index: Traumatic AND/OR non-traumatic brain injury,210
4133611212,condition_era group during day -30 through 0 days relative to index: Traumatic AND/OR non-traumatic brain injury,212
4134705602,device_exposure during day -365 through 0 days relative to index: Papillotome,602
4134705604,device_exposure during day -30 through 0 days relative to index: Papillotome,604
4140920502,procedure_occurrence during day -365 through 0 days relative to index: Fiberoptic endoscopic submucosal resection of lesion of colon,502
4144111210,condition_era group during day -365 through 0 days relative to index: Gastroesophageal reflux disease without esophagitis,210
4144111212,condition_era group during day -30 through 0 days relative to index: Gastroesophageal reflux disease without esophagitis,212
4144289802,observation during day -365 through 0 days relative to index: H/O: malignant neoplasm,802
4145825210,condition_era group during day -365 through 0 days relative to index: Anorectal disorder,210
4145825212,condition_era group during day -30 through 0 days relative to index: Anorectal disorder,212
4147035210,condition_era group during day -365 through 0 days relative to index: Perioperative injury,210
4147035212,condition_era group during day -30 through 0 days relative to index: Perioperative injury,212
4149922602,device_exposure during day -365 through 0 days relative to index: Armored endotracheal tube,602
4149922604,device_exposure during day -30 through 0 days relative to index: Armored endotracheal tube,604
4151121502,procedure_occurrence during day -365 through 0 days relative to index: Low anterior resection of rectum,502
4153192504,procedure_occurrence during day -30 through 0 days relative to index: Evaluation of arterial blood gas studies,504
4180792210,condition_era group during day -365 through 0 days relative to index: Malignant tumor of rectosigmoid junction,210
4180792212,condition_era group during day -30 through 0 days relative to index: Malignant tumor of rectosigmoid junction,212
4185207210,condition_era group during day -365 through 0 days relative to index: Lesion of neck,210
4185207212,condition_era group during day -30 through 0 days relative to index: Lesion of neck,212
4189586502,procedure_occurrence during day -365 through 0 days relative to index: Colposcopy,502
4194195502,"procedure_occurrence during day -365 through 0 days relative to index: Epidural injection of anesthetic substance, therapeutic, caudal, continuous",502
4200710502,procedure_occurrence during day -365 through 0 days relative to index: Arterial cannulization with cardiac output,502
4201402210,condition_era group during day -365 through 0 days relative to index: Inflammation of large intestine,210
4201402212,condition_era group during day -30 through 0 days relative to index: Inflammation of large intestine,212
4204138502,procedure_occurrence during day -365 through 0 days relative to index: Warming subject using infusion of warm intravenous fluid,502
4215650210,condition_era group during day -365 through 0 days relative to index: Chronic cholangitis,210
4215650212,condition_era group during day -30 through 0 days relative to index: Chronic cholangitis,212
4215685802,observation during day -365 through 0 days relative to index: Past history of procedure,802
4215685804,observation during day -30 through 0 days relative to index: Past history of procedure,804
4226401502,procedure_occurrence during day -365 through 0 days relative to index: Taking arterial blood pressure,502
4230167504,procedure_occurrence during day -30 through 0 days relative to index: Artificial respiration,504
4233816210,condition_era group during day -365 through 0 days relative to index: Polyp of vocal cord,210
4233816212,condition_era group during day -30 through 0 days relative to index: Polyp of vocal cord,212
4234112210,condition_era group during day -365 through 0 days relative to index: Brain injury without open intracranial wound,210
4234112212,condition_era group during day -30 through 0 days relative to index: Brain injury without open intracranial wound,212
4236024502,procedure_occurrence during day -365 through 0 days relative to index: Diagnostic radiography of lumbar spine,502
4236024504,procedure_occurrence during day -30 through 0 days relative to index: Diagnostic radiography of lumbar spine,504
4236078602,device_exposure during day -365 through 0 days relative to index: Esophageal stethoscope,602
4241033210,condition_era group during day -365 through 0 days relative to index: Acute abdomen,210
4241033212,condition_era group during day -30 through 0 days relative to index: Acute abdomen,212
4246330502,procedure_occurrence during day -365 through 0 days relative to index: Electronystagmogram,502
4248965602,device_exposure during day -365 through 0 days relative to index: Wound drainage bag,602
4248965604,device_exposure during day -30 through 0 days relative to index: Wound drainage bag,604
4249893502,procedure_occurrence during day -365 through 0 days relative to index: Colonoscopy,502
4251314502,procedure_occurrence during day -365 through 0 days relative to index: Laparoscopy,502
4252403502,procedure_occurrence during day -365 through 0 days relative to index: Optokinetic nystagmus test,502
4254766502,procedure_occurrence during day -365 through 0 days relative to index: Digital examination of rectum,502
4254766504,procedure_occurrence during day -30 through 0 days relative to index: Digital examination of rectum,504
4260263504,procedure_occurrence during day -30 through 0 days relative to index: Diffusion weighted magnetic resonance imaging,504
4264518502,"procedure_occurrence during day -365 through 0 days relative to index: Cytopathology procedure, cell block preparation",502
4294382504,procedure_occurrence during day -30 through 0 days relative to index: Esophagogastroduodenoscopy,504
4294917502,procedure_occurrence during day -365 through 0 days relative to index: Enema administration management,502
4294917504,procedure_occurrence during day -30 through 0 days relative to index: Enema administration management,504
4296919602,device_exposure during day -365 through 0 days relative to index: Polyurethane foam film dressing sterile without adhesive border 5cm x 5cm square,602
4296919604,device_exposure during day -30 through 0 days relative to index: Polyurethane foam film dressing sterile without adhesive border 5cm x 5cm square,604
4300243210,condition_era group during day -365 through 0 days relative to index: Postoperative complication,210
4300243212,condition_era group during day -30 through 0 days relative to index: Postoperative complication,212
4304943502,procedure_occurrence during day -365 through 0 days relative to index: Endoscopic retrograde cholangiopancreatography,502
4304943504,procedure_occurrence during day -30 through 0 days relative to index: Endoscopic retrograde cholangiopancreatography,504
4312604502,procedure_occurrence during day -365 through 0 days relative to index: Puncture procedure,502
4312604504,procedure_occurrence during day -30 through 0 days relative to index: Puncture procedure,504
4313723210,condition_era group during day -365 through 0 days relative to index: Polyp of larynx,210
4313723212,condition_era group during day -30 through 0 days relative to index: Polyp of larynx,212
4330519502,procedure_occurrence during day -365 through 0 days relative to index: Transcranial doppler ultrasonography,502
4337604502,procedure_occurrence during day -365 through 0 days relative to index: Single wedge excision of lung,502
4339468210,"condition_era group during day -365 through 0 days relative to index: Ear, nose and throat disorder",210
4339468212,"condition_era group during day -30 through 0 days relative to index: Ear, nose and throat disorder",212
19000537413,drug_era group during day 0 through 0 days relative to index: Threonine,413
19003201410,drug_era group during day -365 through 0 days relative to index: iodixanol,410
19003953413,drug_era group during day 0 through 0 days relative to index: Rocuronium,413
19004724413,drug_era group during day 0 through 0 days relative to index: Methionine,413
19006186413,drug_era group during day 0 through 0 days relative to index: Tryptophan,413
19006410413,drug_era group during day 0 through 0 days relative to index: Arginine,413
19006692413,drug_era group during day 0 through 0 days relative to index: Tyrosine,413
19007572413,drug_era group during day 0 through 0 days relative to index: Valine,413
19011035413,drug_era group during day 0 through 0 days relative to index: Lactate,413
19012598410,drug_era group during day -365 through 0 days relative to index: Vecuronium,410
19012598412,drug_era group during day -30 through 0 days relative to index: Vecuronium,412
19012598413,drug_era group during day 0 through 0 days relative to index: Vecuronium,413
19012686413,drug_era group during day 0 through 0 days relative to index: Aspartic Acid,413
19014035410,drug_era group during day -365 through 0 days relative to index: Nafronyl,410
19014035412,drug_era group during day -30 through 0 days relative to index: Nafronyl,412
19014035413,drug_era group during day 0 through 0 days relative to index: Nafronyl,413
19016749413,drug_era group during day 0 through 0 days relative to index: remifentanil,413
19017390410,drug_era group during day -365 through 0 days relative to index: Indigotindisulfonate,410
19020124410,drug_era group during day -365 through 0 days relative to index: BETAHISTINE,410
19027475410,drug_era group during day -365 through 0 days relative to index: potassium sulfate,410
19029393410,drug_era group during day -365 through 0 days relative to index: aceclofenac,410
19029393412,drug_era group during day -30 through 0 days relative to index: aceclofenac,412
19029393413,drug_era group during day 0 through 0 days relative to index: aceclofenac,413
19035577413,drug_era group during day 0 through 0 days relative to index: Phenylalanine,413
19036781413,drug_era group during day 0 through 0 days relative to index: Calcium Chloride,413
19037038412,drug_era group during day -30 through 0 days relative to index: Calcium Gluconate,412
19037038413,drug_era group during day 0 through 0 days relative to index: Calcium Gluconate,413
19041222410,drug_era group during day -365 through 0 days relative to index: Phloroglucinol,410
19044727413,drug_era group during day 0 through 0 days relative to index: Vitamin K 1,413
19049038410,drug_era group during day -365 through 0 days relative to index: Estriol,410
19050104410,drug_era group during day -365 through 0 days relative to index: Carnitine,410
19050104412,drug_era group during day -30 through 0 days relative to index: Carnitine,412
19050488410,drug_era group during day -365 through 0 days relative to index: Etomidate,410
19050488412,drug_era group during day -30 through 0 days relative to index: Etomidate,412
19050488413,drug_era group during day 0 through 0 days relative to index: Etomidate,413
19052489413,drug_era group during day 0 through 0 days relative to index: Alanine,413
19052736413,drug_era group during day 0 through 0 days relative to index: Proline,413
19055153410,drug_era group during day -365 through 0 days relative to index: Flumazenil,410
19055153412,drug_era group during day -30 through 0 days relative to index: Flumazenil,412
19055153413,drug_era group during day 0 through 0 days relative to index: Flumazenil,413
19058354410,drug_era group during day -365 through 0 days relative to index: Aconite,410
19060985413,drug_era group during day 0 through 0 days relative to index: Glutamine,413
19061083410,drug_era group during day -365 through 0 days relative to index: Glutathione,410
19061083412,drug_era group during day -30 through 0 days relative to index: Glutathione,412
19061083413,drug_era group during day 0 through 0 days relative to index: Glutathione,413
19063575410,drug_era group during day -365 through 0 days relative to index: esmolol,410
19063575412,drug_era group during day -30 through 0 days relative to index: esmolol,412
19063575413,drug_era group during day 0 through 0 days relative to index: esmolol,413
19066774413,drug_era group during day 0 through 0 days relative to index: Serine,413
19069104410,drug_era group during day -365 through 0 days relative to index: imidazole-2-hydroxybenzoate,410
19069149413,drug_era group during day 0 through 0 days relative to index: Histidine,413
19071836410,drug_era group during day -365 through 0 days relative to index: Calendula officinalis extract,410
19071966410,drug_era group during day -365 through 0 days relative to index: Adenine,410
19071966412,drug_era group during day -30 through 0 days relative to index: Adenine,412
19077117412,drug_era group during day -30 through 0 days relative to index: Hetastarch,412
19077117413,drug_era group during day 0 through 0 days relative to index: Hetastarch,413
19078612410,drug_era group during day -365 through 0 days relative to index: Indocyanine Green,410
19078612412,drug_era group during day -30 through 0 days relative to index: Indocyanine Green,412
19078612413,drug_era group during day 0 through 0 days relative to index: Indocyanine Green,413
19082306413,drug_era group during day 0 through 0 days relative to index: Isoleucine,413
19088571413,drug_era group during day 0 through 0 days relative to index: Leucine,413
19091701410,drug_era group during day -365 through 0 days relative to index: Liver Extract,410
19091701412,drug_era group during day -30 through 0 days relative to index: Liver Extract,412
19091701413,drug_era group during day 0 through 0 days relative to index: Liver Extract,413
19092167412,drug_era group during day -30 through 0 days relative to index: Sodium Acetate Trihydrate,412
19092167413,drug_era group during day 0 through 0 days relative to index: Sodium Acetate Trihydrate,413
19092377413,drug_era group during day 0 through 0 days relative to index: Lysine,413
19093848410,drug_era group during day -365 through 0 days relative to index: Magnesium Sulfate,410
19097664410,drug_era group during day -365 through 0 days relative to index: Citrulline,410
19100759410,drug_era group during day -365 through 0 days relative to index: tiropramide,410
21600161410,"drug_era group during day -365 through 0 days relative to index: Synthetic antispasmodics, amides with tertiary amines",410
21600174410,drug_era group during day -365 through 0 days relative to index: Other drugs for functional gastrointestinal disorders,410
21600190413,"drug_era group during day 0 through 0 days relative to index: BELLADONNA AND DERIVATIVES, PLAIN",413
21600191413,"drug_era group during day 0 through 0 days relative to index: Belladonna alkaloids, tertiary amines",413
21600248410,"drug_era group during day -365 through 0 days relative to index: ANTIARRHYTHMICS, CLASS I AND III",410
21600248412,"drug_era group during day -30 through 0 days relative to index: ANTIARRHYTHMICS, CLASS I AND III",412
21600248413,"drug_era group during day 0 through 0 days relative to index: ANTIARRHYTHMICS, CLASS I AND III",413
21600269410,"drug_era group during day -365 through 0 days relative to index: Antiarrhythmics, class III",410
21600269412,"drug_era group during day -30 through 0 days relative to index: Antiarrhythmics, class III",412
21600269413,"drug_era group during day 0 through 0 days relative to index: Antiarrhythmics, class III",413
21600381410,drug_era group during day -365 through 0 days relative to index: ANTIHYPERTENSIVES,410
21600409410,"drug_era group during day -365 through 0 days relative to index: ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",410
21600410410,drug_era group during day -365 through 0 days relative to index: Alpha-adrenoreceptor antagonists,410
21600509413,drug_era group during day 0 through 0 days relative to index: BILE AND LIVER THERAPY,413
21600510413,drug_era group during day 0 through 0 days relative to index: BILE THERAPY,413
21600511413,drug_era group during day 0 through 0 days relative to index: Bile acids and derivatives,413
21600521413,"drug_era group during day 0 through 0 days relative to index: LIVER THERAPY, LIPOTROPICS",413
21600522413,drug_era group during day 0 through 0 days relative to index: Liver therapy,413
21600537410,drug_era group during day -365 through 0 days relative to index: Contact laxatives,410
21600537412,drug_era group during day -30 through 0 days relative to index: Contact laxatives,412
21600596413,drug_era group during day 0 through 0 days relative to index: Other drugs for constipation,413
21600601413,drug_era group during day 0 through 0 days relative to index: INTESTINAL ANTIINFECTIVES,413
21600602413,drug_era group during day 0 through 0 days relative to index: Antibiotics,413
21600642413,drug_era group during day 0 through 0 days relative to index: ANTIPROPULSIVES,413
21600643413,drug_era group during day 0 through 0 days relative to index: Antipropulsives,413
21600697413,"drug_era group during day 0 through 0 days relative to index: DIGESTIVES, INCL. ENZYMES",413
21600698413,"drug_era group during day 0 through 0 days relative to index: DIGESTIVES, INCL. ENZYMES",413
21600704413,drug_era group during day 0 through 0 days relative to index: Acid preparations,413
21601032413,drug_era group during day 0 through 0 days relative to index: ANTIHEMORRHAGICS,413
21601043413,drug_era group during day 0 through 0 days relative to index: VITAMIN K AND OTHER HEMOSTATICS,413
21601044413,drug_era group during day 0 through 0 days relative to index: Vitamin K,413
21601215413,drug_era group during day 0 through 0 days relative to index: Amino acids,413
21601532412,drug_era group during day -30 through 0 days relative to index: POTASSIUM-SPARING AGENTS,412
21601533412,drug_era group during day -30 through 0 days relative to index: Aldosterone antagonists,412
21601560410,drug_era group during day -365 through 0 days relative to index: PERIPHERAL VASODILATORS,410
21601560412,drug_era group during day -30 through 0 days relative to index: PERIPHERAL VASODILATORS,412
21601560413,drug_era group during day 0 through 0 days relative to index: PERIPHERAL VASODILATORS,413
21601561410,drug_era group during day -365 through 0 days relative to index: PERIPHERAL VASODILATORS,410
21601561412,drug_era group during day -30 through 0 days relative to index: PERIPHERAL VASODILATORS,412
21601561413,drug_era group during day 0 through 0 days relative to index: PERIPHERAL VASODILATORS,413
21601587410,drug_era group during day -365 through 0 days relative to index: Other peripheral vasodilators,410
21601587412,drug_era group during day -30 through 0 days relative to index: Other peripheral vasodilators,412
21601587413,drug_era group during day 0 through 0 days relative to index: Other peripheral vasodilators,413
21601682413,"drug_era group during day 0 through 0 days relative to index: Beta blocking agents, selective",413
21602360413,drug_era group during day 0 through 0 days relative to index: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS,413
21602361413,"drug_era group during day 0 through 0 days relative to index: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS",413
21602384413,drug_era group during day 0 through 0 days relative to index: Organic acids,413
21602514410,drug_era group during day -365 through 0 days relative to index: ESTROGENS,410
21602515410,"drug_era group during day -365 through 0 days relative to index: Natural and semisynthetic estrogens, plain",410
21603159413,drug_era group during day 0 through 0 days relative to index: Nucleoside and nucleotide reverse transcriptase inhibitors,413
21603303413,drug_era group during day 0 through 0 days relative to index: Alpha- and beta-adrenoreceptor agonists,413
21603327410,drug_era group during day -365 through 0 days relative to index: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES,410
21603353410,drug_era group during day -365 through 0 days relative to index: Leukotriene receptor antagonists,410
21603553410,drug_era group during day -365 through 0 days relative to index: Antibiotics,410
21603671413,drug_era group during day 0 through 0 days relative to index: ANTIGLAUCOMA PREPARATIONS AND MIOTICS,413
21603672413,drug_era group during day 0 through 0 days relative to index: Sympathomimetics in glaucoma therapy,413
21603722412,drug_era group during day -30 through 0 days relative to index: Taxanes,412
21603728410,drug_era group during day -365 through 0 days relative to index: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES,410
21603741410,drug_era group during day -365 through 0 days relative to index: Other cytotoxic antibiotics,410
21604069413,drug_era group during day 0 through 0 days relative to index: MUSCLE RELAXANTS,413
21604070413,"drug_era group during day 0 through 0 days relative to index: MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",413
21604077413,drug_era group during day 0 through 0 days relative to index: Other quaternary ammonium compounds,413
21604208413,drug_era group during day 0 through 0 days relative to index: Other general anesthetics,413
21604288410,drug_era group during day -365 through 0 days relative to index: Morphinan derivatives,410
21604414412,drug_era group during day -30 through 0 days relative to index: Benzodiazepine derivatives,412
21604414413,drug_era group during day 0 through 0 days relative to index: Benzodiazepine derivatives,413
21604540412,"drug_era group during day -30 through 0 days relative to index: Diazepines, oxazepines, thiazepines and oxepines",412
21604635413,drug_era group during day 0 through 0 days relative to index: Benzodiazepine derivatives,413
21604687412,drug_era group during day -30 through 0 days relative to index: Non-selective monoamine reuptake inhibitors,412
21604687413,drug_era group during day 0 through 0 days relative to index: Non-selective monoamine reuptake inhibitors,413
21604831410,drug_era group during day -365 through 0 days relative to index: ANTIVERTIGO PREPARATIONS,410
21604832410,drug_era group during day -365 through 0 days relative to index: Antivertigo preparations,410
21604838410,drug_era group during day -365 through 0 days relative to index: OTHER NERVOUS SYSTEM DRUGS,410
21604838412,drug_era group during day -30 through 0 days relative to index: OTHER NERVOUS SYSTEM DRUGS,412
21604838413,drug_era group during day 0 through 0 days relative to index: OTHER NERVOUS SYSTEM DRUGS,413
21604840410,drug_era group during day -365 through 0 days relative to index: Other nervous system drugs,410
21604840412,drug_era group during day -30 through 0 days relative to index: Other nervous system drugs,412
21604840413,drug_era group during day 0 through 0 days relative to index: Other nervous system drugs,413
21605059413,drug_era group during day 0 through 0 days relative to index: Anticholinergics,413
21605291410,drug_era group during day -365 through 0 days relative to index: Other therapeutic products,410
21605291412,drug_era group during day -30 through 0 days relative to index: Other therapeutic products,412
21605291413,drug_era group during day 0 through 0 days relative to index: Other therapeutic products,413
30041193710,measurement above normal range during day -365 through 0 days relative to index: Hemoglobin [Mass/volume] in Venous blood,710
30116482710,measurement within normal range during day -365 through 0 days relative to index: Oxygen content in Venous blood,710
30124711710,measurement below normal range during day -365 through 0 days relative to index: Hemoglobin.gastrointestinal.lower [Presence] in Stool by Immunoassay,710
30170282710,measurement within normal range during day -365 through 0 days relative to index: Hepatitis B virus DNA [Mass/volume] (viral load) in Serum by Probe with signal amplification,710
30213913710,measurement above normal range during day -365 through 0 days relative to index: Anion gap 3 in Serum or Plasma,710
30263613710,measurement above normal range during day -365 through 0 days relative to index: Erythrocytes [#/volume] in Blood,710
36878929410,drug_era group during day -365 through 0 days relative to index: Homeopathic hepar sulphuris,410
37111256504,procedure_occurrence during day -30 through 0 days relative to index: PET CT FDG (fluorodeoxyglucose) imaging of base of brain to mid-thigh,504
40168303410,drug_era group during day -365 through 0 days relative to index: levoleucovorin,410
40480560504,procedure_occurrence during day -30 through 0 days relative to index: Single photon emission computed tomography with computed tomography cardiac stress ventriculography,504
40481420504,procedure_occurrence during day -30 through 0 days relative to index: Single photon emission computed tomography with computed tomography ventriculography at cardiac rest,504
40481841210,condition_era group during day -365 through 0 days relative to index: Measurement finding outside reference range,210
40481841212,condition_era group during day -30 through 0 days relative to index: Measurement finding outside reference range,212
40481902210,condition_era group during day -365 through 0 days relative to index: Malignant neoplasm of anorectum,210
40481902212,condition_era group during day -30 through 0 days relative to index: Malignant neoplasm of anorectum,212
40481977502,procedure_occurrence during day -365 through 0 days relative to index: Change of drainage collection device,502
40481977504,procedure_occurrence during day -30 through 0 days relative to index: Change of drainage collection device,504
40484935210,condition_era group during day -365 through 0 days relative to index: Measurement finding above reference range,210
40484935212,condition_era group during day -30 through 0 days relative to index: Measurement finding above reference range,212
40490929210,condition_era group during day -365 through 0 days relative to index: Primary malignant neoplasm of intrahepatic bile duct,210
40490929212,condition_era group during day -30 through 0 days relative to index: Primary malignant neoplasm of intrahepatic bile duct,212
40492969210,condition_era group during day -365 through 0 days relative to index: Intraparenchymal hemorrhage of brain,210
40492969212,condition_era group during day -30 through 0 days relative to index: Intraparenchymal hemorrhage of brain,212
40758310702,measurement during day -365 through 0 days relative to index: Human epididymis protein 4 [Moles/volume] in Serum or Plasma,702
40758310704,measurement during day -30 through 0 days relative to index: Human epididymis protein 4 [Moles/volume] in Serum or Plasma,704
40765040704,measurement during day -30 through 0 days relative to index: 25-Hydroxyvitamin D2+25-Hydroxyvitamin D3 [Mass/volume] in Serum or Plasma,704
42529199704,measurement during day -30 through 0 days relative to index: Cancer Ag 125 [Units/volume] in Serum or Plasma by Immunoassay,704
42538046210,condition_era group during day -365 through 0 days relative to index: Perioperative complication,210
42538046212,condition_era group during day -30 through 0 days relative to index: Perioperative complication,212
42538966502,procedure_occurrence during day -365 through 0 days relative to index: Doppler ultrasonography of bilateral carotid arteries,502
42538966504,procedure_occurrence during day -30 through 0 days relative to index: Doppler ultrasonography of bilateral carotid arteries,504
42709988504,procedure_occurrence during day -30 through 0 days relative to index: Insertion of nontunneled central venous catheter,504
42872565502,procedure_occurrence during day -365 through 0 days relative to index: Endoscopic ultrasonography,502
42872565504,procedure_occurrence during day -30 through 0 days relative to index: Endoscopic ultrasonography,504
42874220410,drug_era group during day -365 through 0 days relative to index: cobicistat,410
42874220412,drug_era group during day -30 through 0 days relative to index: cobicistat,412
42874220413,drug_era group during day 0 through 0 days relative to index: cobicistat,413
42899139410,drug_era group during day -365 through 0 days relative to index: Hypericum extract,410
42899367410,drug_era group during day -365 through 0 days relative to index: Matricaria chamomilla whole extract,410
42903868410,drug_era group during day -365 through 0 days relative to index: Flavin-Adenine Dinucleotide,410
42903868412,drug_era group during day -30 through 0 days relative to index: Flavin-Adenine Dinucleotide,412
42903868413,drug_era group during day 0 through 0 days relative to index: Flavin-Adenine Dinucleotide,413
42903989410,drug_era group during day -365 through 0 days relative to index: Bellis perennis extract,410
42904285410,drug_era group during day -365 through 0 days relative to index: alanylglutamine,410
43008868602,device_exposure during day -365 through 0 days relative to index: FREAMINE Injectable Solution,602
43008979602,device_exposure during day -365 through 0 days relative to index: TRAUMASTERIL Injectable Solution,602
43008992412,drug_era group during day -30 through 0 days relative to index: biphenyl dimethyl dicarboxylate,412
43009001413,drug_era group during day 0 through 0 days relative to index: fimasartan potassium,413
43009003412,drug_era group during day -30 through 0 days relative to index: lafutidine,412
43009005410,drug_era group during day -365 through 0 days relative to index: micronized purified flavonoid fraction,410
43009021410,drug_era group during day -365 through 0 days relative to index: iron acetyl transferrin,410
43009021412,drug_era group during day -30 through 0 days relative to index: iron acetyl transferrin,412
43009021413,drug_era group during day 0 through 0 days relative to index: iron acetyl transferrin,413
43009023410,drug_era group during day -365 through 0 days relative to index: levosulpiride,410
43009023412,drug_era group during day -30 through 0 days relative to index: levosulpiride,412
43009043410,drug_era group during day -365 through 0 days relative to index: camostat mesilate,410
43009043412,drug_era group during day -30 through 0 days relative to index: camostat mesilate,412
43009053412,drug_era group during day -30 through 0 days relative to index: itopride hydrochloride,412
43009088410,drug_era group during day -365 through 0 days relative to index: gabexate mesilate,410
43009088412,drug_era group during day -30 through 0 days relative to index: gabexate mesilate,412
43009088413,drug_era group during day 0 through 0 days relative to index: gabexate mesilate,413
43009090412,drug_era group during day -30 through 0 days relative to index: hemocoagulase,412
43009090413,drug_era group during day 0 through 0 days relative to index: hemocoagulase,413
43009091410,drug_era group during day -365 through 0 days relative to index: ibudilast,410
43009099413,drug_era group during day 0 through 0 days relative to index: ramosetron hydrochloride,413
43525846410,drug_era group during day -365 through 0 days relative to index: Achillea millefolium extract,410
43560392410,drug_era group during day -365 through 0 days relative to index: ferric carboxymaltose,410
44788943502,procedure_occurrence during day -365 through 0 days relative to index: Speech assessment,502
44788943504,procedure_occurrence during day -30 through 0 days relative to index: Speech assessment,504
44806598502,procedure_occurrence during day -365 through 0 days relative to index: Specimen collection by resection,502
44814448410,drug_era group during day -365 through 0 days relative to index: Symphytum officinale whole extract,410
44818489410,drug_era group during day -365 through 0 days relative to index: ramucirumab,410
44818489412,drug_era group during day -30 through 0 days relative to index: ramucirumab,412
45758967602,device_exposure during day -365 through 0 days relative to index: Polydioxanone suture,602
45759635602,"device_exposure during day -365 through 0 days relative to index: Nasal snare, single-use",602
45759692602,device_exposure during day -365 through 0 days relative to index: Ureteral dilatation/injection catheter,602
45759711602,device_exposure during day -365 through 0 days relative to index: Tissue extraction bag,602
45759711604,device_exposure during day -30 through 0 days relative to index: Tissue extraction bag,604
45760407604,"device_exposure during day -30 through 0 days relative to index: Backflow valve, in-line, single-use",604
45760468602,device_exposure during day -365 through 0 days relative to index: Warming/high-flow infusion pump,602
45761207602,"device_exposure during day -365 through 0 days relative to index: Catgut suture, chromic",602
45762077602,device_exposure during day -365 through 0 days relative to index: Endotherapy ligature loop,602
45762077604,device_exposure during day -30 through 0 days relative to index: Endotherapy ligature loop,604
45762157602,"device_exposure during day -365 through 0 days relative to index: Endotherapy guidewire, single-use",602
45762157604,"device_exposure during day -30 through 0 days relative to index: Endotherapy guidewire, single-use",604
45762223602,"device_exposure during day -365 through 0 days relative to index: Endotherapy trocar, single-use",602
45762223604,"device_exposure during day -30 through 0 days relative to index: Endotherapy trocar, single-use",604
45762899604,device_exposure during day -30 through 0 days relative to index: Intravenous line filter,604
45763231602,device_exposure during day -365 through 0 days relative to index: Laparoscopic electrosurgical scissors,602
45763258602,device_exposure during day -365 through 0 days relative to index: Laparoscopic multi-instrument access port,602
45763434602,device_exposure during day -365 through 0 days relative to index: Laparoscopic trocar,602
45764864602,device_exposure during day -365 through 0 days relative to index: Externally-anchored laparoscopic retractor,602
45766877502,procedure_occurrence during day -365 through 0 days relative to index: Vaginal care management,502
45767955602,device_exposure during day -365 through 0 days relative to index: Laparoscopic surgical procedure kit,602
45767955604,device_exposure during day -30 through 0 days relative to index: Laparoscopic surgical procedure kit,604
45767977602,device_exposure during day -365 through 0 days relative to index: Endoscopic stapler,602
45768200604,device_exposure during day -30 through 0 days relative to index: Ventilator breathing circuit,604
45768386602,device_exposure during day -365 through 0 days relative to index: Aspiration needle,602
45771219602,device_exposure during day -365 through 0 days relative to index: Intraluminal circular stapler,602
45772322602,device_exposure during day -365 through 0 days relative to index: Invasive blood pressure monitor,602
45772322604,device_exposure during day -30 through 0 days relative to index: Invasive blood pressure monitor,604
45772812602,device_exposure during day -365 through 0 days relative to index: Pancreatic stent,602
45772812604,device_exposure during day -30 through 0 days relative to index: Pancreatic stent,604
46274106502,procedure_occurrence during day -365 through 0 days relative to index: Doppler ultrasonography of artery,502
46274106504,procedure_occurrence during day -30 through 0 days relative to index: Doppler ultrasonography of artery,504
